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ABSTRACT 
A retrospective study from 1968 to 1996, of children diagnosed with posterior fossa 
brain tumours and treated at Red Cross Children's Hospital and Groote Schuur 
Hospital was carried out. The aims of the study were: 1) Describe the 
neuropsychological and quality of life outcomes after treatment with surgery, 
radiotherapy and chemotherapy: 2) Examine the relationship between the 
independent variables (age and time variables, socioeconomic status, pretreatment 
factors, tumour type, treatment and complications after treatment) and the dependent 
outcome variables using a battery of neuropsychological tests and quality of life 
measurements. A sample of 174 children was obtained from the hospital records. Of 
these 44% of the sample were deceased, 44% survived and 12% could not be traced. 
Fifty one subjects agreed to participate and were divided into three groups according 
to the type of treatment administered: Group 1 (n=12) surgery only treatment 
comprised astrocytomas ; Group 2 (n=20), surgery and radiotherapy treatment 
included astrocytomas (n=4), medulloblastomas (n=11), ependymomas (n=4) and 
brain stem glioma (n=1); Group 3 (n=19) surgery, radiotherapy and chemotherapy 
treatment were all medulloblastomas. Medical and treatment details were extracted 
form the records. Background information, developmental history, schooling, 
occupational details and current functioning were obtained from the parents and/or 
adult survivors. The mean Age-at Diagnosis was 7.6 years and the mean Years-
since-Treatment was 8.5 years. Analysis of Variance showed statistically significant 
differences between the Groups on the neuropsychological test battery in the 
domains of: attention, visuomotor integration, memory and motor functions. Group 3 
were significantly worse than the other two Groups on all the measures. Quality of 
Life outcome was not statistically different between the Groups but on all measures 
Group 3 tended to have the worst outcome (Walker Problem Behaviour Identification 
Checklist, Health Related Quality of Life, Educational Attainment, Height). Post hoc 
analysis on medulloblastoma subjects showed that verbal intelligence was 
significantly lower with increasing Years-since-Treatment. A significant difference was 
also found on prorated full scale intelligence scores between the medulloblastoma 
survivors treated with surgery and radiotherapy and those treated with additional 
chemotherapy. Overall quality of life was compromised by the treatment of 
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CHAPTER 1 
INTRODUCTION 
"And still they gaz'd and still the wonder grew, 
That one small head could carry all he knew." 
1 
Oliver Goldsmith, The Deserted Village 
Neuropsychological assessments, by their very nature are themselves a 
measurement of quality of life. Quality of life, however, defies finite 
definition and it is perhaps simplest to understand it in the overall context of 
health. According to the World Health Organization (1958) "Health is a state 
of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity". The dilemma that exists between the 
importance of the cure of the disease and the preservation of the quality of 
life in the treatment of children with posterior fossa brain tumours is an 
ongoing one which is subject to increasingly sophisticated treatment 
(Mulhern, Horowitz, Kovnar et al., 1989, Sutton, Packer, Siegel et aI., 
1989). 
The treatment of childhood brain tumours requires a multidisciplinary team 
approach. Research into the quality of life of the survivors thus needs to be 
broad enough to include the relevant treatment dimensions such as 
surgery, radiation and chemotherapy together with the pre-treatment factors 
and post-treatment complications which may arise as a result of the 
treatment. An implicit consensus reached by reviewers of research on 
radiotherapy in children is that cranial irradiation is a risk factor for impaired 
neuropsychological functioning in intellectual, visual perceptual, motor, 
memory, emotional and behavioural functions. It also results in academic 
underachievement, an increased need for special educational services in 
school and leads to subsequent employment problems (Crossen, Garwood, 
2 
Glatstein et a/., 1994; Hoppe-Hirsch, Renier, Lellouch-Tubiana et a/., 1990; 
Johnson, McCabe, Nicholson, 1994; Kun, Mulhern and Crisco,1983; 
Lannering, Marky, Lundberg et aI., 1990; LeBaron, Zeiter, Zeiter et a/., 
1988; Mostow, Byrne, Connelly et a/., 1991; Packer, Sutton, Atkins, 1989; 
Radcliffe, Packer, Atkins et a/., 1992; Ris & Noll, 1994). 
With the introduction of more refined forms of treatment in the combat of 
disease, the usual morbidity and mortality markers become inadequate. 
There is now a challge to the "new morbidity" in paediatrics, referring 
specifically to developmental, behavioural and learning disorders as well as 
social dysfunctions of children and adolescents (Rosenbaum, Cadman and 
Kirpalani, 1990). 
Medulloblastoma is the most common paediatric posterior fossa brain 
tumour, followed by low grade cerebellar astrocytoma, brain stem glioma 
and ependymoma tumours (Halperin, Constine, Tarbell et a/., 1994). The 
survival rates of different types of posterior fossa tumours indicate that 
cerebellar astrocytomas have the best prognosis followed by 
medulloblastomas, ependymomas and brain stem gliomas. With the recent 
progress in treatment, the prognosis for patients with these tumours has 
improved and now about 60% of children with medulloblastoma can expect 
to live five years longer (Jenkin, 1996 Packer, Sutton, Atkins et a/., 1989). 
Tumour type and the associated natural morbidity are interdependent 
factors when investigating the neuropsychological effects on outcome. 
Therefore an important consideration in assessing neuropsychological 
outcomes is the disparity between tumour types. Ris and Noll (1994) in an 
extensive literature review found that many researchers had not taken this 
into account and commented that it was both a function of the controversy 
surrounding the classification and the rarity of the tumours. 
The diagnosis of all brain tumours must incorporate histology findings in 
order to determine whether children are treated with surgery only, or a 
combination of surgery and adjuvant radiotherapy. Surgery only is not 
3 
usually associated with cognitive morbidity (Bordeaux, Dowell, Copeland et 
aI., 1988), nor is there clear evidence that the amount of tumour in the 
surgical resection is associated with intellectual decline (Ellenberg, 
McComb, Siegel et aI., 1987; Johnson et al., 1994; Yang, Wong, Cheng et 
al., 1997). Difficulty in the evaluation of the surgical resection comes from 
variation in surgical procedures, in the pre-treatment variables and in the 
intraoperative support and post-operative management. 
Children with posterior fossa tumours are predisposed to hydrocephalus 
because of proximity to the fourth ventricle and the cerebrospinal fluid 
pathways (Kumar, Phipps, Harkness et aI., 1996). The complications 
caused by raised intracranial pressure, due to both the tumour and the 
hydrocephalus, and the diverse policies of neurosurgical departments, 
contribute to the difficulty in interpreting the neuropsychological results. 
This difficulty is exacerbated by pre-treatment factors. The duration of the 
presenting symptoms, the extent of cerebellar and brain stem dysfunction, 
and seizure activity are not well documented in the literature. Pre-treatment 
factors may thus playa vital role in neuropsychological outcomes and it is 
difficult to isolate individual contributions to neuropsychological outcomes. 
The impact of non-methotrexate chemotherapy on the developing brain and 
subsequent cognitive functions is not clearly defined in the literature 
(Dowell, Copeland and Judd 1989; Jenkin, Greenberg, Hoffman et aI., 
1995; Packer, 1999). The majority of treatment protocols are in a 
continuous state of flux as oncologists attempt to minimize the effects of 
radiation therapy (RT) on the developing brain by revising the RT doses 
and chemotherapy protocols. The researcher is thus faced with changes in 
treatment protocols over time, which are always a potential source of bias. 
The complications following the treatment of posterior fossa tumours, such 
as transient cerebellar mutism, growth hormone deficiency, seizures and 
repeated shunt revision, are seldom mentioned in assessing the impact of 
treatment on neuropsychological outcomes. 
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With the change of emphasis to a holistic conceptualization of quality of life, 
paediatric neuropsychology needs to be defined in the broader context of 
child and adolescent development. This is an evolving process where the 
following major obstacles must be considered. 
a) The constantly changing picture of the developing child with age. 
While some generalizations can be made about the adult with a 
specific type of lesion the effects of brain tumours in children can 
vary greatly with age (Mulhern 1994; Ris and Noll, 1994; Spreen, 
Risser, Edgell, 1995; Taylor and Alden, 1997). Different 
researchers have focussed on the effect on Age-at-Diagnosis (when 
the diagnosis of the tumour was made) and subsequent 
neuropsychological outcomes (Chapman, Waber, Berstein et a/., 
1995; Dennis, Spiegler, Hetherington et a/., 1996; Ellenberg et a/., 
1987; Kimmings, Kleinlugtebeld, Casey et a/., 1995; Moore, Ater & 
Copeland, 1992; Mulhern & Kun, 1985; Nishiyama, Funakoshi, 
Izumoto et a/., 1994; Radcliffe et aI., 1992; Silber, Radcliffe, 
Peckham et aI., 1992; Sutton et a/., 1989). 
The relationship between Age-at-Diagnosis and resultant 
neuropsychological functioning is difficult to identify because of the 
variations in the definitions of "younger". Diagnosis at under three 
years old has a poor prognosis particularly when children are 
treated with radiation (Hoppe-Hirsh et a/., 1990; Johnson et a/., 
1994; Sutton et a/., 1989). In addition the potential confound 
between Age-at-Diagnosis and the interval between 
neuropsychological evaluation remains a dilemma as stated in the 
review of Ris and Noll (1994). 
The influence of the Time-since-Treatment on neuropsychological 
functioning is a possible confound as some effects may emerge late. 
Sheline (1977), describes the sequential stages of radiation reaction 
which can range from many months to several years with the peak 
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of symptoms only manifesting 6 to 24 months after cranial 
irradiation. Time-since-Treatment is thus a complex issue as some 
authors suggest progressive deterioration in FSIQ in survivors of 
brain tumours (Ellenberg et al., 1987; Hoppe-Hirsch et al., 1990; 
Hoppe-Hirsch, Brunet, Laroussinie et al., 1995; Moore, et al., 1992; 
Nishiyama et al., 1994; Packer et al., 1989; Seaver, Geyer, 
Sulzbacher et al., 1994). 
The relationship between Age-at-Diagnosis and Time-since-
Treatment is seldom addressed. Dennis, Spiegler, Hetherington et 
al., (1996), in assessing a group of medulloblastoma tumour 
survivors found that Age-at-Diagnosis and Time-since-Treatment 
contributed separately to intellectual morbidity. 
b} The interaction of the developing child within the environment. 
Socio-economic factors impact on the quality of life. These include 
the home and school environment, parental education and a number 
of psychographics which may limit or enhance recovery (Fletcher & 
Copeland, 1988; Hemp, 1989; Taylor & Alden, 1997). However, the 
crucial role of socio-economic status (SES) on long term 
neuropsychological outcomes of children with brain tumours is 
seldom addressed (Ris & Noll, 1994). 
Extensive literature reviews on children treated for brain tumours show that 
there is no distinct neuropsychological profile (Glauser & Packer, 1991; Ris 
& Noll, 1994). A pattern of deficits in attention, memory and non-verbal 
skills, but with relative preservation of language abilities, is found in patient 
populations with congenital hydrocephalus or head injury who sustain 
damage to the cerebral white matter. Fletcher and Copeland (1988), report 
the same deficit pattern in children with acute lymphoblastic leukaemia 
(ALL) treated with prophylactic cranial irradiation. Moore, et aI., (1992) 
reveal a similar pattern in children treated in infancy with cranial irradiation. 
6 
The early vulnerability hypothesis of various researchers proposes that 
widely distributed cortical and subcortical systems are important for skill 
acquisition in early life and that learning capacities in young children are 
vulnerable to brain injury (Stiles & Thai, 1993; Dall'Oglio et aI., 1993 in 
Taylor & Alden, 1997). Alternatively, treatment at a young age may limit the 
brain's capacity to develop normally or interfere with the timing of neural 
development (Jenkin, Danjoux & Greenberg, 1998). Increasing deficits over 
time may also be due to disruptions in the child's ability to interact with the 
environment at ages when these interactions are critical to further 
development (Fletcher, Levin & Landry, 1984). According to Spreen et al., 
(1995) the brain-damaged child does not reflect a simple diagnostic entity, 
but may vary from one individual to another. 
The difficulty in reaching consensus about the consequences of treatment 
for childhood brain-tumour survivors has in part, been attributed to 
variations in research methodology (Glauser & Packer, 1991; Mulhern, 
1994; Roman & Sperduto, 1995; Ris & Noll, 1994). Studies differ in terms of 
the samples, the interval at which they were followed-up, the prospective 
or retrospective design, the use of control groups, the tests used, the 
methods of statistical analysis and hence the conclusions. 
1.1. RETROSPECTIVE STUDIES 
As brain tumours are relatively rare, the majority of studies are 
retrospective. Such ex post facto studies, are frequently referred to as 
correlational studies (Brink, 1990). In this type of research there is no 
manipulation of the independent variables because the event of interest has 
already occurred. The purpose of this type of design therefore is to describe 
existing relationships between the variables and to determine the 
relationship between independent and dependent variables. Where there is 
a correlation, a change in one variable corresponds with a change in 
another variable. However the presence of a correlation does not indicate 
causation. According to Christensen (1994), a correlational approach 
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measures the variables in their natural state as the variables are not 
manipulated. If a reliable relationship is found between two variables, then 
not only can the relationship between the variables be described but one 
variable can be predicted through knowing the other. 
Advantages of retrospective designs are that: they are cost-effective and 
time-efficient, they utilize large samples from a given population, they may 
be the only feasible approach to studying rare diseases, such as paediatric 
brain tumours and they provide meaningful information about the way 
variables function in relation to one another. 
However a major disadvantage is the problem of backward contingency 
probabilities. Huge advances in science and technology can skew results. 
"the selected sample of the subjects is an unknown proportion of the 
affected population and therefore does not represent the true frequency of 
such individuals in the population." 
(Gottfried 1973, in Spreen, 1995 p, 177). 
Other potential sources of bias are incomplete or inaccurate historical 
records, attrition and selection bias. 
1.2. OB .. IECTIVES OF STUDY 
Neuropsychological assessment is part of an Oncology Clinic Programme 
for children with brain tumours being treated at Red Cross War Memorial 
and Groote Schuur Hospitals in Cape Town, South Africa. The present 
research attempts to identify which children are at risk following treatment 
for paediatric posterior fossa brain tumours, understanding the types of risk 
they face and creating a climate in which they can optimize their quality of 
life. 
The two aims of the study are: 
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• to describe the neuropsychological sequelae and quality of life of 
posterior fossa brain tumour survivors treated by means of surgery, 
radiotherapy and chemotherapy. 
• to examine the relationship between the independent variables and 
dependent outcome variables measured by a neuropsychological test 
battery and quality of life instruments. 
The independent variables are: 
• Age-at-Diagnosis, Age-at-Testing, Years-since-Treatment 
• socio economic status, demographics and psychosocial disadvantage 
• tumour type - astrocytoma, medulloblastoma, ependymoma and brain 
stem glioma 
• pretreatment factors 
• treatment, - surgery, shunt revisions, radiotherapy and chemotherapy. 
• selected post treatment complications - transient cerebellar mutism, 
growth hormone deficiency and seizures 
The dependent variables are: 
• the neuropsychological test scores in the domains of attention, motor 
functions, speech and language, visual perceptual information 
processing, memory and intelligence 
• emotional and behavioural test scores 
• health-related quality of life test scores 
This is a unique study in that it is the first of its kind to be undertaken at 
South African hospitals. Quality of life in the context of outcomes for brain 
tumour survivors is measured by a battery of neuropsychological, 
emotional, behavioural and health tests. 
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In the subsequent chapters the medical and surgical findings pertinent to 
the topic are given, followed by the neuropsychological and quality of life 
outcomes. Chapter 2 describes the problems associated with both the 
classification and incidence of posterior fossa brain tumours. A literature 
review of the pretreatment factors appears in Chapter 3, followed by a 
survey of the treatment factors of surgery, radiotherapy and chemotherapy 
in Chapter 4. Selected complications following treatment are discussed in 
Chapter 5, while Chapter 6 reviews the neuropsychological and quality of 
life outcomes in brain tumours. Appendix H cites all the studies discussed 
in Chapter 6. The method of the research and the results are in Chapter 7. 
Appendix A tabulates a description of the Groups and the treatment related 
variables. The neuropsychological test results are in Chapter 8, quality of 
life results are in Chapter 9, age-at-diagnosis and time-since-treatment 
findings are in Chapter 10. Chapter 11 covers medulloblastoma tumours. 
The model predictive of outcome is described in Chapter 12. The 
discussion, conclusions and recornmendations for future research are to be 




TUMOURS OF THE POSTERIOR FOSSA OF THE BRAIN 
2.1. INTRODUCTION 
Approximately half the number of all childhood brain tumours arise in the 
posterior fossa (Packer, Schut, Sutton et aI., 1990), which is the largest and 
deepest of the three cranial fossae. This area is bounded anteriorally by the 
dorsum sellae, the posterior aspect of the body of the spenoid bone, and 
the basilar aspect of the occipital bone. Inferiorally, the posterior fossa is 
bordered by the occipital bone and laterally by portions of the temporal, 
occipital, and parietal bones. Superiorally, the contents of the posterior 
fossa are enclosed by the tentorium cerebelli. This portion of the dura mater 
covers the cerebellum and supports the occipital lobes. The cerebellum and 
the inferior aspect of the brainstem are contained within the posterior fossa 
(Halperin et al., 1994). 
The majority of paediatric brain tumours occur below the tentorium 
(infratentorial) and 40 percent of these are embryonal in type (mainly 
medulloblastomas). In adults, most tumours occur above the tentorium 
(supratentorial) and are cornmonly astrocytomas or secondary tumours 
(Poldenak & Flannery, 1995). 
2.2 CLASSIFICATION 
The lack of a uniformly accepted classification system has been a major 
stumbling block in the evaluation of both the incidence of types of posterior 
fossa brain tumours and of the impact of treatment on children with brain 
tumours (O'Anglio, Rorke, Packer et aI., 1990; Miller, Young, Novakovic et 
al., 1995). 
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Classifying cancer by anatomic site, reveals not only the frequency of one 
form of cancer, but the combined frequency of diverse cancers of that site. 
Among the childhood cancers, classified according to anatomical axis, 
leukaemia (31.4%) has the highest "frequency, followed by a 17.6% 
frequency for malignant brain and CNS neoplasms (Miller et a/., 1995). 
Rorke, Gilles, Davis et a/., (1985) recommend that all childhood brain 
tumours composed of primitive or undifferentiated cells be called primitive 
neuroectodermal tumours (PNET). Within the category of PNET are 
childhood brain tumours in different regions of the neuraxis which have 
been identified by a variety of names, including medulloblastoma and 
ependymoblastoma. The 1993 World Health Organization (WHO) 
classification of CNS neoplasms includes medulloblastoma as one of the 
paediatric embryonal tumours, identified as a specific PNET arising in the 
posterior fossa (Kleinhues, 1993). In this study, cognisance has been 
taken of this and the histological diagnosis is included in a description of the 
groups (see Appendix A). 
2.3. TUMOUR TYPE AND INCIDENCE 
The most common childhood tumours of the posterior fossa are 
medulloblastoma, low-grade cerebellar astrocytoma, brain stem tumours 
and ependymoma (Halperin et a/., 1994). 
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Medulloblastomas are primitive neuroectodermal tumours occurring in the 
posterior fossa, predominately in children. They arise in the cerebellar 
vermis and usually extend into the fourth ventricle and can spread through 
the CSF pathways, seeding into the lateral ventricles or spinal theca 
(Lindsay, Bone & Callander, 1991). 
Medulloblastoma was first categorized in 1925 as a malignant neoplasm of 
the cerebellar region by Bailey and Cushing in their classification of CNS 
tumours (Cushing, 1930). Medulloblastoma is the most common childhood 
brain tumour occurring in the posterior fossa (Bloom, Glees & Bell 1990; 
Danjoux, Jenkin, McLaughlin et aI., 1996). As shown in the above table, the 
incidence ranges between 30 - 40% (Halperin et al., 1994) 
A retrospective population-based study carried out in Avon, U.K. from 1976 
to 1991, indicated a significant decline in the incidence rates for 
medulloblastoma in children, from 9.6 to 1.7 per million per year (Thorne 
Parson, Nicoll et al., 1994). This decline was not found in other types of 
posterior fossa tumours. 
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Certain diagnostic terms have been used to describe the histological 
variations of medulloblastoma (Sutton et al., 1989). 
• Rorke (1983) proposes that all such tumours composed of 
undifferentiated neuroepithelial cells be considered as a group and 
labelled primitive neuroectodermal tumours (PNET). This system further 
subclassifies PNET on the basis of the presence or absence of cellular 
differentiation along neuronal, glial or ependymal lines. 
• Sutton et al., (1989) classifies medulloblastomas as undifferentiated and 
multidifferentiated as they believe the degree of differentiation to be an 
important predictor of outcome. In their study, 15/23 children with 
differentiated tumours relapsed compared with only 4120 with 
undifferentiated tumours. However, Caputy (1987) in Sutton et aI., 
(1989), discovered the opposite, showing that degree of cellular 
differentiation was predictive of improved outcome. 
• According to Packer (1999) approximately 30% of children with 
medulloblastoma tumours will have disseminated disease at the time of 
diagnosis. Prospective randomized trails performed in the 1970's and 
early 1980's showed that staging studies were useful in stratifying 
children with medulloblastoma tumours into "average risk" and "poor 
risk" according to the dissemination of the tumour, extent of the surgical 
resection and involvement of the brain stem. With improved technology, 
the advent of the MRI and time there has been a reassessment of risk 
factors in determining the treatment protocols of radiotherapy and 
chemotherapy for children with medulloblastoma tumours. These are 
given in the table below. 
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Table 2-2 Stratification of Medulloblastoma Tumours 
----
Poor risk (any factor) Average risk 
--------------
Extent of disease at Disseminated Localized 
diagnosis 
---- ._-----
Extent of primary Lump disease Minimal or no residual 
disease after surgery (especially after biopsy disease 
only) ----
Age at diagnosis Less than 3 years 3 years or greater 
Source Packer et al., (1999) page 77. 
The histological variations in medulloblastoma are a cause of confusion in 
predicting outcome as well as the reassessment of the risk factors which 
have occurred over time. 
2.3.2 Brain Stem Tumours 
The management of brainstem glioma, is an area of controversy (Hoffman 
& Goumnerova, 1991). 
Brain stem tumours represent 10% to 15% of all intracranial childhood 
neoplasms (Packer, Nicholson, Venzina et al., 1992 in Kaplan, Albright, 
Zimmerman et al., 1996). At the same time, the incidence of unbiopsied 
brain stem gliomas of the posterior fossa tumours in childhood is 5% to 
20% (Cohen & Duffner 1984; Undjian, Marinov & Georgiev, 1989). 
However, some studies cite slightly higher incidence rates of 10% to 20% 
or 25% (Hoffman & Goumnerova 1991), whereas other reports suggest that 
brain stem tumours occur as frequently as medulloblastomas and 
astrocytomas (Stroink, Hoffman, Hendrick et aI., 1987). 
In 1969, Matson stated that "regardless of specific histology, brain stem 
gliomas must be classified as malignant tumours as their location itself 
renders them inoperable" (Matson, 1969 in Hoffman & Goumnerova, 1991, 
p326). 
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The number of classification systems of brain stem tumours may lead to 
confusion not only in the literature but in calculating the incidence. 
• Epstein classified brain stem tumours radiographically into four types: 
diffuse, focal, cystic and cervicomedullary (Epstein & Wisoff, 1989, in 
Halperin et aI., 1994). 
• A fifth category of brain stem glioma, the tectal gliomas, was added 
(Molloy, Sutton, Yachnis et a/., 1995). 
• A staging system based on computerised tomography (CT) criteria of 
tumour location and characteristics; such as intrinsic versus extrinsic 
tumour, solid versus cystic components and contrast enhancement has 
also been described (Stroink, Hoffman, Hendrick et aI., 1987). 
• Another difficulty is that surgical biopsy is often not performed because 
of the morbidity associated with the procedure, or the inconclusive 
pathological report (Molloy et a/., 1995). 
In the Surveillance, Epidemiology and End Result (SEER) programme 
(1973 -1987), of 1642 brain tumours with a confirmed diagnosis, 198 cases 
of gliomas were excluded from the series because the diagnosis was made 
without histological confirmation, due to the inaccessibility of the tumour for 
a biopsy (Miller et aI., 1995). 
Diagnosis normally depends upon procedures such as computerised 
tomography (CT) and magnetic resonance imaging (MRI). As the quality of 
radiology has improved over the last 10 years, lesions are now detected at 
an earlier stage, with a concomitant variation in the incidence of the 
tumours (Molloy et a/., 1995). 
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2.3.3 Cerebellar Astrocytoma 
Cerebellar astrocytomas are low grade, well-circumscribed slow-growing 
lesions. Two thirds of these are cystic and in them the tumour is present as 
a mural nodule in 40%, with the remaining cyst wall being compressed 
cerebellar tissue. In the remaining 60%, the entire cyst wall is lined by 
tumour (Kernohan & Sayre, 1952; Russell & Rubinstein, 1971 in Halperin et 
aI., 1994). Initially Cushing (1931, in Halperin et aI., 1994) did not recognize 
that the mural nodule represented the malignant portion of many cerebellar 
astrocytomas. Without removal of it, the cyst was likely to recur, but once 
the nodule was recognized and removed by surgery, results improved. 
In a review by Halperin et al., (1994) cerebellar astrocytomas constituted 
25% to 35% percent of all childhood posterior fossa brain tumours. 
• The frequency of childhood cancer by histologic type according to 
SEER 1973 - 1987, reveals that astrocytoma is the second most 
common childhood cancer type after ALL and occurs at an incidental 
rate of 9.6% (Miller et aI., 1995). 
• In considering the incidence of specific histologic types within the CNS, 
that of astrocytomas according to SEER 1973 - 1987 is 54.3% (Miller et 
al., 1995). The incidence rates can then be subdivided in terms of 
confirmed histologic astrocytoma type. 
• According to Gurney in Morris, Krawiecki, Kullgren et al., (2000) 
European American children have incidence rates 22% higher than 
those of African American children. Incidence rates in South Africa may 
thus be lower for African children in South Africa compared to those of 
European extraction. 
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• Astrocytomas are described histologically as anaplastic and benign 
types. The benign types can be further subdivided into low-grade 
tumours of the fibrillary, juvenile pilocystic or diffuse types (Lindsay, 
Bone & Callender 1991). 
2.3.4 Ependymoma 
Ependymomas may arise from the ependymal lining of the floor, lateral 
recess, or roof of the fourth ventricle, third ventricle or lateral ventricles 
(Halperin et al., 1994). 
The incidence of ependymoma in all childhood cancer types according to 
histology, in the SEER 1973-1987 classification is, 1.7% (Miller et a/., 
1995). 
The incidence of ependymoma according to histologic types of CNS in 
children age 0 to 14 years of age, in the SEER 1973 - 1987 classification is 
9.9% (Miller et al., 1995). 
Intracranial ependymomas, including supratentorial and infratentorial sites 
represent 1 %-3% of all intracranial tumours in all age groups and 10% of 
intracranial tumours in children (Vanuytsel, Bessel, Ashley et al., 1992). 
The incidence of ependymomas among childhood tumours of the posterior 
fossa is 6%-12% (Bouffet, Perilongo, Canete et al., 1998). 
Incidence rates are confused, due to the lack of specification between 
infratentorial and supratentorial ependymomas and the different 
classification systems. 
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The histological subtypes are: 
• Predominantly cellular, predominantly fibrillary, mixed cellular and 
papillary groups (Bailey, 1948; Healey, Braners, Kupsky et a/., 1991; 
Salazar, Castro-Vita, VanHoutte et a/., 1983; Schiffer, Chio, Girodana et 
a/., 1991, all cited in Haplerin et a/., 1994). 
• Ependymomas may also be classified as Grade I, II, III, or IV based on 
the degree of anaplasia, cellular pleomorphism and necrosis (Kernohan 
& Sayre, 1952; Ringertz & Reymond, 1949; Russell & Rubinstein, 1971; 
Salazar et a/., 1983, all cited in Halperin et a/., 1994). 
• Most pathologists prefer to group the cases as low grade or high grade 
(Halperin et a/., 1994). Other pathologists may prefer to classify them 
as ependymoma (equivalent to "low grade" ependymoma or "benign" 
ependymoma), anaplastic ependymoma or the rare embryonal tumour 
ependymoblastoma (Goldwein, Leahy, Packer et aI., 1990). 
2.4 INCIDENCE RATES OF CANCER IN SOUTH AFRICA 1990-
1991 
In all histologically diagnosed cancer, the incidence of brain cancer, among 
all age groups, for females is 0.529% and for males is 0.608% (South 
African National Cancer Registery Report, 1990 - 1991). 
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Table 2-3 Age specific cancer rates per 100 000, 1990 - 1991, South Africa 
FEMALE ~ 
A9_e Y_r~ __ ± ___ 0_-~ __ t___-5-9 _~, __ 1_0-_1_4_--+_ 15-19 
Brain _ _ _o_.4_7_----'-_ 0.?77 ~ 0.748 0.511 
MALE 1 
f-:-~=-ae-i-n-Y-rs--t----0-~~--:-4--:E-0-~7--~-6--f--~-~~-;-~--:E~~ __ ~ 
Brain cancer in children is rare as indicated by the South African rates, 
there being little difference shown in the female and male incidence rates. 
At the time of writing this thesis, these were the only figures available. 
2.5. SURVIVAL 
Mortality in the general population is low among children, and there is little 
difference in survival rates with different conditions. Thus almost one in four 
children with cancer has an 80% or better chance of surviving for five years 
(Miller et a/., 1995). 
The trend in relative survival rates for the most common histological types 
of childhood cancers for 1973-1987 is shown below. The number of cases 
in each category for both sexes and all races combined over this period 
ranges from 120 to 753. Little change in survival rate is shown in any of the 
main forms of brain cancer. Patients with astrocytomas had the best 
survival (approximately 70%) followed by those with medulloblastoma and 
ependymoma. 
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Table 2-4 Five- Year Relative Survival Rates for the Most Common 
Histologic Types of Cancer Among Children Age 0 - 14, All Races, Both 
Sexes, SEER 1983-87 
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During the past 30 years, radical surgical removal of the medulloblastoma 
brain tumour, followed by radiotherapy to the craniospinal axis, with or 
without complementary chemotherapy, has been responsible for an 
improvement in the five-year survival rate to 50% or better for these 
tumours (David, Casey, Haywood et al., 1997; Jenkin, 1996; Packer, 
Sutton, Elterman et aI., 1994). 
2.5.2 Brain Stem Tumours 
Brain stem tumours were once regarded as a universally fatal disorder but, 
depending on the specific type, the amenability to surgery, improved 
radiotherapy and chemotherapy regimes, the prognosis has improved 
(Hoffman & Goumnerova, 1991; Mulhern, Heideman, Khatib et al., 1994). 
A paediatric oncology group study, with 136 patients aged between three 
and 21 years, with tumours arising in the midbrain, pons or medulla, were 
treated with radiotherapy delivered to local fields. The results were poor; 
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the median survival time was ten months; survival at one year was 39.9% 
and at two years, seven percent (Freeman, Krischer, Sanford et al., 1993). 
A study was carried out in France between 1970 and 1990 on 75 children, 
who had intrinsic (3 cases) and exophytic (72 cases) brain stem tumours. 
The goal of surgery was to remove as much tumour as possible (Pierre-
Kahn, Hirsch, Vinchon et al., 1993). The study supports the hypothesis that 
surgical removal of brain stem tumours is only beneficial to children with 
benign tumours in which long term survival is the rule (Epstein & Wisoff, 
1987; Hoffman, Becker & Craven, 1980; Littman, Jarrett, Bilaniuk, et al., 
1980; Stroink et al., 1987). In this study surgery does not improve the 
prognosis of malignant tumours and survival time rarely exceeds 18 months 
(Pierre-Kahn et al., 1993). 
2.5.3 Cerebellar Astrocytoma 
The survival rate of low-grade gliomas, (pilocytic astrocytomas, nonpilocytic 
fibrillary and protoplasmic astrocytomas, low grade oligoastrocytomas and 
oligodendrogliomas) has been reported to be 95% at 5 years, 93% at 10 
years and 85% at 20 years (Pollack, Claasen, AI-Shboul et al., 1995). On 
the other hand a cure rate of 80% to 100 % for patients treated for grade 1 
and grade 11 cerebellar astrocytomas is reported at the Mayo Clinic 
(Morreale, Ebersold, Quast et al., 1997). High-grade cerebellar 
astrocytomas in children are rare, survival is poor and dependent on 
individual treatment regimes (Campbell, Pollack, Martinez et al., 1996). 
2.5.4 Ependymoma 
The survival rates of posterior fossa ependymoma are difficult to interpret 
because most series do not distinguish tumour location in their evaluations, 
although it has been reported that biological activity is related to tumour 
location. Contrary to expectations Needle, Goldwein, Grass et al., (1997) 
found treatment failure occurred in patients with posterior fossa tumours 
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whereas others claimed that supratentorial tumours were a poor prognostic 
factor. Survival rates are further confused by the addition of single 
institution reports as opposed to large national or international studies, 
which could provide enough information for multivariate analysis of 
prognostic factors (Bouffet et aI., 1998). 
In a literature review of posterior fossa ependymomas from the Mayo Clinic, 
confounding factors are highlighted (Lyons & Kelly, 1991) 
1. The journal articles span several decades and do not take note of 
changes in treatment options. 
2. They include patients with pre-existing metastases. 
3. They do not report the degree of tumour resection. 
4. They interpret the grading systems differently. 
Consequently the five year survival rate ranges from 11 % to 80% (Chin, 
Maruyama Markesbery et a/., 1982; Ernestus, Wilke & Schroder, 1989; 
Garrett and Simpson, 1983; Goldwein, Leahy, Packer et a/., 1990; Salazar, 
Castro-Vita, Van Houtte et a/., 1983; Shaw, Evans Schethauer et aI., 1987). 
At the same time the five year survival rate for children in the Mayo Clinic 
series was 14% (Lyons & Kelly 1991). 
2.6. EXPLORATION OF TUMOUR SITE AND TYPE TO NEURO-
PSYCHOLOGICAL AND QUALITY OF LIFE OUTCOMES 
One of the most challenging tasks facing the investigation of the effects of 
treatment on survivors of posterior fossa tumours is the heterogeneity of the 
disease in regard to tumour site and the type of tumour. It is typical for 
samples to include various types of tumours located in diverse regions of 
the brain. Of the sixty three studies reviewed (See Appendix H) 21 % (13) 
studies used posterior fossa site of tumour and different types of posterior 
fossa tumours within the sample as the main organizing variables to 
demonstrate the effects of treatment on outcome (Chapman et a/., 1995; 
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Duffner, Cohen, Anderson et al., 1983; Grill, Kieffer-Renaux, Bultea et al., 
1999; Hetherington, Dennis P Spiegler, et al., 2000; Hirsch, Renier, 
Czernichow et al., 1979; Hoppe-Hirsch et al., 1995; Le Baron, Zeiter, Zeiter 
et al.,1988; Mulhern, Reddick, Palmer et aI., 1999; Packer et al., 1989; 
Radcliffe et al., 1992; Riva, Pantaleoni, Milani et aI., 1989; Seaver et al., 
1994; Sutton et al., 1989). 
2.6.1 Classification Of Paediatric Brain Tumours 
Understanding the literature on paediatric brain tumours requires a 
familiarity with the current nomenclature as well as the historical 
development of these systems. As shown in the review, authors moved 
between old terminology such as glioma or non glioma tumours (Onoyama, 
Mitsuyuki, Takahashi et al., 1975) to primitive neuroectodermal tumours 
when referring to medulloblastoma (Packer et al., 1987; Packer et al., 
1989). Others differentiated medulloblastoma and primitive 
neuroectodremal tumours (Moore et al., 1992) whereas some researches 
categorized them together (Packer et al., 1987; Packer et al., 1989). 
The classification of astrocytoma brain tumours is also confusing. Most 
authors referred to cerebellar astrocytomas when describing astrocytomas 
which are sited in the posterior fossa brain region. However, some authors 
graded the astrocytoma tumours as type 1 or type 2 (Moore et al., 1992) or 
used terminology such as dorsally exophytic /juvenile pilocytic astrocytoma 
and fibrillary astrocytoma (Mulhern et aI., 1994) or low grade astrocytoma 
(Chadderton et al., 1995). 
These different interpretations of the classification of posterior fossa brain 
tumours could possibly confound the results when comparing studies by 
different authors over a long time span. 
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2.6.2 Tumour Site and the Cerebellum 
The contribution of tumour site to intellectual outcome is a debatable issue 
in resolving the impact of treatment on paediatric posterior fossa tumours, 
especially as the role of the cerebellum in cognition has recently come to 
the fore. The traditional view of the cerebellum is that it coordinates gait and 
voluntary movement, is responsible for balance and posture, and is 
important in speech and control of gaze (Schmahmann, 1997). However a 
more recent theory is that the role of the cerebellum is not limited to motor 
control, although this view has not gained wide acceptance. Neuroimaging 
studies (Parsons & Fox in Schmahmann, 1997) report cerebellar activation 
in support of such cognitive processes as semantic association, attention, 
working memory, verbal learning and memory. Neuroimaging studies also 
indicate that vermal cerebellar activation is associated with emotional states 
such as panic, sadness, depression and fear. It is likely that these mental 
conditions have few or no motor components but possess various sensory 
and cognitive components. A double dissociation between (a) cerebellar 
activity and sensory processing and (b) motor behaviour and activity in 
known motor areas in the cerebral cortex, is proposed by Parsons & Fox in 
Schmahmann (1997). 
2.6.3 Neuropsychological Functioning and Quality of Life Related to 
Tumour Site 
Many authors used supratentorial versus infratentorial site as a basis for 
comparison to predict cognitive and quality of life outcome (Cohen, Packer 
Siegel ef a/., 1993; Duffner, Cohen & Parker, 1988; Horowitz, lVIulhern, Kun 
ef a/., 1988; Jannoun & Bloom, 1990; Kun ef a/., 1983; Lannering ef a/., 
1990; Mulhern and Kun, 1985). 
A greater than normal risk for late neuropsychological alterations among 
children with supratentorial tumours and/or cranial irradiation as opposed to 
infratentorial and/or cranial irradiation is described by Kun ef aI., (1983), 
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who found that children with posterior fossa tumours had no intellectual 
impairment at diagnosis. However, abnormal social emotional functioning 
was recorded in a greater number of children with supratentorial tumours 
than posterior fossa tumours after surgery and radiotherapy treatment. The 
small sample size limits the interpretation of the results. According to 
Mulhern and Kun (1985), there was no consistent influence of tumour site 
on selective attention, intellectual functioning or emotional adjustment 
except for younger patients. The children younger than six years at 
diagnosis with supratentorial tumours were less likely to improve their 
cognitive performance than the infratentorial group. 
Ellenberg et al., (1987) demonstrated that tumour site is critical to the 
degree and nature of functional sequelae in children with brain tumours. 
The deficits observed in children with hemispheric tumours are similar to 
those of adults and support notions of early lateralization in human 
development. The patients also showed general intellectual deficits that 
predated the diqgnosis. The global dysfunction was hypothesized as being 
due to interference by the tumour with surrounding brain tissue. Children 
with lesions of the anterior third ventricle, craniopharyngioma or 
hypothalamic tumours were more likely to be severely impaired. They, like 
adults with third ventricle tumours, showed prolonged periods of lowered 
consciousness, amnesia or confused thinking that lasted up to four months 
after the operation. 
As 10 data was collected prospectively, over time it was possible to 
examine 10 changes by using each subject as their own control. Children 
with hemispheric tumours showed much lower 10 scores at all testing 
points than those with third or fourth ventricle tumours. Patients with third 
ventricle tumours maintained their 10 levels from four months post 
diagnosis over the one to four years of the study whereas subjects with 
fourth ventricle tumours showed a significant drop in 10 from four months to 
between two to four years post diagnosis. The downward trend was also 
found in patients with hemispheric tumours, but, because of small numbers, 
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the trend did not reach a significant level. The decline in IQ over time for 
patients with fourth ventricle tumours was attributed to RT rather than 
tumour site. 
By controlling for tumour type and site and using a variety of 
neuropsychological tests, Brookshire, Copeland, Moore et aI., (1990) 
identified the relationship between tumour-related factors and specific 
neuropsychological abilities. Tumour site and symptom duration correlated 
with the executive domain score, indicating that patients with cerebral 
hemisphere tumours and a longer duration of symptoms performed less 
well on executive measures. Seventy one percent of the cerebral 
hemisphere, 64% of the supratentorial midline and 73% of the infratentorial 
tumour groups performed within or above the normal limits on all 
neuropsychological tests except the executive domain. A significant 
correlation between cerebellar signs and visual motor and fine motor 
domain scores indicated a strong relationship amongst these indices of 
motor function. The authors note that the association between cerebellar 
deficits and fine motor and visual motor domains is an expected finding 
since the cerebellum is associated with motor functions. The results of the 
study also showed that as a group, children with primary brain tumours are 
not intellectually impaired before treatment. 
The most important factors underlying moderate to severe disabilities in 
long term survivors of paediatric brain tumours are the presence of 
supratentorial tumours and cranial irradiation. According to Jannoun and 
Bloom (1990), intellectual differences were not found between infratentorial 
and supratentorial tumours but quality of life indices were better in the 
infratentorial group. The Bloom Functional Disability Scale showed that 
72% of patients with supratentorial tumours had mild to severe neurological 
and physical disability compared with 44% in the infratentorial group. 
Lannering et al., (1990) compared the functioning of subjects with 
supratentorial and infratentorial tumours, treated by means of surgery only. 
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No significant differences were found in intellectual scores, motor 
dysfunction, visual dysfunction, or short stature. Subjects with 
supratentorial tumours had significant psychological and emotional 
difficulties and moderate to severe disability impairment profiles, compared 
with those with infratentorial tumours. Motor impairment was expressed 
according to tumour site. Hemisyndromes in supratentorial tumours 
generally caused little disability whereas truncal ataxia in infratentorial 
tumours caused moderate to severe disability and had confined two 
patients to wheelchairs. Despite normal findings on gross neurological 
examination, Stott's test reveals moderate to significant problems in 45% of 
all the subjects which was significantly more than expected in the normal 
population. For supratentorial tumours the dysfunction affected manual 
dexterity, eye and hand coordination and balance. However, for 
infratentorial tumours the dominant finding was in disturbed balance. 
Tumour site and treatment were associated with changed quality of life 
measures in the studies by Mostow et al, (1991). Survivors of 
supratentorial tumours and those who received radiation treatment were at 
greater risk of adverse outcomes than survivors of infratentorial tumours 
who had not received radiation. The findings were verified by using sibling 
controls. The greatest difference between supratentorial and in·fratentorial 
tumours was in emotional problems and mental incompetence. These 
findings are based on a large retrospective sample (342 subjects and 479 
sibling controls) over a 29 year period. 
The association between brain tumour site and memory functions is 
reported in a series of publications (Dennis, Spiegler, Fitz et al, 1991; 
Dennis, Spiegler, Hoffman et al, 1991; Dennis, Spiegler, Obonsawin et a/. , 
1992). A complex tabulation of brain tumours by means of both focal site 
and invasion of the tumour into other regions was completed, based on CT 
scans. Subjects could have more than one entry to account for both the 
focal and the invasive areas of the tumour. The diencephalon and the 
cerebellum were the most common tumour sites. The sample of 46 
28 
paediatric brain tumours comprised 23 craniopharyngiomas (50%) localized 
in the diencephalon and six medulloblastomas (13%) which were in the 
cerebellum. Tumours such as astrocytomas (17%), germinomas (7%), 
other cysts (7%), neuroectodermal (2%) lipoma (2%) had multiple entries in 
various parts of the brain. 
The working memory tasks were unaffected by demographic and medical 
variables, although the memory for serial order of pictures that corresponds 
with the heard word was inversely related to Age-at-Diagnosis. 
Notwithstanding the demonstrated importance of anatomical locus of the 
tumour, Dennis highlights the fact that a considerable variance in the 
memory score remains unaccounted for, showing that factors other than 
anatomical sites of damage contribute to memory deficits in brain tumour 
subjects. 
Working memory in a sample of craniopharyngioma, anterior third ventricle, 
posterior third ventricle and fourth ventricle tumours showed no effect for 
tumour site (Dennis, Hetherington and Spiegler, 1998). The authors 
suggest that tumour site in future studies should be analysed on the basis 
of neuroimaging studies to include tumour dam~ge, as well as location of 
the primary tumour. 
Tumours that involve the hypothalamus and/or optic chiasm have been 
directly related to decline in IQ and memory functioning (Danoff, Cowchock, 
Marquette et a/., 1982 in Mulhern and Kun, 1985). 
Two prospective studies (Packer et a/., 1989; Sutton et a/., 1989) that used 
serial testing showed that the site of the tumour is an important determinant 
on cognitive outcome. Both these studies found that at baseline testing 
after surgical intervention, the cerebellar astrocytoma group and the 
medulloblastoma group, had fine motor speed and dexterity impairments. In 
the cerebellar astrocytoma group that had no further treatment, no 
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improvement in these functions was found two years later. The deficits 
were thus attributed to the site of the tumour. 
Of the studies reviewed only one study discussed astrocytoma tumours 
located in various sites of the brain as the organizing variable to illustrate 
the effects of treatment outcome (Chadderton et a/., 1995). They found that 
the site of the tumour had little impact on intellectual functioning but that 
treatment related factors negatively affected cognitive functioning. 
Children treated by means of surgery only had relatively intact 10 scores 
whereas a decline in 10 scores was shown for those tumours sited in the 
posterior fossa area treated by means of Surgery and RT. 
2.6.4 Neuropsychological and Quality of Life Outcomes related to 
Tumour Type. 
The survival rates for different types of posterior fossa tumours indicate that 
cerebellar astrocytoma have the best prognosis, followed by 
medulloblastoma, ependymoma and lastly brain stem glioma tumours. 
Therefore, an important consideration in the interpretation of 
neuropsychological outcome is the differentiation between tumour types. 
Ris and Noll (1994) find in their review of paediatric brain tumours, that 
many authors had not taken this into account. They feel it is both a function 
of the rarity of many brain tumours as well as the controversy surrounding 
the classification of them. 
Studies comparing the treatment outcome of children with malignant 
medulloblastoma tumours to children with low grade cerebellar astrocytoma 
tumours showed that the progression of the disease state and the biology 
of the type of tumour prescribed the type of treatment of surgery only or 
surgery RT and! or chemotherapy (Grill et aI., 1999; Hetherington et aI., 
2000; Hirsch et aI., 1979; LeBaron et aI., 1988; Mulhern et a/., 1999; Packer 
et a/., 1989; Riva et a/., 1989; Sutton et a/., 1989). 
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Studies comparing the performance of cerebellar astrocytoma tumours with 
other posterior fossa tumours, such as medulloblastoma tumours at 
baseline testing prior to treatment show that there is little difference 
between the cerebellar astrocytoma group and the medulloblastoma group 
in base line IQ test score results. Both these groups function within the 
normal range (Packer et al., 1989; Sutton et al., 1989). 
However, at baseline testing Packer et al., (1989) found that the 
medulloblastoma group had difficulties in fine motor function in motor speed 
and dexterity in both the dominant and non-dominant hand. Visual motor 
integration and visual spatial difficulties were only found in one or two 
subjects. Language difficulties were marginally evident, whereas memory 
difficulty was shown in more than half the sample. A similar pattern of 
difficulties was found in the astrocytoma group with the exception of 
memory, which was relatively well preserved and language difficulties in 
which two children were severely impaired. Small sample size (11) has a 
limiting influence on the generalizability of the results. 
A retrospective comparison of low grade astrocytoma tumours in different 
sites showed that at baseline assessment there was no difference in the 
neurological function of all the tumour groups (Chadderton et aI., 1995). 
Later differences were attributed to treatment effects. 
A unique study by Mulhern et aI., (1999) using a MRI protocol illustrated 
variations in the normal white matter and subsequent lower FSIQ induced 
by the caraniospinal radiation treatment of medulloblstoma tumours with or 
without chemotherapy. This result was not evident in the low grade 
astrocytoma tumours, all of which were sited in the posterior fossa. These 
results suggest that tumour site is not a contributing factor to these results. 
However the use of only FSIQ test scores is a limiting factor. A more 
extensive test battery may have illustrated deficits in other domains, such 
as visual perceptual information processing, thus highlighting the possible 
effect of the site of the tumour. 
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Hetherington et aI., (2000) demonstrated that childhood lesions of the 
cerebellum produced enduring deficits in short term duration perception, but 
spared the ability to functionally estimate duration, regardless of pathology 
or treatment. Evidence did not support any functional recovery over time of 
the cerebellar system that underlies short duration perception. A control 
group matched for age was used by the authors to verify their findings. 
In the literature reviewed (Appendix H) three studies used ependymoma 
and medulloblastoma brain tumours as the organizing variables (Grill et aI., 
1999; Hoppe-Hirsch et a/., 1995; Seaver et aI., 1994). Both these tumour 
types were treated with surgery, radiotherapy and to some extent 
chemotherapy. The study of Seaver et a/., (1994) was limited by small 
number of subjects. However the authors state that they specifically chose 
survivors of ependymoma and medulloblastoma brain tumours as both 
tumours are located in the posterior fossa and received similar types of 
radiation protocols. Tumour type was thus not considered a potential 
confound. 
Hoppe-Hirsch et a/., (1995) found that ten years after treatment the FSIO 
scores of the subjects with ependymoma tumours remained stable whereas 
FSIO scores of the subjects treated for medulloblastoma brain tumours 
deteriorated. The same pattern was evident for school performance and 
behaviour. The authors concluded that progressive deterioration in function 
was due to treatment factors and not the type of tumour. 
Grill et a/., (1999) discussed that tumour type and the presence of 
metastasis or incomplete surgical resection strongly correlated with the 
radiation dose as stipulated in the treatment policies and was therefore 
associated with poorer intellectual outcome. High risk medulloblastoma 
patients had metastasis of the tumour or incomplete surgery. After 1989 all 
children with standard risk medulloblastoma received the same amount of 
RT. After adjusting for confounding factors cranio spinal radiation dose was 
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found to be the most implicated in low intellectual scores. However the 
authors concede that studies of children treated for medulloblastoma and 
ependymoma brain tumours treated without radiation may be the only way 
of discovering if the site of radiotherapy treatment is implicated in low 
neuropsychological test scores. 
Twenty one percent (13) of the studies reviewed (Appendix H) used 
medulloblastoma tumours only as the organizing variable (Broadbent, 
Barnes & Wheeler, 1981; Chin & Maruyama, 1984; Dennis et aI., 1996; 
Gajjar, Mulhern Heideman et al., 1994; Hoppe-Hirsch et al., 1990; Hudson 
& Murdoch, 1992; Johnson et aI., 1994; Koa, Goldwein Shultz et al., 1994; 
Kimmings et al., 1995; Nishiyama et al., 1994; Packer et aI., 1987; 
Silverman, Plakes, Talent et al., 1984; Yang et al., 1997). 
Long term survivors of medulloblastoma tumours are at risk for significant 
sequelae, including tumour related and treatment related complications. A 
major gap in the understanding and management of children with 
medulloblastoma tumours is the lack of biological factors, which can be 
used to stratify patients. 
The longitudinal study of Radcliffe et aI., (1992) showed that neither the 
progression of the medulloblatoma tumours nor the site of the tumour 
affected the outcome as measured by FSIQ scores. The authors measured 
the extent of the disease at the time of diagnosis. Radcliffe et aI., (1992) 
also found that children younger than seven years of age at diagnosis fared 
worse after treatment than older children This study is unfortunately limited 
by the attrition of the sample over the four year period of the study, small 
size of the sample at commencement of the study and a possible lack of 
infants or very young children in the sample to adequately verify the age 
effects. 
Grill et al., (1999) demonstrated that poor risk medulloblastoma subjects 
who had higher doses of RT treatment had lower FSIQ scores than children 
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with standard risk medulloblastoma tumours. Few studies take this factor 
into account. This may be due to the fact that over time there has been a 
reassessment of these risk factors. In addition prior to the availability of 
MRI, which has only been available at most centres for the past ten years, 
myelography was the most sensitive means to determine spinal 
dissemination. This procedure could only be performed after surgery as 
medulloblastoma tumours occur in the fourth ventricle and are associated 
with hydrocephalus and a possible risk of brain herniation if done prior to 
surgery. Cerebrospinal fluid cytology is also used to diagnose spinal 
metastasis as according to Packer (1999) about 20% of children with 
medulloblastoma tumours will have positive cerebrospinal fluid cytology 
despite not having evidence of radiographic disease dissemination. Thus 
over time, progress in technology and improved diagnostic skills have led to 
a reassessment of the risk factors associated with medulloblastoma brain 
tumours which few researchers have taken into account. 
2.7. SUMMARY 
• The controversy surrounding a uniformly accepted classification system 
reflects the complexity of the diseases and the differing perspectives of 
the authors when presenting the incidence of posterior fossa tumours, 
as well as the impact of treatment on children with brain tumours. 
• Medulloblastoma is the most common childhood brain tumour, followed 
by low-grade cerebellar astrocytoma, brain stem tumours and 
ependymoma. 
• Cerebellar astrocytoma tumours have the best survival with a cure rate 
of 80% to 100%. The survival rate of medulloblastoma tumours has 
improved to about 50%, or better due to treatment changes whereas the 
survival rates for ependymoma are difficult to interpret and range from 
11 % to 80%. Brain stem tumours have a poor survival rate but 
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depending upon the diagnosis and treatment the prognosis has 
improved. 
• The different interpretations of the classification of posterior fossa brain 
tumours is a possible confounding factor when comparing studies on 
neuropsychological and quality of life outcomes over a long period of 
time. 
• The contribution of tumour site to neuropsychological and quality of life 
functioning is critical to the degree and nature of sequelae. Results 
discussed are variable but generally supratentorial tumours have a 
poorer outcome than infratentorial tumours in terms of 
neuropsychological impairment. Specifically for infratentorial tumours, 
attention and memory functions do not appear to be affected, IQ scores 
are reported to be within normal range at baseline testing, as are 
emotional functions. Overall motor impairment in both supratentorial 
and infratentorial tumours, which is expressed differently according to 
tumour site needs further evaluation. 
• According to Packer (1999) in almost every series to date, children with 
tumours that arise outside of the posterior fossa have fared less well 
than children with posterior fossa tumours. It is unclear if this is related 
to the treatment or is due to biological differences between tumours of 
similar histology in different sites of the nervous system. 
• Tumour type is an important consideration in the neuropsychological 
outcome of posterior fossa tumours, which many researchers do not 
include in their reviews of paediatric brain tumour survivors. At baseline 
testing however both astrocytoma and medulloblastoma survivors have 
similar patterns of neuropsychological difficulties and FSIQ scores 
(Packer et aI., 1989; Sutton et al., 1989). The treatment decisions are 
often based on the diagnosis of the tumour type and site and underpin 
the neuropsychological outcome. 
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• Studies comparing children with ependymoma tumours to children with 
medulloblastoma tumours found that tumour type is not a confounding 
variable in the interpretation of the neuropsychological test scores. Low 
scores were attributed to treatment related factors rather than tumour 
related factors. 
• Few researchers have considered the extent of the disease of the 
medulloblastoma tumours or the risk factors as described by Packer 
(1999) either in the compilation of their samples or the in the 
interpretation of the cognitive or quality of life results. The longitudinal 
study of Radcliffe ef aI., (1992) found that the progression of the 
medulloblastoma tumour did not affect the outcome of FSIQ scores. A 
later study by Grill ef aI., (1999) showed that the diagnostic criteria of 
the brain tumour survivors (tumour type and extent of the disease) 
correlated with the RT and/or chemotherapy treatment and the 




FACTORS ASSOCIATED WITH PRETREATMENT STATUS 
3.1. PRESENTING SYMPTOMS 
According to Ris and Noll (1994), the role of the type and duration of 
clinical phenomena, such as nausea, vomiting, cranial nerve impairment, 
mental status changes, motor impairment and subsequent cognitive 
morbidity has not been well documented for posterior fossa brain tumours. 
A study by Packer, Sposto, Atkins et a/., (1987) shows that a lowered Pia 
score was significantly associated with altered mental status and 
oculomotor deficit at diagnosis in 24 long-term survivors of PNET 
(medulloblastoma) located in the posterior fossa. In addition, children with 
a shorter duration of presenting symptoms showed a trend towards a 
poorer Pia score. 
Brookshire et a/., (1990), tested 31 children one to three days prior to 
removal of primary brain tumours. They reported that patients with 
infratentorial tumours had presenting symptoms such as headache, 
nausea and vomiting for a briefer period than patients with supratentorial 
tumours, with 58% of the sample indicating that the symptoms lasted for 
no more than three months. Fifty percent of the patients with infratentorial 
tumours also had ocular nerve deficits, while 77% of the group had 
cerebellar signs. A significant correlation between cerebellar signs and 
visual motor and fine motor domain score was found. However the 
correlation between tumour location and symptom duration and executive 
domain was not significant for infratentorial tumours. 
A perioperative summary score, which included the tumour extending to 
the vermis, obtundation at presentation, hydrocephalus at presentation, 
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surgical intervention and post operative complications, was calculated by 
Chapman et al., (1995). They found a significant association between 
perioperative summary score and poor neuropsychological outcome in 
their sample of 15 long-term survivors of posterior fossa brain tumours. 
It may be that the lack of literature concerning the relationship between 
presenting symptoms and neuropsychological outcome is due to the fact 
of the signs and symptoms of the presenting symptoms being enmeshed 
in the symptoms of hydrocephalus and raised intracranial pressure (ICP). 
3.2. HYDROCEPHALUS 
Hydrocephalus is an abnormal increase in the amount of cerebrospinal 
fluid within the ventricles of the brain which may be acquired at any age 
as a result of neoplasm, trauma or brain infection. Children with posterior 
fossa tumours are predisposed to hydrocephalus because of the proximity 
of the fourth ventricle and the CSF pathways (Kumar et aI., 1996). 
3.3. RAISED INTRACRANIAL PRESSURE 
Although the brain tumour itself causes symptoms and signs, the 
complicating secondary hydrocephalus is often responsible for the 
increased intracranial pressure (lCP), thus superimposing a clinical 
picture of "midline syndrome", described by Raimondi & Tomita (1981), as 
"an increase in ICP without lateralizing signs". Thus the child may be 
considered to have two distinctly different diseases, a tumour and 
hydrocephalus, which complicate one another and contribute to the 
complex picture of increasing ICP (Raimondi & Tomita, 1981). Some 
children will require a CNS diversion procedure, such as a ventriculo-
peritoneal shunt or an extraventricular drain, at some time during the 
course of their illness (Culley, Berger, Shaw et al., 1994). Some authors 
advocate the pre-operative placement of a permanent shunt prior to 
surgical resection of the tumour, suggesting that this decreases patient 
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morbidity and mortality following the tumour resection (Raimondi & 
Tomita, 1981). Others find that pre-operative shunts can expose children 
to unnecessary risks such as upward herniation and other complications 
of shunting (Kumar et al., 1996; Lee, Wisoff, Abbott et al., 1994). 
David et al., (1997) report that, in their sample of medulloblastoma tumour 
children, those who required early CSF drainage were in the younger age 
group, were male and had a significantly shorter survival time. They 
suggest that the failure of hydrocephalus to respond to the tumour 
removal corresponds with the severity of the disease. 
3.3.1 Complications Of Shunts 
Complications associated with cerebral shunts are shunt malfunction, 
upward cerebellar herniation, infection, tumour haemorrhage and 
abdominal complications (Raimondi & Tomita, 1981). An added problem, 
the risk of extra neural metastases via the placement of shunts, has been 
suggested by some authors (Hoffman, Hendrick & Humphreys, 1976; 
Jamjoom, Jamjoom, Sulaiman et al., 1993) but contested by others 
(Berger, Baumeister, Geyer et al., 1991; Raimondi and Tomita, 1981). 
Preoperative external ventricular drainage and the use of corticosteriods 
as methods of controlling the symptoms of hydrocephalus and avoiding 
the placement of a permanent shunt, together with the associated 
complications, have been advocated by some authors. They suggest that 
the use of this approach results in the majority of children remaining shunt 
free after resection of the brain tumour (Dias, Albright, 1989; Rappaport & 
Shalit, 1989 in Culley et al., 1994). 
The management of hydrocephalus in children with posterior fossa 
tumours thus differs according to the policy of the institution and the 
presenting symptoms. 
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3.4. HYDROCEPHALUS AND NEUROPSYCHOLOGICAL 
FUNCTIONING 
As hydrocephalus is a syndrome with heterogeneous etiologies, it is 
difficult to distinguish which signs and symptoms result from the 
underlying lesion and which are related to the hydrocephalus itself. The 
research on hydrocephalus in animal experiments and human biopsy 
material shows that tissue damage is limited to the periventicular white 
matter with no accompanying loss of neurons (Bangash, D'Souza, 
Barbosa in Ashbury, McKhann, McDonald, 1992). 
Although the study by Fletcher, Bohan, Brandt et a/., (1992) on cerebral 
white matter and hydrocephalus was carried out on children with 
meningomyelocele, meningocele and aqueductal stenosis and normal 
subjects, their findings on white matter changes and the concomitant 
neuropsychological effects are of relevance: 
• The corpus callosum in the meningomyelocele and aqueductal 
stenosis groups was smaller. 
• The lateral ventricles were larger and the internal capsules were 
smaller in the hydrocephalic groups than the normal subjects. 
• No difference in the size of the centra semiovale was found. 
• Verbal and nonverbal measures correlated positively with the size of 
the corpus collosum and a higher correlation was shown for 
nonverbal measures. 
• Nonverbal measures correlated with the size of the right, but not the 
left lateral ventricle and with areas around the right and left internal 
capsule. 
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• Verbal measures correlated with the size of the left, not the right 
lateral ventricle and the left but not the right internal capsule 
In order to obtain these results, the researchers measured cerebral white 
matter structures and lateral ventricles of the MRI of the age-matched 
sample 
The volume of each lateral ventricle and the cross sectional area of the 
corpus callosum and internal capsules were correlated with the measures 
of verbal and nonverbal skills. The authors conclude from the findings the 
importance of white matter structures in the development of nonverbal 
cognitive skills and that the integrity of the central system white matter in 
both hemispheres is important for the development of nonverbal skills. 
Although specific language and attention deficits were not found, an 
impairment in higher cortical functions (as often shown in association with 
the posterior parietal areas of the right hemisphere) was demonstrated. 
The authors suggest that the failure of the system to develop because of 
reduced interhemispheric communication supports the facilitatory model 
of the corpus collosum and current theories of hemispheric specialization 
as described by Rourke (1982; 1987). 
Dennis, Fitz, Netley et al. J (1981) show in a study of 78 children 
diagnosed with hydrocephalus before the age of 12 months, all of whom 
had been shunted, showed that the children had an uneven growth of 
intelligence during childhood. This study however excludes children with 
brain tumours or other lateralized neurological signs. In this instance 
nonverbal intelligence developed less well than verbal. Dennis 
hypothesizes that it was neither the hydrocephalic condition nor the 
treatment but the developmental brain anomalies and symptoms to which 
the hydrocephalic children are prone (ocular abnormalities, motor deficits 
and seizures) that accounted for the deficits. Specifically impairments 
found in fine motor control resulted in difficulties on time-limited nonverbal 
tasks. Impaired tactile perceptual performance was also found. Analysis of 
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variance was not significant for any IQ measurement in relation to type or 
number of shunts inserted. The average number of shunt revisions in the 
sample was 4.41. 
The relationship between language development and hydrocephalus is 
well documented by Dennis, Hendrick, Hoffman et al., (1987). They 
studied the language development of 75 children diagnosed with 
hydrocephalus in the first year of life and compared the results with those 
of 50 control subjects. They found that both groups showed the same age 
increments in language performance but that, with increasing age, 
hydrocephalic children fell behind. Deficits were also found in word finding 
and higher levels of language related academic skills. As language and 
intelligence shared a common variance of only 18% to 39%, it was 
suggested that language tapped functions other than those involved in 
intelligence. 
Thus from these studies, it is clear that hydrocephalus per se can produce 
neuropsychological sequelae. 
3.5. RELATIONSHIP BETWEEN HYDROCEPHALUS AND 
NEUROPSYCHOLOGICAL FUNCTIONING IN CHILDREN WITH 
POSTERIOR FOSSA TUMOURS 
Hydrocephalus is a significant complication of infratentorial brain tumours 
(Raimondi & Tomita, 1981). Nevertheless the relationship between 
hydrocephalus, posterior fossa brain tumours and the subsequent effect 
on neuropsychological functioning is not clear. Mulhern (1994) suggests 
that the effects of episodic and temporary increases in intracranial 
pressure are not well understood. According to Cochrane, Gustavsson, 
Poskitt et a/., (1994), 8% of the children with posterior fossa tumours in 
their study required post operative shunts. This is a much lower incidence 
than that reported by Lee et al., (1994), who found that 40% of children 
42 
with medulloblastoma tumours required a permanent post- operative 
shunt. 
The effects of hydrocephalus on cognitive recovery are contradictory. A 
prospective study by Ellenberg et a/., (1987) shows that acute 
hydrocephalus is a common clinical presentation of children with brain 
tumours. The mean FSIQ scores of children with and without 
hydrocephalus, and third and fourth ventricle tumours improved over a 
four-month recovery period while the FSIQ of those with hemispheric 
tumours did not. Gains made by the non- hydrocephalic and 
hydrocephalic groups on FSIQ test scores over a three month test period 
were of the same order (5.5 points). 
The hydrocephalic children who required shunts were more likely to have 
a diagnosis of third ventricle tumours, whereas those not needing a shunt 
(in whom the hydrocephalus resolved after tumour resection) were more 
likely to have fourth ventricle tumours. Children who required shunts four 
months post diagnosis, were more likely to have a higher mean FSIQ than 
those who did not. The seven point gain in FSIQ score by the group 
requiring shunts was significant while the four-point FSIQ gain by the 
group not requiring shunts failed to reach significance. This therefore 
suggests that in children with the most severe hydrocephalus there is an 
initial depression of cognitive functioning beyond that produced by the 
craniotomy and hence more early recovery. 
Jannoun and Bloom (1990) show that the difference in FSIQ scores did 
not reach statistical difference in children with primary intracranial tumours 
and hydrocephalus (n=40; FSIQ=89) compared with those with brain 
tumours without hydrocephalus (n=22; FSIQ=99). Children with 
hydrocephalus were twice as likely to have a FSIQ within the 
educationally subnormal range as those without hydrocephalus (28% 
versus 14%). The authors give no explanation to account for these 
results, instead reporting that hydrocephalus was a presenting symptom 
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at the time of diagnosis and that in seven patients a CSF shunt was 
inserted. As this is a retrospective study, it could be assumed that by the 
time the subjects were given the neuropsychological assessment (3-20 
years post treatment), factors other than hydrocephalus contributed to the 
scores, as well as the uneven distribution of subjects within each group. 
The requirement of shunt placement to relieve intracranial pressure is 
shown by Packer et aI., (1987) to have a negative effect on FSIQ scores. 
In a retrospective study of 43 children diagnosed with medulloblastoma 
tumours, they found that children who had a shunt placement had a lower 
FSIQ (73) than those not requiring a shunt (FSIQ = 99). 
Medulloblastoma survivors with a shunt placement for hydrocephalus had 
higher FSIQ scores (FSIQ = 79 versus 68), compared with those who did 
without (Johnson et aI., 1994). Achievement in reading, spelling and 
maths indices were also better for the hydrocephalic-shunt-placement 
group. Reduced motor dexterity and speed were significantly associated 
with a shunt placement. The authors conclude that their findings warrant 
replication because of the relatively small sample size (n=13). 
Repeated shunt revisions carry a risk in cognitive morbidity. Kao, et al., 
(1994) describe a case of an 18 month old infant who developed brain 
herniation, obdundation and arrest. She was subsequently revived and 
underwent emergency ventricuoloperitoneal shunting. One week after the 
second surgery she had meningitis and the shunt became infected. She 
required a third revision of her shunt and ultimately experienced a IQ drop 
of more than 40 points. This prospective study found a significant 
correlation between adverse perioperative factors such as shunt infections 
and IQ deficits. The authors used a multiple logistic regression analysis to 
evaluate the significance of the independent contribution of the prognostic 
factors, that is perioperative factors, in predicting the outcome (FSIQ) on 
28 children diagnosed with medulloblastoma brain tumours. 
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The effects of increased intracranial pressure (ICP) on cognitive 
functioning remain uncertain in the study by Kun et aI., (1983). In their 
prospective study of 30 children with primary brain tumours they found 
that raised ICP did not differentiate between those children who exhibited 
intellectual delays and those who did not. In the sample of 17 children 
who had shunting procedures secondary to raised ICP, only 5 children 
(29%) showed intellectual delays, whereas, of the 13 not requiring shunts, 
5 children (39%) had intellectual delays. The authors conclude that the 
results need to be confirmed with larger numbers of patients longitudinally 
studied prior to and following treatment. 
Raised ICP was shown by Mulhern and Kun (1985) to have no significant 
effect on changes in IQ test scores. Prospectively, they assessed a group 
of 26 children with primary brain tumours (11 posterior fossa tumours and 
15 supratentorial tumours) and tested them at baseline and six months 
after irradiation. Mixed tumour types and an uneven number of children 
with and without shunts are potential sources of distortion in their results. 
The authors hypothesize that their study may not adequately represent 
the late sequelae of brain tumours and their treatment as these are only 
likely to be recognized about five years after treatment. The study 
therefore provides insight only into early functional changes. 
No significant difference between the presence of hydrocephalus 
(FSIQ=83) and the absence of hydrocephalus (FSIQ=90) on intelligence 
test scores was found by Yang et aI., (1997). They assessed 19 children 
diagnosed with medulloblastoma tumours, in 12 of whom a shunting 
procedure was performed for raised ICP. Small sample size and the fact 
that the majority of the sample required a shunting procedure have the 
potential to bias the results. 
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3.6 SUMMARY 
• The role of presenting symptoms and subsequent neuropsychological 
functioning has not been well documented for posterior fossa brain 
tumours. 
• Children with posterior fossa tumours are predisposed to 
hydrocephalus because of the proximity of the tumour to the fourth 
ventricle and CNS pathways. 
• The placement of a ventriculo-peritoneal shunt or extraventricular 
drain to relieve the symptoms of raised ICP differs according to the 
policy of the neurosurgeons. 
• Between 8% and 40% of children with a posterior tumours will require 
a post-operative shunt. Repeated shunt revisions and perioperative 
complications have been found to be associated with a dramatic drop 
in FSIQ (Kao ef al., 1994). 
• Changes in cerebral white matter due to hydrocephalus and 
concomitant neuropsychological functions indicate that the integrity of 
the CNS white matter in both cerebral hemispheres is important for 
the development of nonverbal skills. The developmental brain 
anomalies and symptoms to which hydrocephalic children are prone 
are hypothesized to account for uneven growth of intelligence during 
childhood with nonverbal intelligence developing less well than verbal 
(Dennis ef al., 1981). The relationship between hydrocephalus 
diagnosed in the 'first year of life and language development showed 
that with increasing age, hydrocephalic children lag behind (Dennis ef 
al., 1987). 
• Contradictory neuropsychological results have been found with regard 
to hydrocephalus and shunt placements in posterior fossa brain 
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tumour children. Low FSIO scores are reported by some researchers 
(Jannoun & Bloom, 1990; Packer et al., 1987). Others (Mulhern & 
Kun 1985; Yang et al., 1997) report no difference; whereas Johnson et 
al., (1994) found higher FSIO scores in those who had a shunt 






Cushing's critical review (1930) of his inability to cure children of 
medulloblastoma brain tumours by means of surgical resection only, 
paved the way for a possibility of cure by means of post-operative 
irradiation. The modern goal of surgical resection in the treatment of 
posterior fossa tumours involves relief of obstructive symptoms by 
surgical decompression of the tumour and, when necessary, placement of 
a shunt as well as tumour removal (Halperin et al., 1994). 
Most literature on posterior fossa tumours and the role of surgical 
resection is concerned with survival. The evidence strongly suggests that 
a survival benefit accrues after the removal of as much tumour as 
possible, consistent with preservation of neurological function (Albright, 
Wisoff, Zeltzer et al., 1996; Bloom et al., 1990; Lyons & Kelly, 1991; 
Packer, Sutton, Goldwein et al., 1991). 
4.2. SURGICAL RESECTION OF BRAIN TUMOURS 
Tumour type and the associated natural morbidity of the tumour are 
confounding variables when investigating the effects of the extent of 
surgical resection on outcome. 
This is well illustrated in a study by Cochrane et al., (1994) who 
investigated the surgical and natural morbidity of aggressive surgical 
resection of posterior fossa tumours in a sample of 102 children, all of 
whom underwent gross total resection. Thirty three of them suffered from 
intra and post-operative complications. Worsening of pre-operative deficit 
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occurred in 41 % of the children operated on for medulloblastoma tumours, 
in 53% of ependymomas and 30% of astrocytomas. However complete 
recovery of the new post-operative deficits occurred within about six 
months in 14% of the medulloblastoma tumours, in 50% of the 
ependymoma and in 47% of the astrocytoma tumours. Residual 
neurological morbidity, due to the persistence of pre-operative symptoms 
or deficits incurred during the surgical procedure was not shown in 38% of 
the children, although 62% of the children continued to demonstrate 
abnormal cerebellar or bulbar signs. Limitation of function due to a 
residual deficit was shown in 43% of the subjects. 
The variability of the results in association with tumour type, show that it is 
not only the extent of the surgical resection but the natural morbidity of the 
tumour type and other variables, such as peri-operative and intra-
operative factors, that influence the outcome. 
Albright et al., (1996) in reviewing the extent of surgical resection in 
children with medulloblastoma tumours on outcome, conclude that the 
extent of residual tumour rather than the extent of surgical resection 
correlates with the prognosis in certain children. They found that children 
older than three years have a better outcome with total tumour resections 
compared with those who have not had a total resection. 
An important methodological consideration is whether the extent of the 
surgical resection is defined by neurosurgical or neuroimaging criteria 
since the two estimates may differ. There could be little agreement 
between the neurosurgeon's report and the CT scan findings for a number 
of reasons, such as the timing of the reports, as there is often a delay 
between the operating procedure and the CT scan. Therefore, if possible, 
both estimates should be used (Packer, Sutton, D'Angio, 1986 in Ris & 
Noll, 1994). In the articles reviewed on the extent of the surgical resection 
and neuropsychological outcome, only Packer et al., (1987) have taken 
this into account. 
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4.3. EXTENT OF SURGICAL RESECTION AND NEURO-
PSYCHOLOGICAL FUNCTION 
Although an inverse relationship between percent of tumour resected and 
mortality has been shown the relationship between percent of tumour 
resected and neuropsychological morbidity is inconsistent (Ris & Noll, 
1994). 
Surgery itself is not associated with acute effects on neuropsychological 
functioning according to Bordeaux et al., (1988). They designed a study to 
provide both an understanding of the acute treatment effects and provide 
a baseline against which delayed sequelae could be evaluated. In this, 
they compared children treated by means of surgery only with those 
children treated by of surgery and radiotherapy. The groups were 
composed of children with tumours of heterogeneous diagnosis and 
locations, including posterior fossa location. The pre- therapy findings of 
both groups revealed that they performed within the average range on 
most neuropsychological measures. Deficits found at baseline were 
attributed to tumour-related effects and not to surgery. The pre- versus 
post-therapy test findings showed no significant changes for either group. 
The authors suggested that the results indicated that surgery and 
radiotherapy are not associated with acute effects on neuropsychological 
functions. Unfortunately the small sample size (14) influenced the 
statistical power to test for differences. 
Three studies report that the extent of surgical resection of posterior fossa 
tumours had little impact on neuropsychological functioning. (Ellenberg et 
al., 1987; Johnson et al., 1994; Yang et al., 1997) 
Ellenberg et aI., (1987), in a prospective study, found that children who 
had gross total surgical (n=16) resections were more likely to have had 
fourth ventricle tumours. The partial surgical resection (n=24) group 
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comprised an equal number of fourth and third ventricle tumours, the 
remainder being hemispheric tumours. No significant difference between 
the mean IQ scores was found at the first, fourth or long-term post-
operative follow-up assessments of the tumour groups. The amount of 
surgical tumour resection did not therefore impact on cognitive 
functioning. An attempt was made to control for the type of tumour by 
serial testing and having each child act as their own control. 
Johnson et al., (1994), in a retrospective study show that there was no 
significant difference between the extent of surgical resection (seven 
children had total resection: six children had partial resection) and IQ test 
scores or achievement test results in children treated for medulloblastoma 
brain tumours. However visual motor tracking and speed correlated with 
surgery and was significantly poorer for children who had partial surgical 
resections. The authors felt that this impaired specific skill may be 
confounded by other post-operative variables such as vasospasm, 
duration of surgery and intra -operative complications. Although all the 
children had craniospinal radiation of variable doses, two or three children 
were treated with chemotherapy protocols which included Methotrexate. 
Radiation dosage and chemotherapy treatment protocols are thus also 
potential sources of bias. The small number of full-study participants (13) 
is an added limiting factor. The authors verified the presence of the 
tumour and the extent of metastasis according to the staging system 
employed by Chang, Housepian and Herbert Jr (1969). 
A retrospective study by Yang et al., (1997) of 19 children with 
medulloblastoma brain tumours find that there was no significant 
difference in FSIQ scores between the group of children who had gross 
surgical resections and those who had partial surgical resections. Small 
patient numbers, unevenly distributed in the variable categories are a 
potential source of bias in this study in addition to the incomplete records 
documenting the extent of the surgical resection. 
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Conversely Packer et aI., (1987) in a retrospective study demonstrates 
that the extent of the surgical resection is significantly related to FSIQ, 
and this is the only study in the review which documents how the extent of 
surgical resection was verified. The extent of the surgical resection was 
according to the opinion of the surgeon at the completion of surgery and 
the post- operative CT scan (subtotal, near total, total) Post-operatively, 
all patients underwent a repeat CT scan, with and without intravenous 
contrast to determine the extent of the residual tumour and the size of the 
ventricles. An M stage as developed by Allen, Bloom, Ertel et al., (1985) 
and Chang et aI., (1969), was used to verify the stage of the tumour and 
the stage of metastasis. Children with a total resection had a mean FSIQ 
of 98 compared with a mean FSIQ of 60 in children with a less than total 
resection. The number of the children in each surgical resection group is 
not specified but the morbidity of the sample is shown by the decreasing 
number of participants. The total number of medulloblastoma children 
who completed the testing is 17, which is a small sample, when compared 
to the original 43 children. The review is a retrospective study which the 
authors consider a flaw. However, they contend that multi-factorial issues 
such as pre and post-operative mental state as well as size of tumour 
exert an influence on outcome, although the association is not clear. 
Larger tumours which cannot be resected may cause permanent CNS 
damage prior to diagnosis. 
4.4 ADJUVANT TREATMENT 
Cranial radiation and chemotherapy are adjuncts to surgery for the 
treatment of children with posterior fossa brain tumours. These forms of 
adjuvant therapy carry a risk of neuropsychological and quality of life 
morbidity, the extent of which has only now been exposed as children are 
assessed over longer periods of time due to their improved life 
expectancy. The type of treatment regime advocated for posterior fossa 
tumours is dependent on the histological diagnosis of the tumour, the 
stage of the growth and the extent of the surgical resection. 
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Treatment strategies are in a continual state of flux as oncologists attempt 
to minimize the late radiation effects on the young developing brain. Some 
centres reduce the total radiation dose and fraction size in young children 
compared with older children and adults (Bloom & Glees, 1989). 
However, despite modification in the total dose and fractionation, there is 
increasing concern about intellectual impairment and poor quality of life in 
long-term survivors (Bloom & Glees, 1989; Duffner, Cohen, Thomas et aI., 
1985; Duffner & Cohen, 1991; Ellenberg et al., 1987; Kun et al., 1983; 
Mulhern & Kun, 1985; Plowman 1999). In reviewing the literature on 
neuropsychological and quality of life effects of treatment, the researcher 
is faced with the fact of there having been changes in treatment regimes 
over time, as different centres adopt different strategies, which are not 
always considered and are thus a potential source of bias. 
The most serious of the late effects of radiotherapy is necrosis resulting 
from high doses of radiation. This is considered an irreversible vascular 
condition which generally does not become manifest until approximately 
nine to twelve months following cranial irradiation and sometimes even 
years later (Crossen et a/., 1994). Radiation necrosis is a structural term, 
findings of which are based on either imaging or tissue pathology, or both 
methods. The definition implies toxic effects of dosage applied over time 
to some finite portion of normal brain (Crossen et al., 1994). However a 
functional compromise of the patient's neuropsychological status can 
result without overt necrosis occurring and is defined as radiation 
encephalopathy and may resemble normal pressure hydrocephalus or 
leukodystrophy (Frytak in Crossen et al., 1994). 
The pathologic end state of radiation necrosis involves coagulation 
necrosis and gross demyelination of white matter in affected areas. The 
major observation from the long-term follow-up of radiation therapy is 
atrophy of tissues and organs (Crossen et al., 1994). 
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According to Waldrop, Davis, Padgett et a/., (1998) proton MR 
spectroscopy provides biochemical information that can potentially affect 
treatment planning or prompt early intervention to prevent cognitive 
impairment. They found that in children with brain tumours, MR 
spectroscopy of brain tissue remote from the tumour reveals treatment 
related biochemical changes. Chemotherapy as a component of 
multitreatment protocol was associated with significant reduction in the 
biochemical ratios (NAA/Cr ). A trend was shown for patients treated with 
chemotherapy before radiation therapy to have lower biochemical ratios 
suggesting that chemotherapy may alter subsequent effects of radiation 
therapy. In addition a trend was found for children treated with whole brain 
radiation to have lower biochemical ratios relative to those treated only 
with focal tumour therapy and to those not treated with radiation therapy. 
4.5. SEQUENTIAL STAGES OF RADIATION REACTION AND 
NEUROPSYCHOLOGICAL FUNCTIONS 
Sheline (1977) in Crossen et a/., (1994) describes sequential stages of 
radiation reaction and tissue injury for different types of brain tumours: 
acute reaction, early and late delayed reactions. 
These range from many months to several years with the peak of 
symptoms emerging approximately 6 to 24 months after cranial irradiation. 
A prospective study (Bordeaux et a/., 1988) on the acute effects (within 
one year of post-radiation treatment) shows that the treatment modalities 
of surgery only and surgery and radiotherapy are not associated with 
acute effects on neuropsychological functions. The pre- versus post-
therapy neuropsychological test findings indicated no significant interval 
change for either group. The deficits in fine motor, psychomotor and timed 
language skills found at baseline testing were attributed to tumour-related 
effects. The absence of an interval change in the groups shows the 
importance of a follow-up time period of more than a year. At this stage 
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the deficits are more likely to emerge. In addition baseline pre-
radiotherapy test scores are a valuable method of assessing change in 
neuropsychological test scores. 
4.6. PROGRESSIVE INTELLECTUAL DETERIORATION 
As early as the 1970's, it was suggested that mental handicap might be 
progressive or that patients might remain on a plateau of mental 
development following treatment for brain tumours (Glauser & Packer, 
1991 ). 
Subsequent research supports this claim of progressive intellectual 
deterioration in survivors of posterior fossa brain tumours treated by 
means of adjuvant therapy (Duffner et a/., 1988; Ellenberg et a/., 1987; 
Gajjar, et a/., 1994; Hoppe-Hirsch et a/., 1990; Hoppe-Hirsch et a/., 1995; 
Nishiyama et a/., 1994; Packer et a/., 1989). 
Hoppe-Hirsch et a/., (1990) retrospectively assessed an original sample of 
120 medulloblastoma subjects which revealed that the decrease in 
mortality reduced the number of subjects to a sample of 55 patients who 
were assessed five years post treatment. Five years post adjuvant 
treatment (12 patients having received intrathecal Methotrexate in the first 
years of the study), 58% of the sample patients had a FSIO above 80 and 
10% had FSIO < 60. At the ten year post treatment, the sample was 
reduced to 13 patients who were tested. Of these 15% had an FSIO >80, 
35% had a FSIO 60-80 and 46% FSIO < 60. Unfortunately, as this is a 
retrospective study over a long period of time, subject attrition is a 
confounding issue in interpreting the results but nonetheless shows that 
FSIO scores deteriorate over time. 
Hoppe-Hirsch et a/., (1995) again show that, in survivors of 
medulloblastoma tumours (n=59) treated with adjuvant radiotherapy 
(chemotherapy did not include methotrexate) the FSIO deteriorated 
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progressively. In the first year of the assessment, 43% of the sample had 
FSIQ of above 90, whereas at the 10 year assessment only 10% of the 
sample had a FSIQ above 90. The sample is compared with survivors of 
ependymoma tumours (n=37) who did not show the same FSIQ 
deterioration. In the first year of the assessment 63% of the ependymoma 
sample had a FSIQ above 90, while 56% of the sample maintained the 
FSIQ of above 90 at the 10 year assessment. School performance in the 
ependymoma group remained stable whereas in the medulloblastoma 
group school performance showed progressive deterioration over time, 
with 80% of the group in special education at the 10 year assessment. 
Emotional and behavioural disorders were found in 20% of both groups of 
survivors. However, a progressive increase in the emotional and 
behavioural difficulties, such as emotional regression, inhibition, negative 
attitude, instability and attention difficulties, plagued 40% of the survivors 
at the five year assessment and 56% of the survivors at the ten year 
assessment. The authors state that the only difference between the 
groups is the radiotherapy treatment. The medulloblastoma survivors 
were treated with radiotherapy to the cerebral hemispheres whereas the 
ependymoma group were treated with radiotherapy to the posterior fossa. 
In an editorial comment Richard D. Hayward (1995) suggests that the 
chemotherapy may also have been a contributing factor, as only 27% or 
10 out of 37, of the ependymoma patients received chemotherapy 
compared with 76% or 45 out of 59 of the medulloblastoma patients. 
Unfortunately, Hoppe-Hirsch, et aI., (1995) have not included the 
neuropsychological test battery or scores. A cut-off FSIQ score of 90 was 
used as it represented the border between normal and special school. It is 
therefore difficult to make adequate comment on the stated 
neuropsychological deficits of spatial orientation or verbal performance 
discrepancies. 
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A decline in FSIQ is shown by means of serial testing over a four year 
time span in a sample of 19 medulloblastoma children treated with whole 
brain radiotherapy; 14 of these also received adjuvant chemotherapy. 
(Radcliffe et al., 1992) For the group as a whole the mean FSIQ fell from 
a baseline of 104 to 92 at follow-up. The decline in FSIQ occurred 
between the baseline testing and year two of follow-up, but none could be 
documented between years two and four. Children younger than seven 
years of Age-at-Diagnosis had a mean FSIQ loss of 27 points, compared 
with children over seven years of age who showed no significant decrease 
in FSIQ. Special education placements were needed for all the children 
treated at age less than seven years at Age-at-Diqgnosis. Supplementary 
education was required for half the older children. All the children received 
a generally uniform amount of whole brain radiotherapy. The adjuvant 
chemotherapy comprises of cisplatinum, CCNU and vincristine. The 
authors hypothesize that the results are most likely due to the effects of 
the radiotherapy treatment but that the synergistic neurotoxic effect of the 
chemotherapy could not be ruled out on account of the small sample size. 
Although a deterioration in FSIQ was shown up to two years post-
treatment, the same deterioration was not evident beyond the third and 
fourth years of treatment. The children in the study received intensive 
educational therapy which may in part account for the stabilization in 
intellect. 
4.7 YEARS-SINCE-TREATMENT 
Years-since-Treatment effects are complex when one considers specific 
neuropsychological functions (Dennis et al., 1996) Nevertheless memory 
deficits have been found to increase with follow-up time (Packer et al., 
1989). Quality of life issues in survivors of medulloblastoma and 
ependymoma tumours have been reported as impaired psychosocial 
adjustment, the greater the Years-since-Treatment (Seaver et al., 1994). 
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The studies of Ellenberg et al., (1987); Hoppe- Hirsch et aI., (1990); 
Hoppe-Hirsch et al., (1995); Moore, Ater and Copeland (1992); 
Nishiyama et al., (1994); Packer et al., (1989), suggest progressive 
deterioration in FSIO in survivors of brain tumours with Years-since-
Treatment. These studies are discussed in the following chapter. 
4.8 INTERACTION OF AGE-AT-DIAGNOSIS AND YEARS-
SINCE-TREATMENT 
Dennis et al., (1996) attempt to clarify the interaction of Age-at-Diagnosis 
and Years-since-Treatment, in predicting the outcome in a sample of 25 
survivors of medulloblastoma brain tumours treated with surgery and 
radiotherapy. They found that Age-at-Diagnosis and Years-since-
Treatment contribute separately to intellectual morbidity. PIO varied with 
the chronological age of the child at tumour diagnosis (the younger 
children had lower PIO's) and appeared to measure some general effects 
of cerebral insults, but was relatively constant in magnitude once 
established. VIO declined with Years-since-Treatment and seemed to be 
less dependent on the stage of development at which the tumour was 
diagnosed. The ranges of Age-at-Diagnosis 0-12 years and Years-since-
Treatment are 0 - 15 years respectively. In the younger Age-at-Diagnosis 
group < 4 years of age, the Years-since-Treatment is the longest (9 years 
compared with the other age cohorts of about 4 years) time span. The 
authors felt that failure to acquire knowledge might be a consequence of a 
time-limited brain pathology, interacting with environmental issues over 
time. The result was that the VIO scores dropped with increasing Years-
since-Treatment. In other words the medulloblastoma survivors failed to 
increase their verbal capacities at the same rate as other children of the 
same age, over the same period. 
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4.9. SURGERY AND RADIATION TREATMENT 
Studies comparing children who do not undergo radiation as part of their 
treatment with those children whose tumours have been treated with 
radiation and surgery, show that regardless of the age at which the 
tumour was diagnosed, radiation treatment lowers IQ scores (Chadderton 
et a/., 1995; Chin & Maruyama, 1984; LeBaron et aI., 1988; Mulhern et a/., 
1992; Roman & Sperduto, 1995). 
Silverman, Plakes, Talent et aI., (1984) compared the late 
neuropsychological outcome of children treated for medulloblastoma 
tumours with craniospinal irradiation to their sibling controls. The patient's 
FSIQ score (average to low average range), compared with the non-
irradiated sibling (average to bright average range) was found to be 
significantly lower but a striking difference was found between PIQ of 
patients compared with the sibling controls. All nine siblings scored at 
least 11 points higher on the PIQ than the irradiated patients. The effects 
on VIQ score were less dramatic but significant. Analysis of the FSIQ 
scores relative to whole brain radiation dose showed no significant effects. 
All patients had mild cerebellar dysfunction such as ataxic gait and 
dysdiadochokinesis and five patients had severe tremors. None of the 
neurological findings interfered with test performance and vision and 
hearing were normal in all but one patient. No correlation was found 
between FSIQ scores and objective physical or neurological findings. 
The authors conclude that the decreased FSIQ scores of the patients are 
due to the treatment effects of radiation therapy. The use of sibling 
controls strengthens the conclusions of the hypothesis. The significant 
effects of the PIQ are discussed in terms of a decreased ability to 
assimilate new information and apply it to unfamiliar situations. This effect 
was more profound in the children younger than eight years of age at 
treatment who had not yet established strong reading skills or other rote 
functions mastered by the older patients. The patients' significantly lower 
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scores in arithmetic skills were discussed in terms of difficulty in ability to 
reason abstractly rather than a function which relies on over-learned skills. 
A trend towards increased effects of the treatment on cognitive function 
from Years-since-Treatment was also found. The authors conclude that 
serial evaluations are needed to explore this. 
4.9.1 Radiation Dose Response Relationship 
Children who undergo radiation treatment for brain tumours receive higher 
doses than those treated for leukemia and are therefore at greater risk for 
significant cognitive decline. Cousens, Waters, Said et a/., (1988) indicate 
that 1800 - 2400 centigray (Gy) of Whole Brain Radiotherapy Treatment 
(WBRT) is associated with an average decline of 10 FSIQ points, in 
children treated for leukemia. According to Ris and Noll (1994) and 
Roman and Sperduto, (1995), the data showing the relationship between 
radiation dose and outcome in children with brain tumours are 
inconsistent. The absence of a dose- response relationship may reflect a 
restriction in the range of the dose studied, as most children treated for 
posterior fossa brain tumours receive similar amounts of WBRT (Dennis 
et a/., 1996; Packer et a/., 1987; Sutton et a/., 1989). The articles by 
Mulhern (1994) and Ris and Noll (1994) of children treated with brain 
tumours find that there were few studies relating the radiation dose to 
decreased IQ scores. The effects of the range of radiation are better 
clarified in articles comparing the effects of radiation in children with 
posterior fossa tumours with those children treated for leukemia, as 
shown by Silber et a/., (1992). In a mixed group of ALL and 
medulloblastoma patients they found a greater FSIQ loss at two years 
post WBRT. In other words the higher the radiation dose the lower was 
the FSIQ. Thus a radiation dose of 36 Gy to the whole brain resulted in 
FSIQ scores of 8 points less on IQ testing than those children treated with 
24 Gy, who achieved 12 points less on IQ testing than those treated with 
a radiation dose of 18 Gy. Young children showed a significantly greater 
negative effect of RT than older ones. 
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Recently Grill et aI., (1999) found long term intellectual fall outs in children 
with posterior fossa tumours according to the radiation doses and 
volumes. Long term cognitive impairment occurred in most of the patients 
as well as those receiving treatment only to the posterior fossa area. A 
significant correlation was shown between FSIO scores and CSI dose. 
The higher the dose the lower the FSIO score. The contribution of 
chemotherapy to the low scores according to the authors was not 
associated with impaired intellectual outcome. Half the subjects (10/21) 
did not receive chemotherapy. However no details are given as to how 
this finding occurred or the neuropsychologcal scores of those receiving 
chemotherapy compared to those not receiving chemotherapy treatment. 
The outcome of restricted field radiation (RFRT) is also inconsistent as at 
present most treatments for children with brain tumours include RFRT. 
Dennis, Spiegler, Obsawin et aI., (1992) found deficits in working memory, 
but only in children with thalamic tumours treated with RFRT. 
The differences in the fractionation, duration of RFRT and WBRT and 
whether treatment was completed or terminated due to complications, are 
often not reported in the results, making interpretation difficult. 
4.9.2 Methotrexate Chemotherapy 
Research on the effects of chemotherapeutic agents on cognitive 
functioning is minimal (Dowell et al., 1989). An additional difficulty is that 
the chemotherapy protocols are not specified. Considerable evidence 
suggests that the use of methotrexate, intravenous or intrathecal, is 
associated with neuropsychological decline, particularly when used in 
conjunction with WBRT (Bleyer 1981; Duffner, Cohen, Anderson et aI., 
1983; Duffner et al., 1988). 
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As early as 1979, Hirsch and his French colleagues (Glauser & Packer, 
1991) show that the treatment effects of surgery, radiotherapy and 
chemotherapy caused a decrease in 10 scores, although they had 
difficulty in deciding which treatment factors caused the decrease in 10 
scores and behavioural difficulties found in the sample. Only 11 % of the 
subjects who were treated for PNET had an FSIO > 90, while 31 % had an 
FSIO <70. Craniospinal irradiation increased to doses of 5000 rads and 
chemotherapy included intrathecal methotrexate, vincristine and CCNU. 
Ninety three percent of the sample had emotional and behavioural 
disorders. Functional disability, assessed by Bloom's criteria, showed that 
15% were in functional category 11 (mild disability, active life) and 12% in 
category 1V (total disability). Hirsch et al., (1979) used a control 
astrocytoma group (surgery only treatment) to compare the deficits and 
found that 62% of the astrocytoma subjects had an 10 > 90. However, 
59% of them had emotional and behavioural problems, suggesting that 
factors, other than treatment of radiotherapy, chemotherapy and surgery, 
were associated with the difficulties. 
Studies of children with ALL have suggested that children treated with a 
combination of CNS radiation and chemotherapy, intrathecal 
methotrexate, may have learning disabilities, perceptual difficulties and in 
some cases dementia (Meadows & Evans; 1976). According to Duffner et 
al., (1983) and Waber, Tarbell, Kahn ef al., (1992) it is likely that 
prophylactic radiation of the CNS in children, together with intrathecal 
methorexate, may lead to a mild but significant lowering of 10. Conflicting 
results regarding CNS prophylactic therapy on cognition appear to be due 
to inconsistencies in methodology (Fletcher & Copeland, 1988). More 
recently, Butler, Hill, Steinhertz et al., (1994) find that cranial radiation in 
conjunction with methotrexate is associated with impairment in nonverbal 
intelligence, perceptual abilities and a susceptibility to distraction. 
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4.9.3 Nonmethotrexate Chemotherapy 
The role of chemotherapy in posterior fossa tumours depends on the 
histological diagnosis. The Grade 1 and Grade 11 cerebellar 
astrocytomas are resistant to chemotherapy (Karabus, 1996). The 
platinum compounds and several single agents are however the most 
effective treatment for ependymoma brain tumours (Karabus, 1996), while 
only short duration responses to single or multiple agent chemotherapy 
regimes are reported for brain stem glioma treatment (Levin, 1985). 
Medulloblastoma / primitive neuroectodermal tumours appear to be the 
most chemosensitive. Alkylators such as cyclophosphamide and 
melphalan and the platinum compounds are single active agents. 
Combinations such as 8-drugs-in-one-day devised by Bleyer and her 
colleagues, MOPP or CCNU, vincristine and procarbazine have shown 
some positive effect (Karabus, 1996). The few randomized trials 
performed suggest a marginal benefit for the addition of chemotherapy 
only in patients at high risk, which is described as young age, incomplete 
resection or advanced Chang stage (Evans et al., 1990; Pezotta, 
Montezemolo, Arrigoni et al., 1996;Tait, Horton-Jones, Bloom et al., 
1990). 
The blood brain barrier (BBB) and the blood cerebrospinal fluid (CSF) 
barrier have decreased permeability in patients with CNS malignant 
tumours and are therefore major obstacles to anti-tumour drug delivery. 
When visualized on contrast-enhanced imaging, the surrounding tumour 
infiltrated brain has a relatively intact barrier. Even if the main bulk of the 
tumour has a permeable vascular endothelium, the edge of the tumour, in 
which tumour proliferation is most rapid, has decreased permeability to 
anti-tumour agents (Williams, Henner, Roman-Goldstein et al., 1995). 
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4.9.4 Complications Of Chemotherapy 
4.9.4.1 Platinum- Based Chemotherapy Hearing Loss 
Institutions use different chemotherapy protocols over varied periods of 
time, with the result that the effects of the chemotherapeutic agents on the 
neuropsychological functions of children with posterior fossa brain 
tumours are difficult to extrapolate. The interactive, synergistic effects of 
methotrexate chemotherapy and radiotherapy are well documented. The 
interaction may also apply to modern platinum based chemotherapy. Thus 
cisplatin is cumulatively toxic to the inner ear, leading first to high tone 
hearing loss, and this is synergised by prior radiotherapy encompassing 
that organ (Plowman, 1996). The hearing loss caused by cisplatin is, 
however irreversible (Duffner et aI., 1988), while hearing loss extending to 
speech can limit cognitive development (Mulhern, 1994). 
Marked intellectual deficits have been observed following platinum/brain 
radiation scheduling (Duffner et al., 1988; Vijayraghaven, Brock, Monson 
et aI., 1993). 
Differences in toxic profiles between carboplatin (primarily 
myelosuppression) and cisplatin (mainly nephrotoxicity, peripheral 
neuropathy and ototoxicity) have led to their combination in regimes for a 
variety of malignancies (Freilich, Kraus, Budnick et aI., 1996). Castello, 
Schiavetti, Padula et a/., (1995) found no evidence of ototoxicity in a 
group of low grade astrocytoma children treated with chemotherapy 
protocols which included carboplatin. Freilich et al., (1996) found that 
hearing deteriorated in five out of 14 children under six years of age, 
diagnosed with malignant brain tumours and treated with surgery and 
combinations of cisplatin and vincristine, cyclophosphamide and 
Etoposide followed by consolidation with carboplatin, ThioTEPA. 
Etoposide and autologous bone marrow rescue. The authors conclude 
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that ototoxicity is related to the consolidation therapy and is probably due 
to the high dose of carboplatin used prior to cisplatin therapy, 
aminoglycosides and cranial irradiation in one patient. According to 
Williams et aI., (1995) despite these side effects carboplatin and 
Etoposide with BBB disruption are sometimes an active treatment in 
malignant astrocytomas and have produced dramatic responses in PNET. 
4.9.4.2 Vincristine 
Vincristine, one of the biologically active alkaloids, is used in the treatment 
of solid tumours, lymphoma and lymphoblastic leukaemia (Roux, 1987)" 
Neurotoxicity is dose limiting in vincristine therapy while RT may enhance 
vincristine neurotoxicity (Byfield, 1972 in Roux, 1987). 
Vincristine causes peripheral neuropathy which improves after treatment 
stops. However, without due care muscular contractures may occur (Ryan 
and Emani, 1983)" Neuromyopathy is present in all patients treated with 
vincristine for more than two months. Vincristine does not appear to cross 
the BBB, but intrathecal administration of vincristine has been uniformly 
fataL The drug is rapidly distributed and bound to neurons, causing 
neuronal death (Gaidys, Dickerman Walters et al., 1983) Neurotoxicity 
due to vincristine, occurs outside the CNS, in the absence of intrathecal 
administration (Roux, 1987). 
The outcome of radiation and an adjuvant chemotherapeutic regimen of 
vincristine, cisplatin, and CCNU is discussed with regard to the toxicity of 
the adjuvant chemotherapy in a study of 63 children with posterior fossa 
medulloblastoma tumours (Packer et aI., 1994). Forty seven percent of 
patients developed significant audiological toxicity, usually after the fourth 
dose of cisplatin. but only one child required a hearing aid at the end of 
treatment and another developed a progressive hearing loss three years 
following completion of treatment and now requires a hearing aid. Renal 
toxicity developed in 13 children, but no child developed clinically 
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significant kidney dysfunction. Eleven children required platelet 
transfusion. Severe vincristine-related peripheral neuropathy was 
relatively infrequent. Seizures or other neurotoxicity due to the 
chemotherapy were not found. The authors state that using a modified 
dose of cisplatin is a means of allaying the concerns over the ototoxicity of 
the drug. However, a head-to-head trial of any other drug regime 
compared with CCNU, cisplatin and vincristine regimen has never been 
undertaken and there are no data to determine the potential toxicity of 
other adjuvant drug regimens. 
4.10. SUMMARY 
• Tumour type and the associated morbidity of the brain tumour are 
interrelated factors when investigating the effects of the surgical 
resection on outcome. How the resection is defined is a 
methodological consideration in the evaluation of outcome. 
• Surgical resection per se is not usually associated with cognitive 
morbidity and quality of life outcome is generally not considered. 
• There is no clear evidence that the extent of the surgical resection is 
associated with intellectual decline. 
• An overall difficulty in the evaluation of surgical resection is the 
heterogeneity of the surgical procedures as well as the intraoperative 
support and peri-and post-operative management which are sources 
of variance which should be taken into account when evaluating the 
overall treatment outcome. 
• Cranial radiation and chemotherapy are often adjuncts to surgery for 
the treatment of posterior fossa tumours. These are in a continual 
state of flux in an attempt to improve the neuropsychological 
functioning and quality of life outcomes on the developing brain. A 
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detailed discussion of factors pertaining to neuropsychological and 
quality of life outcome, based on the literature review found in 
Appendix H, is presented in Chapter 6. 
• The sequential stages of radiation reaction for different types of brain 
tumours may range from six to 24 months. In the acute stage, within 
one year post-radiation treatment impaired neuropsychological scores 
may not be found in posterior fossa brain tumour survivors (Bordeaux 
et a/., 1988). However, progressive intellectual deterioration is 
reported by some researchers (Duffner et a/., 1988; Ellenberg et aI., 
1987; Gajjar et aI., 1994; Hoppe-Hirsch et a/., 1990; Hoppe-Hirsch et 
a/., 1995; Nishiyama et a/., 1994; Packer et aI., 1989) or patients may 
remain at a plateau of mental development (Bamford et a/., 1976). 
• A correlation between radiation dose and volume and cognitive 
decline in scores is described, but the contribution of chemotherapy to 
the low scores is not clearly illustrated. 
• Years-since-Treatment effects are complex and are discussed in 
greater detail in later chapters as well the interaction of Age-at-
Diagnosis and Years-since-Treatment. 
• The contributions of chemotherapy to the neuropsychological outcome 
are difficult to extrapolate and are presumed to be interactive unless a 
longitudinal design is employed to partial out the effects of each type 
of treatment. 
• Hearing loss is a complication following cisplatin chemotherapy. 
Vincristine causes neuropathy which improves after treatment stops 
but RT may enhance vincristine neurotoxicity. 
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CHAPTER 5 
SELECTED POST-TREATMENT COMPLICATIONS 
5.1. TRANSIENT CEREBELLAR MUTISM 
In 1985, two separate studies Rekate, Grubb, Aram et a/., (1985) and 
Yonemasu, (1985), in Humphreys (1989), define transient cerebellar 
mutism, as the temporary absence of speech and sound in an awake and 
conscious patient. This was first recognised as a complication following 
surgery for the resection of posterior fossa tumours in children. Although 
Hirsch et a/., (1979) acknowledge the problem of speech disorders 
including post-operative mutism in their patients treated for 
medulloblastoma tumours, they do not expand on the entity of mutism 
which can occur as a post-operative phenomenon in some children who 
have recently had surgery for cerebellar-tumours (Humphreys, 1989) 
5.1.1 Definition of the Syndrome 
Humphreys et a/., (1989) cite that the syndrome first described by 
Yonemasu and Rekate et a/., developed after the removal of very large 
fourth ventricular tumours. Post-operative speech loss occurred after a 
brief interval of normal speech. The mute state persisted for one to three 
months and was followed by a severe cerebellar speech disturbance with 
a subsequent return to normal patterns of speech. Despite the presence 
of severe cerebellar ataxia, the children were otherwise alert and 
exhibited no obvious brain-stem signs. The children showed no 
disturbance of phonation, were able to comprehend words well and to 
communicate with others by gesture. Yonemasu attributed the 
phenomenon to aphasia rather than mutism and cited an earlier paper by 
Sakai (1980) on the subject. Rekate et aI., (1985) on the other hand 
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favoured a cerebellar rather than a brain-stem process. The absence of 
long tract and other cranial nerve dysfunctions supported their hypothesis. 
Debate on the aetiology is rife and, since the syndrome was first 
described, many other cases have been reported (Wisoff and Epstein, 
1984; Humphreys, 1989; Ferrante et al., 1990; Asamoto, Ito, Suzuki et 
al." 1994; Cochrane et aI., 1994; Crutchfield, Sawaya, Meyers et al., 
1994; Kingma, Mooij, Metzemaekers et aI., 1994; Van Dongen, Catsman-
Berrevoets and Van Mourik 1994; Dailey, McKhann II and Berger, 1995; 
Pollack et al., 1995; Van Calenbergh, Van der Laar, Plets et aI., 1995; 
Ersahin, Mutluer, Cagli, et al., 1996; Jones, Kirollos and Van Hille 1996; 
Liu, Phillips, Molloy et al., 1998) 
The syndrome, although uncommon, is now a well-documented 
complication. The incidence of transient cerebellar mutism in children with 
posterior fossa tumours is reported as 8.2% by Dailey et al., (1995), 5.7% 
by Cochrane et al., (1994) and 8.5% by Pollack et al., (1995). Risk factors 
appear to be large tumour size, midline location, brain stem and fourth 
ventricle involvement, hydrocephalus and post-surgical oedema or 
meningitis (Van Calenbergh, et aI., 1995). 
The types of posterior fossa tumours associated with mutism are; 
medulloblastoma, astrocytoma and ependymoma (Ersahin et al., 1996; 
Ferrante et al., 1990; Pollack et al., 1995). However 61 % of the cases 
occurred after the removal of a medulloblastoma brain tumour. (Van 
Calenbergh et al., 1995) 
The literature suggests that 90% of the children with cerebellar mutism 
are less than 10 years old (Van Dongen et aI., 1994), that the mean age 
of the children is 7.5 years at onset of the mutism syndrome and that 72% 
of the cases occur in boys. All cases are transient and the average 
interval of mutism is 6.5 weeks (Van Calenbergh et aI., 1995). 
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5.1.2 Visual Impairment Associated With Mutism 
Visual impairment associated with mutism after posterior fossa surgery 
has recently been described in four children (Liu et al., 1998) The authors 
report that they are not sure if they are describing a new phenomenon or 
one unrecognized in some of the previously reported children. Pre-
operatively, none of the children had visual complaints apart from diplopia. 
Post-operatively all four children became mute and withdrawn. Neuro-
opthalmology consultation revealed that no child blinked to threat or 
followed, although the pupils were reactive to light. Each child had 
papilloedema: one child reached for an object of interest while another 
had an inconsistent optokinetic response. Visual impairment improved 
roughly in parallel with the recovery of speech. Within three weeks to six 
months the disc swelling had resolved and the optic discs retained their 
normal colour. Follow-up neuroimaging did not reveal any causative lesion 
in the visual pathways. The authors discounted a variety of causes for the 
visual loss such as retinal or choroidal ischaemia, errant shunts and 
cortical blindness. They hypothesize that the children suffered from visual 
inattention caused by damage to the cerebellar structures having an 
influence on higher cortical functions including attention and language. 
They suggest that the cerebellum may be important in tasks that require 
rapid shifts of attention between auditory and visual stimuli as suggested 
by Courchesne, Townsend, Akshoomoff et al., (1994) 
5.2 ENDOCRINE DYSFUNCTION 
5.2.1 Growth Hormone Deficiency (GHD) 
According to Duffner and Cohen (1991) a review of retrospective studies, 
suggests that cranial irradiation will cause GHD in up to 80% of children 
with brain tumours and that the biochemical effects can be identified as 
early as three months following completion of radiation. 
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Several retrospective studies demonstrate that GHD is the first and most 
frequent pituitary deficiency to occur in children who receive cranial 
irradiation for tumours distant from the hypothalamus and pituitary region 
(Brauner, Rappaport, Prevot et aI., 1989; Duffner et a/., 1985; Johnson et 
aI., 1994) A prospective study comparing a group of patients who received 
cranial irradiation only with a group who received craniospinal radiation 
show that pituitary GH secretion is more rapidly impaired in children than 
adults (Lam, Tse, Wang et aI., 1987 in Brauner et aI., 1989). However, the 
effect of GH impairment was minimal two years after radiation and most of 
the growth retardation found in children treated with craniospinal radiation 
was due to the additional spinal radiation. The children with 
medulloblastoma and ependymona brain tumours who received an 
irradiation dose between 31-42 Gy, lost almost 1.5 standard deviations of 
height after two years craniospinal radiation. 
GHD does not appear to be reversible, as the children in the Duffner 
(1985) study remained GHD for as long as eight years following 
treatment. Most GHD children with brain tumours will grow on GH 
treatment. Lannering et a/., (1990) found that 57% of the sample of adults 
treated for brain tumours as children had short stature. AlthoUgh the GH 
had been given to all prepubertal patients with GHD, it had been started 
too late to prevent short stature. 
Meanwhile there is a concern that administration of GH may induce 
recurrent tumours (Ogilvy-Stuart, Ryder, Gattameni et a/., 1992). A 
reassuring study on 1262 children with brain tumours treated with GH 
shows that children with the more common types of brain tumours, such 
as glioma and medulloblastoma, do not seem to be at excessive risk of 
recurrence (Moshang Jr, Rundle, Graves, et a/., 1996). 
An additional cause of short stature in children treated for brain tumours, 
is failure of the vertebral body growth due to radiation (Chin and 
Maruyama, 1984). The adverse influence of young age at Time-of-
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Treatment is reported by Duffner and Cohen (1991) who find that the 
younger the child at the time of spinal radiation, the worse the subsequent 
disproportion. A loss of 9cm in height is anticipated in children treated with 
spinal radiation at the age of one year compared to a S.Scm loss in 
children radiated at ten years of age. As GH treatment will not improve 
spinal growth, height will be significantly affected. 
Adjuvant chemotherapy also adversely affects height (Duffner and Cohen, 
1991; Mulhern et al., 1989). Poor nutrition and the associated side effects 
of chemotherapy of nausea, vomiting and lack of appetite are likely to 
increase the role of poor nutrition in growth failure (Duffner and Cohen, 
1991 ). 
Endocrine deficiencies and growth retardation in height at less than the 
fifth percentile appear in a retrospective study where of 9 out of 14 
children with brain tumours have been treated with radiation (Moore, 
Copeland, Reid et al., 1992). A study of a twin who was treated for a 
medulloblastoma, indicates that her height was 3.6cm shorter than that of 
her twin one year after treatment. Three and a half years later, the 
difference in height had increased to 7cm but has not changed since then. 
An interesting aspect of the study is that the treated twin was not short in 
stature compared with Japanese girls of the same age (Nishiyama et al., 
1994). 
Growth hormone supplementation has not been found to affect cognitive 
function. Dennis et al., (1992), for example found no difference in memory 
scores between children and adolescents who are being treated for brain 
tumours and receiving growth hormone supplementation and those not 
supplemented. However, the authors did show that certain combinations 
of age and hormone variables produce deficient serial order memory 
scores but state that further research is needed. 
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Weight measurement is not often reported and this may be due to the fact 
that few abnormalities in weight are reported. Li, Winston and Gimbrere 
(1984), reveal that in 96 survivors of brain tumours treated with surgery 
and adjuvant therapy, only 2% had a weight of below the 3rd percentile 
and 13% were above the 9th percentile. A Japanese study (Onoyama, 
Mitsuyuki, Takahashi et al., 1975) shows that stunted growth of more than 
2 standard deviations below the mean was found in 36% of the brain 
tumour survivors treated with surgery and radiotherapy. However, only 
eight children, or 19% of the sample, had an abnormal decrease in weight 
of more than two standard deviations. Bamford, Jones Peason et aI., 
(1976) also report a low incidence, 23%, of weight below the 25th 
percentile, in a sample of long term survivors of brain tumours. 
Robertson, Ackerman and Traynelis (1997) surprisingly report increased 
height in patients with medulloblastoma tumours. The pre-operative height 
and weight were documented and compared with a control group of 
cerebellar astrocytoma tumour patients. A significant number of patients 
presenting with medulloblastoma brain tumours had attained increased 
height but maintained normal weight, which was inconsistent with the 
weight loss generally observed with neoplasms. A similar finding in height 
was not observed in the astrocytoma brain tumour group who were of 
average height and low average body weight. The authors conclude that 
medulloblastoma brain tumours may be influenced by GH production or 
may produce growth factors in vivo. 
5.3. SEIZURES 
Virtually any insult to the developing nervous system can result in 
seizures. The terms seizures, convulsions and epilepsy are sometimes 
used synonymously but do not in fact refer to the same phenomenon 
altho~gh they have the same common denominator - involvement of 
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abnormal electrical activity or discharge of cerebral neurons (Spreen et 
al., 1995). 
The cerebellum therefore does not have the ability to generate seizures. 
As suggested by Cohen and Duffner (1984) seizures as a presenting 
symptom of posterior fossa tumours are rarely reported, as this implies 
spread of the tumour into other areas, unlike hemispheric tumours in 
which seizures as a presenting symptom occur in 30% to 60% of cases. 
In cortical tumours in childhood, seizures are second only to headache as 
the most common presenting symptom (Giles, Sobel, Leviton et al., 1992; 
Penfield, Erickson and Tarlov et al., 1940; Piepmeier, 1987). Meanwhile 
Packer, Sutton, Patel et al., (1994) report the incidence of seizure control 
following tumour surgery for childhood low grade gliomas. Tumour-related 
seizures are more frequently associated with slow growing, infiltrating 
neoplasm and they may have their origin in the tumour-free cortex 
adjacent to the neoplastic nidus. 
As epilepsy is a symptom of disease rather than a disease itself, the 
investigation of post-operative seizures depends on knowledge of 
potential causes. These may be due to shunt complications, spread of the 
tumour into the cerebral cortex, electrolyte imbalance or cranial irradiation. 
An 11.5% seizure disorder was reported following treatment in a sample 
of brain tumour children, a higher incidence occurring in those children 
with supratentorial tumours (Gjerris, 1976). A similar incidence of post-
operative seizures is found by Hoppe-Hirsch et al., (1990), five years after 
treatment, in a sample of 84 medulloblastoma brain tumour patients. At 
the ten year post-treatment assessment, the number of survivors reported 
with epilepsy was the same as at the five year assessment (nine patients) 
but due to the decrease in the size of the sample, the incidence was 
reported as 26%. 
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A long-term retrospective study of children treated with irradiation for brain 
tumours indicates that epilepsy emerged as the only significant variable 
independently associated with poor cognitive function (Syndikus et al., 
1994). Moreover, Ellenberg et aI., (1987) report that two children with 
hemispheric tumours and a history of seizures prior to cranial irradiation 
had the lowest FSIQ scores in the sample. 
It is well documented that seizures and anticonvulsant medication may 
contribute to neurobehavioural morbidity (Kun et al., 1983; Syndikus et al., 
1994). 
According to Spreen et al., (1995), the developing brain is more 
susceptible to repeated seizure activity, with resulting cell death or at least 
inhibition of continuing cell enlargement and the formation of more 
complex connections between neurons, so that the effect on intelligence 
in children is more profound. Mental retardation following seizures was 
found to be more common in children if the seizures have been 
uncontrolled for two years and if there was an early onset (Huttenlocher 
and Hapke, 1990). 
In a detailed study of neuropsychological performance, O'Leary, Lovell, 
Sackellares et al., (1983) reveal that early onset, regardless of seizure 
type, places a child at risk of cognitive dysfunction. However it is not 
possible to examine the consequences of a convulsant disorder 
independently of the underlying aetiological condition. Accordingly 
epilepsy - recurrent and frequent seizure activity - is often associated with 
motor disorders (Spreen et al., 1995). 
5.4 SUMMARY 
• The incidence of transient cerebellar mutism in children with posterior 
fossa tumours varies from 8.5% to 5.7%. Visual impairment 
associated with mutism has recently been described and improvement 
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parallels recovery of speech associated with improvement in the 
mutism condition. 
• Growth hormone deficiency due to cranial irradiation occurs in up to 
80% of children with brain tumours and is not reversible. An adverse 
influence of young Age-at-Diagnosis at Time-of-Treatment causes 
short stature in which there is failure of the vertebral body to grow due 
to retardation. Adjuvant chemotherapy adversely affects height, such 
that height may be below the 5th percentile. 
• Weight is often not reported as few abnormalities have been shown. 
• Recurring seizures, as presenting symptoms in posterior fossa 
tumours are rarely reported as the cerebellum does not have the 
ability to generate seizures. However seizures as a presenting 
symptom may be associated with slow-growing tumours which have 
their origin in the tumour-free cortex adjacent to the neoplastic nidus 
(Packer et al., 1994). 
• An 11 % post-operative incidence of seizure disorder in 
medulloblastoma survivors is reported. 
• Epilepsy is associated with poor cognitive functioning in brain tumour 
survivors treated with cranial irradiation. 
• The developing brain is more susceptible to repeated seizure activity 





LITERATURE REVIEW OF NEUROPSYCHOLOGICAL FINDINGS 
AND QUALITY OF LIFE ISSUES 
6.1. INTRODUCTION 
In an extensive literature review on paediatric brain tumours there is no 
distinct neuropsychological profile for paediatric brain tumours (Glauser 
and Packer, 1991 ;Ris and Noll, 1994). This is not unexpected given the 
broad spectrum of tumours studied and the concomitant wide array of 
treatments given to both children and adult survivors over differing time 
spans. 
A deficit pattern of attention, memory and nonverbal skills with the relative 
preservation of language ability is found in patient populations such as 
those with congenital hydrocephalus or head injury, who sustain damage 
to the cerebral white matter. Fletcher and Copeland (1988) reported the 
same deficit pattern in children treated with CNS prophylaxis diagnosed 
with ALL and treated with cranial radiation. 
Moore, Ater et al., (1992) discussed this pattern in children diagnosed with 
brain tumours in infancy and treated with cranial irradiation, whose 
weakest scores were in PIQ and visual spatial ability. The authors 
postulated that tasks emphasizing nonverbal processing skills (believed to 
be subserved by the non-dominant hemisphere) are more vulnerable to 
white matter damage caused by radiation than those subserved by the 
dominant hemisphere. This hypothesis is based on findings that in normal 
right-handed adults, the blood flow is greater in the cerebral white matter 
of the right than of the left hemisphere (Gur et al., 1980 in Moore, Ater et 
aI., 1992). Greater white matter volume is then presumed in the right 
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rather than the left hemisphere. The vulnerability of white matter to 
radiation induced damage should therefore be manifested to a greater 
degree in the hemisphere with the greatest proportion of white matter. 
Deficits would then be more nonverbal than verbal in nature. The pattern 
of relative preservation of language skills supports the hypothesis that 
dominant hemisphere functions are less vulnerable to the effects of 
cranial irradiation (Fletcher and Levin in Moore, Ater et aI., 1992). 
Further evidence to support the loss of white matter was found by 
Mulhern, Reddick Palmer et al., (1999). They showed that patients treated 
for medulloblastoma brain tumours by means of surgery, radiation and 
chemotherapy had significantly less normal white matter and significantly 
lower FSIQ scores than patients treated by means of surgery for 
astrocytoma brain tumours. The authors concluded that irradiation or 
chemotherapy treatment induced destruction of normal white matter. This 
can partially explain intellectual and academic achievement deficits 
among medulloblastoma survivors. Their obtained model suggests that 
variations in the subjects normal white matter may provide a more direct 
explanation for variations in FSIQ scores than the patient's age at 
treatment. 
The literature review covers a time span of twenty five years, 1975 to 
2000. Appendix H lists the papers found through a computer search and 
review of principle professional journals in the areas of paediatric 
oncology. Papers presented in the review include both the acute (less 
than one year post treatment) and chronic effects of treatment on 
neuropsychological and quality of life outcome measures. Although the 
review by Ris and Noll (1994) selected one year after treatment as a point 
of demarcation, other reviews (Crossen et al., 1994; Glauser & Packer, 
1991; Roman & Sperduto, 1995) have included subjects in both the acute 
and chronic treatment stages. The review by Mulhern (1994) concentrates 
on late effects, which occur after completion of medical treatment, at 
about two or more years from the time of diagnosis. The inclusion of 
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subjects in both early and late treatment stages in the present review 
should give one a better idea of the vulnerability of the functional status of 
the childhood survivors. 
The review focuses on studies in which the outcome for children with 
posterior fossa brain tumours can be ascertained. It includes studies of 
childhood tumours that provide illustrative contexts or relevant contrasts to 
posterior fossa brain tumours and studies using only specific types of 
posterior fossa brain tumours such as medullblastoma, astrocytoma, 
ependymoma or brain stem glioma brain tumours. As there are few 
articles on the social, behavioural and health related quality of life of brain 
tumour survivors, selected studies on children surviving ALL have also 
been included. ALL and brain tumours are fatal if untreated, both disease 
states are carcinogenic and the treatment for both diseases involves 
radiotherapy and chemotherapy. The ALL studies should therefore add 
pertinent information about treatment related toxicity. 
6.2 DETERMINANTS OF NEUROPSYCHOLOGICAL AND 
QUALITY OF LIFE OUTCOME AFTER POSTERIOR 
FOSSA BRAIN TUMOURS IN CHILDHOOD 
Studies of cognitive morbidity have explored how neuropsychological and 
quality of life outcomes are related to several variables. These include 
factors in the child such as SES and Age-at-Diagnosis: features of the 
tumour (Chapter 2), factors associated with pretreatment (Chapter 3), 
treatment (Chapter 4) complications following treatment (Chapter 5), 
Time-since-Treatment and the interaction among these factors. 
6.2.1 The influence of Socio-economic Status (SES) 
SES is an index that reflects diverse factors: these include nutrition, 
quality of home environment, parental education, quality of school and 
79 
quality of medical care. Although most of the studies reviewed reported 
that they had considered SES in the sample no study found that SES had 
contributed to either a good or poor outcome. Ris and Noll (1994) stated 
that little research has considered these factors. Two studies (detailed 
below) conducted at Groote Schuur Hospital, in Cape Town, South Africa, 
support the crucial role of SES in understanding neurobehavioural 
outcome. 
Roux (1987) compared survivors of ALL treated with RT and 
chemotherapy at Groote Schuur Hospital to children with solid tumours 
treated without RT and chemotherapy. The ALL children had significantly 
lower scores on growth, intellectual measures, neurological status and 
miscellaneous organ damage. Low scores were attributed to CNS injury 
caused by RT, with or without a synergistic effect of methotrexate. In this 
study the author suggested that psychosocial adaptation was surprisingly 
good, relative to poor family functioning found in a minority of the families 
in the sample. Evidence of educational disadvantage was obtained from 
the results of the IQ test scores on the Senior South African Individual 
Scale (SSAIS) of certain children. These children came from relatively 
deprived circumstances, but the test did not have norms for the 
disadvantaged children such as that of the Senior South African Individual 
Scale Revised (SSAIS-R) version. A global pattern of impairment with 
negative trends in verbal reasoning, abstract language, memory and the 
use of spatial concepts was shown. 
In a prospective study of 1134 children with head injuries, Hemp (1989) 
found a high incidence of psychosocial adversity in all the head injured 
subjects as well as the control group with orthopaedic injuries. A high 
psychosocial adversity score contributed to predicting a bad rather than a 
good neuropsychological outcome. 
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6.2.2 Age-at-Diagnosis 
The terms Age-at-Diagnosis and Age-at-Treatment are used 
interchangeably in the literature. The association between Age-at-
Diagnosis and neuropsychological impairment has been difficult to specify 
because of the variations in the definition of "younger". Some investigators 
define young age to be three years old or less (Hoppe-Hirsch et aI., 1990; 
Johnson et a/., 1994; Nishiyama et a/., 1994; Sutton et a/., 1989); others 
as below six years (Chapman et a/., 1995; Chin & Maruyama, 1984; 
Ellenberg et a/., 1987; Jannoun & Bloom, 1990; Mulhern & Kun, 1985; 
Seaver et a/., 1994) yet others as below seven years (Ellenberg et a/., 
1987; Packer et a/., 1987; Radcliffe et aI., 1992); or even as below eight 
years (Chin & Maruyama, 1984). Moore et a/., (1992) and Sutton et a/., 
(1989) find that at Age nine to ten years-at-Diagnosis neuropsychological 
functions were relatively unaffected. 
A problem in the assessment of age at diagnosis is the inclusion of a 
sufficient number of children across a broad range of ages which will yield 
conclusive results. All six longitudinal studies reviewed (Duffner et a/., 
1988; Ellenberg et a/., 1987; Gajjar et a/., 1994; Koa et a/., 1994; Mulhern 
et a/., 1989; Radcliffe et aI., 1992) encountered this difficulty. 
6.2.3 Time-Since-Treatment 
Time is an important moderator of outcome. With time cognitive status 
may improve, relapse, plateau, exacerbate old deficits or change the rate 
of development. 
An interrelationship between Age-at-Diagnosis, Time-since-Treatment and 
lower FSIQ score with increasing Time-since-Treatment has been 
reported by several researchers (Hoppe-Hirsch et a/., 1990; Hoppe-Hirsch 
et a/., 1995; Nishiyama et a/., 1994; Sutton et a/., 1989). 
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Silber et al., (1992) use a multiple regression model to predict the final 
FSIQ score based on the initial FSIQ score, dose of irradiation and age at 
time of irradiation. The application of this model predicts higher FSIQ 
score with lower dose and increasing age at radiation. The authors found 
that the following factors are not significant in predicting FSIQ: SES; 
gender; type of IQ measure used; diagnosis (ALL or PNET tumour); if 
tested prior to two years from treatment or after two years from treatment; 
presence or absence of surgery; post-operative infection; presence or 
absence of shunt and inclusion of methotrexate chemotherapy. These 
factors have been disputed by other researches and are discussed under 
the relevant heading in the present literature review. 
The importance of time factors is well illustrated in the longitudinal studies 
(Duffner et aI., 1988; Ellenberg et aI., 1987; Gajjar et al., 1994; Koa et al., 
1994; Mulhern et al., 1989; Radcliffe et al., 1992) 
These studies show that the cognitive functioning of the children fluctuate 
and illustrate that young age at testing and diagnosis interact over time. 
The two studies which had very young children in the sample (Gajjar et 
aI., 1994; Mulhern et al., 1989) illustrated that the timing and 
administration of chemotherapy either improved or decreased cognitive 
functioning. Duffner et al., (1988) only found significant declines in 
cognitive functioning two years after administration of treatment by means 
of surgery, radiotherapy and lor chemotherapy whereas Radcliffe et aI., 
(1992) showed declines in cognitive functioning occurred from baseline to 
year two after treatment and thereafter cognitive functioning appeared to 
plateau in year four. Ellenberg et al., (1987) found a similar trend in that 
cognitive functions declined from year one to year three and thereafter 
reached a plateau. Koa et al., (1994) are the earliest researchers to 
demonstrated that perioperative factors contribute to the decline in 
cognitive functioning from baseline testing to year four. 
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Thus the importance of perioperative factors as an additional adverse 
influence on the decline of cognitive functioning needs to be taken into 
account in future studies. Although longitudinal studies measure the 
child's performance compared to normative data that change with age, 
they provide little information on the child's future or past course of 
development. This approach fails to model behaviour as a function of 
time. According to Fletcher and Taylor in Broman and Michel (1995) the 
process of development marked by age and reflecting change are the 
important factors. 
However Dennis et a/., (1996) found that Age-at-Diagnosis and Time -
since - Treatment made separate contributions to intellectual morbidity. 
To summarise Age-at-Diagnosis, Time-since-Treatment, tumour type and 
treatment variables are complex factors in the assessment of change and 
prediction of outcome following treatment for posterior fossa brain 
tumours. 
6.3 MEASUREMENT ISSUES IN OUTCOME STUDIES OF 
CHILDREN WITH POSTERIOR FOSSA BRAIN TUMOURS 
6.3.1. Methodological Considerations 
In clinical research, it is not possible to control all potential threats to 
internal validity and firmly established cause and effect relationships. 
Moreover, theoretical approaches to study design have led to the use of 
outcome measures that may fail to illuminate treatment effects. The 
following factors were considered in reviewing the literature: 
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6.3.2 Types of Desjgns 
6.3.2.1 Retrospective Studies 
Of the sixty three studies reviewed, forty four studies or 70% utilized 
retrospective designs: 
(Bamford et aI., 1976; Bauld et al., 1998; Broadbent et al., 1981; 
Chadderton et aI., 1995; Chapman et al., 1995; Chin & Maruyama, 1984; 
Cohen et aI., 1993; Danoff et al., 1982; Dennis, Spiegler, Fitz et al., 1991; 
Dennis, Spiegler, Hoffman et al., 1991; Dennis et al., 1992; Dennis et al., 
1996; Dennis et al., 1998; Eiser et al., 1981; Feeney et al., 1992; Feeny et 
al., 1993; Grill et aI., 1999; Hetherington et al., 2000; Hirsch et al., 1979; 
Hoppe-Hirsch et aI., 1990; Hoppe-Hirsch et al., 1995; Jannoun & Bloom et 
al., 1990; Jenkin et al., 1998; Johnson et aI., 1994; Jordan et aI., 1995; 
Kimmings et al., 1995; Lannering et al., 1990; Le Baron et aI., 1988; Li et 
al., 1984; Moore et al.,1992; Moore et al., 1994; Mostow et al., 1991; 
Mulhern et al., 1999; Nishiyama et al., 1994; Noll et al., 1999; Onoyama et 
al., 1975; Packer et aI., 1987; Riva et al., 1989; Roux, 1987; Seaver et 
al., 1994; Silverman et al., 1984; Syndikus et al., 1994; Yang et al., 1997 ) 
Advantages of this type of design: 
• They are cost effective, time efficient, utilize large samples from a 
given population, may be the only feasible approach to studying rare 
diseases such as paediatric brain tumours and provide meaningful 
information about the way the variables function in relation to one and 
other. 
Disadvantages which may lead to bias: 
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• The problem of backward contingency, incomplete or inaccurate 
historical information, and attrition of the sample due to death or loss 
of follow Lip. 
Retrospective studies thus lack the necessary controls for internal and 
external validity. 
Inspection of the following retrospective studies using large samples of 
more than one hundred subjects over a long time span, twenty to thirty 
five years (Hoppe-Hirsch et aI., 1990; Jannoun & Bloom, 1990; Jenkin et 
al., 1998; Lannering et al., 1990; Onoyama et al., 1975; Syndikus et aI., 
1994) illustrates the effects of attrition in which the samples are reduced in 
numbers due to death and being lost to follow up. Consequently, only a 
relatively small number of survivors are tested. The very large sample of 
over two hundred subjects of Jenkin et al., (1998) was reduced to only 
10% of the original sample. Jannoun & Bloom (1990) fared better as 33% 
of the sample were tested. Lannering et al., (1990) attempted to overcome 
the attrition of their sample by extracting a sub group of half the subjects 
who were tested and compared their Quality of Life to a matched control 
group. 
The cohort effects of designs over a long period of time are increased as 
the time span of the investigation lengthens. The year or decade in which 
a particular person was born may affect performance, suggesting that the 
developmental course of the particular cohort may differ from cohort 
groups born earlier or later. The retrospective study of Hetherington et al., 
(2000) covered a thirty one year time span. The authors attempted to 
strengthen the validity of the design by introducing a control group 
matched approximately on age and socioeconomic status. The age 
factors are clearly illustrated but the SES factors are not detailed, which is 
a potential source of bias over such a long time span. 
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Prior to 1980 all the studies reviewed used retrospective descriptive 
designs and non parametric statistics. 
6.3.2.2 Prospective Studies 
Prospective designs provide more direct evidence of risk and are most 
valuable when specific hypotheses have been developed from previous 
retrospective studies. However prospective designs are time consuming, 
difficult to execute and are inefficient for studying rare attributes. They are 
also not suitable for exploratory research where the examiner wishes to 
look at a large number of factors of doubtful significance such as 
hydrocephalus, the presence of seizures or cerebellar mutism. 
Nineteen or 30% of the studies reviewed are prospective studies.(Barr et 
al., 1993; Billison Walker, 1994; Bordeaux et aI., 1983; Brookshire et aI., 
1990; Duffner et al., 1988; Ellenberg et al., 1987; Gajjar et al., 1994; 
Hudson & Murdoch, 1992; Kao et al., 1994; Kun et al., 1983; Lazereff et 
al., 1996; Mulhern & Kun, 1985; Mulhern et al., 1989; Mulhern et aI., 1994; 
Packer et aI., 1989; Radcliffe et al., 1992; Roux, 1987; Silber et al., 1992; 
Sutton et al., 1989; Whitton et al., 1997). 
Twelve or two thirds of the prospective studies, utilized repeated 
measures as a means of verifying the outcome results (Bordeaux et al., 
1988; Duffner et aI., 1988; Ellenberg et al., 1987; Gajjar et al., 1994; Kao 
et al., 1994; Kun et al. J 1983; Mulhern et al. J 1985; Mulhern et al., 1989; 
Packer et al., 1989; Radcliffe et al. J 1992; Silber et al., 1992; Sutton et al. J 
1989). 
The advantages of repeated measures are that they provide critical data 
regarding the continuities or discontinuities related to the impact of acute 
and chronic processes as these interact with developmental factors 
(Achenbach in Ris & Noll, 1994). In addition each child acts as his or her 
own control. 
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A major disadvantage of repeated measures is the issue of practice 
effects. However given sufficient time between test administrations this 
may not be a confounding factor 
6.3.3 Treatment Interaction Effects 
The treatment effects of surgery, radiotherapy, chemotherapy and other 
medical interventions are difficult to extrapolate. The treatments used 
singly may affect cognitive status or may interact with RT to potentiate its 
effect (Duffner et 81., 1988). Longitudinal designs over at least four years 
are the best method of illustrating the effects of treatment on 
neuropsychological functioning and the outcome on quality of life (Fletcher 
and Copeland, 1988; Ris and Noll, 1994). As discussed six longitudinal 
studies were identified (Duffner et 8/., 1988; Ellenberg et 8/., 1987; Gajjar 
et 81., 1994; Kao et 8/., 1994; Mulhern et 8/., 1989; Radcliffe et 8/., 1992). 
6.3.4 Treatment Group Assignment 
In most published studies the random assignment of subjects to treatment 
groups is rare. In research on survivors of children of posterior fossa brain 
tumours, subjects are self-selected into groups according to tumour types 
or treatment protocols. The problem of small sample size and extreme 
outlying scores are difficulties that bias compatibility between groups 
across all critical domains. Baseline testing is a means of establishing 
group equality, but is often not possible when ill children are being tested. 
Control groups are seldom ideal but provide an alternative to random 
allocation treatment group assignment. 
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6.3.5 Control Groups 
According to Fletcher and Copeland (1988) in their review of CNS 
prophylaxis of treatment of cancer in children, there are no ideal contrast 
groups, but the inclusion of children with cancer who do not receive CNS 
treatment represents a minimal comparative condition. In the studies 
reviewed only nine studies (14%) used matched sibling or relatives as 
controls and one study used random adolescent controls (Bauld et al., 
1998; Hetherington et al., 2000; Lannering et a/., 1990; Roux, 1987; Riva 
etal., 1989; Mostowetal., 1991; Noll etal., 1994; Nishiyamaetal., 1994). 
All these studies are retrospective in design. 
6.3.6 Statistical Analyses 
Small sample size is a major constraint on the statistical power and the 
type of analysis used in the studies examined. Nineteen or 30% of the 
studies used descriptive statistics( Bamford et al., 1976; Broadbent et al., 
1981; Chin et al., 1984; Cohen et aI., 1993; ; Danoff et al., 1982; Duffner 
et al., 1983; Feeny et al., 1993; GClliar et al., 1994; Hirsch et aI., 1979; 
Hoppe-Hirsch et al., 1990; Hoppe-Hirsch et a/., 1995; Jenkin et al., 1998; 
Kimmings et al., 1995; Le Baron et al., 1988; Li et al., 1984; Mulhern et 
aI., 1989; Nishiyama et al., 1994; Onoyama et al., 1975). 
Twenty one or 33% of the studies used non parametric statistics. 
(Barr et aI., 1993; Billison et al., 1994; Chadderton et aI., 1995; Chapman 
et al., 1995; Duffner et al., 1988; Eiser, 1981; Johnson et al., 1994; Kao 
et aI., 1994; Kun et al., 1983; Lazareff and Castro-Sierra, 1996; Moore et 
aI., 1992; Mulhern & Kun, 1985; Mulhern et aI., 1994; Packer et al., 1989; 
Radcliffe et al., 1992; Roux, 1987; Seaver et al., 1994; Silverman et aI., 
1984; Sutton et al., 1989; Whitton et al., 1997; Yang et al., 1997) 
Twenty three or 37% of the studies used parametric procedures such as 
analysis of variance (Bauld et al., 1998; Bordeaux et al., 1988; Brookshire 
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et al., 1990; Dennis et al., 1991; Dennis et al., 1991; Dennis et al., 1992; 
Dennis et al., 1996; Dennis et al., 1998; Ellenberg et aI., 1987;Grill et al., 
1999; Hetherington et al., 1999; Jannoun & Bloom 1990; Jordan et al., 
1995; Lannering et al., 1990; Moore et al., 1994; Mostow et al., 1991; 
Mulhern et al., 1999; Noll et al., 1999; Packer et al., 1987; Riva et al., 
1989; Silber et al., 1992; Syndikus et aI., 1994) 
6.4 MEASUREMENT ISSUES RELATING TO NEURO-
PSYCHOLOGICAL OUTCOME. 
The measurement of neuropsychological outcome has ranged from 
general impressions of outcome to detailed studies of specific cognitive 
functions. 
6.4.1 Psychometric Issues 
A comprehensive neuropsychological battery of tests designed to 
measure specific domains is the ideal method of assessment (Mulhern, 
Armstrong & Thompson, 1998). This form of assessment has been done 
in 32% (20) of the articles reviewed (Bordeaux et al., 1988; Brookshire et 
al., 1990; Chadderton et aI., 1995; Chapman et al., 1995; Packer et al., 
1987; Dennis, Spiegler, Fitz et aI., 1991; Dennis Spiegler, Hofman et al., 
1991; Dennis et aJ., 1992; Grill et al., 1999; Johnson et al., 1994; Le Baron 
et al., 1988; Mulhern and Kun 1985; Mulhern et al., 1989; Moore et al., 
1992; Moore et al., 1994; Packer et al., 1987; Packer et al., 1989; Seaver 
etal., 1994; Sutton etal., 1989) 
As neuropathological investigations suggest that white matter and 
subcortical structures are more likely to be damaged by RT than the 
cortex (Crossen et al., 1994; Price & Birdwell, 1978 in Mulhern, 1994), 
the use of 10 tests may not be the most sensitive measure to illustrate the 
impact of RT. None the less some authors relied only on 10 test scores as 
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the measure of assessment (Dennis et aI., 1996; Eiser, 1981; Gajjar et 
a/., 1994; Mulhern et a/., 1999; Silber et a/., 1992). 
Mulhern et a/., (1999) showed that the IQ test scores illustrated the effects 
of treatment on intellectual functioning. Serial testing as a means of 
showing the child's cognitive response to treatment over a period of time 
was done by Silber et aI., (1992) who showed that the higher the dose of 
radiotherapy the greater the decline in FSIQ. However Gajjar et a/., (1994) 
found that IQ scores improved during chemotherapy but decreased over 
time when chemotherapy was terminated and radiotherapy treatment 
commenced. The use of IQ tests in these instances measured the deficits 
in intellectual functioning. 
The use of different types of IQ tests to assess survivors over different 
ages may be problematic. Generally this was not discussed in the 
interpretation of the results (Brookshire et a/., 1990; Bordeaux et a/., 1983; 
Chadderton et a/., 1995; Dennis Spiegler Fitz et a/., 1991; Dennis, 
Spiegler, Hoffman et a/., 1991; Dennis et a/., 1992 Duffner et aI., 1988; 
Ellenberg et a/., 1987; Grill et a/., 1999; Johnson et a/., 1994; LeBaron et 
a/., 1988; Moore et a/., 1992; Packer et a/., 1989; Radcliffe et a/., 1992; 
Seaver et a/., 1994; Sutton et a/., 1989) 
Silber et a/., (1992) are the only authors in the review who discussed the 
effect of eight different IQ test instruments to measure intellectual and 
developmental functioning. In their analysis of IQ change as a function of 
irradiation dose and age they found that change of testing instrument did 
not contribute significantly to outcome. Patients who had initially been 
tested using the WPPSI, Stanford Binet, McCarthy or Bayley measures 
and who were subsequently tested on the WISC, WISC-R, WAIS or 
WAIS-R were considered to have changed tests. This effect size was 
minus 4.3 points for those who had changed tests, which was not 
significantly different from zero. The authors then explored other models 
for the other IQ measures and adjusted the initial FSIQ downward by 2.5 
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and 5 IQ points when the measures challged in the younger patients from 
the WPPSI to the WISC-R. The coefficients on the initial FSIQ, age at 
irradiation and dose were almost identical between the adjusted and 
unadjusted models. The authors thus chose to report the unadjusted 
models for their analysis. One could thus postulate that although the use 
of different IQ tests may have some influence when pooling IQ scores 
across age rallges, the effect is not significant. It must be noted that when 
the authors reported in the summary of their study that they corrected for 
age at irradiation and initial IQ this was not deemed to be a result of using 
different IQ test measures. Rather the variation in initial IQ scores across 
patients was seen to be the most important predictor of future IQ score 
with a partial correlation of 39%. In the normal test, retest situation scores 
tend to fall within five points of each other. It is for this reason that the 
authors corrected the initial IQ scores. 
6.5 NEUROPSYCHOLOGICAL DOMAINS OF OUTCOME 
6.5.1. Intelligence 
Impaired intelligence test scores are not present in survivors of all 
posterior fossa brain tumours but are predominant in survivors of 
medulloblastoma brain tumours (Dennis et al., 1996; Duffner et aI., 1983; 
Grill et al., 1999; Hirsch et al., 1979; Hoppe-Hirsch et al., 1990;Johnson et 
al., 1994; Mostow et aI., 1991; Mulhern et aI., 1999; Packer et aI., 1987; 
Silverman et aI., 1984; Yang et al., 1997) Children with other types of 
posterior fossa brain tumours, such as non malignant cerebellar 
astrocytoma brain tumour survivors not treated with radiotherapy, show 
non-significant changes in their IQ scores (Chadderton et aI., 1995; 
Mulhern et al., 1999; Packer et al., 1989; Sutton et al., 1989). The type of 
posterior fossa tumour and the extent of the treatment are thus potentially 
confounding variables in the cognitive outcome of posterior fossa brain 
tumour survivors. 
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Several studies revealed that VIQ is significantly higher than PIQ in 
posterior fossa tumour survivors (Dennis et aI., 1996; Johnson et al., 
1994; Mulhern and Kun 1985; Moore and Copeland et al., 1992; Packer et 
al., 1989; Sutton et aI., 1989). However, Silverman et al., (1984) reported 
no discrepancy and LeBaron et al., (1988) found a slight discrepancies of 
not more than five points. Two studies in which pre- and post-operative IQ 
scores are available (Packer et al., 1989; Sutton et aI., 1989) illustrated 
that the significant difference between VIQ and PIQ not only appeared in 
the medulloblastoma group but also in the control astrocytoma group. 
Implying that the site of the tumour is a possible contributing factor to the 
outcome. 
Dennis et al., (1996) attempted to clarify the issue in a sample of 
medulloblastoma children, and demonstrated that PIQ was related to 
chronological age at which tumour diagnosis was made, whereas VIQ 
increased with time elapsed since treatment, being less dependent on the 
stage of development at which the tumour was diagnosed. 
6.5.2. Attention 
Problems with selective attending and excessive distractibility during 
neuropsychological testing were identified by Mulhern and Kun (1985) in 
younger children with no consistent influence for gender, increased 
intracranial pressure, tumour site, irradiation treatment or sensorimotor 
impairment. Small patient numbers preclude Kun et al., (1983) from 
identifying the specific aetiologies of attentional difficulties in their sample. 
Problems with cognitive flexibility and problem-solving skills were noted by 
LeBaron et aI., (1988). They were unable to clarify if the difficulty was 
related to age, tumour type or treatment. 
Riva, Pantaleoni, Malani, et al., (1989) proposed that tumour or surgically-
related disturbance of the reticular activating system was the common 
mechanism for the observed difficulties found on the attentional tests of 
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TMT A and B and the computer administered Continuous Performance 
Test. They found that different tests measured different parameters of 
attention showing that some aspects of attention are not affected by 
treatment. 
Moore, Ater et al., (1992) reported that the mean freedom from 
distractibility score of the no-radiation group of brain tumour children was 
significantly better than the radiated brain tumour group. A significant 
negative correlation occurred between the time after cranial irradiation 
and the attention domain suggesting that the deficit became more 
pronounced with time. 
Dennis et al., (1998) showed that survivors treated with RT performed 
less well than those treated without RT on both focused and selective 
attention tasks. Later age at onset of tumour symptoms correlated with a 
higher selective attention score whereas a shorter Time-since-Treatment 
correlated with a higher focused and selective attention scores. 
Survivors of different kinds of cancer other than brain tumours and treated 
with intrathecacal chemotherapy, cranial RT and no cranial RT, were 
assessed by event-related potentials and motor reaction time tests 
(Moore, Copeland et al., 1992). Mean reaction time and P300 latency 
were slower in the group given intrathecal chemotherapy relative to the 
group who received no CNS treatment. Significantly delayed reaction 
times were shown in the cranial RT group and correlations were shown 
with neuropsychological results. The authors conclude that the slowing of 
cortical activity secondary to white matter damage may underlie the 
cognitive decline in children treated with intensive CNS therapy, especially 
cranial RT. 
In summary deficits in attention may well underlie impairments in cognitive 
functioning found in children with posterior fossa tumour tumours. 
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6.5.3 Speech and Language 
Since the beginning of the 20th century it has been documented that 
cerebellar lesions induce speech deficits. These were thought to result 
from lack of motor coordination to the muscular activity needed for 
phonation (Molinari, Leggio, Silveri, 1997; in Schmahmann, 1997). 
Jordan, Murdoch, Buttesworth et al., (1995) found that language functions 
in three different brain injured groups (posterior fossa brain tumours, ALL 
and severe closed head injuries) were all compromised when compared 
to the control groups. However specific language deficits were not found 
in any of the brain injured groups. Scores obtained on Listening Quotient, 
Speaking Quotient, Boston Naming Test and Word Association subtest of 
clinical evaluation show that the groups did not differ from each other 
despite the varying underlying pathologies. Motor speech impairment was 
absent, except for only two of the posterior fossa tumour subjects 
demonstrating speech difficulty. The authors postulate that the similarities 
in deficits of the three brain-injured groups indicated that the language 
deficits were secondary to the primary injury. The common denominator in 
all the groups therefore is some degree of diffuse brain injury with or 
without concomitant focal lesions. 
Bordeaux et al., (1988) reported deficits in rapid word retrieval under time 
constraints at baseline testing. The authors suggested that the deficits 
shown in the children with a variety of brain tumours, were due to tumour 
related effects and/or secondary effects of hydrocephalus, cranial nerve 
palsies or systemic medication, rather than treatment, as there was little 
difference in the scores from pre- to post-treatment. 
94 
Significant language impairment was not found in children treated for 
malignant or benign brain tumours located predominantly in the posterior 
fossa (Brookshire et al., 1990; Moore et aI., 1992; Packer et al., 1989). 
However, a slight increase in language difficulties occurred two years after 
treatment according to Packer et al., (1989). The authors argued against 
an age effect being responsible for the preservation of language abilities 
and proposed a hypothesis that dominant hemisphere functions are 
relatively less vulnerable to the effects of cranial RT than non-dominant 
hemisphere functions. 
Johnson et al., (1994) maintain that verbal fluency was moderately to 
severely impaired in only four cases or 31 % of long term survivors treated 
for medulloblastoma brain tumours. 
Hudson and Murdoch, (1992) discerned changes in language abilities of 
three children treated for medulloblastoma tumours and monitored over a 
period of 28 months. The presence of residual language deficits was 
hypothesized as being a possible but not an inevitable outcome. Severe 
semantic-lexical deficits detected immediately post-treatment improved 
dramatically in the first six months after treatment The authors speculated 
that as none of the language difficulties were present prior to surgery, they 
could not be attributed to the direct effects of the tumour. Age and the 
effects of raised intracranial pressure as possible contributing factors were 
also discounted. Structural and functional changes in the cerebrum as a 
result of exposure to the effects of radiation treatment, are offered as a 
possible explanation of the language disturbance. The small sample size 
is a major constraint on the interpretation of these results. 
A marked drop in verbal comprehension scores was identified by Grill et 
al., (1999) in children who had received higher doses of radiation 
treatment. 
95 
In summary, some language and verbal difficulties were identified by 
various authors. It is difficult to extrapolate the reasons for these 
difficulties as small sample size, the retrospective nature of the designs, 
variable age at diagnosis and time since treatment are potential 
confounding factors in the interpretation of the results. Grill et aI., (1999) 
are the only authors to have shown that lower verbal comprehension 
scores are due to high doses of radiation treatment in posterior fossa 
tumour subjects. 
6.5.4 Visual Perceptual Information Processing 
Visuomotor integration, fine motor speed and dexterity difficulties were 
documented following treatment of RT and chemotherapy for posterior 
fossa brain tumours (Hoppe-Hirsch et aI., 1995; Packer et aI., 1987; 
Packer et al., 1989). 
Prior to treatment Brookshire et al., (1990) showed that the mean visual 
motor scores of a group of children with primary brain tumours were 
slightly lower than the mean scores in other neuropsychological domains. 
However, when the patients were grouped according to tumour location, 
73% of the infratentorial tumour group performed within or above the 
normal limits. 
The visual spatial scores for a group of children, diagnosed with cancer 
other than brain tumours, were decreased according to the intensity of the 
treatment received (Moore, Copeland et al., 1992). The visual spatial 
skills were measured by means of Visual Motor Integration Tests and 
Block Design subtest of Wechsler Intelligence Scale for Children -
Revised. 
In another study on children with tumours of various types diagnosed 
during infancy, mean scores for the children in the no RT group were 
significantly below age-based normative means. The RT group scored 
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significantly lower in visual perceptual skills than the no RT group (Moore, 
Ater et a/., 1992). On the other hand Johnson et aI., (1994) found that 
perceptual organization was moderately to severely impaired in 23% of 
the sample of subjects treated for medulloblastoma brain tumours. When 
motor skills were also required, the incidence of impairment increased to 
54% of the supjects. 
In summary visuomotor integration, fine motor speed and dexterity deficits 
are documented both at baseline testing and following treatment in 
survivors of posterior fossa tumours. Treatment-related effects on 
functioning are variable. 
6.5.5 Memory 
In the domain of memory deficits or the lack thereof are not often 
reported. Difficulties in verbal memory were found in younger but not older 
children in a sample of those treated for tumours of various sites by 
Mulhern and Kun (1985). 
Packer et a/., (1987) showed that only 33% of a sample of long-term 
survivors of medulloblstoma tumours had deficits in verbal memory after 
RT. Assessment before and after receiving RT showed no significant 
changes in verbal memory modalities in a sample of children diagnosed 
with brain tumours of various origins by Bordeaux et a/., (1988). 
Sutton et aJ., (1989) showed that memory functions were normal at 
baseline testing in both the medulloblastoma and astrocytoma brain 
tumour groups. Two years post RT the memory scores fell into the mild to 
moderate range of dysfunction in 38% of the children in the group treated 
with RT, particularly among those under seven years old at time of 
treatment. 
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A greater proportion of survivors of medulloblastoma brain tumour 
subjects, indicated moderate to severe deficits in visual memory as 
opposed to verbal memory according to Johnson et al., (1994). 
Dennis, Spiegler, Hoffman et al., (1991) in a complex study, demonstrated 
that memory impairment was present in their entire sample of children and 
adolescents diagnosed and treated for brain tumours of various types. 
Verbal intelligence accounted for less than one quarter of the variance in 
scores. Working memory and memory for semantically based word picture 
associations were unaffected by Age-at-Diagnosis, Time-from-Treatment 
to testing, sex, pre-tumour developmental disturbances, closed head 
injury, post-tumour anticonvulsant treatment and post-tumour seizures. 
Memory for serial order of pictures that corresponded with heard words 
varied inversely with Age-at-Diagnosis. The older the subject, the lower 
the memory test score. 
Dennis, Spiegler, Fitz et al., (1991) elaborated on the memory tasks, 
finding that memory for semantically-based word picture associations was 
unaffected by tumour location. They postulated that memory for serial 
order pictures that corresponded with the heard words involved structures 
in the limbic and hypothalamic pituitary axis. However, working memory, 
in which a succession of heard words is stored in temporary memory long 
enough to be compared and contrasted with incoming words, involved the 
pineal region and anterior and medial thalamic nuclei. 
Dennis, Spiegler, Obonsawin et al., (1992) explored the effects of 
radiation on memory and showed that memory for word meaning was not 
associated with either RT history or hormone status. Severe deficits in 
working memory were associated with a history of RT and principle 
tumour site that involved thalamic epithalamic regions. Severe deficits 
also occurred in serial position memory associated with impaired hormone 
function and older age at tumour diagnosis. 
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Dennis et al' J (1998) reviewed working memory in children treated for 
various brain tumours with and without RT in the chronic phase of 
recovery. The mean percentile scores were within the normal range. 
However 41 % percent of the sample scored within the lowest quarter of 
percentile distribution. The RT effects were more pronounced in the 
posterior third ventricle tumour group and the fourth ventricle group but 
neither Age-at-Diagnosis nor Time-since-Treatment correlated with 
working memory deficits. 
Dennis et al' J (1998) also tested implicit memory in a sample of 
adolescents treated for brain tumours of the third ventricle and brain stem 
and matched to controls. Both the tumour group and the controls had a 
high level of explicit recognition. Unexpectedly, the tumour group revealed 
perfect explicit recognition less often than the control group under 
conditions of divided but not full attention, although the tumour group 
showed less priming than the controls when they were treated under 
either full or divided attention. Age-at-Diagnosis did not affect 
performance. The authors considered that the tumour group needed less 
priming than the controls, as they benefited less from exposed material, 
even material to which they did not attend consciously. 
In summary working memory is influenced by tumour site, type and 
treatment and is worse in third ventricle and fourth ventricle posterior 
fossa tumour subjects. Visual memory is not often assessed but was 
found to be defective in medulloblastoma tumour survivors. Verbal 
memory scores were variable and were related to Age-at-Diagnosis, type 
of tumour and hormonal effects. 
6.5.6 Motor Functions 
Impairment in motor functions in survivors of posterior fossa tumours are 
reported by several authors. This is not surprising given the site of the 
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tumour. Brookshire et al., (1990) found poor motor functions prior to 
treatment and Bordeaux et al., (1988), Johnson et al., (1994), LeBaron et 
al., 1988, Packer et al., (1987)) described impairment in motor functions 
after treatment. These authors attributed the impairment to the effects of 
the site of the tumour. 
Moore Ater et al., (1992) suggested that the combination of young Age at 
Diagnosis and cranial RT had a significant detrimental effect on motor 
functions. 
However the implication of Time since treatment on motor functions is 
variable. Hoppe-Hirsch et al., (1990), Hoppe-Hirsch et al., (1995) and 
Packer et al., (1989) showed that motor skills did not deteriorate with 
Time-since-Treatment. Whereas Lannering et al., (1990) showed that 
despite normal motor functioning on neurological examination, Stott's test 
revealed a definite motor problem in the ability to balance. 
Johnson et al., (1994) indicated that medulloblastoma survivors who did 
not undergo shunting performed worse with both the preferred hand and 
the non-preferred hand than those who had shunts. 
Variable findings are thus shown in the domain of motor functions. These 
findings are associated with the effects of the tumour, treatment, Age-at-
Diagnosis, time-since-Treatment and shunts. 
6.6 THE MEASUREMENT OF OUTCOME PERTAINING TO 
QUALITY OF LIFE ISSUES. 
6.6.1 Quality of Survival versus Quality of Life 
In early studies of brain tumour survivors gross quality of life measures did 
not predict psychometric or educational outcome and researchers were 
more concerned about issues relating to Quality of Survival (Onoyana et 
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al., 1975) rather than Quality of Life. This was completed without the use 
of norm referred tests and involved an analysis of school performance or 
placement, the presence or absence of mental retardation or a global 
assessment of daily functioning. There were two major classifications 
based on daily functioning: Bouchard's (1966) three levels of daily 
functioning and Bloom et al., (1969) four categories of functioning. The 
Bloom rating scale, in conjunction with an intelligence test, is still being 
used in the literature to give levels of function applicable to daily living 
(Ellenberg et al., 1987; Hirsch et al., 1979; Jannoun & Bloom, 1990; Kun 
et al., 1983; LeBaron et al., 1988; Yang et al., 1997). 
As an index of global functioning Kun et al., (1983) found that Bloom's 
criteria (four categories of disability from no disability, partial disability 
active life, partial disability capable of self care to total disability, incapable 
of self care) provided information on gross survival characteristics, 
excluding detailed psychological analysis. The authors noted that the 20% 
incidence of significant disabilities shown in their sample is almost 
identical to data from Bloom's initial medulloblastoma report and other 
reviews of childhood brain tumours. 
Ellenberg et al., (1987) estimated significant functional difficulties in 
almost 50% of the sample of subjects with brain tumours. This is higher 
than that obtained by Bloom et al., (1969) who rated 30% of the sample 
as slow learners and 18% as being in category 111 or 1V. Ellenberg 
surmises that the discrepancy in findings could be due to the inclusion of 
all patients and not just long-term survivors, as patients who are more 
severely affected have a poorer long-term prognosis. Alternatively, it 
maybe that the thorough neuropsychological battery uncovered disabilities 
not apparent in less detailed studies. 
LeBaron et al., (1988) found that both global quality of life ratings and 
specific neuropsychological testing are necessary to uncover the severity 
of and range of deficits. 
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The Bloom criteria were specifically utilized as a quality of life rating and 
discussed and compared to the FSIQ findings according to tumour 
location, site of maximum RT dose and Age-at-Treatment by Jannoun and 
Bloom (1990). Quality of Life was better in the infratentorial brain tumours 
survivors than the supratentorial brain tumours survivors. Quality of life 
according to Bloom criteria supported the FSIQ outcome scores showing 
that the older the Age-at-Treatment the better one's quality of life. In 
summary the authors conclude that three to twenty years after receiving 
treatment for brain tumours 60% of the patients are functioning in the 
average range of intelligence or higher and about 57% of them are 
leading normal lives without any neurological or physical disability. 
Of note in the articles is the assessment of both cognitive outcome and 
functional outcome. However, emotional, behavioural and scholastic 
functioning have not been well investigated. As will be seen in the rest of 
the review, these are ongoing domains of difficulty which have emerged in 
the discussions on Quality of Life in the 1990's. 
6.6.2 School Performance 
School failure is prevalent in children treated for posterior fossa brain 
tumours and approximately 74% of children treated for medulloblastoma 
tumours experience academic failure or report learning difficulties (Hirsch 
et al., 1979), a rate which does not appear to have decreased in the 
intervening years (Johnson et al., 1994). The incidence is not as high for 
survivors of cerebellar astrocytoma brain tumours (Hirsch et aI., 1979; 
Sutton et al., 1989) 
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Special education arrangements are often required following RT and 
additional chemotherapy treatment as reported by several researchers 
(Chadderton et al., 1995; Duffner et aI., 1988; Hoppe-Hirsch et al., 1990; 
Hoppe-Hirsch et al., 1995; Packer et al., 1989; Yang et al., 1997). 
Several studies indicated that treatment which did not include 
chemotherapy, but included surgery and RT, compromised school 
performance, resulting in learning problems which need remedial help or 
placement in a special school (Grill et aI., 1999; LeBaron et al., 1988; 
Hoppe-Hirsch et al., 1995; Jenkin et al., 1998; Packer et aI., 1989; Sutton 
et al., 1989). 
Young Age-at-Diagnosis was found to have a negative influence on the 
development of learning problems at school (Chin & Maruyama, 1984; 
Johnson et al., 1994). Many children treated at a young age have special 
educational requirements, although what is meant by "young age" is a 
debatable issue among the various researchers. Sutton et al., (1989) 
suggested that children of between the age of eight years and ten years, 
or who have attained greater CNS maturation may have no serious 
learning difficulties. 
Learning problems cited by several authors (Johnson et al., 1994; Packer 
et al., 1989; Packer et al., 1987; Seaver et al., 1994; Sutton et aI., 1989) in 
survivors of posterior fossa brain tumours include problems in maths, 
arithmetic, reading and spelling. 
Grill et aI., (1999) showed that poor academic progress was due to high 
doses of cranio spinal irradiation treatment. 
Yang et al., (1997) document the Taiwan experience of a group of 
children with medulloblastomas brain tumours. He showed that there was 
a significant positive correlation between academic achievement and 
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intellectual performance, although no significant correlation was observed 
between functional status and intellectual performance. 
In summary the incidence of school failure is higher in children treated for 
medulloblastoma tumours with adjuvant treatment compared with 
astrocytoma survivors treated by surgery only. However high doses of 
craniospinal irradiation have a negative effect on school progress. Young 
Age-at-Diagnosis has a variable influence on learning problems and 
special education needs. The correlation between intellectual status and 
functional status is reported as not significant by one researcher, but 
needs further exploration. 
6.6.3 Emotional And Behavioral Functioning 
A high proportion of children treated for brain tumours may have chronic 
problems with emotional adjustment. According to Kun et al., (1983) and 
Mulhern (1994) it is difficult to ascertain whether these problems are due 
primarily to the tumour and the subsequent treatment affecting the eNS 
directly, making the child more vulnerable to stress. Alternatively these 
may be secondary difficulties of the tumour and treatment in which 
children have difficulty in adapting to the functional limitations imposed by 
the tumour and treatment. Estimates of clinical maladjustment have been 
at rated as at least 50% by Mulhern and Kun, (1985) and LeBaron et al., 
(1988) 
Seaver et al., (1994) found no evidence of psychosocial difficulties where 
as Lannering et al., (1990) rated psychological-emotional sequelae as 
having a heavier impact on the patients' lives than functional motor 
impairment. 
According to Bauld, Anderson and Arnold (1998), no single predictor of 
psychosocial outcome has been identified in the adjustment of cancer 
survivors (predominately ALL subjects). The complex interaction of 
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factors which seem to play a role in the adjustment of cancer survivors 
makes it difficult to determine those who are at greatest risk for 
psychosocial problems. In their sample of adolescent survivors there was 
no evidence of overt psychological impairment compared with healthy 
controls. The authors suggest that time has healed some psychological 
difficulties, but health professionals need to be aware of both overt and 
covert psychological scars. 
Hoppe-Hirsch et a/., (1995) described an increase in the incidence of 
behavioural problems such as emotional regression, inhibition, slowness, 
negative attitude, instability and attention difficulties, in survivors of 
medulloblastoma but not ependymoma brain tumours, with increasing 
time. At the initial assessment one to two years after treatment, about 
20% of the children in each tumour group were affected. The percentage 
remained stable in the ependymoma group, at the five and ten year post-
treatment assessments. However, in the medulloblastoma group, the 
percentage of disorders increased to 40% and 56% at five and ten year 
post-treatment assessments. Specific details as to how the ratings were 
calculated are not given. 
In summary variable findings on emotional and behavioural functioning 
ranging from normal to problematic are reported in survivors. No single 
predictor can account for the findings but the interaction of tumour, 
treatment and Time-since-Treatment are hypothesized. 
6.6.4 Quality Of Life In Oncology 
As neuropsychological measures are themselves indicators of quality of 
life a more theoretically grounded assessment of health related quality of 
life including emotional and behavioural functioning in school and work 
related fields is necessary. 
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Health status, functional status and quality of life statements are often 
used interchangeably although this is not appropriate according to 
Jenney, Kane and Lurie (1995). In 1998, Jeeney argued that quality of life 
is a broad concept which includes aspects of health over and above 
medical issues such as education, standard of living, community and 
family life. 
The World Health Organization (WHO, 1948) defined health as "a state of 
complete physical, mental and social well being and not merely the 
absence of disease or infirmity." 
The term "health related quality of life" in the context of health usage, 
implies that illness can have a consequence in almost all domains of life 
and supports the WHO definition of health (Jenney et a/.,1995; 
Rosenbaum et a/., 1990). 
Child health has been defined as the ability to participate fully in 
developmentally appropriate activities and requires physical, 
psychological and social energy (Pantell & Lewis, 1987 in Rosenbaum et 
a/., 1990). Children, unlike adults, are developing and changing with time 
and any instrument used to measure health-related quality of life must be 
sensitive to these changes (Feeny, Furlong and Barr, 1998; Jenney et a/., 
1995). 
6.6.5 Functional Measures Used To Assess Health Status 
Developmental measures, such as the Vineland Social Maturity Scales, 
which are targeted at functional assessment of neurological maturation, 
implicitly judge the quality of life of the child across functional domains 
such as personal-social and fine motor adaptive ability. Numerous 
measures suitable for health assessment include the Sickness Impact 
Profile, Medical Outcomes Study, Nottingham Health Profile and the Child 
Health and Illness Profile. In the evaluation of these measures, it is 
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evident that they have been developed for varying purposes such as 
clinical evaluation of function, survey data gathering, or disease-specific 
outcome evaluation (Rosenbaum et a/., 1990). Thus in evaluating the 
assessment of quality of life, goals and measurement need to be clarified. 
Assessment of quality in life in patients with cancer has concentrated on 
adult patients and the most used instrument has been the Karnofsky 
score (Karnofsky et a/., 1948) which was not developed for use in the 
paediatric population despite the adaptations made, but to assess both 
adults and children. Children have a better long-term survival following 
treatment for cancer than adults and any instrument used to examine the 
issues faced by children should address long term questions bearing in 
mind the possibility of a cure. According to Jenney et a/., (1995) in a 
review of the issues relating to the development of a measure of health 
outcomes in survivors of childhood cancer the measure should: 
• Be reliable, valid and responsive to changes in health status 
• Be quick and easy to use, yet comprehensive 
• Be able to identify specific issues for cancer patients yet be applicable 
to all children and adolescents of similar ages so that comparisons 
can be made with the general population 
• Be interpretable by paediatric oncologists with an index of overall 
value in order to compare the outcome of groups of individuals 
• Include principal domains of functioning such as, activity/ mobility, 
psychological well-being, social integration, comfort/pain, achievement 
of cognitive developmental expectations, fertility/sexual maturation, 
sensory functions and satisfaction with life should be included. 
6.6.5.1 The Multiattribute Health Status Classification (MHSC) 
The MHSC consists of three to five levels of function within seven 
attributes of: sensation, mobility, emotion, cognition, self-care, pain and 
fertility. 
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Independent ratings by clinicians using the MHSC indicate that brain 
tumour children on active treatment have a higher morbidity than children 
undergoing ALL, Wilms tumour or neuroblastoma treatment (Feeny, 
Furlong, Barr et a/., 1992). 
Barr, Furlong, Dawson et a/., (1993) applied the MHSC to survivors of 
ALL. They reported that the overall morbidity was greater in those who 
had high risk disease rather than standard risk disease. Deficits in 
emotion and cognition were common but more prevalent in younger 
patients and showed a dose relationship to cranial irradiation. 
Feeny, Leiper, Barr et a/., (1993) used the MHSC to follow up long-term 
survivors of childhood cancer. The results showed that ALL survivors 
have a greater morbidity than the general population in Great Britain. Of 
the All survivors, 7% had deficits in sensation compared with 1.9% of the 
children in Great Britain who suffer from disabilities in seeing, hearing or 
communication. Similarly, while 28% of the ALL children have deficits in 
emotion, only 2.1 % of the British children have problems in behaviour. Of 
ALL survivors 39% had problems in cognition compared with 0.9% in the 
British population. 
A 80% functional morbidity was found using the MHSC to assess adult 
survivors of brain tumours and there were frequent problems in hearing, 
speech, ambulation and dexterity (Whitton, Rhydderch, Furlong et aI., 
1997). Doctors identified fewer health deficits in survivors of cancer than 
patients or parents. Survivors of neuroaxial tumours had lower scores 
than other diagnostic groups (Billson and Walker, 1994). 
In summary the MHSC is the only available rating scale specifically suited 
to survivors of RT and chemotherapy treatment. If the goal of the 
assessment is to monitor functional changes in both children and adults, it 
is a useful tool (Jenney et a/., 1995). 
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6.7 CONCLUSION 
The literature review has explored how neuropsychological function and 
quality of life are related to several critical variables. 
• Some studies have suggested that patient characteristics such as 
Age-at-Diagnosis and treatment, tumour site and type are the major 
predictors of long term outcome, with evidence of the detrimental 
effect being suggested for young age and chemotherapy on top of RT 
and surgery. 
• Impaired intelligence is predominant in survivors of medulloblastoma 
tumours, with some studies suggesting a greater effect on PIQ than 
VIQ. Some disease consequences may not be fully apparent for 
several years after treatment has been completed. 
• The areas where most deficits have been noted are visuomotor 
integration, fine motor speed and dexterity. 
• Speech and language functions tend to be relatively spared. However 
more in depth studies may detect subtle deficits. 
• Working memory and visual memory have been found to be sensitive 
to posterior fossa tumours, while findings are variable on verbal 
memory. 
• Although both cognitive and health outcomes have been well 
investigated emotional, behavioural and scholastic functioning have 







The sample was collected by examining the records, from 1968 to 1996, 
of all children under the age of 17 years 11 months, admitted to Red 
Cross War Memorial Children's Hospital and Groote Schuur Hospital with 
a diagnosis of posterior fossa brain tumour. 
• 174 such cases were found. 
7.1.2. Diagnosis 
The type of posterior fossa tumour was determined by histology. In the 
absence of surgery, the diagnosis was determined by CT Scan or MRI. 
• 76.4% (133) of the tumours were diagnosed by means of histology. 
• 23.5% (41) of the tumours were diagnosed on CT Scan or MRI. The 
majority of these tumours were brain stem gliomas. 
7.1.3. Incidence of Tumour Types 
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Figure 7-1 Incidence of Paediatric Posterior Fossa Brain Tumours 
110 
7.1.4. Mortality 
An intensive tracing system was set up using the seNices of community 
health workers, clinic sisters, schools, work places and the Department of 
Deaths to determine which patients died and those which sUNived. 
N= 174 
SURVIVAL OF PATIENTS WITH POSTERIOR FOSSA 
TUMOURS 1968 - 1996 
o Deceased 
44% 
II!ISurvived o Deceased 




• Lost to Follow Up 
Figure 7-2 Incidence of Survived, Deceased and Lost to Follow Up 
Patients 
The Lost to Follow Up Children, 12 % (21), could not be traced at the 
addresses given and no one in the neighbourhood could supply any 
information regarding their whereabouts. Of those that could be traced, 
there was an equal split between sUNivors (n=77) and deceased (n=76). 





51 subjects or their parents gave consent to participating 
in the study 
17 subjects resided in other provinces and were 
inaccessible. 
6 subjects failed to keep their appointments despite 
repeated efforts to contact them. 
2 children did not fit the treatment criteria which included 
surgery A brain stem glioma (radiotherapy and 
chemotherapy only) and a medulloblatoma (radiotherapy 
only). 
1 arent refused to artici ate. 
7.2. INCIDENCE OF TUMOUR TYPES AS PER GROUP 
INCIDENCE OF TUMOUR TYPES PER GROUP 
1968 ·1996 
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Figure 7 -3 Incidence of Tumour Types in Tested and Untested Subjects 
This figure shows that the deceased sample has an increased proportion 
of Brain Stem Gliomas (54%) but that the tested sample is representative 
of the survivors in terms of tumour type. 
7.3. TREATMENT GROUPS 
Criteria for inclusion in the study: 
• Confirmation of diagnosis by histology 
• No evidence of tumour recurrence 
• The treatment had to include surgery 
In accordance with the research design the tested sample (51 cases) 
were divided into three treatment groups according to the categories of 
treatment administered: 
Group 1 Surgery only (n= 12) 
Group 2:Surgery and Radiotherapy (n=20) 
Group 3: Surgery, Radiotherapy and Chemotherapy (n= 19) 
112 
7.4. DEMOGRAPHY 
Table 7-2 Observed Frequencies of Gender, Race and Language. 
GROUP 1 GROUP 2 GROUP 3 ALL GROUPS 
- (n=12)_ (n=2Qt (n=191 (n=51) 
GENDER 
Male 3 (25%) 10(50%) 11 (58%) 24 (47%) 
Female 9 (75%) 10(50%) 8 (42%) 27 (53%) 
RACE 
I Coloured 8 (67%) 14 (70%) 15 (79%) 37 (73%) 
White 4 (33%) 5 (25%) 2 (11 %) 11(21%) 
Black 0 1 (5%) 2 (11 %) 3 (6%) 
LANGUAGE 
English 9 (75%) 6 (30%) 9 (47%) 24 (47%) 
I Afrikaans 3 (25%) 13 (65%) 8 (42%) 24 (47%) 
Xhosa 0 1 (5%) 2(11%) 3 (6%) 
7.4.1. Gender 
There is no significant difference between the treatment groups in terms 
of gender (Pearson Chi Square = 3.309, df = 2; p=.19123). 
7.4.2. Race 
There are no significant differences between the treatment groups in 
terms of race (Pearson Chi Square = 3.565; df=4; p=.46812) In terms of 
the population of the Western Cape: (Central Statistics of the Western 
Cape Province,1995; in Central Statistics 1996), the White group is 
adequately represented (21.5% of the sample versus 23.8% of the 
population), the Coloured group IS over-represented (72.5% within the 
sample versus 57.1 % of the population), while the Black group is 




There are no significant differences between the groups in terms of 
language (Peason Chi Square = 7.365; df=4; p=.11783). As shown by the 
Population Census (1991) of the Western Cape (Central Statistics 1996), 
Afrikaans is the predominant language (62.2% in the population versus 
47% in the sample); English speakers are over represented in the sample 
(20.05% in the population versus 47% in the sample); Xhosa speakers 
are under-represented (15.3% in the population versus 5.8% in the 
sample). 
7.4.4. Marital Status 
Although the retrospective study covers a time span of 28.5 years, only 
three subjects are married or cohabiting with a partner. However the 
number of single parents is shown in the Psychosocial Adversity table. 
7.5. AGE AND YEARS- SINCE- TREATMENT 
Table 7-3 Age-at-Diagnosis, Age-at-Testing and Years-since- Treatment, 




X 11.38 20.07 16.24 
SO 4.84 11.34 9.50 
4.8 -17 4.1-42.5 4.1 -42.5 
YEARS- SINCE- TREATMENT 
X 4.25 11.96 7.57 8.51 
SO 4.63 9.29 5.92 7.72 
Range 1.7 - 15 0.5 - 28.5 0.25 - 22.8 0.25-28.5 
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7.5.1. Age-at-Diagnosis 
There are no significant differences between the treatment groups in Age-
at-Diagnosis (Anova F=.275; df=2,48; p=.760). 
7.5.2. Age- at-Testing 
There is a statistically sjgnificant difference between the treatment groups 
in Age-at-Testing according to the Analysis of Variance (F=3.630; 
df=2,48; p=.034 ) where Group 1 (surgery) has the youngest children and 
Group 2 (S+RT) has the oldest subjects. An attempt has been made to 
control these possible confounding factors by using age-appropriate 
psychometric tests and age-related norms. 
7.5.3. Years-since-Treatment 
There is a statistically significant difference in the total sample in terms of 
Years-since-Treatment according to the Analysis of Variance (F=4.529; 
df=2.48; p=.015). The interaction between these variables is explored 
later. 
7.6. OCCUPATION AS A MEASURE OF SOCIO-ECONOMIC 
STATUS 
Occupational status was classified according to the breadwinner of the 
family. Where that person was not in current employment, his/her most 
recent occupation was taken as a criterion. Occupation was ranked 
according to the Centre for Applied Social Sciences (Schlemmer, 
Stopforth and Bulteel, 1979). There are five broad categories from 
professional to unskilled and menial class. An overview of the criteria for 
ranking occupational status for the group is shown in Appendix B. 
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Table 7-4 Summary of Percentages Ranked in order according to 
Occupational Status in Treatment Groups. 
17% (2) 10% (2) 10% (2) 12% (6) 
17% (2) 35% (7) 16% (3) 24% (12) 
Manual 
Foreman & 42% (5) 20% (4) 42% (8) 33% (17) 
Skilled 
Routine Non 
17% (2) 20% (4) 26% (5) 21%(11) 
Manual 
Unskilled 
Manual & 8% (1) 15% (3) 5% (1) 10% (5) 
Menial 
There are no significant differences between the treatment groups 
according to occupational status (Pearson Chi Square=5.25,df=8;p=.073). 
7.7. PSYCHOSOCIAL ADVERSITY 
The distribution of various psychosocial adversity factors within the groups 
is summarized below. In rounded percentages a psychosocial adversity 
score was calculated for each child, based on one point for the presence 
of each of the factors (Hemp, 1989). 
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Table 7-5 PSYCHOSOCIAL ADVERSITY 
Median Psychosocial Adversity Score 
1 2 2 1.8 
This table shows that there is a high incidence of mothers who have less 
than standard 6 level of education and are single parents. The unskilled 
and unemployment incidence reflects the present economic climate in 
which retrenchment and unemployment figures in the country are high. 
According a report in the Cape Times, 74,000 jobs are expected to be 
shed by the year 2003 (Nxumalo F, 1999). 
7.8. MEDICAL VARIABLES 
The history was established by medical folder review and patient/parent 
interview. As proposed by Mulhern et aI., (1998), all medical variables 
regarding pre-treatment, treatment and post-treatment were assessed. In 
addition a detailed pre-natal, developmental, scholastic and occupational 
history was recorded for each subject (see Appendix E). 
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7.8.1. Tumour Type As Per Treatment Group 
Table 7-6 Tumour Types as per Group 
In Group 1 the tumours are diagnosed as non-malignant astrocytomas 
whereas those in Group 3 are malignant medulloblastomas. Group 2 
comprises a mixture of different types of posterior fossa tumours; 
astrocytoma, medulloblastoma, ependymoma and brain stem glioma, all 
graded as malignant brain tumours. See Appendix A for histological 
diagnosis of tumours. 
7.8.2. Presenting Symptoms 
The signs and symptoms of posterior fossa tumours were grouped 
according to the criteria of Halperin et al., (1994): 
• The pressure syndrome which presents as vomiting, 
lethargy/headache and/or papilloedema due to an increase in 
intracranial pressure from obstruction to the flow of the cerebral spinal 
fluid 
• The cerebellar syndrome which presents as ataxia and/or difficulty in 
handling objects, due to interference with function in the local area of 
the cerebellum 
• Seizures are uncommon as presenting symptoms in posterior fossa 
subjects. 
Table 7-7 Presenting Symptoms expressed as Percentages 





PIS = Presenting Symptoms H/L= HeadachelLethargy V = Vomiting 
P = Papilloedema Cranial= cranial nerve palsy 
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The mean duration of presenting symptoms is shortest in Group 3, which 
comprises medulloblastomas. 
• Pressure symptoms: headaches and lethargy were common to all 
groups. Papilloedema occurred most frequently in Group 3, the 
medulloblastoma group. Cranial palsies occurred in almost half the 
subjects with sixth cranial nerve palsy being the most "frequent. 
• Cerebellar signs were common in all the groups but showed an 
upward trend from Group 1 to Group 3. 
• Seizures: only three children presented with seizures. 
7.8.3. Surgical Intervention 
Surgery was coded as total or subtotal according to the operation notes 
written by the neurosurgeon. Some neurosurgeons used the term partial 
surgical resection, which was coded as a subtotal resection. In the 
sample, there were no instances of only a biopsy of the tumour being 
performed. 
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The standard procedure in the Neurosurgery Department is to insert 
ventriculo peritoneal shunts prior to surgical resection of the tumour in 
children who present with signs of raised intracranial pressure. 






SHUNT + EVD 
n=51 
83% (10) 





There is an inversion between Group 1 (only astrocytoma tumours) the 
majority of which were total surgical resections and Group 3 (only 
medulloblastoma tumours) the minority of which were total surgical 
resections. 
The majority of the children needed shunting. In three children, external 
ventricular drains were inserted prior to the surgical resection of the 
tumour, and in two cases (Group 3) were later replaced with shunts. 
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7.8.4. Radiotherapy Treatment 
Table 7-9 Sites of Radiation and the Range of Radiation Doses 
Administered. 
As this is a retrospective research study of 28 years, during which time 
there have been many changes in RT regimes, the dosage of 
radiotherapy has not been taken into account in any of the statistical 
analyses. However, it was included for descriptive purposes (see 
Appendix A for details). All the children in Group 3 (100%) received 
craniospinal RT with a boost to the posterior fossa area, compared with 
80% in Group 2. The remaining 20% in Group 2 received RT to the 
posterior fossa area only. A radiation boost to the cribriform plate was 
given to one child only in Group 2 but to four children in Group 3. Children 
in Group 3 thus received more RT than those in Group 2. 
The average duration of radiotherapy was six weeks for children in Group 
2 and seven weeks for the Group 3 children (Appendix A). They all 
completed their treatment protocols. 
7.8.5 Chemotherapy 
Chemotherapy protocols consisted of vincristine, CCNU, cisplatin, MOPP 
and other agents but no children were given methotrexate (see Appendix 
A for details). In all cases chemotherapy was commenced during RT, 
although in two cases this was interrupted due to neutopenia. In one 
case, the mother of a child became distressed at the length of the 
treatment and refused consent for further chemotherapy. 
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7.8.S. Intra-Operative and Post-Operative Complications 
Table 7-10 Summary of Frequency of Intra-Operative and Post-Operative 
Complications 
In the above table Intra-operative complications occurred in two children. 
A child in Group 1 (astrocytoma tumours only) developed episodes of 
hypotension which resulted in bilateral motor weakness, hypotonia and 
seizures. A case of airway obstruction occurred in a child in Group 3 
(medulloblastoma tumours only) with the result that the operation was 
abandoned and rescheduled for a later date. 
Post-operative infections included shunt infection and meningitis. Post-
operative seizures necessitating medication and confirmed on 
electroencephalogram were found in 6% of the sample. Transient 
cerebellar mutism occurred in 12% (six cases) of the sample. The 
syndrome affected all tumour types, but was more prevalent in patients 
with medulloblastoma tumours (Group 2 = 1; Group 3 = 2). The vermis 
was the site of the tumour and hydrocephalus was present in all the 
children. The mutism was noticed in up to six days after the surgery and 
lasted from two to ten weeks. Cortical blindness in association with 
mutism developed in one child (Group 1) and was resolved within four 
days. The total incidence of complications showed an upward trend 
according to the addition of RT and chemotherapy treatment. 
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7.9. TEST BATTERY 
7.9.1. Principles of Test Selection 
• Measures of general ability and of specific neuropsychological 
functions were required for both adult and child survivors of brain 
tumours. 
• As a result of the brain tumour and subsequent treatment, it was 
expected that many subjects would score below their age levels, so 
tests with a wide range and a low floor were selected. Tests with age 
norms were preferred. The intention was to make the test results 
comparable to those of other international studies. 
• Tests which have been developed and validated using norms obtained 
in British and American population groups need to be interpreted with 
reserve (Anderson, 1998; Murdoch, Flemming, Skuy et a/., 1994). 
Therefore, use has been made of the South African Wechsler Adult 
Intelligence Scale (SAWAIS, 1962), the Senior South African 
Individual Scale Revised (SSAIS-R, 1991, 1991 b) and the Individual 
Scale for Xhosa Speaking Pupils (lSX, 1988), which have been 
standardized according to the population predominating in this study. 
• Tests should be repeatable, culture free and available. 
• In the selection of the test battery an attempt was made to adhere to 
the Proposed Requirements for Practice Standards, Practice 
Guidelines and Practice Options in choosing psychological tests 
advocated by Mulhern et a/., see Appendix C. 
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7.9.1.1. Adjustment of Test Scores 
• The SSAIS-R (1991) provides norms for the population of the non-
environmentally as well as environmentally disadvantaged subjects 
with Afrikaans and English as their mother tongue. In order to apply 
the norms correctly, The Socio-Economic Deprivation Questionnaire, 
developed by the Human Science Research Council (Van Eeden, 
1991 b), was applied to determine which set of norms should be used 
for each particular child. The environmentally disadvantaged norms 
were used in 13 cases. For the most part, these children were from 
the Coloured Community. Where only the mental age equivalents of 
scores were available, scores are expressed as age ratios (MAICA x 
100). Test scores are expressed as scale scores, percentiles or T 
scores. 
7.9.2 Intelligence 
• SAWAIS (16 cases, 18 years - 59 years) 
• Verbal Subtests: Comprehension, Similarities, Digit Repetition 
• Performance Subtests; Block Design, Digit Symbol Substitution (Coding) 
• Subtotals prorated to give Via, Pia and FSIO 
• SSAIS-R (22 cases, 7 years to 16 years 11 months) 
• Verbal Subtests: Comprehension, Similarities, Story Memory, Digits 
• Performance Subtests: Blocks, Coding 
• Subtotal prorated to give Via, Pia and FSIO 
• ISX (2 cases, 9 years to 19 years 11 months) 
• Verbal Subtests: Comprehension, Similarities, Story Memory 
• Performance Subtest: Blocks 
• Additional Tests: Digits, Coding from SSAIS-R 
• Subtotals prorated to give Via, Pia and FSIO 
• The Griffiths Scales of Mental Development (1984), 8 cases (0- 8 years) 
• Verbal Scale: Hearing and Speech 
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• Performance Scales: Hand and Eye Co-ordination, Performance Scale. 
• VIQ =Mental age I chronological Age x 100 
• PIQ = Mental age I chronological Age x 100 
• FSIQ = mean mental age score of 5 scales: Speech and Hearing, Hand and 
Eye Co-ordination, Performance Scale, Practical Reasoning Scale. Mean 
mental age then transposed into GQ 
SUBJECTS UNABLE TO DO ABOVE IQ TESTS (3 cases) 
The Individual Scale of the National Bureau of Educational Research (1960) - Old South 
African Individual Scale (OSAIS). 
• FSIQ = level of mental retardation 
7.9.2.1. SAWAIS 
The SAWAIS is based on the American Wechsler Adult Intelligence Scale and it was 
adapted for South African conditions and standardized on a South African norm group by 
the National Institute for Personnel Research (Liddicoat & Roberts, 1962; in Huysamen, 
1996). Items specifically related to American conditions were rewritten to fit the South 
African context (Huysamen, 1996) the final standardization of the SAWAIS was in 1969. 
As it has not been revised since 1955, there is considerable criticism that the norms do not 
reflect the present day population (Nell, 1994) A means of maximizing the utility of the 
SAWAIS is for it to be part of a comprehensive neuropsychological evaluation which would 
include other tests covering functional abilities. (Adan 1986; Nell, 1994; Pieters & Louw, 
1994 in Van Eeden, Robinson & Postuma, 1994). 
Coetzee (1982, in Van Eeden et a/., 1994) finds that the verbal subtests of 
Comprehension and Similarities are good hold tests which are not affected by age, 
language or sex. Block Design and Coding are valid PIQ tests. All four subtests are good 
indicators of general intelligence. Coding is a good indicator of perceptual organization in a 
brain damaged population (Cohen, 1952 in Madge and Coetzee, 1982). 
7.9.2.2 SSAIS-R 
The SSAIS-R was developed from the original New South African Individual Scale 
(NSAIS,1964) which was renamed the Senior South African Individual Scale (SSAIS) in 
1980. This scale was revised and normed from 1986 to 1988 on a sample of 2000 
children, with English or Afrikaans as their mother tongue. The rank order correlation of the 
SSAIS-R total score, 0.44, with the index of socia-economic status, indicated that 
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environmental factors were partly responsible for the low scores obtained on the SSAIS-R. 
The HSRC therefore devised advantaged and environmentally-deprived norms based on a 
broader sample of 4,767 pupils which included both the advantaged and environmentally 
deprived subjects. This sample was a proportional representation of pupils extracted form 
school registers of the Tripartite Departments of Education. 
The inter-correlations of all the subtests are high and show a common underlying factor 
which could be interpreted as "g" or general intelligence. Comprehension and Similarities 
form part of VIQ. Block design is a good indicator of PIQ. Coding does not form part of the 
composite scale as it had a loading of 0.40 and not 0.50 which was a criterion for 
inclusion. However, Picture Arrangement has the same loading and only after 
reconsideration was included by the test compilers in the composite scale (van Eeden & 
Visser, in van Eeden et al., (1994). As Coding is a good indicator of visual perceptual 
dysfunction in a brain damaged population (Lezak, 1995) and in accordance with its 
inclusion in the SAWAIS in the testing of adults, it is part of the composite scale in the 
present study. 
7.9.2.3. ThelSX 
The ISX was developed from the Indian Scale for South Africans which in turn was 
adapted from the New South African Scale, later know as the Senior South African 
Individual Scale (SSAIS). Norms were established from Xhosa speaking pupils age 9 to 
19 years from schools in the Transkei and Ciskei of the Republic of South Africa. 
In the development of the short form of the ISX, in which all the age groups were treated 
as one group, Blocks were shown to have the highest correlation of 0.72 with FSIQ 
(Landman, 1989, in Van Eeden etal., 1994). 
7.9.2.4. Griffiths Scales of Mental Development 
The Griffith Scales were originally developed in Great Britain, for the assessment of 
children 0 to 8 years of age (Griffiths, 1984; Griffiths, 1986). The six scales, which make up 
the General Quotient are of equal difficulty for each age level: 
A The Locomotor Scale assesses physical weakness. 
B The Personal Social Scale gives an indication of personal and social 
development. 
C The Hearing and Speech Scale is the most intellectual of all the scales assessing 
growth and development of language. 
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o The Eye and Hand Co-ordination Scale consists of items relating to handwork 
and visual ability. 
E The Performance Scale measures skill in manipulation, speed of work and 
precision and is largely a performance test. 
F The Practical Reasoning Scale depicts the earliest indication of numeric 
comprehension and practical problems. 
The Griffiths Scales were introduced in South Africa in 1977 and have been well 
researched (Allan, Luiz, Foxcroft,1988; 1992; Luiz, Foxcroft, Sweeney, Kotras, 1997; Luiz, 
Foxcroft, Kotras, 1997; Luiz, Foxcroft, Stewart, 1998; 
Luiz, 1997). 
Heimes, 1983; Krige, in 
Heimes , find that the scales correlated well with the Junior South African Individual Scale 
(JSAIS). However Griffiths mean scores were higher than those of the JSAIS mean scores 
and this was consistent with other research (Ramsay & Fitzhardinge, 1977, in Van Eeden 
et aI., 1994). 
A comparison of the performance of normal pre-school South African and British children 
on the Griffiths Scales by Allan et al., (1988) indicates that when the South African sample 
of 1986 was compared with the original British sample of 1960, significant differences were 
found between the two groups. However, when the South African sample was compared 
with a later equivalent British age group sample, no significant differences were found. 
Allan et al., (1988) suggest that a time factor rather than a cultural factor was responsible 
for the differences. The time factor was described as the changes that had taken place in 
the intervening years since the original sample were tested. 
According to Allan et al., (1992) an items analysis of the Griffiths scales demonstrated that 
the ethnic groups differed significantly in the percentage of items which they passed in 
each scale. The authors suggested that the British norms do not apply to South African 
White and Indian children but are more suited to South African Black and Coloured 
children. 
Luiz, Foxcroft Stewart record significant correlations between the subscales of the 
Griffiths scales and the General Quotient for the White, Coloured, Indian and Black South 
African samples and the British standardized sample. 
In the administration of the Griffiths scales, the locomotor scale was excluded as the 
children in this sample have motor difficulties and it was felt that these difficulties would 
bias the cognitive results. Specific tests of motor function were included in the battery. Luiz 
and Heimes (1988) found a high positive correlation between JSAIS GIQ and Griffiths GQ 
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when the locomotor scale was excluded. The personal social scale was also excluded as 
these items did not occur in intelligence tests. Heimes (1983) shows a high correlation 
between the JSAIS GIQ and the Griffiths GQ after the personal social scale was excluded. 
A possible limitation of the test is that there is only one sub scale for speech and language. 
None the less the scale incorporates the process of both encoding and decoding of 
language as the child is asked to name as well as define objects and includes 
comprehension questions. 
7.9.3. Motor Functions 
7.9.3.1. Speed and Co-ordination 
Purdue Pegboard (Purdue Research Foundation, 1948) 
The number of pegs correctly placed in 30 seconds using the preferred hand, non 
preferred hand and both hands are counted. Scores are then transformed into Percentiles 
using the norms in Spreen and Strauss (1991) for girls and boys and the normative data 
published by Gardner and Broman (1979) and Yeudall, Fromm, Reddon et al., (1986) for 
adults. The use of the Purdue pegboard (Johnson et al., 1994) and the grooved pegboard 
has demonstrated significant findings in an oncology setting (Chapman et aI., 1995; 
Mulhhern et al., 1998). 
7.9.3.2. Successive finger Taps (Denckla, 1973, 1974) 
Time taken to do 20 successive finger taps, that is five sets of four, with the thumb moving 
from the index finger to the little finger just in the Preferred hand and then the Non 
preferred hand. The Denckla norms are guidelines based on small samples of children 
aged between ages of five to ten years and were supplemented by data collected locally at 
a particular Coloured school (Hemp, 1989) 
Tests of manual dexterity are recommended by Mulhern et al., (1998) whereas tests of fine 
motor co-ordination within an oncology setting are used by Bordeaux et al., 1988; 
Brookshire et al., (1990); Copeland, Dowell Jr, Fletcher et al., (1988); LeBaron et al., 
(1988); Packer et a/., (1989). 
7.9.3.3. Balance (Denckla 1973, 1974) 
The time for which balance on either the Preferred leg or the Non Preferred Leg can be 
maintained is recorded. In this instance Denckla norms are guidelines based on a small 
sample of children between five to ten years of age. 
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7.9.3.4. Gait 
Ability of subject to walk on a two meter long straight chalk line. Ataxia was scored as 
present or not present. If gait was normal, the test was repeated with tandem walking 
which would confirm the presence of instability. Ataxic gait was included in battery by 
LeBaron et al., (1988). 
7.9.4. Attention 
7.9.4.1 Trail Making A and B (norms of Spreen and Strausss, 1991). 
TMT A is time taken to join consecutively numbered circles from 1 to 25 as quickly as 
possible. TMT B consists of double or a simultaneous tracking task and is considered to 
be more challenging. The subject must draw the lines alternating between numbers and 
letters as quickly as possible. Errors count only in the increased time of performance, as 
the examiner does not stop timing whilst the error is corrected. 
TMT A and B are measures of attention, concentration, mental flexibility and speed under 
time constraints. A successful performance depends on intact visual perceptual motor 
ability. According to Lezak (1995), the test is sensitive to the most subtle forms of brain 
damage. TMT A and B used in the assessment of survivors of brain tumours by Bordeaux 
et al., (1988); Copeland et al., (1988) Johnson et al., (1994) and is recommended by 
(Mulhern et al., 1998). 
7.9.4.2. Digit Span 
Digit span consists of the raw scores of Digits Forward and Digits Backward and the scale 
score based on the combined total of Digits Forward and Backward. In Digits Forward the 
examiner reads a series of digits at one per second and then asks the subject to repeat 
them. If the subject answers correctly on one of two consecutive trials of the same length, 
the examiner proceeds to the next series which is one digit longer, up to a maximum of 
nine digits. For Digits Backwards a similar procedure is used except that the subject must 
repeat the digits in reverse order up to a maximum length of eight digits. Digit Span is a 
measure of immediate auditory recall for numbers for which facility with numbers, good 
attention and freedom from distractibility are required. Performance on the test may be 
affected by anxiety or fatigue. Digit repetition is considered to be a test of freedom from 
distractibility in the SSAIS-R and ISX (Van Eeden and Visser, 1992; Landman in Van 
Eeden et al., 1994). Obtaining adequate control over the ability to sustain and shift 
attention appears to develop by the age of four years (Butler,1998; Griffiths,1984). Digit 
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span as a test of attention in children with brain tumours is used by Chapman et al., (1995) 
and Moore, Ater and Copeland (1992). 
7.9.5. VISUAL PERCEPTUAL INFORMATION PROCESSING 
THE DEVELOPMENTAL TEST OF VISUAL MOTOR INTEGRATION (VMI or Beery, 
1989). 
First published in 1967, the VMI is a well researched and internationally accepted test. The 
1989 edition was used in the study and administered to both children and adults. The 1989 
norms which are based on the 1981 normative sample were found to be virtually identical 
with the original 1964 sample (Beery, 1989). The revised scoring allows for finer 
discrimination between the performance of subjects especially at the older age levels 
(Beery, 1989). Mean scores, standard scores and percentile scores are given for ages 
three to 18 years. Interrater reliability for the original form is reported from 0.58 to 0.99 
(Crosden, 1985 in Spreen and Strauss, 1991). 
In the context of a neuropsychological battery for survivors of brain tumours and ALL, the 
VMI proved useful in America (Brookshire et al., 1990; Moore, Ater et al., 1992; Moore 
Copeland et al., 1992; Mulhern et al., 1998; Packer et al., 1989; Packer et al., 1988) as 
well as in South Africa (Roux, 1987). VMI is recommended by Mulhern et al., (1998). 
Given the cognitive limitations of the adults in the sample it was decided to use tests which 
have been shown to be reliable on children. According to Spreen and Strauss (1998) for 
practical purposes the norms for thirteen and fourteen year olds can be used for older age 
groups. 
7.9.S. Test of Visual Perceptual Skills (non-motor) (TVPS) (1988) 
The TVPS was devised by Morrison Gardner (1982) and distributed by the Health 
Publishing Company in affiliation with the Children's Hospital of San Francisco USA. The 
1988 edition is used in interpreting the scores. 
A non-motor, short, test, based on a choice between four or five items, was included in the 
battery to clarify the visual perceptual difficulty. The test has seven scales of visual 
perceptual skills of which three are used in the study: Visual Discrimination, Visual 
Memory and Visual Spatial Relationships. The diagnostic validity was shown by finding 
significant differences in test scores between a learning handicapped group and a 
matched control group and by establishing the subtest intercorrelations. 
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Menken, Cermak and Fisher (1987) show that the TVPS is a valuable tool in assessing 
visual perceptual functioning in children with cerebral palsy. Given the cognitive limitations 
of the adults in the sample it was decided to use tests which have been shown to be 
reliable on children. Although the TVPS is designed for children and adolescents Su, 
Chien, Cheng and Lin (1995) have shown that it can be used on adults. 
7.9.7. Memory and Learning 
7.9.7.1. Incidental Recall 
CODING. 
Kaplan, Fein et al., (1991) in Lezak (1995) use Coding both as a measure of incidental 
recall and a standardized score on the relevant IQ Test. The norms of Spreen and Strauss 
(1991) were used for children from age 8 years to 12 years. The test requires the subject 
copy symbols for the numbers one to nine. The examiner notes how long the child takes to 
complete the test and also records how much of the test the person managed to finish in 
90 or 120 seconds, depending on the age of the subject. The examiner then folds the test 
sheet so that only the unmarked row of digits are shown and the subject is asked to fill in 
from memory as many of the symbols as can be recalled. A recall of six of the nine 
symbols is the low range of normal adult recall (Lezak, 1995). 
For children the coding is done in standard fashion and on completing the task the child is 
provided with another sheet of paper containing the numbers one to nine and asked to fill 
in the associated symbols. One point is awarded for each accurately drawn symbol, while 
a half a point is given for any accurately drawn but incorrectly associated symbol. Visual 
perceptual difficulties rather than memory could confound the incidental recall score. 
7.9.7.2 Verbal Memory -Immediate Recall (SSAIS-R, scale score) 
The story is read slowly to the subject and the examiner writes down verbatim the child's 
response. Scoring is according to the protocol. 
7.9.7.3 Wechsler Memory Scale-REVISED (WMS-R, 1987) 
This is an update of the WMS (1945). The revised version is considered an improvement 
over the original version (Franzen, 1989; Loring, 1989; Powell, 1988 in Elwood, 1991) 
especially with the addition of the delayed recall data (Loring, Papanicolaou, 1987 in 
Rourke, Costa, Cicchetti et al., 1991). Wechsler (1987) reports that inter-scorer reliability 
coefficients for Logical Memory and Visual Reproduction as .99 and .97 respectively. He 
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also shows the mean reliability coefficients for Logical Memory 1 = .71; 11 =.75 and Visual 
Reproduction 1 = .71; 11 = .69. 
7.9.7.4. Logical Memory (WMS-R, 1987) 
The passages from the WMS-R story were developed for the American population. The 
passages which have been used in the Department of Neurosurgery, Groote Schuur 
Hospital, over the past decade are a slightly modified form of the American version. They 
are available in English and Afrikaans and have the same number of items as the WMS-R 
story. Words in the original text have been changed where necessary to make the story 
more suited to South African culture: 
Story A: Anna Botha instead of Anna Thompson; Bellville instead of Boston; Rands 
instead of dollars 
Story B: National road instead of highway; Hex River Valley instead of Mississippi Delta; 
Laingsburg instead of Nashville. 
All instructions were given as stated in the manual: The stories were read slowly to the 
subject and the responses written down verbatim. Scoring was done according to the 
manual and a Percentile score obtained for immediate and delayed recall. 
WMS and WMS-R Logical and Visual Tests were used to assess brain tumour patients by 
Chapman et al., (1995); Johnson et al., (1994) and are recommended as part of a battery 
(Mulhern et al., (1998). 
7.9.7.5. Visual Memory (WMS-R, 1987; TVPS, 1988). 
WMS-R, VISUAL MEMORY 1 and 11. 
Administered and scored according to the instructions in the manual. Percentile scores for 
immediate and delayed recall were obtained for the adults. Mulhern et al., (1998) 
recommend a visual memory test as part of the battery. 
The TVPS Gardner, visual memory subtest (non-motor), a brief screening test was 
included to supplement the other visual perceptual functions and to determine, if possible, 
the extent of the visual memory difficulty and the contribution, if any, of the visual motor 
problem (see visual perceptual information). The Percentile scores were used. 
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7.9.8. Learning 
7.9.8.1. Auditory Verbal Learning Test (AVLT) 
The norms of Bishop, Knights and Stoddart, (1990) were used for children and those of 
Wiens, McMinn and Crossen, (1988) for the adults. According to Spreen and Strauss 
(1991) the AVLT was devised by Swiss psychologist Andre Rey (1964) and adapted by 
Taylor (1959) and Lezak (1983) for English speaking subjects. The test is a widely used 
test of verbal memory and new learning in both children and adults. It consists of a list of 
15 words (List A) which is read to the subject at a rate of one word per second. The 
subject is then asked to recall as many of the words as possible, in any order and this is 
repeated for four additional trials. The order of the presentation of the words remains fixed 
and instructions are repeated before each trial to minimize forgetting. On completion of 
trial 5, an interference list of 15 words (List B) is presented and recalled, followed by a 
recall of the original list (trial 6). After 20 to 30 minutes' delay period, filled with other 
activities, the subject is asked to recall the items from List A again. The examiner notes the 
order of the words recalled, repetition of words, words that are not on the list 
(confabulations) or intrusions from other sources (such as, words from List B). 
Examination of the first five trials indicates the quality of the learning curve. Proactive 
interference can be assessed by comparing recall on Trial 1 (List A) with recall on the 
distraction trial (List B). Retroactive interference can then be assessed by comparing the 
number of words recalled on Trials 5 and 7 (delayed recall). 
7.9.8.2. Recognition Test - AVL T 
On completion of the delay recall trial (T 7), the recognition trial is administered. This task 
requires the subject to identify as many words as possible, from an array of 50 words 
derived from List A & B as well as words that are semantically associated with or 
phonetically similar to words on these Lists. If the subject can read, the subject is asked to 
read the list and to circle the correct words. If the subject is unable to read, or has difficulty 
in doing so, the examiner should read the list to the child. 
The AVL T has modest test-retest reliability with a correlation of about .55 (Snow et a/., 
1988, in Spreen and Strauss, 1991). The AVL T is sensitive to laterality of brain damage 
and to verbal memory deficits in a variety of patient groups (Bigler, Rosa, Schultz et aI., 
1989; Lezak, 1983; Miceli, Caltagirona, Gainotti et a/., 1981; Mungas, 1983; Rosenberg, 
Ryan and Prifiteria 1984 in Spreen and Strauss, 1991). 
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7.9.9. Emotional and Behavioural Functions 
A short screening measurement to identify children with problem behaviours was needed. 
Checklists represent an efficient means of sampling a wide range of behaviours that may 
be present in a child or adolescent. Various tests used in an oncology setting were 
considered but discarded because they were too long: 
7.9.9.1. Walker Problem Behaviour Identification Checklist (WPBIC, 1989) 
The 1983 version of the Walker Problem Behaviour Identification Checklist is a revision of 
the 1970 edition published (1989) and distributed by Western Psychological Services, 
USA. The checklist fulfils the requirements of Mulhern et al., (1998) for "practice option" 
and includes 50 items which measure problem behaviours in five areas: 
ACTING OUT; WITHDRAWAL; DISTRACTIBILITY; DISTURBED PEER RELATIONS and 
IMMATURITY. The domains, at face value, seem to be appropriate for children with 
cancer. In addition to scores for each of the domains, a Total Score is derived to provide a 
measure of overall problem behaviour functioning. 
Although the checklist was designed to be completed by teachers to assess a pupil's 
classroom behaviour, research has shown that it is useful as a parent's rating device 
(Mash and Mercer, 1979 in Walker, 1989). The checklist was completed by the parents in 
the presence of the examiner In this way the examiner was able to overcome any 
difficulties that the parents may have had with it, and to verify that the behaviours did 
indeed qualify for inclusion on the list. 
Each item is scored as either present or absent and carries a score weight that represents 
a handicapping influence on the child's adjustment. The scored items are summed up for 
each domain and a total score calculated. The scores are then converted to a T Score for 
interpretation. According to the manual, T Scores of 60 or higher on any of the five scales 
suggest the need for referral for further evaluation and! or testing. 
The 50 selected item behaviours were selected from operational descriptions of 
behaviours that concerned teachers. The normative sample comprised 1840 children from 
kindergarten, primary and intermediate school as well as from a school for handicapped 
children. According to the manual, the item validity indices on the 50 items varied from .03 
to .67 indicating that the items discriminate between subjects in the upper and lower 27% 
of the sample in terms of checklist score. Intercorrelation coefficients among the 50 items 
ranged from .00 to .83, showing that the items measured separate functions of the same 
behaviour domain. 
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7.9.10. Health Related Quality of Life 
THE MULTIATTRIBUTE HEALTH STATUS CLASSIFICATION (MHSC) 
Feeny et al., in (1992) developed a Multiattribute Health Status Classification for 
evaluating the functional capacity of survivors of cancer treatment (see Appendix D). The 
list of attributes has been well researched (Cadman, Goldsmith, Torrence et al., 1986; 
Cadman and Goldsmith, 1986; Rosenbaum et al., 1990, Feeny et al., 1993) and includes: 
PHYSICAL FUNCTION AND MOBILITY 
COGNITION 




The ability to function is described by levels that vary from poor to good or normal. The 
M HSC was filled in by the adult patients (n-13) if they were clinically cognitively intact or 
otherwise by the parent / care giver (n=38) but the fertility domain omitted as it did not 
apply to many of the subjects. 
The system is an extension of a system developed by Torrance to evaluate outcomes of 
low birth weight infants (Boyle et al.,. 1983, Boyle and Torrence, 1984, Torrence et al., 
1982 in Feeny et al., 1993) and by Cadman and colleagues to assess health status in 
handicapped children (Cadman et al., 1986; Cadman and Goldsmith, 1986). 
Feeny et al., (1992) conducted an initial survey using the MHSC on children with ALL, 
Wilm's tumour and neuroblastoma. A second survey was carried out on children with brain 
tumours on active treatment and compared with the children in the first survey. The brain 
tumour children were found to experience higher degrees of morbidity. 
'M1itton et al., (1997) explores the health status of adult brain tumour patients using a 
format devised for children and adolescents and showing the overall burden of morbidity to 
be 80%. The authors have revised the scale as the Health Utilities Index Mark 2 and Mark 
3 (HUI2 & HUI3), broadened the Sensation Attribute into two separate attributes; Vision 
and Hearing, and added another Attribute, Speech. The revised format was not available 
at the outset of this study, but it appears to have remedied the minor shortfalls in 
administration of the scale. According to the criteria of Mulhern et al., (1998) the test fulfils 
the criteria for "practice guidelines" (see Appendix C). 
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7.10. PROCEDURE 
7.10.1. Test Interval 
At the time of testing, none of the children were on active treatment 
regimes of surgery, radiotherapy or chemotherapy and none of the 
sample had suffered a recurrence of the brain tumour in the years 
between the treatment and the current neuropsychological assessment. 
Within the sample four children were tested at < 1 year since Treatment 
(Group 2 = 2 cases; Group 3 = 2 cases). 
7.10.2 Test Conditions 
Individual appointments were made for each subject and the assessments 
were carried out by the clinical psychologists of the Neurosurgery 
Department in a quiet, airy office. Every effort was made to provide a 
stress-free environment and to overcome difficulties. Attempts were also 
made to minimize the possible effects of fatigue on test performance by 
arranging for tests to be administered in the morning. The subjects were 
allowed short breaks to minimize fatigue. 
Many of the children were known to the psychologist and a good 
relationship with the families existed. Tea and biscuits were provided for 
those children who had not had an adequate breakfast or who had 
travelled a long distance. Transport costs were refunded to those who 
could not afford them. Employers were requested not to deduct wages for 
time missed. Letters were written to schools, welfare agencies, work 
places and referrals made to other hospital departments whenever 
necessary. 
The interview with the parent or the subject included: 
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• An explanation of the purpose of the research study and the signing of 
the consent form. Parental consent had to be obtained for subjects 
under the age of 18 years, or those subjects who did not fully 
comprehend the purpose of the assessment and were in the care of 
their family or guardian. The Intake Questionnaire was then completed 
(see Appendix E). 
• The WPBIC and MHSC were completed after the administration of the 
test battery. 
The neuropsychological assessment followed the interview and various 
tests were administered in a flexible order format, designed to put 
subjects at ease, create a sense of rapport and reduce any anxiety. Some 
tests, such as the memory tests, may provide more anxiety than others. 
When testing children, a flexible approach is needed and where 
necessary, the order of presentation was changed to suit the demands of 
the individual. Lezak (1995), in a review of research in this area, 
concluded that the order of test presentation does not have an 
appreciable effect on test performance. A typical order of test presentation 
was as follows: 
Purdue Pegboard 
AVLT 
Trail Making Test (adults) 
WMS - R, logical & visual memory scales (adults) 
Developmental Test of Visual Motor Integration 
Sub-Scales of the appropriate IQ Test (SAWAIS; SSAIS-R; ISX; Griffiths; 
OASIS) 
Successive Finger Taps 
Balance 
Tandem Gait 
AVL T delayed recall 
WMS - R, Delayed Recall logical & visual memory scales (adults) 
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Test of Visual Perceptual Skills (non-motor) 
The three mother tongue Xhosa-speaking subjects could all speak 
English. Two of these were attending schools in which Xhosa and 
English were the language of tuition. In each case the ISX was 
administered with the help of an interpreter from the Child Guidance 
Clinic, University of Cape Town, who had been trained specifically to help 
in the interpretation of tests and test administration. The third Xhosa 
speaking subject was tested in English as he was attending the University 
of the Western Cape and had completed all his schooling in English. 
The time taken for the administration of the neuropsychological 
assessment was approximately 80 to 120 minutes. From the examiner's 
perspective the test-taking behaviour was appropriate in all cases and the 
participants were judged to have given their best performance throughout. 
On completion of the testing, the parents and subjects were all given 
feedback appointments to discuss the test results. 
7.11. TREATMENT OF RAW DATA 
Assistance was obtained for the collection of the data from the hospital 
records by a trained nursing sister and an undergraduate psychology 
student who entered the data onto summary sheets. Each subject had a 
research folder with photocopies of relevant medical information such as 
operation details and treatment progress reports in order to check 
information. Following the collection of the raw data, the tests were scored 
according to the directions specified by the various test manuals and 
entered onto a Test Summary Sheet (see Appendix F). 
All data were captured on a computer spreadsheet using Excel 
Programme from MicroSoft Office 1997, and this information was checked 
against the raw data with the help of an undergraduate student. A variety 
of statistical analyses were computed: 
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• The differences between the treatment groups were analysed by using 
one way ANOVA for parametric data and frequency tables for non-
parametric data 
• The relationships between the variables were explored by means of 
Pearson's Product Moment Correlation Coefficient 
• Multiple regression analysis were carried out to predict which 
variables predicted outcome in terms of neuropsychological 
functioning and quality of life 
• Taking the test variables which had differed significantly between the 
treatment groups, plus prorated FSIQ scores, the following ad hoc 
analyses were conducted: 
• Age-at-Diagnosis: All the subjects were categorically grouped 
according to whether they were < 4 years; 4-6 years; > 7 years- at-
Diagnosis. The ANOVA was done to determine whether there were 
significant differences in the test results according to the Age-at-
Diagnosis. 
• Years-since-Treatment: All the subjects were categorically grouped 
according to <4 years; 4-6 years; 7-10 years; 10+ years - since 
Treatment. The ANOVA was done to determine whether there were 
significant differences in the test results according to the variable 
Years- since- Treatment. 
• It was decided to repeat this analysis on the medulloblastoma group in 
order to be able to see if the variable age effects detected by Dennis 
et aI., (1996) could be replicated on Age-at-Diagnosis and Years-
since-Treatment. Multiple regression analysis done on the predictors 
of Age -at- Diagnosis and Years-since-Treatment failed to show the 
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predicted change in IQ score. When these results were not significant, 
those subjects over 18 years old were excluded (Dennis et al.,. 1996 
only had subjects < 18 years) and the analyses repeated. 
• The analysis was then repeated for the astrocytoma subjects, all of 
whom were younger than 18 years of age, and had been treated by 
surgery only. 
• In order to explore if the type of tumour or the treatment was 
influencing the cognitive outcome as measured by prorated FSIQ 
scores, further statistical analysis was done on the medulloblastoma 
subjects. Medulloblastoma subjects were chosen as there were 
sufficient numbers to carry out the analysis (n=30). A t-test was 
applied to determine if there were significant differences between the 
medulloblastoma subjects treated by means of surgery and 
radiotherapy (Group 4) and those treated by means of surgery, 
radiotherapy and chemotherapy (Group 3). Thereafter the ANOVA 
was computed to assess the extent to which each of the categorical 
variables, SES and Treatment Group, discriminate between the 
medulloblastoma cases assessed on prorated FSIQ scores. A further 
ANOVA was computed to investigate the effect of SES on the prorated 
FSIQ scores. 
• Principal Component Analyses: 
• Cognitive variables that had proved sensitive to differences between 
the groups or major variables like prorated FSIQ were included in a 
principal component analysis in order to reduce the number of 
outcome variables to one or two principal components. 
• The independent predictors were then entered into a stepwise 
regression analysis to build a model for predicting the outcome 
components. Some of the independent variables are categorical (e.g. 
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shunt revision/no shunt revision), tumour type divided into 
medulloblastoma/astrocytoma, some ordinal (e.g. treatment groups, 
SES) and some continuous (e.g. Age-at-Diagnosis, Years-since-
Treatment, Age-at-Testing). 
• The effect of Type 1 error per comparison was controlled by the 
selection of the significance level, which means that the level of the 
risk is controlled. In this way the analysis will yield results which lead 
to an incorrect rejection of the null hypothesis only a certain 
proportion of the time (for example, p=.05). In an attempt to control 
the likelihood of Type 1 errors, the Fisher's least significance 
difference (LSD) was calculated when the F for the ANOVA was 
significant The Fisher's LSD test guarantees that the probability of 
making at least one Type 1 error will not exceed .05 (Howell, 1995). 
The Bonferroni test is a multiple comparison procedure in which the 
familywise error rate is divided by the number of comparisons 
(Howell, 1995). As the present study involved many comparisons this 
technique was rejected in favour of the Fisher LSD test. Thus every 
effort was made to minimize the probability of a Type 1 error. 
• Type 11 error, the probability of not finding a difference between the 
groups, that is there, may also occur. Attempts to minimize the 
probability are difficult as the sample size is small. 
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CHAPTER 8 
NEUROPSYCHOLOGICAL TEST RESULTS 
8.1. INTELLIGENCE 
Table 8-1 Summary table of Means on prorated 10 Scores (Griffiths, 
SSAIS-R, ISX, SAWAIS and OSAIS) 
GRP 1 GRP2 GRP3 




f-'(~ Idf-c-=-c2=,4_,-"S:,<-I) ___ > __ 
F I p-value 
In Table 8-1 and Figure 8-1 the Analysis of Variance indicates no 
statistically significant differences in performance between the treatment 
groups in prorated FlO, via or Pia. The difference between the via and 
Pia for the total sample is also not statistically significant This was 
established by determining a 95% confidence interval -on the difference 
which was (-1.54, 597) The trend as shown in Table 8-1 and Figure8-1 is 
for Group 3 to have the lower mean scores in prorated FSIO, via and 
Pia The mean prorated FSIO, via and Pia scale scores of age 
appropriate different 10 test scores however, appear in the Appendix G. 
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Figure 81 Differences between Treatment Groups on 10 Scores 
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Significant at r< 05 
There is no statistically significant difference in performance between the 
treatment groups in the Comprehension or Similarities subtests However, 
143 
a non-significant trend is shown for Group 3 to have a poorer performance 
than the other groups in both these subtests. 
However, there is a statistically significant difference in performance in 
Digit Repetition, where the mean scale score trend indicates that Group 3 
has the most impaired performance. This is discussed in Section 2. 
Table 8-3 Summary of Mean Performance Subtest Scale Scores 













n=10 n=15 n=12 
~--~-----------~---.--.-------~-------. 
7.60 7.53 3.67 X 
SO 2.99 3.54 2.77 
significant at p<.01 
The summary table indicates a statistically significant difference in 
functioning between the treatment groups in Block Design. A post- hoc 
analysis using the Fisher Least Significant Difference (LSD) clari"fies that 
the significant difference is between Groups 1 and 3 (p< .008) and Groups 
2 and 3 (p<.025). Group 3, the medulloblastoma tumour subjects, treated 
by means of surgery, RT and chemotherapy, is the most impaired. 
There is also a statistically significant difference in performance in Coding. 
Fisher LSD shows that the difference is between Groups 1 and 3 (p<.006) 
and Groups 2 and 3 (p <.003). Group 3 is thus significantly impaired 
relative to the others in both Block Design and Coding which are both 




Summary of Mean Scale Score on Digit Repetition and Mean Percentile 
Score on Trail Making Test A and Test B. 
Digits 
n=10 n=17 n=17 n=44 
X 8.40 8.00 5.17 7.00 
SO 4.09 3.29 3.36 3.73 
TMTA 
n=3 n=10 n=5 n=18 
X 3.67 19.60 9.00 14.00 
SO 5.51 27.79 17.46 22.99 
TMTB 
n=3 n=10 n=5 n=18 
X 39.00 23.78 20.50 25.62 
SO 0.00 22.39 28.99 21.00 
significant at p<.05 
In table 8-4 the ANOVA shows a statistically difference in performance on 
Digit Repetition (F=3.77; df=2.41; p<.031). Group 3 has the lowest mean 
scale score. 
Digit Repetition is normally reported as digits forwards and digits 
backwards, in this instance it was difficult to do that kind of analysis as the 
age range of the sample would have confounded the results. Results were 
therefore computed on the scale scores. However, differences in raw 
scores between Digits Forwards and Digits Backwards were calculated to 
establish if the mean treatment group differences in scores exceeded 
three digits which would have suggested a difficulty in mental flexibility 
(mean differences=1.8; 1.6; 1.6). No difference between the groups was 
apparent. 
The numbers in TMT A & TMT B are insufficient for statistical analysis. 
The mean percentile scores indicate that the subjects have achieved 
better in Part B than Part A. This suggests that the difficulty could be one 
of motor slowing and concomitant visual perceptual difficulties, rather than 
double mental tracking. 
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8.3. VISUAL PERCEPTUAL INFORMATION PROCESSING 
Table 8-5 Summary of Mean Percentile Scores on Non-Motor Visual 
Discrimination and Visual Spatial Relations (TVPS) and Visual Motor 
Integration (Beery) 
Visual Discrimination - TVPS 
n=11 n=16 n=16 
X 76.27 53.44 39.25 
.072 SO 32.92 45.53 38.40 
Visual Spatial Relations - TVPS 
n=11 n=16 n=16 
X 11.00 12.69 8.69 
SO 4.34 4.76 6.23 
Visual Motor Integration-Beery 
n=11 n=16 n=18 
X 41.00 19.75 9.39 
SO 31.76 23.38 15.19 
significant at p<.01 
In Table 8-5 the Analysis of Variance shows that there is a statistically 
significant difference in performance between the treatment groups in 
Visual Motor Integration (Beery). A post hoc analysis using the Fisher 
(LSD) shows that the significant difference in performance is between 
Groups 1 and 2 (p< .023) and Groups 1 and 3 (p< .0008), the functioning 
of Group 3 being the most impaired. 
The Visual Discrimination and Visual Spatial Relations tests are "motor 
free" tests which have not elicited a significant difference in performance 
between the treatment groups. However, a downward trend is shown in 
the mean percentile scores in Visual Discrimination according to the 
addition of treatment whereas the scores in Visual Spatial Relations are 
within the impaired range for all the treatment groups 
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The Analysis of Variance between the two non-motor tests, Visual 
Discrimination Test and the Visual Spatial Relations Test, shows that 
there is a significant difference in performance between the results of the 
two tests. (df=2,40; F=2.S12, P < .050). 
The overall impaired performance of the subjects in the Visual Spatial 
Relations Test is significantly worse than the overall performance on the 
Visual Discrimination Test (t = 6.5; df=42; P < .0001). 
In summary in the domain of Visual Perceptual Information Processing, 
the results of the above tests, plus the results obtained on the Block 
Design and Coding tests, indicate that the subjects in Group 3 are 
significantly impaired on both the motor-free tests and the motor tests of 
Visual Perceptual Information processing. In terms of Visual Spatial 




Table 8-6 Summary Table of Mean Scale Scores on Story Memory, 































In the above table, descriptive statistics are presented as the number of 
subjects in some groups are insufficient for statistical analysis. 
School-going children from the ages of 7 years to 17 years 11 months 
participated in the SSAIS-R story memory test. The overall trend of the 
mean scale scores of the three treatment groups indicates that they are all 
functioning within the average range in immediate recall of a story. 
Subjects 18 years and older completed the WMS-R test. The mean 
percentile score of the Story (logical) Memory on both Immediate and 
Delayed Recall shows that both Group 1 and Group 2 are functioning in 
the 30.5 - 41.4 percentile range whereas Group 3 are in the impaired 
range on both Immediate and Delayed recall. The small numbers in each 
group and the large variation in standard deviation scores preclude further 
analysis. 
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The Age-of-Testing for those who did the WMS-R is from 18 years to 42 
years, representing an older age group than the children who were tested 
on the SSAIS-R Story Memory. Although it is difficult to compare the 
results of two different tests, the mean percentile scores of the Story 
Memory WMS-R show that the group is functioning from the low average 
to impaired range whereas the Mean Scale scores of the SSAIS-R are 
within the average range. It is possible that Age-at-Testing and Years-
since-Treatment may have influenced or played some part in these 
results. 




















n=11 n=16 n=16 
50.91 59.94 26.04 
26.44 35.14 33.82 
~~L-. ______________ ~~ ______ ~ _____ ~ ____ __ 
significant at p<.05; significant at p<.01 
On the TVPS-non-motor test of Immediate Visual Recall, there are 
statistically significant differences in functioning between the treatment 
groups according to ANOVA calculation (F=5.91; df=2.40; p<0.005). 
Post-hoc analysis using the Fisher (LSD) shows that the significant 
difference in functioning between Groups 2 and 3 is just short of statistical 
significance (p < .058) but that there is a statistically significant difference 
between Groups 2 and 3 (p < .006). Group 3 has the most impaired level 
of functioning. As most of subjects over the age of four years were able to 
participate in the test, the sample is larger than the number of subjects 
completing the WMS-R. The robustness of the statistical results are thus 
enhanced by the larger number of participants. 
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On the WMS-R Visual Memory the small number of subjects restrict the 
analysis A trend is shown for Group 2 to perform better both in 
Immediate and Delayed Visual Recall and for Group 3 to perform the 
worst on Delayed Visual Recall. Interestingly, Group 1 have improved 
their percentile scores from Immediate to Delayed recall, suggesting a 
minimum or no loss of information, whereas Group 2 and 3 have lost 
information. 
8.5. LEARNING 
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Figure 8-3 Histogram of Total Words Achieved and Expected on A VL T 
In the Figures 8-2 and 8-3 the trend of the Learning Curve indicates that 
all the groups have the ability to learn a list of words after repeated 
rehearsal. 
However, Group 3 is slow to start (Trial 1), and appear to have difficulty in 
sustaining their attention (Trials 3 and 4), although they regain their 
momentum (Trial 5). After an interference task (B), Group 3 have difficulty 
in shifting their response from one task to another. The differences 
between the groups are significant for Trial 4 (F=5.92 P < 006) and Trial 5 
(F=3.65; P < .036). 
There is a statistically significant difference between the groups in the 
Total Number of Words Recalled (df=2,34; F=414; p < 05). A post hoc 
analysis, (LSD <.007) shows that the significant difference is between 
Groups 2 and 3 
The ANOVA (df=2, 33; F = 2.60; P >.089) indicates that there are no 
statistically significant differences between the groups in terms of their 
performance on the Recognition score 
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Table 8-8 Supplementary Indices of the Auditory Verbal Learning Test 
Learning over trials 
(cumulative T1-T5 
minus 5 x T1 
% retention (T5-T6) 
Long term % retention 
T7 
I 
Learning Index (highest 
score T1-T5 minus T1 













The Supplementary Indices clarify the quality of the subjects' ability to 
learn. Qualitatively, Group 2 appear to have marginally better scores in 
learning over trials and in ability to retain both long-term and short-term 
information. Group 3, on the other hand have the poorer scores. The 
scores are almost identical for Short Term Retention and Long Term 
Retention. 
The Number of Words Recalled on Trial 1 of AVL T are similar to the 
Number of Digits Forwards Recalled for each group (5,5,4 versus 4,5,4). 
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B.S. MOTOR FUNCTIONS 



















The summary table shows that there is a statistically significant difference 
between the treatment groups in performance on all three measures of 
the Purdue Pegboard. 
Post-hoc analysis using the Fisher (LSD) on all the parameters indicates 
that Group 2 is significantly better than Group 3 on both the Preferred 
Hand Functioning (p <.009); and the in Non-Preferred Hand Functioning 
(p < .006); and that in Both Hand Functioning Group 2 is significantly 
better than Group 3 (p < .058), and Group 1 is significantly better than 
Group 3 (p < .006). 
There are no statistically significant differences between Group 1 and 2. 
The trend of the mean percentile scores of the entire group, with the 
exception of the Surgery group's performance when using Both Hands, 
indicate that the sample is functioning within the borderline to impaired 
range in Preferred, Non Preferred and Both Hands. The larger standard 
deviation score of the Surgery group highlights that the scores of the 
group are more widely dispersed than the other scores. In Group 3, the 
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medulloblastoma subjects who had surgery, RT and chemotherapy, all 
had scores within the impaired range. 
8.6.1 Successive Finger Taps 

























The summary table of mean differences in seconds between the observed 
and expected scores to execute Successive Finger Taps indicates that 
Group 3 is slower than the other groups in the performance of the task 
using the Preferred Hand and the Non- Preferred Hand. The significant 
difference was established at the 95% Confidence Level on the difference 
in time (seconds) on the Preferred Hand functioning (0.737; 2.976) and 
Non-Preferred Hand functioning (0.621 ;2.988). The difference is 
significant as the interval does not include O. 
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8.6.2 Balance and Gait 
Table 8-11 The number of Subjects in each group (expressed as 
percentage) who could maintain their Balance on the Preferred and Non-
Preferred Leg 
% (4) 36% 
% (7) 64% 
Adequate norms are not available for this test but the expected age 
appropriate scores for boys and girls of Denckla (1973, 1974) were used. 
The trend in the table shows that a large number of children in Group 3 
had difficulty balancing on either leg. The statistically significance of 
differences were established by determining the 95% confidence level on 
the differences which were (-17.76; -6.60) preferred leg and (-19.07; -
8.67) non-preferred leg. 
Table 8-12 Ataxic Gait 2-Way Summary Table: Observed Frequencies 
(4) 36% (9) 47% (12) 63% (25) 51% 
The summary table shows a trend for an increasing proportion of subjects 
from Group 1 to Group 3 to have ataxic gait but the difference did not 
reach statistical significance (Pearson Chi-Square, 2.167; df=2; P >.338). 
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8.7. THE EFFECT OF TUMOUR TYPE 
Table 8-13 The Means and Standard Deviations of Tumour Types on 
Cognitive Variables 
Prorated FSIQ 
n=16 n=4 n=30 n=1 
X 79.12 68.25 75.90 73.00 
SD 21.19 17.63 20.20 0.00 
TVPS- MOTOR VISUAL MEMORY PERCENTILES 
n=13 n=3 n=26 n=1 
X 9.23 P 12.00 P 8.84 P 73.00 P 
SD 3.21 4.00 4.66 0.00 
AVLT/RAW SCORES 
n=11 n=3 n=22 n=1 
X 44.18 42.00 39.90 42.00 
SD 12.36 14.00 15.87 0.00 
VMI-BEERY PERCENTILES 
n=13 n=3 n=28 n=1 
X 42.53 P 2.33 P 13.2'1 P 6.00 P 
SD 30.05 1.52 18.47 0.00 
PURDUE/BOTH HANDS PERCENTILES 
n=14 n=4 n=27 n=1 
X 37.14 P 27.50 P 21.11 P 10.00 P 
SD 31.23 35.00 18.67 0.00 
The small numbers in some groups are insufficient for statistical analysis. 
The prorated FSIQ scores show that the astrocytoma and 
medulloblastoma groups are both in the borderline range, whereas the 
ependymoma group, all of whom had the same treatment of Surgery + RT 
are in the mental retardation range. The small numbers of subjects across 
the groups as well as the different treatment modalities and possibly the 
severity of the various tumours are complicating factors in the 
interpretation of the results. 
With the exception of the single case in the brain stem glioma tumour 
group, the mean percentile scores of all the subjects in the astrocytoma 
156 
tumour group, ependymoma tumour group and the medulloblastoma 
tumour group are within the impaired range on Visual Memory (TVPS) 
non-motor functioning. 
Raw scores between the tumour groups on the AVL T total scores show a 
downward trend with the medulloblastoma group having the lowest scores 
but indicating that the survivors are capable of learning a novel list of 
words with repetition and rehearsal. 
On the Visual Motor Integration Test (Beery) the astrocytoma brain 
tumour mean percentile scores are in the average range whereas the 
medulloblastoma scores are in the below average range. The astrocytoma 
tumour group comprises of low grade tumours as well as tumours of 
higher grades treated by means of surgery only as well as surgery and 
radiotherapy. The medulloblastoma tumour groups are malignant tumours 
treated with surgery and radiotherapy or surgery, radiotherapy and 
chemotherapy. Treatment is thus a potential confound in the interpretation 
of the results. The scores of the ependymoma tumour group are in the 
impaired range. 
The different treatment variables, small numbers, wide scatter of the 
scores as well as the retrospective nature of the design are potential 
confounds in the interpretation of the results. In Chapter 10 the effects of 
age and time on tumour type are evaluated. Chapter 11 explores the 
factors that are influencing the outcome of the medullobastoma tumours 
subjects. Appendix A shows the histology of the various tumours. 
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8.8. SURGICAL RESECTION AND SELECTED POST 
TREATMENT COMPLICATIONS 
Table 8-14 The Effects of Surgical Resection and Selected Post 
Treatment Complications on prorated FSIQ 
X 
SO 





The table shows there are no statistically significant differences in 
prorated FSIQ scores between the children undergoing subtotal and total 
tumour resections or between those rendered mute and not mute 
following surgery. There is a statistically significant difference between 
those undergoing repeated shunt revisions and those not having a 
repeated shunt revision. The difference in prorated FSIQ scores between 
the three patients suffering from seizures and those who do not does not 
reach statistical significance, possibly due to the small numbers involved. 

















Although there is no statistically significant difference in weight between 
the treatment groups. the table shows a trend for decreasing weight as 
radiotherapy and chemotherapy are added to the treatment protocols. 
There is a statistically significant difference in percentile height between 
the treatment groups showing that Group 3 have the shorter stature 
(Fisher's LSD p =.01). 
8.9. SOCIO-ECONOMIC STATUS AND EFFECTS ON 
PRORATED IQ SCORE 
A marginally significant correlation between the occupational status of the 
sample and prorated 10 scores shows that the higher the occupational 
status the higher the prorated 10 score (see tables 8-16 and 8-17 below) 
Table 8-16 Prorated IQ and Occupational Status in Entire Group 
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Routine Non Means 73.27 75.18 
Manual SO 10.36 11.23 
n=11 
Unskilled Manual Means 68.60 70.40 






Ali Groups Means 76.54 78.27 
-----~~--~----~-~. -=~---~ 
76.05 
n=51 SO 19.95 20.37 
~~------------~------------~---
21.63 
One way ANOVA on the three prorated IQ measures with Occupational 
status as the independent variable shows that there are expected 
significant differences between the occupational categories on FSIQ 
(df=4;F=4.09; p=.006), VIQ (df=4;F=3.79;p=.009), PIQ (df=4; F=3.66; 
p=.011). The summary table indicates that Occupational category group 2 
(Middle white collar class) is higher than Occupational categories 
1 (Professional and managerial), 3 (Manual, foreman and skilled), 4 
(Routine non manual) and 5 (Unskilled manual). However, as shown in 
Table 7-4, there are no significant differences between the Treatment 




QUALITY OF LIFE 
9.1. INTRODUCTION 
Quality of Life refers to how well the survivors are functioning in the 
domains of emotion, behaviour, health, education and occupational 
status. The WPBIC was administered to all school-going children and the 
MHSC was given to the entire sample. 
9.2. WALKER PROBLEM BEHAVIOUR IDENTIFICATION 
CHECKLIST 
Boxplol - Walker Behaviour Checklisl 
Mean; Whisker: Mean-SE, Mean+SE 
80 
74 
II 68 I 




2 3 • WK_IMMT 
Trealmenl group 
WK ACTT = Acling Out WK WITHT = Withdrawal WK DISTT = Distractibility 
WK PEERT = Peer Relations WK IMMT = Immaturity 
Figure 9-1 Summary of Mean T Scores on WPBIC 
In the Figures 9-1 and 9-2, the Analysis of Variance shows no significant 
difference between the treatment groups in: Acting Out (F= 0.46; df=2, 31; 
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p> .636); Withdrawal (F= 0 .67; df=2, 31; p >.518); Distractibility (F=0.75; 
df=2.31,p> .480); Disturbed Peer Relations (F= 0.53; df=2, 31; P >.593); 
Immaturity (F= 2.51; df=2, 31; p > 0 ,097) and Total T Score (F= 1 18; 












GROUP 1 GROUP 2 
Figure 9-2 Mean Total T Scores on WPBIC 
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GROUP 3 
A score between T40-T60 is considered to be within the average range: 
the higher the score the more impaired the functioning The trend of the 
total scores indicates that Group 1 and Group 2 are functioning within the 
upper limits of the average range, whereas Group 3 falls in the below 
average range in terms of problem behaviour. Figure 9-1 demonstrates 
the domains of difficulty experienced by each group: 
• Acting Out (ACTT) this is a problem behaviour for all the groups 
• Immaturity (IMMT): all the children in Group 3, the majority of those in 
Group 1, but none in Group 2 are immature 
• Disturbed Peer Relation (DISTT): more than half the children in 
Groups 2 and 3 have difficulties with this domain 
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• Withdrawal and Distractibility (WITHT; DISTT): few children in the 
treatment groups have difficulties in these areas 
9.3. AGE-AT-DIAGNOSIS AND WPBIC 
The effects of Age-at-Diagnosis on psychosocial functioning are seldom 
described. Age-at-Diagnosis and WPBIC total score are not significantly 
correlated (r=.077; p=.667). 
9.4 WPBIC AND NEUROPSYCHOLOGICAL TESTS 
An analysis was done to explore the possibility of an association between 
problem behaviour and cognitive deficits with the neuropsychological tests 
found to be sensitive to differences between the treatment groups. 
Table 9-1 Correlation on WBPIC and Cognitive Test Results 
The above table shows a statistically significant albeit moderate, negative 
association between prorated FSIQ and total score on WBPIC, with 
problems increasing as FSIQ decreases. 
9.5. HEALTH RELATED QUALITY OF LIFE 
Functional Morbidity (MHSC) 
The functional morbidity of the sample, is the sum of the number of 
attributes scored in each domain of sensation, mobility, emotion, 
cognition, self care and pain, on MHSC. Attribute level 1 describes normal 
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developmental functioning for the specific age. Attribute level 5 describes 
the most impaired level of functioning in each domain. Subjects may 
endorse different levels of function in the domains. 












The above table indicates that 36% of the sample have only endorsed 
attribute level 1 indicating that they have no functional difficulties. Thus, 
64% of the sample have some degree of functional morbidity 
(percentages have been rounded off for ease of interpretation). 
Table 9-3 Frequencies of Domains of Attributes Affected -MHSC 
36 (70%) 28 (55%) 23 (45%) 15 (29%) 40 (78%) 45(82%) 
2 11 (22%) 18 (35%) 23 (45%) 12 (24%) 8 (16%) 6 (12%) 
3 2 (4%) 3 (6%) 5 (10%) 21 (41%) 0 
4 2 (4%) 1 (2%) 0 3 (6%) 3 (6%) 
5 1 (2%) 0 
n=51 
This table shows the level of attributed difficulty found in each domain of 
functioning. 
Sensation: Within the sample, 22% of the subjects require some form of 
equipment such as glasses or a hearing aid to see or hear adequately. 




various sensations: The hearing and vision of two subjects is limited, in 
spite of equipment. One late survivor is mute and another blind. 
Mobility: Only about one third (35%) of the sample endorsed attribute 
level 2, which describes limitations in locomotor ability such as gait 
disturbances and difficulties in balance. The scale does not include upper 
limb movements or differentiate between left-side or right-side functioning. 
A small number of subjects (6%) require wheelchairs or some form of 
mechanical aid while 2% require the assistance of another person as well 
as mechanical aid. Only one patient endorses the criteria for Attribute 
level 5 in that he is unable to use his legs or one arm. 
Emotion: Almost half the subjects suffer occasional emotional turmoil such 
as fretfulness, anger, anxiety, depression or night terrors whereas only 
10% often complain about these symptoms. 
Cognition: This category has the highest level of difficulties as 41 % of the 
survivors require educational assistance and 6% are unable to learn. 
Self-Care: A small number of subjects require the assistance from another 
person in activities in daily living such as eating, bathing, dressing or toilet 
use. 
Pain: A high percentage of patients are free of pain and only 12% report 
occasional pain which is relieved by non-prescription drugs. 
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9.S. TREATMENT GROUPS AND MHSC 
Table 9-4 MHSC Treatment Group Functioning 
The above table indicates that the trend is for the mean total score to 
increase from Group 1 to Group 3 indicating the presence of one or more 
health-related difficulties. The Anova shows that the difference between 
the treatment groups is not statistically significant (F=1.35; df=2; p>.268). 
9.7. AGE-AT-DIAGNOSIS AND YEARS-SINCE-TREATMENT 
9.7.1 Age-at-Diagnosis 
Statistically significant correlations were not found for the group as a 
whole between Age-at-Diagnosis and MHSC domain scores: Sensation 
(r=.074; p>.607), Mobility (r=-109; p>.446), Emotion (r=.114; p>.424), 
Cognition (r=-139; p>.330), Self Care (r=-.219; p>.123), Pain (r=.148; 
p>.299) or the total Score (r=-.067;p>.639). 
As more than half the sample had indicated some difficulty in Emotion, 
this was explored in more detail. 
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Table 9-5 Age-at-Diagnosis and Emotion on MHSC 
significant at p <.05 
The difference in emotional functioning according to Age-at-Diagnosis 
falls just short of significance (Chi Square 9.11; df=4; p =.058). The older 
the Age-at-Diagnosis, the greater is the likelihood of the person 
occasionally or often fretful. 
9.7.2 Age-at-Diagnosis and Treatment Groups 
Table 9-6 Correlation matrix between Age-at-Diagnosis and MHSC 
Positive significant correlations were only found in Group 3 between Age-
at-Diagnosis and Emotion (p<.024) and Pain (p<.039) indicating that the 
older the subject at diagnosis, the greater the associated incidence of 
emotional difficulty and pain. 
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9.7.3 Years-since-Treatment 
Table 9-7 Correlation between Years-since-Treatment and MHSC 
Years .431 .169 .104 .114 .177 
p<.002 p>.236 p>.563 p>.470 p>427 p>.215 
n=51 significant p<.01 
This table shows only one statistically significant correlation namely a 
moderate positive correlation between the number of Years-since-
Treatment and impaired Sensation: The longer the number of Years-
since-Treatment, the greater is the association in visual or hearing 
difficulty. The following table elaborates on the time parameter. 
Table 9-8 The implication of Years-since-Treatment on Sensation 
This table indicates that 71 % of the subjects have no deficits in sensation 
regardless of the number of Years-since-Treatment. However at six years 
and more post treatment, functional deficits became apparent. The small 
sample size limits the interpretation of the effects of treatment between 
the groups. Either deterioration with the passage of time or an 
improvement in treatment are possible reasons for this observed result. 
9.7.4 Cognitive Outcome Measures and the MHSC 
The neuropsychological test scores found to differentiate statistically 
significantly between the treatment groups were correlated with MHSC. 
Table 9-9 Correlation between MHSC and Cognitive Variables 
MHSC 
Total Score 





The statistically significant negative correlations indicate that the more 
impaired the scores on the tests of FISQ (prorated scores), TVPS (non 
motor) Visual Memory, Auditory Verbal Learning (AVL T), VMI (Beery) and 
Purdue Pegboard both hands, the more impaired is the health rating as 
measured by the total score on MHSC. 
9.8. CORRELATION BETWEEN WPBIC AND MHSC 
The positive significant correlation (r=.441; p<.009) between the total 
scores of the WPBIC (n=34) and the MHSC (n=S1) indicated that there is 
an association between the frequency of scores endorsed in the domains 
of the two measures. 
Specifically statistically significant correlations were shown: 
Total score of WPBIC and sensation MHSC (r=.339; p<.OSO) 
Total score WPBIC and emotion MHSC (r=.S64; p<.001) 
Total score WPBIC and cognition MHSC (r=.41S; p<.01S) 
9.9. EDUCATIONAL STATUS ATTAINED 
Changes in the Government's educational policy in the last five years 
have resulted in wide differences in the availability of education for 
children with special needs. Many of the children in normal school repeat 
standards because special class facilities are either not available in their 
particular school or they have to wait for a place in the special school. In 
addition to changes in educational policy, some parents are unwilling to 
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change their children to a special school because of the perceived social 
stigma. They may fail and yet be moved up to the next standard without 
having achieved the required pass mark. 
The educational achievements of those subjects who have left school and 
those who are still attending school are shown in the tables below. 
Table 9-10 Educational Status Attained of Children and Adults 
Too Young for 
School 15% (3) 5% (1) 8% (4) 
This table indicates that almost half the children attending school are in a 
special class or a special school. There were more children in Group 3 
attending special school compared with Groups 1 or 2. 
9.10. CURRENT OCCUPATIONAL STATUS 
Table 9-11 The Frequency of Current Occupational Status of Adults and 
Young Adults Eligible to enter work market 
DIG = Disability Grant 
The small number of subjects and uneven distribution of patients in each 
group distort the treatment group comparison, but nonetheless highlight 
the positive finding that almost half the group are employed. 
170 
Tertiary Training: All the subjects are from Group 2 and their training 
ranges from a first year BA student to two students attending a technical 
training centre after passing standard 8. 
Working Category: Group 2 has the highest number of employed subjects. 
Work categories range from domestic workers (Groups 1 and 3) to clerks 
and technical workers (Groups 2 and 3). In this latter category, two 
subjects achieved matriculation certificates. 
Home: Disability Grant: All the subjects developed complications such as 
infection, repeated shunt revision, transient mutism or seizures. 
9.11. SUMMARY 
WPBIC 
• There are no statistically significant difficulties in behaviour between 
the treatment groups, but trends showed that Group 3 had the highest 
incidence of problem behaviour. Specifically they had a high incidence 
of Immaturity. This was also a difficulty for Group 1. Disturbed Peer 
Relation was a domain of difficulty for Group 2 and 3, while Acting Out 
behaviour was present to a lesser or greater degree in all the children 
• Age-at-Diagnosis was not statistically significantly correlated with 
problem behaviour 
• A statistically significant negative correlation between prorated FSIQ 
and total score on WPBIC indicates that the lower the prorated FSIQ 
the higher the incidence of problem behaviours 
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MHSC 
• Sixty four percent of the sample have a degree of functional morbidity, 
the cognition, emotion and mobility domains being he most frequently 
endorsed areas of difficulty 
• Treatment effects between the groups were not statistically significant 
but trends showed that the mean total health rating score would 
increase as the adjuvants of RT and chemotherapy were added to the 
treatment protocols. Group 3 had the highest mean total score 
• Age-at-Diagnosis was statistically significantly correlated with the 
domain of emotion. In Group 3, a statistically significant correlation 
was also found with emotion and pain, suggesting an association 
where the older the subject the greater is the incidence of occasional 
emotional difficulty and pain 
• Years-since-Treatment correlated statistically significantly with MHSC 
only in the domain of sensation 
• Statistically significant negative correlations were found between 
MHSC total score and FSIQ (prorated scores), non-motor Visual 
Memory (TVPS), verbal learning (AVLT), visual motor integration 
(VMI) and motor functions (Purdue Pegboard, both hands). There is 
evidence of an association between poor health rating score and 
difficulties in decreased cognitive functioning 
• Forty three percent of the subjects (22 children) attend normal school 
• Forty five percent of the subjects (nine young adults/adults) eligible to 
enter the work market are employed 
172 
CHAPTER 10 
AGE-AT-DIAGNOSIS AND TIME-SINCE-TREATMENT 
10.1. INTRODUCTION 
The frequent confounding of the three age-related factors, Age-at-
Diagnosis, Age-at-Testing and Time-since-Treatment, in studies of 
childhood brain tumours is a major obstacle to understanding their unique 
effects. To clarify these factors, the test measures which were found to 
differ significantly between the treatment groups were regarded as the 
most sensitive and were used to examine the effects of Age-at-Diagnosis 
and Years-since-Treatment. 
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10.2. AGE-AT-DIAGNOSIS AND INFLUENCE ON COGNITIVE 
VARIABLES 
Table 10-1 Effect of Age-at-Diagnosis on Cognitive Variables 
n=13 n=11 n==27 
X 74.53 71.36 79.07 
SO 28.81 24.18 16.10 
TVPS VISUAL MEMORY (Percentile) 
n=10 n=8 n=25 
X 7.80 6.87 10.40 
SO 5.411 2.94 3 .. 58 
AVLT - TOTAL (Raw Score) 
n=6 n=7 n=24 
X 45.33 34.42 41.58 
SO 17.96 8.54 14.87 
VMI Beery (Percentile) 
n=11 n=8 n=26 
X 14.45 24.50 22.34 
SO 22.34 30.25 26.11 
PUROUEPEGBOAROBOTH 
HA N OS( Percenti Ie) 
n=10 n=9 n=27 
X 21.00 38.88 24.07 
SO 16.63 34.07 23.57 
significant at p <.05 
In this above table, there are no statistically significant differences 
between the Cognitive variables and the age groups when divided into the 
Age-at-Diagnosis groups. However, the non-motor Visual Memory (TVPS) 
outcome as indicated by the ANOVA outcome has not quite reached 
statistical significance at the <p.05 level. Inspection of the Scatterplot 



















Figure 10-1 Scatterp/ol of Age-at-Diagnosis versus TVPS Visual Memory 
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10.3 YEARS-SINCE-TREATMENT AND INFLUENCE ON 
COGNITIVE VARIABLES 
Table 10-2 Effect of Years-since- Treatment on Cognitive Variables 
PRORA TED FSIQ 
n=20 n=6 n=8 n=17 
X 79.80 72.83 67.25 77.52 
SO 17.14 22.11 20.43 22.30 
TVPS VISUAL MEMORY (Percentile) 
n=15 n=6 n=7 n=15 
X 8.60 6.50 8.85 10.86 
SO 2.84 4.88 4.01 4.70 
AVL T - TOTAL (Raw Score) 
n=3 n=8 n=14 
X 41.00 30.62 48.50 
SO 19.07 16.73 10.62 
VMI-Beery (Percentile) 
n=16 n=6 n=7 n=16 
X 39.31 15.33 6.42 10.62 
SO 28.49 23.90 12.24 17.03 
PURDUE PEGBOARD BOTH HANDS 
(Percentile) 
n=17 n=6 n=7 n=16 
X 31.76 20.00 15.71 27.50 
.490 SO 29.41 16.73 15.11 25.69 
significant at p <.05; P <.01 
The above table shows a statistically significant difference in functioning 
on the AVL T -total score and Visual Motor Integration (VM I Beery) test 
scores and Years-since-Treatment. Inspection of the trends on the VMI 
(Table 10-2 and Figure 10-3) indicates that the trend of the percentile 
scores is to decrease with Years-since-Treatment. The AVL T results are 
harder to interpret. The scatterplot (Figure 10-2) suggests a slight 
increase with Years-since-Treatment, but the use of raw scores may 
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indicate that this increase is only a reflection of the expected mean 
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Figure 10-3 Scatterp/ot of VMI (Beery) versus Years-since- Treatment 
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10.4 INTERACTION OF AGE-AT-DIAGNOSIS AND YEARS-
SINCE-TREATMENT 
10.4.1 Medulloblastoma Group 
To make the comparison with the analysis of Dennis et al (1996), the 
effect of Age-at-Diagnosis and Time-since-Treatment on prorated IQ 
variables was analysed on the medulloblastoma subjects treated by 
means of surgery and combinations of radiotherapy and chemotherapy. 
The Age-at-Diagnosis categories were matched to those used by Dennis 
et aI. , (1996) . This analysis was then repeated on the astrocytoma 
subjects treated by means of surgery only. 
Table 10-3 Summary of Age-at-Diagnosis, Years-since-Treatment and 
Prorated IQ test scores in Medulloblastoma Group 
0-3yr (n= 1 0) 
X 2.58 8.96 74.90 71 .70 
SO .82 6.01 20.39 21 .15 
4-6yr (n=3) 
X 5.11 6.16 78.66 78.00 
SO .67 .75 34.67 33.86 
> 7yr (n=17) 
11.75 10.54 80.94 75.05 
3.04 8.50 18.43 17.03 
GROUP (n=30) 
8.03 9.58 78.70 74.23 
4.96 7.43 20.18 20.97 
This table shows the means and standard deviations for Years-since-
Treatment and prorated IQ test scores (FSIQ, VIQ, PIQ) in the different 
Age-at-Diagnosis groups. The differences between the Medulloblastoma 
Group and the normative sample (a hypothetical population with a 
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mean=100, and sd=15) were significant for all IQ measures (FSIQ: 
t(29)=6.82, p < 0.0001; VIQ: t(29)= 5.79, p<0.0001; PIQ: t(29) = 7.00, P 
<0.0001). 
The difference between mean VIQ and PIQ scores was however 
statistically significant (t (29) = 2.17, P < 0.04). From another aspect a 
greater number of the sample, 19 out of 30, had lower PIQ than VIQ 
scores although this difference was not statistically significant (.J! (1) = 
2.13, p > 0.14). The ANOVA between Age-at-Diagnosis groups and IQ 
variables failed to show any statistically significant differences (FSIQ; df = 
2,27; F= 0.25; P > .779; VIQ; df=2,27; F=0.26; p>.767; PIQ; df=2,27; F= 
0.12; P >.881) . 
Multiple regression analyses using Age-at-Diagnosis and Years-since-
Treatment as predictor variables also failed to show any joint predictive 
relationship with the dependent variables (FSIQ; df = 2,27; F= 0.85; P > 
.436; VIQ df=2,27; F= 0.37; p> .692; PIQ df=2,27; F=0.82; P >.448) 
A second calculation was done, limiting the sample to children under the 
age of 18 years at age-at-testing, this was done to match the Dennis et a/ 
(1996) analysis. Thus all adults were excluded. 
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Table 10-4 Summary of mean Age-at-Diagnosis, Years-since-Treatment 
and Prorated 10 Test Scores on Medulloblastoma subjects age < 18 years 
, < :.'-: 
, : I:' ,; . , , i (. . J (;.. 
I \ _. I '..:' • ~ 
0-3yr (n=9) 
X 2.48 7.96 72.55 75.00 72.88 
SO 0.81 5.41 23.08 21.62 26.38 
4-6yr (n=3) 
X 5.11 6.16 77.66 78.66 78.00 
SO 0.67 5.75 33.47 34.67 33.86 
> 7yr (n=8) 
X 10.06 3.78 73.55 76.20 76.30 
SO 2.24 1.75 19.95 21.51 17.33 
ALL GROUP (n=20) 
X 5.90 6.02 73.55 76.20 73.30 
SO 3.88 4.56 22.19 22.26 22.99 
TX = Treatment 
The summary table demonstrates that the differences between the mean 
VIQ and PIQ scores were not statistically significant (t (19)= 1.05, p> 0.3). 
The ANOVA showed no statistically significant differences between the 
Age-at-Diagnosis groups on the prorated IQ variables (FSIQ; df=2, 17; F= 
0.05; p > .945; VIQ; df =2, 17; F= 0.02; p > 970; PIQ; df=2,17; F = 0.29; p 
> .933). 
Multiple regression analyses using Age-at-Diagnosis and Years-since-
Treatment as predictor variables also failed to show any joint predictive 
relationship with the dependent prorated IQ variables (FSIQ; df= 2,17; F = 
0.15; p > .859; VIQ ; df= 2,17; F = 0.28; p > .754; PIQ; df=2,17; F = 0.27; 
p> .765). 
Inspection of the scatterplot of the mean prorated IQ scores and Years-
since-Treatment (Figure 10-4) shows that two outlying cases are strongly 
influencing the results as they have unusually high prorated IQ scores for 
the Years-since-Treatment variable. 
180 
Based on the present data the two outlying cases reflect the clear large 
variation in prorated IQ scores at all points on the variable Years-since-
Treatment Therefore if some observations exert great leverage, there is 
justification for removing the outlying cases. In this way the picture 
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Figure 10-4 Scatterplot of mean Prorated 10 scores versus Years-since-
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Figure 10-5 Revised scatterplot of mean prorated 10 scores versus Years-
since-Treatment on Medulloblastoma subjects 
In the revised sample of medulloblastoma subjects (n=18), multiple 
regression analyses indicate there are statistically significant predictive 
relationships with the dependent variables FSIQ and VIQ variables and 
Years-since-Treatment (FSIQ; df= 2,15; F = 3.94; P < .042; VIQ; df = 2,15; 
F = 4.82; P < . 024) No statistically significant relationship is shown on the 
PIQ and Years-since-Treatment (df = 2, 15; F = 2.70; P > .099), so that 
the longer the Years-since-Treatment the lower the FSIQ. The difference 
is apparent in VIQ and not PIQ. This finding needs to be made with 
caution as the heteroscedasticity of the scores has a potentially 
confounding effect on the results. 
10.4.2 Astrocytoma Group 
In order to ascertain whether the same IQ results can be obtained on the 
astrocytoma subjects treated by means of surgery only, the analysis was 
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replicated on those subjects. All the children were younger than the age 
of 18 years at-testing. 
Table 10-5 Summary of Age-at-Diagnosis, Years-since-Treatment and 
prorated 10 Test Scores on children with Astrocytoma Tumours 
-1· . ' .. '.' ':, :o/r '/(" :11'" 
I \ I ... 1 ~ • • i ( \ \ \ ~. ) . 
0-3yr (n=2) 
X 2.16 8.00 65.00 65.00 69.00 
SO 1.18 7.07 19.79 9.89 32.52 
4-6yr (n=4) 
X 5.15 4.75 82.75 87.00 81.00 
SO 0.86 6.84 21.92 14.18 29.29 
> 7yr (n=6) 
X 9.33 2.66 80.16 77.00 85.83 
SO 2.94 0.51 12.60 16.21 11.94 
ALL GROUP (n=12) 
X 6.74 4.25 78.50 78.33 81.41 
SO 3.55 4.63 16.74 15.59 20.82 
TX = Treatment 
This table shows that the differences between the Astrocytoma group and 
the normative sam pie (a hypothetical popu lation with a mean = 100, and 
standard deviation = 15) were significant for all measures (FSIQ: t (11) = 
4.96, P < .0001; VIQ: t (11) = 5.00, P < .0001; PIQ: t (11) = 0.61, P < 
.0001). The difference between VIQ and PIQ scores, was not statistically 
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Figure 10-6 Scatterplot of mean prorated 10 scores versus Age-at-
Diagnosis in Astrocytoma Group 
This figure shows that there are no statistical significant differences 
between Age-at-Oiagnosis and the prorated 10 variables (FSIQ; df = 2, 9; 
F = 0.77; p> .488; VIQ; df= 2,9; F = 1.49; p> .655; PIQ; df = 2,9; F= 0.44, 
p> .656). The scatterplot in the figure 10-6 indicates the 10 trends that the 
younger the Age-at-Oiagnosis the lower the prorated FlO and the older 
the Age-at-Oiagnosis the better the prorated IQ score. This is a tentative 
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Figure 10-7 Scatterplot of Astrocytoma Group showing Years-since-
Treatment and mean prorated 10 Scores 
In this figure correlations between any of the prorated IQ measures and 
Years-since-Treatment showed no significant relationship: FSIQ (r= -
.356; p> .257); VIQ (r= - .318; P >.314); PIQ (r= -.324; p=<.304). Multiple 
regression analysis using Age-at-Diagnosis and Years-since-Treatment 
as predictor variables failed to show any joint predictive relationships with 
the dependent IQ measures. FSIQ (df = 2, 9: F = 2.01; p > .188); VIQ (df 
= 2,9; F = 1.18; p> .349); PIQ (df= 2,9; F = 1.63; p> .247). Unfortunately 
the small size of the sample limits the results. 
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10.5. SUMMARY OF AGE-AT-DIAGNOSIS AND YEARS-SINCE-
TREATMENT FINDINGS 
• A statistically significant effect was found on Years-since-
Treatment and Visual Motor Integration (VMI) Beery scores. The 
VMI scores tend to decrease or plateau with time as the child gets 
older. 
• There was also a statistically significant effect found on Years-
since-Treatment and AVL T total scores. As the raw scores were 
used this may reflect the expected increase from childhood to 
adulthood. 
• An effect which did not quite achieve statistical significance was 
found on Age-at-Diagnosis and immediate non-motor Visual 
Memory (TVPS). 
In the exploration of the interaction of Age-at-Diagnosis and Years-
since-Treatment on the medulloblastoma and astrocytoma tumour 
groups: 
• Medulloblastoma group - the entire group: Multiple regression 
analysis using Age-at-Diagnosis and Time-since-Treatment on the 
prorated 10 variables did not reveal a predictive relationship on the 
prorated 10 variables. 
• Medulloblastoma group restricted to those under age 18 years at-
testing: The correlation between Age-at-Diagnosis and Years-
since-Treatment was negative and of moderate size. The younger 
the Age-at-Diagnosis the longer the Time-since-Treatment. 
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• Medulloblastoma group restricted to those under age 18 years at-
testing. Multiple regression analysis indicated a statistically 
significant difference in Years-since-Treatment on prorated FSIQ 
and VIQ but not on PIQ: The longer the Years-since-Treatment the 
lower the prorated FSIQ and VIQ. 
• Astrocytoma group all of whom were younger than the age of 18 
years at-testing. Multiple regression analyses using Age-at-
Diagnosis and Years-since-Treatment as predictor variables failed 
to show any joint predictive relationship with the dependent IQ 
measures. The correlation between Age-at-Diagnosis and Years-
since-Treatment was negative, non-significant and of a moderate 






In order to explore which factors were influencing the subjects treated by 
means of surgery, radiotherapy and chemotherapy, post hoc analysis was 
done on all the children diagnosed with medulloblastoma tumours. A total of 
thirty subjects was extracted from the sample (see Appendix A). Of these, 
eleven children were treated with Surgery and Radiotherapy (S+RT) and were 
named Group 4. The remaining nineteen medulloblastoma subjects were from 
the original Group 3, treated by means of Surgery, Radiotherapy and 
Chemotherapy (S+RT +C). 
The following tables describe the two medulloblastoma treatment groups 
according to demographic characteristics, age and years since treatment, 
occupation as a measure of socioeconomic status and psychosocial adversity. 
Pre-treatment variables as well as intra-operative and post- operative 
complications are also described and analysed. 
Although the full radiotherapy and chemotherapy treatment details are given in 
the appendix (Appendix A) a summary of the radiotherapy treatment protocols 
of the medulloblastoma subjects is also given. 
In an attempt to try and identify the effect of the inclusion of chemotherapy on 
cognitive outcome on the medulloblastoma subjects the prorated FSIQ scores 
were used as a basis for comparison between Group 4 (S +RT) and Group 3 
(S+RT+C). 
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11.2 DESCRIPTION OF MEDULLOBLASTOMA SAMPLE 
11.2.1 DEMOGRAPHY 
Table 11-1 Observed Frequencies of Gender, Race and Language 
Language 
~~~.~--~-~-~-~--~-+--~----~.--- ~~~--~~·-~--l~-~--·~--~~~~~~-
The above table shows that there are no significant differences at the 5% level 
of significance between the treatment groups in terms of gender, race or 
language. 
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11.2.2 AGE AND YEARS - SINCE - TREATMENT 
Table 11-2 Age-at-Diagnosis, Age-at-Testing and Years-since-Treatment, 
expressed in years. 
Group 3 Grqup4 ; 
S+.RT+C S+RT t-vaJue df p 
(n=19) (n=11) --------
Aue-at-IagnOSiL _--1--_-0.41179 28 .683632 
X 7.68 8.46 
--
._----f-- --- '-.--
~ 4.81 5.47 -'------
~nge 0.9 - 17.2 ___ 1.6 - .17. __ 
Age-a!_'Jesti~ -1.39581 28 .173742 
X 15.29 20.68 1--'-'----
SO 8.24 13.07 ---
Range 3.7 - 39.8 4.08 - 40.75 
Years-since-Treatment -1.55979 28 .130042 ---
X 7.57 12.00 
----- --.~~-.-- ...... ------- ---~.--~--- --"--------- ----------
SO 5.92 9.57 
---------- - - .. -------~-------
The above table indicates that there are no significant differences, at the 5% 
level of significance, between the medulloblastoma subjects treated by means 
of Surgery+RT (Group 4) and Surgery+RT +C (Group 3) in terms of Age-at-
Diagnosis, Age-at-Testing and Years-since-Treatment. 
11.2.3 OCCUPATION AS A MEASURE OF SOCIO-ECONOMIC-STATUS 
AND PSYCHOSOCIAL ADVERSITY 
Occupational status and Psychosocial Adversity were classified according to 
the criteria explained in Chapter 7. 
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Table 11-3 Occupational Status in Subjects with Medulloblastoma Tumours. 




(n=19) (n=11) P =.538462 
Professional & Managerial 10% (2) 18% (2} -
Middle White Collar 16% (3) 36% (4) 
Manual, Foreman & Skilled 42% (8) 18% (2} 1--- ._--
Routine Non Manual 260/0 (5) 18% (2L_ 1---------
Unskilled Manual & Menial 5% (1) 9% (1} 
r-----.-~--~.-- --. -~ 
Median = 3 Median = 2 -------_.-
The above table indicates that there are no statistical differences, at the 5% 
level of significance, between the medulloblastoma tumour groups treated by 
means of Surgery + RT (Group 4) and Surgery RT +C (Group 3) according to 
occupational status. Little difference is shown in the median scores. 
Table 11-4 Psychsocial Adversity of Subjects with Medulloblastoma Tumours. 
--
Group 3 Group 4 
S+RT+O·.··· S+RT 
n= 19 n = 11 
_ Large famHy_.siz~ __ ~ ___ ~~ __ 1--__ ~ __ ._t1~&'l?L _____ r- ____ .l18%)~_ __ 
Overcrowding 11% (2L ____ ._---'-18%) 2 _~_ 
J}nskilled/ UnemQLoyed 37%lZL ----,-45%)2 _______ 
Maternal Education < Std 6 47%1QL (27%} 3 
Mother Psychiatric 5°/illL 0% ---
Father Psychiatric 11% (2) {1§.~~ 2 
Single Parent 11 % (2} _ _ __ l1§~_L~ ____ 
DisharmQ!!Y. in home -- 16% (3} {9%} 1 ---
III health either.2arenL ___ 0% 0% --
Nutrition 26% (5} {27%) 3 
-----~ -- ---
------ Median Psychosocial Advers!!y' Score 
2 2 -- ------- --
The above table shows that according to the median psychosocial adversity 
scores there is little difference between the two groups. A trend is shown for 
Group 3 to have more subjects with mother's who have less than a standard 
six or grade eight level of education. 
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11.3 PRETREATMENT VARIABLES 
11.3.1 Presenting Symptoms 
These are fully described in Chapter 7 and there is little difference between the 
groups. 
11.4 TREATMENT 
The treatment variables explored in relation to the medulloblastoma tumour 
subjects are shunts, the extent of the surgical resection, intra-operative and 
post-operative complications and a description of sites range and mean 
duration of radiation treatment. 
Table 11-5 The Occurrence of Shunts and / or EVD expressed in Percentages 
,---
Group 3 Group 4 
. 
S+RT+C S+RT Pearson Chi Square --
r------- (n=19) (n=11) 
SHUNT/EVD 1.40931; df=2; J 
p=.494282 
SHUNT 89%~ t-- 64% (7L~ 
NO SHUNT 0% __ ~7% (3) 
~VD +SHUNT ____ 11% 2 __ 9% (1) ----- -
As the majority of the children in both groups needed shunting, the presence or 
absence of a shunt and I or EVD is not significantly different between the 
treatment groups. 
However the proportion of children in Group 4 who did not need a shunt is 
higher than that of Group 3, where all the subjects either had a shunt or a 
drain. In addition, the drains of the two children in Group 3 were replaced by 
shunts whereas the drain of the child in Group 4 was removed and did not 
necessitate replacement with a shunt. Thus children in Group 4 have a lower 
incidence of clinical signs of hydrocephalus than the children Group 3. 
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Inspection of the prorated FSIQ outcome in the three subjects who did not 
need a shunt in Group 4 (FSIQ=110, 83, 79) indicates that the one subject 
attained the highest score in the group and the other two subjects have scores 
close to the median FSIQ of 83. Other outcome measures of importance in the 
three subjects is that they have the longest Time-since-Treatment (16 years, 
28 years and 27 years respectively). The mean Time-since-Treatment for the 
groups is 12 years. Thus, subjects that do not have clinical signs of 
hydrocephalus at diagnosis, necessitating the insertion of a shunt appear to 
have a better outcome in terms of cognitive functioning and mortality as shown 
by Time-since-Treatment variable, than those subjects in Group 3. 
Unfortunately the small number of subjects precludes a sounder interpretation 
of the finding. 




Group 3 Group 4 
S+RT+C S+RT 
(n=1~n (n=11 ) 
EXTENT OF SURGERY 
32% (6) 73% (8 
68% (1~ __ L--.?7% (~ 
-~ 
Pearson Chi Square 
3.58852;df=1 ;~=.O58183 
--------
The extent of the surgical resection is just short of signi'ncance at the 5% level 
of significance. Group 4(S+RT) have a higher incidence of total surgical 
resections as compared to Group 3 (S+RT +C) who have a higher incidence of 
sub total resections. 
As Grill et al., (1999) found that an incomplete surgical resection strongly 
correlated with the radiation dose and was thus associated with a poorer 
intellectual outcome the mean prorated FSIQ scores of the two groups was 
explored. 
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GROUP 4 (S+RT) FSIQ = 90.87 (n=8) FSIQ = 74 (n=3) 
n=11 Range 65-110 Range 60 - 83 
GROUP 3 (S+RT +C) FSIQ = 67.5 (n=6) FSIQ = 71 (n=13) 
n=19 Range 45-89 Range 40 - 105 
TOTAL 
n=30 FSIQ = 79.15 (n=14) FSIQ = 722iQ=1 ~ ___ 
Inspection of the prorated FSIQ outcome scores shows that Group 4 subjects, 
who had total surgical resections treated by means of surgery and 
radiotherapy are functioning in the average range of intelligence. The prorated 
FSIQ scores of the subtotal surgical resection subjects (Group 3 & 4) as well 
as the prorated FSIQ scores of the children who had total surgical resections 
(Group 3) shows that they are functioning in the borderline to mild mental 
retardation range of intelligence. An unexpected finding is that the Group 3 
subjects who had total surgical resections have the lowest prorated FSIQ 
scores. 
One suggests that the retrospective nature of the study over a lengthy twenty 
eight year period in which improvement in diagnostic techniques such as CT 
scan and MRI as well as surgical techniques are exerting an immeasurable 
cohort effect on the results. CT scan was developed in the 1970's (Lindsay et 
al., 1998). MRI is more accurate in measuring the amount of residual tumour 
after surgical resection. This technique has only been available to Groote 
Schuur and Red Cross Hospitals in the last ten years. Within the entire sample 
of medulloblasoma subjects, only one child (Group 4), had a post operative 
MRI of the head. 
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GROUP 3 GROUP 4 
S+RT+C S+RT 
(n=19) (11=11 ) 
INTRA-OPERATIVE COMPLICATIONS 
5% (1) I 0% 




_11O/~ __ ~_ ___ ~~~~J1t~ __ ~~ --
5% (1} 0% 
The above table shows that Group 3 has a higher incidence of children who 
developed post operative infections (shunt infections = 3; meningitis = 2) 
compared to Group 4, in which one child had a shunt infection. This finding 
possibly supports the notion that Group 3 has an higher incidence of 
hydrocephalus. 
Table 11-9 Sites of Radiation Treatment, Range of Radiation Dose and Mean 
Duration of Treatment 
------------
------~-~~~~"~----





WHOLE BRAIN 20 -40 Gy 20 - 35 G 
SPINAL 14 - 42 Gy 20.- 47 G'i 
POSTERIOR FOSSA 10 - 58 Gy 10 - 42 G'i 
CRIB BOOST 24 - 32 G.1 32 G'i 
DURATION OF 
7 weeks 5.45 weeks TREATMENT 
-
The above Table indicates that it is difficult to compare the dose of 
radiotherapy as the protocols changed over the twenty eight year period of the 
study. However, inspection of the range of radiotherapy doses shows that 
Group 3 had a slightly broader and higher range of radiation treatment 
compared to Group 4. In Group 4, one child was treated with radiotherapy to 
the Posterior fossa area only (Appendix A case 27) whereas all the children 
in Group 3 received radiotherapy which included the Posterior Fossa site. Only 
one child in Group 4 had a boost of radiotherapy to the cribriform plate (case 
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no 9) compared to three children in Group 3 (Appendix A ). Thus Group 3 
children appear to have had a higher dose of radiotherapy treatment than 
those in Group 4. 
The average duration of the radiotherapy treatment was slightly shorter for 
Group 4 children than those children in Group 3. All the subjects in both groups 
completed their treatment. 
11.5 COGNITIVE FUNCTIONING 
11.5.1 Prorated FSIQ Scores 
The prorated FSIQ scores were used to explore the effects of treatment on 
cognitive functioning. These scores were used as there was no missing data 
and other calculations had been done using prorated FSIQ scores on the Age 
and Time variables (see chapter 10). A description of the prorated FSIQ scores 
obtained between the groups on the relevant IQ test measures is given below. 
Table 11-10 Description mean Prorated FSIQ Scores According to Type of 
IQ Test Administered 
GROUP 3 GROUP 4 
S+RT+C S+RT 
n=19. n=11 
_._--. FSIQ FSIQ 
~-.---~.-----~~--~ -_._-_ ... _----------- - -----_ .... _._-_ .. _----_._._-
I---_---'.SAWAIS Z~2ln=4L 92 (n=Zl __ ---i 
RANGE 53-105 73-110 
.. __ . ____ QRIEfITti..§.____ _ _____ J~2. ~JIl_=:.~ ________ . _____ Z~!l=:.11 _____ _ 
_ ___ __RAN9E_____ __ ___ .......§§_~Q4.... ___ ._ .. __ L_ _____________ . _____ _ 
A trend is shown for Group 3 (S+RT +C) subjects to have lower prorated FSIQ 
scores than Group 4 subjects. The small number of children tested on the 
Griffiths precludes further interpretation. 
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11.5.2 Cognitive Differences Between The Treatment Groups 
A t-tests was applied to try and identify a significant statistical difference 
between the prorated FSIO means of the medulloblastoma tumour subjects, 
Group 3 treated by means of S+ RT + C and Group 4 treated by means of 
S+RT. 
The t-test assumes that the two groups are representative of a larger, inclusive 
population of subjects. In statistical terms a common variance between 
individual observations in each sample is present. 





Pooled Vari ance 
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The above Table shows that at the 3% level of significance the 
medulloblastoma subjects treated by means of Surgery and Radiotherapy 
have significantly higher prorated FSIO scores than those treated by means of 
Surgery, Radiotherapy and Chemotherapy. 
11.6 PRORATED FSIQ AND SES 
The ANOVA statistic was computed to assess the extent to which each of the 
categorical variables, SES and Group (treatment, Group 3 treated by means of 
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Table 11-13 Within cell Regression (ANOVA) to investigate the extent of 
SES on Prorated FSIQ 
Sum of df !. 
Mean ,0 F plevel 
~quares Square 
Effect 735.1445 1 735.1445 2.149353 .154181 ----- - .-
The above calculation shows that the means are not significantly different at 
the 5% level of significance. In other words SES is not found to significantly 
influence prorated FSIQ given the effect of the GRP (treatment) variable. 
11.7 SUMMARY 
Description of Sample 
• There are no significant differences between Group 3 and Group 4 subjects 
in terms of gender, race, language, Age-at-Diagnosis, age-at-testing, and 
years-since-treatment. 
• There are no significant differences between the treatment groups 
according to SES. 
• According to psychosocial adversity measures a trend is found for Group 3 
(S+RT +C) medulloblastoma subjects to have a higher percentage of 
mother's with less than a standard six or grade eight, level of education 
than Group 4. 
Treatment 
• There are no significant differences between the treatment groups in terms 
of the presence of a shunt or external ventricular drain. However the 
proportion of children in Group 4 who do not have shunts is higher than 
that of Group 3. Thus, children in Group 4 have a lower incidence of clinical 
signs of hydrocephalus than those in Group 3. In addition, subjects that do 
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S+RT +C and Group 4 treated by means of S+RT) discriminate between the 
medulloblastoma cases assessed on prorated FSIQ scores. 
The mean prorated FSIQ of both the Groups assessed on each variable are 
used in calculating the test statistic. 
Table 11-12 ANOVA Results on prorated FSIQ scores 
Group 
Group 3S+RT+C mean FSIQ = 69.89474; sd = 3 
Group 4S+RT mean FSIQ = 86.27273; sd = 2.636364 
ANOVA Results: FSIQ 
f~~~ --- (FIR) , Of i F p Fixed 1 3.292235 0.080735 
Fixed 1 4.320748 .04728 
--
The above table shows that for SES the mean prorated FSIQ scores are only 
significant at the 9% level of significance and conclude that the means are not 
significantly different at the 5% level of significance. 
For GRP (treatment group) a significant difference is found at the 5% level of 
significance. 
In other words both SES and GRP (treatment group) are found to significantly 
discriminate between the cases assessed on the prorated FSIQ measures but 
to different degrees of significance. 
A further analysis was done to investigate the extent to which SES is a 
significant discriminator given the 5% significant effect on FSIQ. 
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not have clinical signs of hydrocephalus at diagnosis, necessitating the 
insertion of a shunt appear to have a better outcome in terms of cognitive 
functioning and mortality than those with hydrocephalus. Unfortunately this 
finding needs to be verified on a larger sample. 
• The extent of the surgical resections between the Groups is just short of 
significance at the 5% level. Group 4 (S+RT) children have a higher 
percentage of total resections compared to Group 3 (S+RT +C) children 
who have a higher percentage of sub total resections. 
• The subjects in Group 3 appear to have been treated with a higher dose of 
radiotherapy according to the range and site of treatment than Group 4 
subjects. 
Cognition and Treatment 
• An inconsistent pattern of prorated FSIQ scores was found according to 
the extent of the tumour resection between and within the treatment 
groups. However on inspection of the scores of all the medulloblastoma 
subjects little difference was shown between prorated FSIQ scores 
according to the extent of the surgical resection. The group as a whole is 
functioning in the borderline range of intellectual functioning. One 
suggests that the retrospective nature of the design is exerting some 
degree of a cohort effect on the results. 
• A statistically significant difference in prorated FSIQ scores was found 
between the groups according to the treatment of S+RT (Group 4) and 
S+RT +C (Group 3). Group 4 subjects have a higher level of FSIQ 
functioning and are functioning in the low average range of intelligence 
whereas Group 3 subjects are functioning on the cusp of the borderline/ 
mental retardation range of intelligence. 
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• The ANOVA was calculated to assess the extent to which SES and 
treatment discriminated between the medulloblastoma treatment groups 
on prorated FSIQ scores. SES was not found to significantly influence the 
prorated FSIQ score given the effect of the treatment variable. 
• One thus concludes that in the sample of medulloblastoma subjects, the 
children in Group 4 are functioning better in terms of cognitive outcome 
than the children in Group 3. This is possibly due to : 
the presence of a higher incidence of clinical signs of hydrocephalus, the 
higher dose of radiotherapy and the addition of chemotherapy in the 
children in Group 3. 
However the effects of Age-at-Diagnosis, Age-at-Testing and Time-since-
Treatment need further exploration. 
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CHAPTER 12 
PREDICTORS OF OUTCOME 
12.1 INTRODUCTION 
A series of multiple regression analyses were carried out in order to build 
a Model that would predict outcome variables from a number of predictor 
variables. Since there were multiple outcome variables, Principal 
Component analysis was first used to simplify the set of outcome 
variables. 
12.2 PRINCIPAL COMPONENT ANALYSES 
TVPS (non motor visual memory), AVL T total score, Visual Motor 
Integration (Beery), Purdue Peg Board (both hands) variables that had 
proven sensitive to differences between the treatment groups plus FSIQ 
were included in the Principal Component Analyses. Tables 12-1 and 
Figure 12-1 as indicated below, show the Principal Component Analysis 
which yielded two variables. 
Table 12-1 Summary analysis of Principal Components on dependent 
variables 
Eigenval Variance Eigenval 
Variable 
1 2.8305 56.6118 2.8305 
2 1.0776 21.5537 3.9082 78.1656 
3 .5299 10.5980 4.4381 88.7637 
4 .3406 6.8123 4.7788 95.5760 
5 .2211 4.4239 5.0000 100.0000 
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Table 12-1 and Figure 12-1 indicate that using Kaiser's rule (elgen value 
>1) it will be appropriate to extract 2 components. Component 1 accounts 
for 56% of the total variance and Component 2 accounts for 21 % of the 
total variance. 










0 4 6 
Number or Eigenvalues 
Figure 12-1 Scatterplot of Eigen Values 
Table 12-2 Varimax Normalised Rotation of Components 
~~s _~~_~___~C:M~~:;~T1____~OM~~~fNT 2 
AVL T-TOTAL .8407 .2293 
V 1\/1 I .1568 8749 
Purdue --both hands .1703 8267 
-
Expl Var 21845 1 7237 
---- --~------- -_._-
Prp Total 4369 3447 
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Table 12-2 indicates that component 1 is best defined by FSIQ, TVPS 
(visual memory) and AVL T- total score and appears to represent a global 
outcome based on intelligence and memory. 
Component 2 is best thought of as the composite of VMI (Beery) and 
Purdue pegboard (both hands) and appears to represent a specific visual 
motor outcome. 
12.3. MULTIPLE REGRESSION ANALYSIS 
Stepwise regression analyses were conducted, using the STATISTICA 
programme to determine which independent variables would predict these 
two components. The forward entry method was used. 
The independent variables were Treatment Groups (in three categories), 
Tumour Type (astrocytoma and medulloblastoma), Age-at-Diagnosis, 
Years-since-Treatment, Age-at-Testing, SES and repeated Shunt 
Revision. 
• PC1 




.5719 .3271 .3271 14.5866 .0007 
REVISION 
SES .7504 .5632 .2360 15.6763 .0004 
YEARS .7759 .6020 .0388 2.7323 .1099 
TUMOUR 
.8165 .6667 .0646 5.2353 .0301 
TYPE 
significant at p < .05; P < .01 ; p < .001 
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Table 12-4 Regression Summary for PC1 
Intercpt 3.5055 .5110 6.8599 .0000 
Shunt 
.0001 -.5270 .1170 -1.4679 .3259 -4.5030 
RV 
SES -.5845 .1164 -.5459 .1087 -5.0210 .0000 
YRS .3365 .1285 .0460 .0175 2.6182 .0143 
Tumor 
-.3010 .1315 -.2136 .0933 -2.2880 .0301 
Type 
significant at p<.05; p<.01; p<.OO1 
The best model for predicting PC1 as shown in Tables 12-3 and 12-4 was 
found to be a model employing the indicators SES, Tumour Type, Years-
since-Treatment and Repeated Shunt Revision. 
The regression calculation for PC1 as in Table 12-4 (R =.81651914 
R2=.66670350, Adjusted R2=.6173264; F(4.27)=13.502 p<.OOOOO; Std 
Error of estimate: .63554) explained 61 % of the variance in the dependent 
variable, which is considered a good outcome. Note the association with 
SES is negative because the Groups with the highest occupational status 
have the lowest numbers (e.g. 1 =professional status, 5=unskilled manual 
status). Thus a high PC1 correlates with increasing years since treatment, 
type of tumour, absence of shunt revision and high SES. 
• PC2 
The best model for predicting PC2 is a model employing Years-since-
Treatment (R=.52555078 R2=.27620362, Adjusted R2=.25207707; 
F(1.30)=11.448; p<.00201; Std Error of estimate: .8660). Table 12-5 
below reports the results for the full model. In this instance the equation 
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explained 25% of the variation which is considered an acceptable 
outcome but not as high as that shown in PC1. 
Table 12-5 Summary of Step Wise Multiple Regression on PC2 Years-
since-Treatment 
Multiple iMultlple R .. square F.;..to 
I 
R ; R-square ~hang.,\ ;:Entr/rem p-Ievel 
YRS .5255 .2762 .2762 11.4481 .0020 
--
significant at p < .01 
Table 12-6 Regression Summary for PC2 (Years-since-Treatment) 
Intercpt .7043 .2446 2.8793 .0072 
Years -.5255 .1553 -.0701 .0207 -3.3835 .0020 
The regression summary Table 12-6 shows a large St. Error as the scores 
on PC2 were widely scattered. 
Table 12-7 Regression Summary forPC2 (Tumour Type and SES) 
When Tumour Type and SES were used as predictors (R=.40856365 
R2=.16692425, Adjusted R2=. 1 0947075, F(2,29)=2.9054, p<.07078, Std 
error of estimate:.94561) only Tumour Type was significant, but SES is 
not, as shown in Table 12-7. 
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.1184 -1.1346 .2658 
.0228 -2.5846 .0150 
However Tumour Type and Years-since-Treatment are strongly correlated 
(>0.4, multicollinearity) and it is difficult to decide which has priority over 
the other (R=.5540673, R2=.30696778, Adjusted R2=.25917245, 




DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS 
13.1. REPRESENTATIVENESS OF THE SAMPLE 
The incidence of posterior fossa tumours at Groote Schuur and Red 
Cross Hospitals is comparable with that in international studies. However, 
the lack of a uniformly accepted classification system of brain tumours has 
led to a disparity both in the incidence rate of different types of brain 
tumours and in the impact of treatment on children with brain tumours 
(Becker, 1985; Giles, 1985; Miller et al., 1995). 
In accordance with other findings, medulloblastoma was found to be the 
most common posterior fossa brain tumour in the sample (Bloom et al., 
1990; Cohen and Duffner, 1984; Humphreys, 1982; Johnson et al., 1994; 
Silverberg et al., 1981) The 44% incidence of medulloblastoma tumours in 
the identified sample of 174 posterior fossa brain tumours is reported in 
other studies (Bierbrauer et a/., 1989; Bloom et al., 1990; Halperin et 
al.,1994). The relatively high (30%) incidence of brain stem glioma 
tumours within the sample reflects the confusion surrounding the 
diagnosis which has resulted in incidence rates varying from 10% to 25% 
(Hoffman & Goumnerova, 1991; Panitch and Berg, 1970; Vandertop, 
Hoffman, Drake et al., 1992) or an incidence rate as high as 
medulloblastoma and astrocytoma tumours (Stroink et al., 1987). A low 
incidence rate of 5% to 20% is reported in a series of unbiopsied brain 
stem gliomas (Cohen & Duffner, 1984; Undjian et al., 1989). The brain 
stem gliomas in the sample were confirmed by either a histology report, 
CT scan or MRI report. As the quality of imaging has improved over the 
last 10 years, allowing for earlier detection of lesions, a concomitant 
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variation in the incidence rate has emerged (Packer, Zimmerman, 
Luerssen et a/., 1985; Smith, 1990). 
The 18% incidence of cerebellar astrocytoma tumours in the sample is 
low according to international studies, in which incidence rates of 25% to 
35% are reported (Campbell & Stanley 1996; Packer et a/., 1990; 
Schneider Jr., Raffel & McComb, 1992). Although great care was taken to 
find all the files, one of the difficulties in a retrospective study remains the 
problem of lost information. All the files listed on the computer were found. 
The 8% incidence rate of ependymoma tumours falls within the incidence 
rate of 5% to 10% reported by other international studies (Cohen & 
Duffner, 1984; Undjian et a/., 1989). 
Of the 174 posterior fossa brain tumours identified, 44.3% of the subjects 
have survived and 43.7% are deceased, while 12% of cases are lost-to-
follow-up. The study supports the overall 10 and 20 year survival rates of 
44% and 37% reported respectively for irradiated paediatric brain tumours 
(Jenkin et a/., 1995). These survival rates are dependent on the diagnosis 
of the type of brain tumour and the treatment provided. 
The pattern of tumours in the deceased group is similar to that found in 
other studies: 53% are brain stem gliomas, 31 % are medulloblastomas, 
8% are ependymomas and 7% are cerebellar astrocytoma tumours which 
has shown little change over the years (SEER, 1983-1987). 
In the tested sample of 51 survivors of paediatric posterior fossa brain 
tumours, 59% of the tumours are medulloblastomas, 31 % are 
astrocytomas, 8% are ependymomas and 2% are brain stem glioma 
tumours. The different types of posterior fossa tumour in the tested 
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sample is similar to that in international studies on neuropsychological and 
quality of life functioning (Duffner et al., 1983; LeBaron et al., 1988; 
Packer et aI., 1989; Sutton et al., 1989). Medulloblastomas are the most 
common type of tumour (Halperin et al., 1994). 
Although no significant differences were found between the treatment 
groups in terms of SES, 31 % of the sample had occupations distributed 
among the manual, unskilled and menial occupational categories. 
SES is often not reported in international studies of survivors of brain 
tumours (Ris and Noll, 1994), so that the contribution of SES to the 
rehabilitation of the brain-damaged child remains unexplored. However, 
an attempt was made to counteract this possibility by including a 
Psychosocial Adversity Scale that was used by the Head Injury Research 
Group at Groote Schuur Hospital (Hemp, 1989). In terms of this the head 
injury children are a more disadvantaged group than the posterior fossa 
tumour survivors. In the latter group, there was little difference in the 
mean Psychosocial Adversity Rating Score between the treatment 
groups. Nonetheless, a general finding was that 41 % of the mothers had 
less than standard 6 (grade 8) level of education, with the incidence 
increasing slightly from Group 1 to Group 3 (33% - 47%). Within the 
province of the Western Cape, the mean number of years of schooling of 
persons age 25 years and older is 8.45 years or a grade 8 level of 
education (October Household Survey in Central Statistics, 1996). Thirty 
nine percent of the parents are unemployed and reflect the present 
economic climate in which retrenchment and unemployment figures in the 
country are increasing (Nxumalo, 1999). 
Thirty five percent of survivors come from single parent units. Thus, a third 
of the children may come from social units in which the mothers are both 
educationally disadvantaged and lack the skills necessary to stimulate 
brain-injured children. The concomitant high incidence of single parents, 
lack of occupational skills and unemployment adds to the burden of caring 
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for these children. The lack of resources available for the optimal 
development of the child and the dependence of children on their family to 
use the resources available to them are further difficulties. The children in 
this study probably have more Psychosocial Adversity in their 
backgrounds than survivors in other global studies. 
13.2 TREATMENT RELATED OUTCOMES 
The aim of the research was to explore differences in neuropsychological 
functioning and health-related quality of life in survivors of paediatric 
posterior fossa brain tumours. A retrospective research design over a 28 
year time span, involving 51 subjects, grouped accordillg to the three 
treatment parameters (Group 1 = surgery only; Group 2 = surgery and RT; 
Group 3 = surgery, RT and chemotherapy) was used (See Appendix A). 
An overall finding is that children treated by means of surgery, RT and 
chemotherapy (Group 3) have the greatest incidence of problems, such 
as pretreatment negative factors and post-operative complications, in 
addition to the burden of treatment factors such as surgery, radiotherapy 
and chemotherapy which adversely affected their neuropsychological and 
quality of life functioning. It is difficult to extrapolate which of these factors 
are responsible for the low scores as the type of tumour which prescribes 
the treatment is implicated in the findings. 
The survivors in treatment Group 3, the medulloblastoma subjects treated 
by means of surgery, radiotherapy and chemotherapy have the shortest 
mean duration of presenting symptoms compared with the children in 
treatment Group 1 treated by means of surgery only, for their astrocytoma 
tumours (9 weeks versus 11 weeks). This suggests that medulloblastoma 
tumours develop at a faster rate than astrocytoma tumours, as described 
by Halperin ef al., (1994). Moreover a shorter duration of presenting 
symptoms is associated with a poorer outcome (Packer ef al., 1987). 
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All the children in treatment Group 3 required some form of drainage 
procedure, either a ventriculo-peritoneal shunt or an external ventricular 
drain, to relieve signs of intracranial pressure prior to treatment. The 
incidence of such procedures was slightly lower for the other treatment 
groups (Group 1 = 83% and Group 2 =70%). According to Kumar et aI., 
(1996) children with posterior fossa tumours are predisposed to 
hydrocephalus because of the proximity of the fourth ventricle to the eNS 
pathways. Tumour site thus is an important variable in the consideration 
of the effects of ICP on outcome. Treatment Group 3 children presented 
with the highest percentage of signs of papilloedema and cerebellar motor 
disturbance followed by treatment Group 2. The children in treatment 
Group 1, the surgery only group had the lowest percentage. This may 
suggest a higher incidence of CNS impairment prior to treatment in Group 
3 subjects treated by means of surgery, radiotherapy and chemotherapy, 
than the other treatment Groups as well as a more aggressive type of 
tumour. 
The survivors of Group 3, all of whom had medulloblastoma tumours 
treated by means of surgery, radiotherapy and chemotherapy had the 
least number of cases (32%) which were amenable to total surgical 
resection. This indicates that the group may have had tumours which 
were invading critical areas where such surgery may have caused 
neurological damage as postulated by Halperin et al., (1994). A high 
percentage (83%) of total surgical resections occurred in the surgery only 
treatment Group1 \ in which all the children had the astrocytoma tumours, 
compared with treatment Group 2 (45%), the children treated by means of 
surgery and radiotherapy for a variety of posterior fossa tumours. 
Tumour type and the associated natural morbidity of the tumour are 
therefore potentially confounding issues in the investigation of the effects 
of treatment on neuropsychological outcome. 
Ris and Noll (1994) report that the findings on the relationship between 
the extent of surgical resection and neuropsychological outcome are 
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inconsistent. AlthoL1gh the study of Bordeaux et al., (1988) is limited by a 
small sample, surgery itself was not shown to be associated with poor 
neuropsychological test scores. In this study there were no differences in 
prorated FSIQ scores (FSIQ = 79 versus 73) between the children who 
had undergone total surgical resection compared with those who had 
undergone sUbtotal surgical resections. This finding is similar to Ellenberg 
et al., (1987), Johnson et al., (1994) and Yang et al., (1997) but not 
supported by Packer et al., (1987). A methodological consideration in the 
interpretation of the outcome is how the extent of the resection is 
described. In the present study, the extent of the surgical resection is 
defined by the neurosurgeons' operation notes. Packer et al., (1987) 
report the extent of the surgical resection according to the impressions of 
the surgeon and the post-operative CT scan. They suggest that the extent 
of the surgical resection is significantly related to FSIQ scores. They also 
found that larger tumours (which cannot be resected) contributed to 
permanent CNS damage prior to diagnosis and also to peri-operative and 
post-operative mental state. The diverse manner in which the 
neurosurgical resection of the tumour is defined, as well as the pre-
operative and post-operative management of the children are thus 
sources of variance which contribute to the neuropsychological outcome. 
As most of the children in the sample had ventriculo-peritoneal shunts 
inserted prior to treatment, the treatment-related effects of a single shunt 
placement on FSIQ could not be adequately explored. According to the 
review by Ris and Noll (1994) the majority of research indicates that, if the 
effects of raised intracranial pressure are promptly treated by means of 
shunting, or surgical removal of the obstruction caused by the tumour, 
there will be no lasting measurable effects. The children who had 
repeated shunt revisions had statistically significant lower mean prorated 
FSIQ scores than those without such revisions (FSIQ =58 versus 81). 
Kao et al., (1994) had a similar finding. Shunt revisions, as discussed by 
Scott (1991), are usually performed to relieve obstructions, wound 
complications, infections and other complications that occur subsequent 
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to shunting. In the present sample, shunt revisions occurred as a 
complication of shunt infections subsequent to shunting. 
The subjects in Group 3, treated by means of surgery, radiotherapy and 
chemotherapy have the highest incidence of intra operative and post-
treatment complications (53%), such as infection, transient cerebellar 
mutism and seizures compared with treatment Group 2 subjects (30%), 
treated by means of surgery and radiotherapy and treatment Group 1 
subjects (25%) treated by means of surgery only. Growth hormone 
treatment complications, such as short stature and weight are also more 
prevalent in the children with medulloblastoma tumours treated with 
surgery, radiotherapy and chemotherapy than the children in treatment 
Group 1 with surgically resected astrocytoma tumours. 
A comforting finding for the parents of children who experienced transient 
cerebellar mutism is that there is no difference in the prorated FSIQ 
scores between those who presented with mutism (FSIQ = 73) and those 
who did not (FSIQ=76). The 12% incidence of cerebellar mutism found in 
the sample, is marginally higher than that reported by Dailey et aI., (1995) 
and Pollack et aI., (1995). To date, no research in the literature on the 
effects of cerebellar mutism on FSIQ is described. An unexpected finding 
was a single case of visual impairment in association with cerebellar 
mutism, in which a good visual recovery paralleled the return to normal 
speech. Visual impairment associated with transient cerebellar mutism 
has since been described by Liu et al., (1998) who investigate four cases, 
all of whom made an excellent recovery. 
A low seizure incidence rate for children treated for posterior fossa 
tumours is reported by Cohen and Duffner (1984), Gjerris (1976), Hoppe-
Hirsch et al., (1990) and Syndikus et al., (1994). Children presenting in 
this study who had post-operative seizures have lower mean prorated 
FSIQ scores (57) than those who did not have seizures (77), but only 
three children suffered such seizures. Of the three children one child had 
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an astrocytoma tumour and was treated by means of surgery only and the 
remaining two children had medulloblastoma tumours treated by means 
of surgery, radiotherapy and chemotherapy. Syndikus et aI., (1994) 
reported that epilepsy was the only independent variable associated with 
poor cognitive functioning. 
The mean height of the Group 3 survivors, treated by means of surgery, 
radiotherapy and chemotherapy, is at the 23rd percentile which is 
significantly worse than that of the survivors in Group 1 (55th percentile), 
treated by means of surgery only and children in Group 2 (40th 
percentile), treated by means of surgery and radiotherapy. These results 
are similar to other research findings that indicate that, with the adjuncts 
of cranial RT and chemotherapy treatment, children grow less in terms of 
height (Brauner et al., 1989; Chin & Maruyama, 1984; Duffner and Cohen, 
1991; Hirsch et al., 1979; Johnson et al., 1994; Lam, Tse, Wang et al., 
1987; Moshang Jr. et aI., 1996; Moore et al., 1992; Mulhern et al., 1989; 
Nishiyama et al., 1994; Onoyama et aI., 1975; Syndikus et a/., 1994). 
The findings also imply that the combination of cranial and spinal 
irradiation treatment has negatively affec:ted the height of the children in 
both treatment Group 3 and Group 2. According to Brauner et aI., (1989), 
most of the growth retardation may be due to the lack of spinal growth. 
They suggest that GH deficiency may only occur 12 to 24 months after 
cranial irradiation. The impact of cranial irradiation treatment on growth 
may be limited only to this period. The effect of Time-since-Treatment is 
therefore an unknown influence on these results. A recent finding by 
Robertson et aI., (1997) proposes that tumour type, that is astrocytoma 
versus medulloblastoma tumour, may influence the growth of subjects 
prior to treatment, irrespective of Age-at-Diagnosis. This result needs 
further clarification in future stUdies. 
Although there is no statistically significant difference in weight between 
the treatment groups (Group 1 = 44th percentile; Group 2 = 36th percentile 
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and Group 3 = 26th percentile), there is a trend toward a decrease in 
weight. Weight gain or loss is seldom reported in studies. However when 
it is reported, few children treated with combinations of surgery, RT and 
chemotherapy show weight loss (Bamford et a/., 1976; Li et aI., 1984; 
Onoyama et aI., 1975). 
Thus the survivors in treatment Group 3, had the shortest duration of 
presenting symptoms, the highest incidence of pretreatment symptoms of 
papilloedema and cerebellar signs, as well as the highest incidence of 
shunts or a drains inserted to relieve raised ICP. Treatment Group 3 
subjects also had the least number of cases amenable to total surgical 
resections, as well as the highest incidence of post-operative 
complications, before receiving the additional treatments of RT and 
chemotherapy. 
By comparison Group 1 cases treated by means of surgery only, had a 
similar duration of presenting symptoms as Group 2 subjects who had 
been treated by means of surgery and RT. However, Group 1 had a lower 
incidence of signs of papiloedema and cerebellar difficulties and a higher 
number of cases amenable to total surgical resections. They also had one 
child who presented with seizures whereas no children in treatment Group 
2 presented with this disorder and less cases of post-operative 
complications such as infection and mutism than treatment Group 2 
children. Of importance is that the children in Group 1, the surgery only 
group, had more cases with shunts inserted prior to treatment to relieve 
signs of raised ICP (83%) compared to the children in Group 2, treated by 
means of surgery and radiotherapy, who had shunts (65%) and a drain 
inserted (5%). The Group 1 children, treated by means of surgery only, 
thus presented with a higher incidence of RIP than those in treatment 
Group 2 and a concomitant higher incidence of shunts that were not 
removed. Over the years it has been the policy of the Department of 
Neurosurgery to relieve signs of RIP by the insertion of a shunt or a drain 
prior to surgery, this policy has since changed. Once a shunt is inserted it 
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is a permanent structure which is only removed if the child presents with 
shunt complications. None of the children in the surgery only treatment 
Group 1 had a shunt revision or removal. According to Raimondi and 
Tomita (1981) although the brain tumour itself causes signs of RIP, the 
complicating secondary hydrocephalus is often responsible for RIP. The 
child may thus be considered to have two distinctly different diseases the 
tumour and hydrocephalus which complicate one another and contribute 
to the complex picture of RIP. Hydrocephalus is a dynamic disorder and 
without confirmation on CT scan one is unable to ascertain if the 
ventricles have or have not returned to their normal size. The research 
findings on the neuropsychological effects of RIP and shunts in children 
with brain tumours are contradictory as the type of tumour, treatment 
variables, age at diagnosis of the children as well as the type of study are 
complicating factors. Low FSIQ scores are reported by some researchers 
(Jannoun & Bloom, 1990; Packer et al., 1987) or higher FSIQ scores in 
those who had shunts compared to those who did not have shunts 
(Johnson et al., 1994) whereas other researchers found no difference in 
FSIQ scores in children who had shunts to relive RIP (Ellenberg et al., 
1987; Yang et al., 1997). Hydrocephalus as a disease entity has been 
extensively studied by many researchers (Dennis et al., 1981; Dennis et 
aI., 1987; Fletcher et al., 1992). With improvement in treatment modalities 
over the last thirty years the emphasis in the research has changed to 
adopting a developmental perspective that considers the nature of the 
cognitive deficit, it's characteristic over age and the relationship to the 
particular forms and manifestations of early onset hydrocephalus (Dennis, 
1999). Hydrocephalus predisposes children to changes in white matter 
which have adverse consequences for neuropsychological function. 
Recent research by Mulhern et aI., (1999) has shown that children treated 
for medulloblastoma tumours have significantly less normal white matter 
and lower FSIQ scores than those treated for low grade cerbellar 
astrocytoma tumours thus lending support for the low FSIQ scores of the 
medulloblastoma subjects. However, the children in treatment Group 1 all 
of whom had low grade cerebellar astrocytoma tumours should therefore 
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not be predisposed to changes in cerebral white and subsequent low 
FSIQ scores as their treatment comprised of surgery only and not 
radiotherapy or chemotherapy which were found to be the reasons for the 
white matter changes. However, none of the children in Mulhern's study 
had shunts. Thus, without CT or MRI evidence, one is unsure of the 
consequence of permanent shunt placement on the developing brain of 
the children with cerebellar astrocytoma tumours in Group 1 treated by 
means of surgery only. 
It is therefore apparent that subjects in treatment Group 1, the surgery 
only group, apart from having permanent shunts, have the lowest 
incidence of pre-treatment and post-treatment complications which should 
not adversely affect their neuropsychological outcome compared with 
treatment Group 2 subjects, the surgery and radiotherapy group, and 
treatment Group 3 subjects, the surgery, radiotherapy and chemotherapy 
group. 
13.3. NEUROPSYCHOLOGICAL OUTCOMES 
The differences between the treatment groups in several 
neuropsychological domains were explored. On at least one measure in 
the domains of attention, visual perceptual processing, memory and motor 
functioning, the Group 3 survivors, treated by means of surgery, 
radiotherapy and chemotherapy, had significantly lower scores. 
13.3.1 Intelligence 
No statistically significant differences were found in the prorated FSIQ, 
VIQ or PIQ test scores between the treatment groups. I nspection of the IQ 
test pattern in the treatment groups shows that the mean prorated FSIQ 
scores of both Group 1 (FSIQ=78) and Group 2 (FSIQ=81) are within the 
borderline range of intellectual functioning (according to DSM -IV). The 
mean prorated FSIQ score of Group 3 (FSIQ=70) is on the cusp of the 
DSM-1V mild mental retardation I borderline range. 
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All the groups have a wide range of prorated FSIQ scores (40-118). 
Similar findings are reported for survivors of medulloblastoma tumours 
treated with surgery, RT and/or chemotherapy. Of the researchers who 
report FSIQ scores, Hirsch et al., (1979) found 31 % of the sample had 
FSIQ < 70 and only 11 % had FSIQ >90; Duffner et al., (1983) showed that 
50% had FSIQ <80; Johnson et al., (1994) indicated that FSIQ scores 
ranged from moderately retarded to low average; Silverman et al., (1984) 
found low average to average FSIQ scores while Yang et al., (1997) 
reported mean below average FSIQ scores. In several studies, the effects 
on FSIQ of tumour site are not clear as the samples contain mixed 
supratentorial and infratentorial tumours. In addition those cases who 
received RT and those who received RT and chemotherapy are often not 
specified. In the present sample, the treatment combinations of surgery, 
RT and chemotherapy are clearly defined and the sample is a 
homogenous sample in terms of tumour site: all the tumours are posterior 
fossa tumours. 
Examination of the details of the children in the mental retardation range 
suggests that complications following the treatment may have contributed 
to the low scores. In all three treatment groups, these children had 
seizures, shunt revisions or transient cerebellar mutism. 
The differences between VIQ and PIQ in the treatment groups are not 
significant. This is consistent with Kun et al., (1983); LeBaron et al., 
(1988) and Silverman et a/., (1984) who recorded no discrepancy between 
VIQ and PIQ scores. However, other researchers have found VIQ to be 
significantly higher than PIQ (Dennis et a/., 1996; Johnson et al., 1994; 
Mulhern and Kun, 1985; Moore et al., 1992; Packer et al., 1989; Sutton et 
al., 1989). 
The possibility that the different IQ tests used in this study may have 
contributed in some way to the IQ test scores has been considered. The 
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mean 10 test scores for the age-related 10 tests used are given in the 
Appendix G. The wide scatter of the scores on all the 10 tests indicate that 
the composition of the sample rather than the type of test used 
contributed to the findings. A review of the literature (Chapter 6 and 
Appendix H) shows that when more than one type of measure was used 
to assess cognition this was not discussed in the interpretation of the 
results (Brookshire ef al., 1990; Bordeaux et al., 1983; Chadderton et al., 
1995; Dennis, Spiegler, Fitz et al., 1991; Dennis Spiegler, Hoffman et al., 
1991; Dennis etal., 1992; Duffner etal., 1988; Ellenberg etal., 1987; Grill 
et al., 1999; Johnson et al., 1994; LeBaron et al., 1988; Moore et aI., 
1992; Packer at aI., 1989; Radcliffe et al., 1992; Seaver et al., 1994; 
Sutton et al., 1989). However Silber et aI., (1992) made use of eight 
different 10 test instruments to measure intellectual and developmental 
functioning. They are of the opinion that the change to a different test 
instruments did not contribute significantly to the intellectual outcome. 
In the South African context the SSAIS-R intelligence test as explained in 
Chapter 7 has norms for both advantaged and environmentally 
disadvantaged subjects. These norms were devised to correct for the 
deprived environmental factors and used on the children who used the 
test. The number of children in each treatment group tested on the 
SSAIS-R is consistent across the treatment groups (see Appendix G). 
As no significant differences between the treatment groups was found in 
the sample as regards the demographic factors, occupation as a measure 
of socio economic status and psychosocial adversity, it was not 
considered necessary to adjust the FSIO scores to take these factors into 
account. None the less given the 41 % incidence of mothers who have 
less than standard six level of education in the sample, education is an 
important contributing factor to test performance. According to Nell (2000) 
formal schooling and urbanization override ethnicity as a contribution to 
test performance variance in culturally different settings and are also more 
important than traditional sources of variances found in age, sex and 
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socioeconomic factors. These factors may thus play some part in the wide 
scatter of the prorated FSIQ scores and possible reflect the diversity of 
the sample. 
Age-at-Diagnosis for the entire sample had no significant effect on 
prorated FSIQ score, The effects (or lack of them) for Age-at-Diagnosis 
are discussed later in this chapter. 
13.3.2 Attention 
A statistically significant difference in performance in Digit Repetition scale 
scores showed that subjects in Group 3, treated by means of surgery, 
radiotherapy and chemotherapy, had an impaired performance compared 
with subjects in treatment Groups 1, surgery only group, and treatment 
Group 2, surgery and radiotherapy subjects, who had similar results. The 
effects of RT per se on tasks of attention are not clear, Dennis et al., 
(1998) found that children treated with RT performed more poorly than 
those treated without RT on both focused and selective attention tasks. 
Moore, Copeland et al., (1992). reported that the effects on survivors of 
different types of cancer, other than brain tumours, treated with cranial 
irradiation and chemotherapy indicated that they were slower on their 
mean reaction time compared with their sibling controls. As a variety of 
tests have been used to measure attention, researchers have found 
differing results. 
In the present small sample of adult subjects, the scores of an the 
subjects were in the impaired range on TMT A (mean = 14th Percentile) 
but a slightly better performance was found on TMT lit (mean = 25th 
Percentile) These timed tests measure speed of attention, sequencing, 
mental flexibility, visual search and motor functions. TMT B is more 
difficult than Part A as the subject has to show the ability to do 
simultaneous mental tracking, tnat is, tile ability to alternate between 
counting and the alphabet. The results thus indicate that performance of 
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the posterior fossa brain tumour subjects is more compromised by motor 
speed, attention and visual search than double mental tracking. 
Unfortunately the small number of subjects in the treatment groups restrict 
further interpretation. Dennis et a/., (1998) found that that the attention of 
subjects with posterior fossa tumours is likely to be compromised. Tumour 
or surgically-related disturbance of the reticular activating system could be 
a common mechanism for slow performance found on TMT A and B as 
proposed by Riva et a/., (1989).Moore, et a/., (1992) suggest that the 
slowing of cortical activity secondary to white matter damage, as a result 
of intensive CNS therapy, especially cranial irradiation, may account for 
the slow performance found on test scores, as shown on TMT A and TMT 
B. 
13.3.3 Visual Perceptual Information Processing 
Group 3 subjects treated by means of surgery, RT and chemotherapy had 
statistically lower results on Block Design, Coding and VMI (Beery) than 
the other groups. Visual motor integration, fine motor speed and dexterity 
difficulties were also found following treatment of posterior fossa tumours 
by means of surgery, RT and chemotherapy according to Hoppe-Hirsch et 
aI., (1995) Packer et a/., (1987), Packer et a/., (1989). Children with 
cancer other than brain tumours, treated with chemotherapy and RT but 
excluding surgery, have been found by Moore et a/., (1992) also to have 
impaired visual motor integration skills. 
There were no differences between treatment Group 1, surgery only 
group and treatment Group 2, surgery and radiotherapy group, in terms of 
Coding. There was a trend for lower Block Design scores to be found in 
Group 2 than Group 1, but the difference between these two treatment 
groups reached statistical significance only for VMI (Beery), where Group 
2 subjects, treated by means of surgery and radiotherapy, were clearly 
impaired (mean= 19th percentile). 
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In the motor-free test of Visual Spatial Relations, the subjects in all the 
groups had impaired scores. However, this outcome was not obtained on 
the motor-free test of Visual Discrimination. There was a significant 
difference between the groups only when a motor function was added as 
in the Visual Motor Integration task of the Beery. Johnson et a/., (1994), in 
a group of medulloblastoma survivors treated with surgery and adjuvant 
therapy, also discovered that visual perceptual information processing 
difficulty became evident when motor function skills were required. 
Age-at-Diagnosis did not significantly affect the scores on VMI as 
measured by the Beery. However, a statistically significant difference was 
found between Years-since-Treatment and the copying of the Beery 
designs. The longer the Years-since-Treatment, the poorer the scores on 
the VMI. In the present study the scores for the entire sample on the VMI 
(Beery) were impaired. The posterior fossa site of the tumour, as well as 
the treatment parameters of surgery only, surgery and RT, and surgery, 
RT and chemotherapy appears to be implicated in these results. 
13.3.4 Memory Functions 
A statistically significant difference between the treatment Groups was 
found in the non-motor test of Immediate Visual Memory Recall (TVPS). 
Group 3 had the most impaired performance (26 th percentile) whereas 
Group 1 (51 sl percentile) and Group 2 (60th percentile) functioned in the 
average range. A possible motor confound is ruled out by the use of a 
non- motor test, but the problem may be in visual perceptual difficulties 
rather than visual memory. This is indicated by the impaired scores in the 
non- motor Visual Spatial Relations (TVPS) as well as the downward 
trend across the groups of the scores in Visual Discrimination (TVPS) in 
terms of treatment. Few researchers have explored visual memory 
parameters associated with treatment although Johnson et a/., (1994) 
found visual memory deficits associated with treatment by surgery and 
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adjuvant protocols for medulloblastoma tumours. Lazareff and Castro-
Sierra (1996), on the other hand, reported no visual memory deficits in 
children with cerebellar tumours treated by means of surgery only, either 
at preoperative or post- operative testing. 
Age-at-Diagnosis did not have a statistically significant effect on TVPS-
visual memory but the scatterplot shows a slight improvement with 
increasing Age-at-Diagnosis, although all the scores are within the 
impaired range of functioning. Years-since-Treatment did not have a 
significant effect on TVPS visual memory performance but the scores for 
the entire sample were in the impaired range. 
There is a statistically significant difference between the treatment Groups 
on the Auditory Verbal Learning Test (AVL T) total scores. The surgery, 
RT and chemotherapy group (Group 3) had the poorest performance with 
no clear trend indicated for Group 1, surgery only, or Group 2, surgery, 
radiotherapy and chemotherapy. Packer et a/., (1987) find that one third of 
the long-term survivors treated with surgery, RT and chemotherapy had 
deficits in verbal memory. Group 3 also had a poorer, although non-
significant, performance on the Recognition Task. 
Working memory involves the "active processing of incoming information 
and the prospective updating of the memory" (Dennis et a/., 1998, p27). 
The response of the subjects in treatment Group 3 on the AVL T learning 
curve indicated that the children were slow to start (Trial 1), had difficulty 
in sustaining their attention after an interference task (Trial 6) and had 
difficulty in shifting their response from one task to another. In this manner 
they fulfilled the criteria for working memory difficulties. 
All school going children under the age of 18 years, who were tested on 
the SSAIS-R for auditory verbal story memory, achieved scores in the 
average range regardless of treatment. Subjects older than 18 years who 
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were tested on the WMS-R story memory also had few differences in 
scores according to treatment. The scores of treatment Group 3 subjects 
were considerably lower than those of treatment Group 1 and treatment 
Group 2 both on (WMS-R) immediate and delayed recall. All the subjects 
were able to maintain their scores from immediate to delayed recall, 
indicating that the group as a whole had no difficulty in retrieving verbal 
information. The small number of participants in each treatment group and 
the uneven distribution of the subjects into treatment groups is a potential 
confound in the interpretation of the results. 
Differences on the AVL T total scores according to Age-at-Diagnosis were 
not significant. Mulhern and Kun (1985), report that verbal memory 
difficulties are related to younger Age-at-Diagnosis. 
The AVL T scores differed statistically significantly between the different 
Years-since-Treatment groups but no clear directional trend is evident. 
The lowest scores appear to be after seven to ten years post-treatment 
while the scores at ten Years-since-Treatment seem to be the highest 
scores. The use of raw scores may reflect the expected increase from 
childhood to adulthood. The impairment in memory functions is possibly 
sensitive to the time at which memory was assessed. Bordeaux et aI., 
(1988) recorded no significant changes in verbal memory in children 
tested within one year following treatment of radiotherapy, whereas 
Packer et aI., (1989) showed at two years post treatment, almost half the 
children treated by means of RT performed below the normal range, while 
64% had difficulties in immediate auditory recall. 
Subjects in Group 3, treated by means of surgery, RT and chemotherapy 
have the most impaired scores on working memory as well as on verbal 
learning, according to the scores on the AVL T. 
13.3.5 Motor Functions 
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Schmahmann (1997) reports that impaired voluntary control motor 
functions are an expected finding in survivors of cerebellar brain tumours, 
due to their location in the posterior fossa. Both the site of the tumour and 
the different treatment protocols appear to be implicated in the difficulties 
in motor functioning. 
Differences between the treatment groups were evident in the execution 
of the Purdue Pegboard on the preferred hand, non-preferred hand and 
both hands. On all three parameters, subjects in treatment Group 3 had a 
statistically significantly worse performance, with the scores of other 
treatment groups in the below average range. A similar outcome was 
indicated in the execution of Successive Finger Taps in which Group 3 
subjects, treated by means of surgery, radiotherapy and chemotherapy 
had significantly slower scores than the other treatment groups. There 
was no clear trend between the performance of subjects in treatment 
Group 1, surgery only and treatment involving surgery and radiotherapy, 
Group 2 subjects. Impaired motor functions in survivors of posterior fossa 
tumours, treated with combinations of surgery and adjuvant therapy have 
been reported by other researchers (Brookshire ef aI., 1990; Johnson ef 
al., 1994; Hoppe-Hirsch ef al., 1990; Hoppe-Hirsch ef aI., 1995; LeBaron 
ef aI., 1988; Packer ef aI., 1989). Roux (1987) also found treatment 
related impairment in fine motor co-ordination in ALL children treated with 
chemotherapy and RT. 
Ataxic gait was not significantly different between the treatment Groups 
although subjects in Group 3, treated by means of surgery, radiotherapy 
and chemotherapy showed a significant impairment in the ability to 
balance on both the preferred and the non-preferred leg. A similar finding 
with regard to balance is reported by Lannering ef al., (1990). 
Age-at-Diagnosis and Years-since-Treatment had little impact on the 
Purdue Pegboard (using both hands) scores. 
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13.3.6 Formulation Of Findings Pertaining To Treatment 
In summary, Group 3 survivors treated by means of surgery RT and 
chemotherapy had the worst outcome in the domains of attention, visual 
motor integration, visual memory, verbal learning and fine motor dexterity. 
The differences between Group 1, surgery only, and Group 2, surgery and 
radiotherapy, were not found to be statistically significant except on the 
VMI (Beery) in which subjects in treatment Group 1 performed statistically 
significantly better than those in treatment Group 2. In addition on the 
Blocks, the trend was for Group 1 surgery only subjects, to have a slightly 
better performance than Group 2, surgery and radiotherapy subjects. 
There was also a trend for Group 2 subjects to have slightly better score 
than Group 1 subjects on the verbal tests of Comprehension and 
Similarities, as well as the non-motor Visual Memory test. 
It is therefore evident that the neuropsychological battery of tests 
highlights the differences between the treatment groups in the domains of 
functioning. However, the differences between the treatment Groups 
cannot be attributed solely to the various combinations of the treatment of 
surgery and adjuvant chemotherapy. The Group 1 subjects who had the 
astrocytoma low grade tumours treated by means of surgery only, should 
possibly have perform better than the other Groups treated by means of 
combinations of surgery, RT and chemotherapy. This has only been 
statistically confirmed on the VMI (Beery) with a trend shown on Blocks. 
As discussed the insertion of a pretreatment shunt in the majority of the 
children in surgery only treatment Group 1 may be contributing to the 
lower than expected cognitive test scores of the group. 
The type of posterior fossa tumour is also implicated as shown by the 
finding that the scores of the children with low grade astrocytoma tumours 
in Group 1 were only significantly better than those of both treatment 
Groups 2 and Group 3 on the VMI (Beery). Both these treatment groups 
have a variety of posterior fossa tumours, with a predominance of 
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medulloblastoma tumours treated with various combinations of 
radiotherapy and chemotherapy. Thus, although tumour type is 
implicated, it is difficult to determine if it is the type of tumour alone or the 
combination of the type of tumour and the treatment which is causing the 
difference in test scores. 
A consistent finding is that Group 3, survivors treated with surgery RT and 
chemotherapy had the worst scores. However, this group also had the 
highest incidence of adverse pretreatment factors, as well the least 
number of cases amenable to total surgical resections and the highest 
incidence of post-operative complications. 
13.4. AGE-AT-DIAGNOSIS and YEARS-SINCE-TREATMENT 
In an attempt to clarify the age-related factors, Age-at-Diagnosis and 
Years-since-Treatment were separately analysed on the test measures 
that were shown to be the most sensitive. 
There were no significant effects for Age-at-Diagnosis on prorated FSIO, 
AVL T-total score, VIVII (Beery) and Pudue Pegboard. There appeared to 
be a difference between the Age-at-Diagnosis groups on the non-motor 
test of visual memory (TVPS), but this fell short of statistical significance. 
Inspection of the scattergram indicated a slight improvement in score with 
increasing Age-at-Diagnosis. The majority of research only explores the 
Age-at-Diagnosis effects on FSIO scores and not those of other outcome 
variables as attempted in this study. 
In other studies younger Age-at-Diagnosis has been found to be a critical 
variable as it is possible that those children treated earlier in their 
development are at greatest risk (Crossen et al., 1994; Dennis et al., 
1996; Glauser & Packer, 1991; Roman & Sperduto, 1995; Ris & Noll, 
1994). In this study differences between the three age groups were not 
significant, but on prorated FSIQ and Visual memory (TVPS) there was a 
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trend for those diagnosed after the age of seven years to have higher 
scores. Similar findings that neuropsychological functions were relatively 
unaffected if the diagnosis was made at the age of nine to ten years have 
been reported by Moore et aI., (1992), Sutton et aI., (1989), while Chin 
and Murayama (1984) cite children older than the age of eight at 
diagnosis. 
Inspection of the individual Age-at-Diagnosis prorated FSIQ scores of the 
six children diagnosed at the age less than three years as cited by Packer 
(1999) to be a critical age, shows that the mean prorated FSIQ == 74.8, 
and ranged from 45-118. The wide scatter of the scores, the different 
treatment factors as well as the different tumour types are confounding 
factors in the interpretation of the results. 
Mulhern et a/' J (1999) reported that the rapidly proliferating brain cells are 
more vulnerable to the deleterious effects of CRT in children receiving 
CRT for medulloblastoma tumours with or without chemotherapy before 
the age of four years at treatment. Inspection of the individual prorated 
FSIQ scores of the children treated for medulloblastoma tumours showed 
that four children or 36% of the medulloblastoma group treated before the 
age of four years with S+RT, the mean prorated FSIQ scores == 87.5, 
compared to mean prorated FSIQ == 86.2 of the entire group. Thus little 
difference is indicated in scores. In the six children less than four years at 
diagnosis or 32% of the subjects in the medulloblatoma group treated by 
means of S+RT +C, the prorated FSIQ == 61.6 compared to prorated FSIQ 
== 69.8 of the group. Thus in the present sample of medulloblastoma 
subjects, age younger than four years at diagnosis does not appear to 
have any demonstrable impact on prorated FSIQ scores. 
There was a statistically significant difference between the Years-since-
Treatment groups on VMI (Seery) and the AVL T Total scores but not on 
prorated FSIQ, TVPS visual memory or Pudue Pegboard. The VMI 
(Seery) scores declined with Years-since-Treatment. This is clearly 
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illustrated on the scatterplot. However, there was no direction to the AVL T 
scores which were additionally considered to be confounded by using raw 
scores vulnerable to Age-at-Testing effects, and the small uneven 
distribution of subjects within each cell. 
Interaction effects of Age-at-Diagnosis and Years-since-Treatment were 
further explored in a series of multiple regression analyses similar to those 
used in the Dennis et aI., (1996) study. Multiple regression analyses on 
the prorated IQ scores of the survivors of medulloblastoma tumours 
showed non-significant results for Age-at-Diagnosis and Years-since-
Treatment. These were similar to the previous results of the entire sample 
in which Age-at-Diagnosis and Years-since-Treatment showed no 
significant effect on FSIQ scores. 
When the medulloblastoma tumour sample was restricted to children less 
18 years of Age-at-Testing, similar to Dennis et al., (1996), multiple 
regression analyses showed a statistically predictive relationship between 
Time-since-Treatment and prorated FSIQ and VIQ. The longer the Time-
since-Treatment the lower were FSIQ and VIQ, scores but not the PIQ 
scores. 
This finding is similar to Dennis et al., (1996), who discovered in a sample 
of children with medulloblastoma tumours treated with combinations of 
surgery, RT and chemotherapy, that the effect of Age-at-Diagnosis and 
Time-since-Treatment made separate contributions to IQ scores. In their 
model, VIQ declined with Time-since-Treatment and PIQ was relatively 
constant once established but varied with the Age-at-Diagnosis of the 
child. 
In this research, a lower VIQ over Years-since-Treatment suggests that 
over the years the children have not developed age-appropriate verbal 
recovery abilities as suggested by Dennis et al., (1996). This finding was 
only evident in the younger sample (those under 18 years at testing) and 
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not in the sample as a whole. Similar findings for children treated with 
surgery and adjuvant chemotherapy with posterior fossa tumours were 
indicated in the prospective study by Radcliffe et al., (1992), in which 
there was a significant decline in via from baseline to two years and 
thereafter via seemed to stabilize at four years post diagnosis. This was 
not evident for Pia. Sutton et al., (1989) reported a significant decline in 
both via and Pia in medulloblastoma children tested over a two year 
period, whereas Packer et al., (1989) found a non-significant decline in 
via from baseline to year two post treatment and a marginally significant 
decline in Pia. 
Unfortunately, there are few prospective studies available on children with 
brain tumours who are followed up over a longer period of time to clarify 
the variable findings. The Japanese retrospective case report by 
Nishiyama et al., (1994) of a monozygotic set of twins, one of whom was 
treated for a medulloblastoma brain tumour, shows that over a six year 
period the medulloblastoma twin had significantly lower scores on all 10 
quotients than her twin. However, both twins had lower Pia scores than 
via scores. 
The analyses for the time variables were repeated for the children in the 
astrocytoma group who had been treated by means of surgery only 
(Group 1 subjects with astrocytoma tumours). A multiple regression using 
Age-at-Diagnosis and Time-since-Treatment failed to produce any 
predictive relationships with the dependent 10 measures. The small 
sample unfortunately limits the results. 
The retrospective nature of the design allowed for the composition of the 
treatment groups in terms of Years-since-Treatment, to be significantly 
different. Sheline in Crossen et al., (1994) report that the sequential 
stages of RT reaction and the injury sustained in the brain observed on 
CT scan vary from necrosis to radiation encephalopathy and finally to 
atrophy. The end stage of radiation necrosis involves coagulation necrosis 
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and gross demeylination of the white matter if! affected areas. Necrosis 
results from high doses Of RT and generally may not manifest until nine to 
twelve months following treatment Qr e\{en years later. Furthermore a 
functional compromise of the patient's neuropsychological status may 
occur without overt necrosis. The survivors in the sample were at both 
early and late stages of this process and the effects on 
neuropsychological scores are \lariable as shown in the analysis of the 
time results. 
The inclusion of four subjects within six months after treatment spread 
across the treatment groups (Group 2 = 2 cases; Group 3 ::; 2 cases) is a 
debatable issue as regards the emergence of cognitive tall outs.. Many 
studies have included children at both acute and later stages after 
treatment (Danoff et al., 1982.; Dennis at aI., 1996; Koa et a/., 1994; 
Lazereff et al., 1996; LeBaron et al" 1988; '{ang et aI., 1997}. Mulhern et 
al." (1985) investigated the a.cute effects of treatment Qn intellectual 
functioning and found that the ~I(Ounger age group showed a greater 
tendency to intellectual deterioration, whereas Bordeaux (1988) found that 
deficits observed at baseline testing were likely to be related to the effects 
of the tumour and not the treatment. A problem encountered by many 
researchers as well as the six long.itudinal studies reviewed (Duffner et ai., 
1988; Ellenberg et al., 1987; Galiar et Q/." 1994; Koa et ai., 1994; Mulhern 
et al., 1989; Radcliff et al., 1992) is the inclusion of a sufficient number of 
children across a broad range of ages to verify conclusi\{e results. In the 
present study children across a broad range of ages were included in the 
study. However there were no infants under the age of one year in- the 
study and the study was limited b)l the small number of subjects. 
Future studies should correlate CT scan reports with neuropsychological 
testing as a means of clarif~ing the time e.ffects. 
13.5. TUMOUR TYPE 
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When the subjects were compared according to treatment, the low grade. 
astrocytoma tumour subjects treated by means of surgery only, performed 
significantly better on Visual Motor Lntegration as measured by the Beery 
(VMI) than the subjects in the other treatment groups who had 
medulloblastoma, br~n stem glioma and elgendymoma brain tumours. 
Packer et a/., (1989) found that both astrocytoma and medulloblastoma 
groups had difficulty in visual motor integration and visual spatial 
difficulties after treatment, lending support to the idea of the functional role 
of the cerebellum in visual motor integration. The implication being that 
the type of tumour, (astrocytoma \lersus medulloblastoma), does nat 
influence the neurOPS¥choJogical outcome but that. the difficulties are due 
to the treatment. Further support for tne. treatment, tumour debate !las 
recently been shown by Mulhern at aI., (1999). They showed that changes 
in qMRI and neuropsychological function are related to treatment with 
irradiation and chemotherapy as opposed to the site... or type of tumour 
(astrocytoma versus me.dulloblastoma) and tumour surgery. 
The Chadderton et al., (1995) study on survi\£Ors of astrocytoma. tumours 
in different areas of tl'\e brain, including tl'le cerebellum showed that 
tumour site and site of treatment effect FSIQ sCQres. They reported that 
there was no difference at baseline tesUng in FSIQ score.s in all subjects 
with low grade astrocytoma tumours located in different brain areas. "Fha 
cranial irradiation recipients as w.ell as those with cerebellar tumours 
performed significantly worse on all tests than those who were not treated 
with RT. However a small group of cerebellar astrocytoma survi\wrs was 
treated with surgery and local field irradiation only to the posterior fossa 
area. This group had significantly lower FSIQ, VIQ and PIQ sc.ores...than 
the cerebellar tumours survivors treated by means of surgery only_ On the 
basis of this finding, the authors hypothesized that this may be associated 
with disruption of the neural system involving subcortical structures and 
the frontal lobe. Daum and Ackerman (in Schmahnann 1997) explain that 
cerebellar patients have problems in shifting attention between modalities 
and this is presumed to be consistent with impaired cerebellar-frontal 
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interactions which modulate the ability to change attent/onal behaviour. 
The Chapman findings are interesting, but need to be investigated more 
fully with tests specific to frontal lobe function. 
The relationship between RT dose and neuropsychological outcome may 
have shed more light on the role of treatment and tumour type. However 
as also found by Packer et aI., (1987) most of the children in the study 
received similar doses of RT. In addition the retrospective nature of the 
design and the concomitant changes in treatment over the 28 year period 
made it difficult to determine the contributions of the different treatment 
effects. Similar problems have been experienced by other researchers 
(Bordeaux et al., 1988; Chin and Maruyama, 1984; Johnson et al., 1994: 
Kao et al., 1994; Sutton et ar, 1989). 
In order to further explore the effects of treatment versus tumour type, a 
post hoc analysis was done of the children with medulloblastoma tumours. 
Groups 3 (Surgery+RT + C) remained as before, while Group 4 was 
created from medulloblastoma tumours in Group 2 who had been treated 
with Surgery and RT only. At the commencement of this study no attempt 
was made to grade or classify the children with medulloblastoma tumours 
into "average risk" medulloblastoma or "poor risk" medulloblastoma as 
discussed by Packer (1999). This stratification was useful in the 1970's 
and early 1980's when "average risk" medulloblastoma tumours were 
treated with surgery and radiation and "poor risk" subjects treated with the 
addition of chemotherapy. 
Over the years there has been a reassessment of the risk factors. 
Inspection of the treatment protocols in Appendix A indicates that none of 
medulloblastoma tumours in Group 4 have spinal metastases whereas 
Group 3 has one case of metastases and another of seedling deposits. In 
addition there is significant difference in the number of medulloblastoma 
tumours amenable to total surgical resections. Group 3 subjects treated 
by S+RT +C have a significantly higher incidence of sub total resections. 
Inspection of the Age-at-Diagnosis records shows that theria is little 
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difference in the composition of the groups according to the strati'fication 
criteria of age less than three years old at diagnosis (Group 4 = 2 cases; 
Group 3 = 3 cases). Thus prior to adjuvant treatment or treatment by RT 
only, Group 3 supjects (S+RT +C) could possibly be assessed as "poor 
risk" children compared to Group 4 (S+RT) as "average risk". 
Although the majority of children with medulloblastoma tumours needed a 
shunt or an EVD prior to surgery, three children treated by means of 
S+RT did not need a shunt or a drain compared to none in the S+RT +C 
treatment group. This suggests that children in Group 4 had a lower 
incidence of clinical signs of hydrocephalus than those in Group 3. The 
small numbers preclude further interpretation. 
A statistically significant difference in prorated FSIQ scores was found 
between the medulloblastoma subjects treated by means of surgery and 
radiotherapy (prorated FSIQ in the low average range) and those treated 
by means of surgery, radiotherapy and chemotherapy (prorated FSIQ on 
the cusp of borderline / mental retardation range). Socio economic status 
was not found to significantly influence the prorated FSIQ scores, given 
the effects of the treatment variables. It is difficult to determine if the 
difference in scores is due to the treatment of radiotherapy and 
chemotherapy or the progression of the tumour prior to treatment. This 
finding lends support to Grill et a/., (1999) who reported that "poor risk" 
medulloblastoma subjects, such as those in the present sample, treated 
with surgery, radiotherapy and chemotherapy had lower FSIQ scores than 
children with "standard risk" medulloblastoma tumours. Few researchers 
take these factors into account. 
Thus in the sample of medulloblastoma subjects those in Group 4 treated 
by means of S+RT are functioning better in terms of cognitive outcome 
than the subjects in medulloblastoma tumour Group 3 treated with surgery 
and radiotherapy and chemotherapy. A major gap in the understanding of 
the management of the children with medulloblastoma tumours is the lack 
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of biological factors which can be used to stratify the patients. The 
longitudinal study of Radcliffe et a/., (1992) showed that neither the 
progression of the tumour nor the site of the medulloblastoma tumour 
affected the FSIQ scores. This is possibly due to the biological nature of 
the tumour and the concomitant treatment of surgery, radiotherapy and 
chemotherapy. However the parameters associated with the effects of 
Age-at-Diagnosis, Age-at-Testing and Time-since-Treatment need further 
exploration in prospective cognitive and quality of life studies in which 
children are followed up for longer periods of time. 
13.6. ROLE OF THE CEREBELLUM IN RELATION TO NEURO-
PSYCHOLOGICAL FINDINGS 
The majority of survivors in the study, regardless of type of tumour or 
treatment, had impairment of fine motor skills as indicated by the results 
obtained on the Purdue Pegboard. The cerebellar site of the tumour might 
have led one to expect difficulties in gait and balance, but in fact these 
were not found as a general effect. When difficulties were shown, these 
were attributed to adjuvant treatment as there was a trend for the scores 
to decrease from treatment Group 1 to treatment Group 3. Thus, 
variations in the ability to execute voluntary motor movements was shown 
in the sample and support the discussion of Daum and Ackerman in 
Schmahmann (1997). In their review of subjects with cerebellar 
malformations they state that cerebellar aplasia was frequently but not 
invariably associated with mental retardation. These authors report that 
the clinical symptoms related to malformations of the vermis or the 
cerebellar hemispheres showed considerable variability. In some cases 
there was no evidence of motor or intellectual impairment in life and the 
cerebellar malformations were accidentally discovered during post 
mortems. Therefore neither partial cerebellar malformations nor surgical 
removal of part of the cerebellum necessarily lead to clinically significant 
cognitive impairment. It is possible that impaired cognitive ability in 
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cerebellar developmental malformations may partly result from the 
impaired acquisition of psychomotor skills and it is difficult to disentangle 
the motor and non-motor consequences of early cerebellar dysfunction. 
In terms of visual discrimination alone the groups seem unimpaired, but 
once visuomotor integration is required there is a downward trend 
according to treatment (Group 1 = 41 51 percentile, Group 2 = 19th 
percentile, Group 3 = 9th percentile). This suggests that it is the addition 
of a motor component that produces the effect. 
According to Daum and Ackerman (1997), neuroimaging studies have 
helped clarify the role of the cerebellum in motor skill learning, such as the 
tracing of geometric patterns and the execution of serial movements. At 
the same time there is conflicting evidence with regard to visual spatial 
abilities in patients with cerebellar lesions. 
The two-way link between the cerebellum and the parietal cortex has 
formed the theoretical base for the hypothesis of cerebellar involvement in 
visual spatial organization (Daum and Ackerman in Schmahmann, 1997). 
Studies supporting this hypothesis are the result of research on patients 
with cerebellar syndromes who have impaired visual spatial recall 
(Bracke-Tolkmitt, Linden, Canavan et a/., 1989 in Schmahmann, 1997) 
and impaired visual spatial manupulations (Wallesch and Horn 1990 in 
Schmahmann, 1997). Deficits in similar subjects have not been confirmed 
by other researchers (Appollonio, Grafman, Schwartz et a/., 1993; Daum, 
Ackermann, Schugens et a/., 1993a in Schmahmann 1997). 
It is thus hypothesized that the cerebellum is involved in visual spatial 
organization. This is because disruptions of the cerebellar parietal 
pathway, due to tumours residing in the cerebellar vermis, and the 
treatment of the tumours, are associated with poor scores on the motor-
free test visual spatial relations (TVPS) as well as visual motor integration 
(VMI). In addition impaired visual spatial recall is evident in 
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medulloblastoma survivors after adjuvant RT and chemotherapy 
treatment. 
13.7. QUALITY OF LIFE OUTCOMES 
13.7.1 WPBIC 
Conspicuously absent from the literature on survivors of childhood brain 
tumours are the emotional and behavioural implications of the disease. 
The Walker Problem Behaviour Checklist (WPBIC) showed a negative 
correlation between problem behaviour and prorated FSIO scores, which 
indicates that the lower the FSIO, the higher the incidence of problem 
behaviours. Other research findings have not correlated problem 
behaviour with intellectual functioning in childhood tumour survivors. 
The influence of treatment on problem behaviour was not significant. T 
scores above 60 on the WPBIC indicate problem behaviour. The trend of 
the total scores indicated that treatment Group 1 and treatment Group 2 
subjects were functioning in the average range. Treatment Group 3 
subjects (T=66) were functioning in the impaired range in problem 
behaviour. In terms of domains of behaviour, the group as a whole has 
problems in Acting Out behaviour. All the children in Group 3 treated with 
surgery, radiotherapy and chemotherapy, the majority of children in Group 
1 treated with surgery only, but none on Group 2 treated with surgery and 
radiotherapy experienced some problems in Immaturity. More than half 
the children in Groups 2 and 3 have disturbed Peer Relations. 
Research findings are inconsistent although an overall finding is that a 
high proportion of children treated for brain tumours may have chronic 
problems with emotional adjustment (Kun et a/., 1983; Lannering et a/., 
1990; Mulhern and Kun, 1985; LeBaron et aI., 1988). Seaver et a/., 
(1994), however, found no difference between survivors of brain tumours 
and controls while Hoppe-Hirsch et a/., (1995) reported an increase in 
behaviour problems dependent on tumour type and treatment over a 
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period of time. According to Bauld et al., (1998) no single predictor of 
psychosocial outcome has been identified in the adjustment of cancer 
survivors. A complex interaction of factors seems to play a role in the 
adjustment of cancer survivors making it difficult to establish which 
children are at greatest risk for psychosocial problems. Noll, Gartstein, 
Vannatta, et al., (1999) support the finding that children with cancer 
receiving chemotherapy show considerable psychological hardiness. Most 
children in this study had scores within the normal range. 
13.7.2 Health- Related Quality of Life 
The Multiattribute Health Status Classification has six domains of 
functioning: sensation, mobility, emotion, cognition, self care and pain. 
Each domain has an attribute level which increases according to the 
degree of difficulty. A score is derived for each domain of functioning and 
a total score is also calculated. 
Of the subjects, 64% have some degree of functional morbidity. The 
cognition, emotion and mobility domains were the most frequently 
endorsed areas of difficulty, as was also found by Whitton et al., (1997) in 
adult brain tumour patients. Studies using the same rating scale on both 
children and adult brain tumour as well as ALL survivors, present varying 
results (Barr et a/., 1993; Bilson and Walker, 1994; Feeney et al., 1993). 
An exploration of the effects of treatment on health functioning showed no 
significant difference between the groups on the MHSC total score. 
However, there is trend for the total score to increase as the treatment 
parameters become more intense, from Group 1, surgery only to Group 
3, surgery, radiotherapy and chemotherapy, which is similar to the 
finding by Barr et al., (1993). 
Significant negative correlations were found between the total score of the 
Multiattribute Health Status Classification (MHSC) and FSIQ, TVPS visual 
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memory, AVL T total score, VIVII (Beery) and Purdue Pegboard using both 
hands. This implies~hat as the functional disabilities of the brain tumour 
survivors increase, the neuropsychologicCjI test score results are 
adversely affected. 
A positive correlatiofl was shown between Age-at-Diqgnosis and emotion 
and pain as measured by MHSC in the treatment Group 3 supjects. This 
implies that the old~r the Age-at-Diagnosis, the higher the incidence of 
occasional emotional disturbance and pain in those having the more 
intense type of treatment. This finding is understandable bearing in mind 
that older children are more aware of the implications of the tumour and 
the treatment and of their differences from other children. Barr et aI., 
(1993) found emotional difficulties in younger age group survivors of ALL 
(mean age of four years eight months at-diagnosis) and associates 
greater radiation dose with emotional morbidity. The differences in 
findings may possible be because the Barr study is a prospective one in 
which the check list was completed by a panel of professionals who were 
familiar with the subj~cts, whereas this study is a retrospective design in 
which the checklist was completed by the parents and the survivors. 
A significant correlation between Years-since-Treatment and sensation, 
as measured by IVIHSC, indicates that the longer the Years-since-
Treatment (six years and more post treatment), the higher the incidence 
of subjects who need equipment for their sensory problem. A difficulty in 
seeing and hearing has been indicated by Whitton et aI., (1997). However, 
71 % of the subjects in the present study have not reported deficits in the 
domain of sensation. Similar findings are reported by Feeney et aI., (1993; 
1992). 
The MHRS offers a comprehensive, quick method of monitoring the 
functional health status of both adults and children. The domains of 
sensation, emotion and mobility are not broad enough in the scale used in 
240 
this study but these have been extended in the revised Health Utilities 
I ndex published Whitton et aI., (1997) 
13.7.3 Educ~tiQnal AGhievemen.t and OCG.upational Status 
More than 50% of the survivors in treatment Groups 1, surgery only and 
treatment Group 2, surgery, radiotherapy and chemotherapy were in 
normal school, in contrast to Group 3, surgery, radiotherapy and 
chemotherapy survivors, in which only 21% of the children were in normal 
school. Similar results have been shown by other researchers 
(Chadderton et aI., 1995; Duffner et a/., 1988; Hirsch et a/., 1979; Hoppe-
Hirsch et aI., 1990; Hoppe-Hirsch et a/., 1995; Packer et a/., 1989; Yang et 
a/., 1997). 
Kimmings et a/., (19t35) found that the differences in academic potential 
can be related to the age of the child at diagnosis and the presence or 
absence of post operative complications. As less than half the group in 
the present study are aged 17 years or older (n=20) and treatment Group 
1, surgery only, is composed of fewer subjects eligible for work (n=2), it is 
difficult to compare the effects of treatment on occupational outcome. 
l\Jonetheless of those eligible to work, nine adults (45%) are employed 
whereas five adults (25%) are at home and receive a disability grant. 
These recipients all experienced complications such as repeated shunt 
revisions, transient cj3rebellar mutism or seizures. 
Lannering et a/., (19t30) with a large sample reveal a higher percent to be 
employed (66%). According to Jannoun and Bloom (1990), 60% of brain 
tumour survivors were functioning in the average range of intelligence. Of 
this group 57% were leading normal lives without any neurological or 
physical difficulties. Hoppe-Hirsch et a/., (1990) with a longer follow up of 
medulloblastoma survivors presents a less positive picture. Ten years 
after the onset of the disease, no survivor had normal employment, 
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36% were unemployep and 64% worked in a protective workshop. 
Research findings are thus varied and treatment factors, as well as 
treatment complications, may influence the occupational potential of brain 
tumour survivors. In addition, other factors such as SES, premorbid 
factors and rehabilitation opportunities may also influence the occupation 
potential of survivors. 
13.8. PREDICTOijS OF OUTCOME 
Two Principal CompQnents (PC1 and PC2) were identified from outcome 
variables which had been found to be sensitive to differences between the 
treatment groups: visual memory (TVPS), AVL T total score-verbal 
memory, V 1\11 I (Beery), Purdue Pegboard (both hands) plus prorated FSIQ. 
PC1 appeared to cOrTjprise a global factor of intelligence and memory as it 
included FSIQ, TVPS visual memory and AVL T verbal memory and these 
accounted for 56% of the variance. PC 1 was best predicted by a 
regression equation using SES, Repeated Shunt Revision, Tumour Type 
and Years-since-Treptment. Low SES, Repeated Shunt Revision and 
Medulloblastoma were negatively associated with PC1, whereas an 
increasing number of Years-since-Treatment was associated with better 
scores on PC1. It could be anticipated that low SES, Repeated Shunt 
Revisions and Medulloblastoma rather than Astrocytoma would be 
associated with a 10wFlr score on PC1, which is a global factor. 
The association of in~reasing Years-since-Treatment with high scores on 
PC1 seems surprising considering the earlier finding that VIQ (which 
contributed to FSIQ in PC1) was negatively associated with Years-since-
Treatment. However, it should be realized that this was for a smaller 
group comprising those under 18 years of age-at-testing and only subjects 
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with medulloblastomas. In addition PC1 comprises a memory factor as 
well as FSIQ. 
PC2 which accounted for only 21 % of the variance in the outcome 
variables used, comprised VMI (Beery) and Purdue Pegboard (both 
hands). PC2 seemeq therefore to be a specific visual motor factor and 
was predicted by only Years-since-Treatment. An increasing number of 
Years-since-Treatment was associated with lower PC2 scores. 
When tumour type and SES were used as predictors of PC2, only Tumour 
Type was significant, fTledulioblastoma being associated with poor scores. 
Medulloblastoma tumours appear to be more disruptive to visuomotor 
functions than astrocytomas, as children with medulloblastomas have had 
more posterior fossa irradiation than children with astrocytomas. This 
finding is therefore understandable. 
In view of the retrospective nature of the study, the broad range of ages 
and the wide scatter of test scores, it seems unlikely that this model would 
be used to predict outcome from posterior fossa tumours. Nevertheless 
the model highlights the factors associated with good and bad cognitive 
and visuomotor outcoJ11e. 
13.9. CONCLUSIONS 
The following conclusions were drawn: 
• The Quality of Life of children treated for posterior fossa tumours is 
influenced by a cqmplex interrelationship of factors. 
• Overall, children wit~ posterior fossa tumours tended to have lower 
scores than the norm in the areas of intelligence, attention, visual 
perceptual information processing and motor functions. Relatively 
spared were speech and language functions. Although no distinct 
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neuropsychological profile is reported for children treated for brain 
tumours, the pattern of obtained scores is similar to that found by 
Fletcher and Copeland (1988) in children treated for ALL with 
prophylactic chemotherapy and cranial radiation. 
• The survivors in Group 3, whose medulloblastoma tumours were 
treated by means of surgery, RT and chemotherapy, had impaired 
scores relative to the other treatment Groups in the domains of 
attention, visual perceptual information processing, visual memory, 
verbal list learnin9 and motor functions. 
• When the sample was restricted to only medulloblatoma survivors, 
those treated by means of S+RT performed significantly better than 
those treated by means of S+RT+C when measured on prorated FSIQ 
scores. This is possibly due to the biological nature of the tumour, 
which could not be verified due to the retrospective nature of the 
designs and the adjuvant treatment of chemotherapy. In addition one 
is unable to ascertain if the low scores of the S+RT +C survivors is due 
to the addition of chemotherapy, the two modalities given in 
combination or the relatively higher doses and volume of RT. 
• In general quality of life (as measured by behaviour and health scales) 
was fair with Acting Out and Immaturity appearing as problems in 
school-age children. The majority of the survivors rated themselves, or 
were rated by their parents, as having an adequate functional level in 
the domains of sensation, mobility, emotion, cognition, self care and 
pain on the MHSC. About half the survivors were rated as having 
some degree of impairment on cognition, emotion and mobility. There 
were no significant differences between the treatment groups in terms 
of their behaviour ratings as shown on the WPBIC or health related 
functional status on the rvlHSC. 
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• Almost half the children attended normal school with more children 
from Group 3 treated by means of surgery, RT and chemotherapy 
• attending special school or special classes compared to the other 
groups. Of the small number of survivors eligible to enter the work 
market, about half were employed. 
• Age-at-Diagnosis did not have a significant effect on 
neuropsychological, behavioural or health-related outcome. Years-
since-Treatment also failed to show a significant effect on behaviour 
and health scores and most of the neuropsychological scores, except 
that performance on the visual motor integration as measured by the 
Beery declined with increaSing number of years. In analysing a 
smaller sample of subjects with medulloblastoma tumours, aged under 
18 years at testing, VIQ and FSIQ showed a significant decline as a 
function of Years-Since-Treatment, but PIQ was not affected. 
• Complications such as repeated shunt revisions and seizures (the 
latter not significant due to small numbers) were associated with a 
lower FSIQ. Growth retardation was significantly greater in children 
undergoing RT and chemotherapy than in those having RT alone or 
those being treated with surgery only. A similar effect on weight was 
notfound. 
• Although it is known that the cerebellum is concerned with motor 
functions, it is hypothesized that the cerebellum is also involved in 
visual spatial organization. 
• The Quality of Life of children being treated for posterior fossa brain 
tumours is thus compromised by the dilemma of the treatment 
prescribed to cure the disease. It is hoped, that although neither the 
incidence nor the adverse consequences of the treatment can be 
controlled, the neuropsychologist can directly improve the quality of 
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life of the children by advising and devising special educational 
programmes which build on the c~lildren' s capacity to learn and cope 
with the demands of daily living 
13.10. LIMITATIONS OF STUDY AND RECOIVIMEN-
DATIONS 
One of the major methodological problems in making comparisons 
between the groups is that the unrestricted use of these comparisons can 
lead to a high probaQility of a Type 1 error. That is, the error of rejecting 
the null hypothesis when it is true (Howell, 1995). Another serious 
problem is a Type 11 error (the probability of not finding a difference 
between the Groups, that is there). According to Howell, the more positive 
approach is to discuss this in terms of power, which is the probability of 
correctly rejecting a false null hypothesis. In order to do this, four 
underlying assumptions have to be met, one of which is the size of the 
sample. As this study has a small number of subjects, it follows that only 
large effect sizes are reliably detected, while small and moderate effects 
remain unnoticed. 
Another limitation to this study has been the retrospective nature of the 
design, bearing in mind the concomitant small number of patients, the 
uneven distribution of the test scores within the groups, the self selection 
of patients into treatment groups, the age cohort effect and the attrition of 
patient information. Future research should be a prospective longitudinal 
design, linked to international research centres in which a large patient 
population would meet uniform criteria and permit control of the possible 
confounding variables. 
With the increased survival rate after treatment for brain tumours, the role 
of diet and stress in maintaining an adequate immune system is 
important. Future studies should take these factors into account. 
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Ris and Noll (1994) recommend smaller research centres such as training 
institutions which prQvide an opportunity to carry out prospective time 
restricted research studies on the development of neurobehavioural 
morbidity as it relates to specific neuro-anatomical structures and 
neuropathological processes. Such research could be linked to larger 
cooperative groups, combining the advantages of group and individual 
centres. In this way, by conducting investigations on homogenous groups 
of subjects who are receiving standardized treatment, more sophisticated 
types of research car] be carried out. 
A correlation betweer the CT scan findings and neuropsychological test 
scores may have clarified the treatment effects and age and time 
variables. This unfortunately was not possible but future studies should 
use imaging in conjunction with neuropsychological findings. 
Children with brain tumours should be monitored with proton MR 
spectroscopy to assess brain tumour tissue remote from the tumour site to 
ascertain the effect& of chemotherapy and radiation treatment. These 
results should then be correlated with neuropsychological $st batteries 
which include quality of life scales. 
Although the role of hyperbaric oxygen treatment for decompression 
sickness is uncontested its role in the treatment of chronic neurological 
conditions is controversial. To date this has not been attempted on 
survivors of brain tUlJlours as part of their treatment. Neuropsychological 
assessment and quality of life measures on brain tumour survivors before 
and after hyperbaric oxygen treatment could provide specific measures of 
its effectiveness on t~e injured brain and functional states. 
Few studies have examined the effect of school disruptions on 
neurocognitive outcomes. Treatment of brain tumours requires that 
children miss school for substantial periods of time. The impact of missed 
schooling on functioning is important in studies with a limited number of 
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follow-ups. In general, assessment of children at only one point of time 
has little to offer in ?ldvancing the understanding of the development of 
brain tumours either clinically or conceptually. Individual variability in 
response to treatmert shows that multiple assessments are critical in 
evaluating outcome. 
Precise definitions of "quality of life" and "disability" in future studies would 
enable comparisons in outcomes across studies. These would provide a 
better understanding of the relationship of underlying neurocognitive 
abilities and the interplay among children's pre-existing attributes, the 
effects of treatment and the social environment. 
With the rapid advance in technology the treatment of children with brain 
tumours may become more sophisticated and require dedicated 
multidisciplinary innovative team approaches to the role of research. 
However the volatility of the research environment as the science of 
oncology becomes more exact means that the original dilemma of 
weighing the cure of the brain tumour against the sacrifice in quality of life 
could well lessen over time. As the French mathematician Laplace (1749-
1827) stated: 
"The theory of probability is only common sense reduced to a calculation, 
it exhibits with accuracy what reasonable minds feel by a kind of instinct 
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APPENDIX A : Description of Treatment Groups 




• E. V.D. 
• T 
• S 
= VENTRICULAR PERITONEAL SHUNT 
= EXTERNAL VENTRICULAR DRAIN 
= TOTAL SURGICAL RESECTION 
= SUB TOTAL SURGICAL RESECTION 
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= VENTRICULAR PERITONEAL SHUNT 
= EXTERNAL VENTRICULAR DRAIN 
= TOTAL SURGICAL RESECTION 








44 48 6 
30 30 20 7 
2 
54 8 
20 20 32 7 
32 32 20 32 7 
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• SHUNT = VENTRICULAR PERITONEAL SHUNT 
E. V.D. = EXTERNAL VENTRICULAR DRAIN 
T = TOTAL SURGICAL RESECTION 
S = SUB TOTAL SURGICAL RESECTION 






























APPENDIX B - Socio-Economic Status as defined by occupational category 
RANK ORDER OF BROAD CASS OCCUPATIONAL CATEGORIES 
CASS - CENTRE FOR APPLIED SOCIAL SCIENCES 
CRITERION FOR CODE INDEX (1 - 5 in Descending Order of Prestige) AMONG 5 CATEGORIES OF OCCUPATIONAL STATUS 
* White Farrners in South Africa enjoy a higher social and occupational status than is prevalent in most modern countries. It is therefore possible if the 
case warrants it, to code them as a separate category between Ranks 2 and 3 above. They are included under Rank 3 in the above table. 
** This categorisation reflects the general trend for lower non-manual occupations to sink below the 
traditional manual level in industrialised society . 
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n = 51 
CASS OCCUPATIONAL CATEGORIES 




Manual Foreman, Skilled 




OProfessonal & Managerial 
r;JMiddle White Collar 










o Manual Foreman, Skilled Artisans, Farmers & Status Equivalent 
o Routine Non-Manual & Semi-Skilled Manual 
III Unskilled Manual & Menial 
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APPENDIX C - Guidelines for choosing tests Mulhern et a/ (1998) 
Proposed Requirements for Practice Standards, Practice Guidelines and 
Practice Options in Choosing Psychological Tests* (Mulhern et a/1998) 
Requirements for "practice standards" 
1.1 The test has a high degree of general clinical acceptance with 
overwhelming scientific evidence of usefulness in the evaluation of 
children surviving ALL and BT, and 
1.2 The test is published and has developmental norms appropriate to 
the age range of ALL and BT, and 
1.3 Evidence of validity with ALL or BT survivors (>2 years from 
completion of therapy) from one or more publications in a peer-
reviewed journal that the test: 
1.3.1 Discriminates between patients and normal controls (not 
just test norms), or 
1.3.2 Discriminates between subgroups of patients with known 
different risks of impairment, or 
1.3.3 Demonstrates sensitivity to change in process over time 
among a sample of patients, or 
1.3.4 Correlates with abnormalities of the brain seen on CT/MRI 
2.0 Requirements for "practice guidelines" 
2.1 The test has at least some general clinical acceptance and some 
scientific evidence of usefulness in the evaluation of children 
surviving ALL and BT, and 
2.2 Criteria 1.2 and 1.3 under practice standards 
3.0 Requirements for "practice options" 
3.1 The test has some general clinical acceptance with unknown 
usefulness in the evaluation of children surviving ALL and BT, and 
3.2 The test purports to assess cognitive processing abilities that 
appear relevant to learning problems of the school-age child after 
treatment for ALL or BT 
*ALL, acute lymphoblastic leukaemia; BT, brain tumour; CT/MRI, 
computed tomography/magnetic resonance imaging 
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~nt"n,"r person to eat, bathe, dress or 
Occasional pain. Discomfort relieved by non prescription 
drugs or self control activity without disruption to normal 

APPENDIX E - Neuropsychological Intake Questionnaire 
Name 
Address __________________________ __ 
Tel (h) 




Folder # RXH/GSH 
Case # 
DIAGNOSIS 
Date & Age at Presentation 
Date & Age at Testing 





Folder # RT 
Duration of Presenting Symptoms ______________ _ 
Vomiting 0 Headache 0 
Papilloedema [J Seizures [J 
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Raised ICP 0 Hydrocephalus 0 Diplopia 0 
Cranial Nerve Palsy 
Speech Dysarthria 
Affect 
Loss of Consciousness 










Investigations Pre-Op and Post-Op 
X Ray 0 Date 
EEG 0 Date 
CT Scan 0 Date 
MRI [J Date 
Histology 0 Date 






























































Reason ________ _ 
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Administered: During RT o After RT o 
Date Completed 
Date Discontinued 
Radiotherapy & Chemotherapy Complications Immediate 
Neutropenia 0 Other 0 
Radiotherapy & Chemotherapy Complications Chronic 
Reason __________ _ 
Hearing Problems: Wax Build Up 0 Hearing Aid 0 
Visual Problems: Glasses 0 
Growth: Height Date Percentile __ _ 
Weight Date 
Late Phase 
Recurrence of Tumour 
Percentile __ _ 
Immune System Depletion: TB 0 Leukemia 0 
Post Operative Treatment/Rehabilitation: Physiotherapy 0 OT 0 Speech 0 
Neuropsychological Testing Date: 
Other: 
Follow Up 
Still in Contact: 0 Date Last Seen: ____ _ 
Discharge Date: 










Parents Marital History: 
Single Male 0 Single Female 0 Living Together 0 Married 0 
Divorced 0 Other 
Siblings 
Number __ _ Problems 0 Development 0 MedicaiD 
Education: Failed 0 Passed 0 Repeated 0 
Other 
Religion 
Parents Hx Medical Problems 
Subject Development 





Seizures 0 CAD 








APPENDIX F - Test Results 
IQ Test 
Type: 









Speech & Language 
Comprehension Scale Score 





Incidental Recall Coding Scale Score 
Number correctly attributed 








Griffiths 0 Oasis 0 
Backward 
TMTB P 




APPENDIX F - Test Results 
Learning 
AVLT 
Trial 1 Raw Score 
Trial 2 Raw Score 
Trial 3 Raw Score 
Trial 4 Raw Score 
Trial 5 Raw Score 
Total Score: 
List B Raw Score 
Trial 6 Raw Score 
Trial? Raw Score 
Recognition 
Raw Score 
Errors: Intrusions ____ _ 
Expected Score _____ _ 
Expected Score _____ _ 
Expected Score ______ _ 
Expected Score _____ _ 
Expected Score _____ _ 
Expected Score _____ _ 
Expected Score _____ _ 
Expected Score _____ _ 
Expected Score _____ _ 
Confabulations _____ _ 
Visual Perceptual Information Processing 
VMI P 
TVPS Visual Discrimination _____ P 
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TVPS Visual Spatial Relations P 
Visual Construction Blocks Scale Score ______ _ 
Motor Functions 
Purdue Pegboard: 
Preferred R/L ___ P Non Preferred R/L P Both Hands 
Comments ______________________________ __ 
Successive Finger Taps: 
Preferred R/L seconds Non Preferred R/L seconds 
P 
Comments __________________________ __ 
299 
Legs Balance 10/20/30 Seconds 
Right seconds Left ____ seconds 
Gait Ataxia Yes 0 NoO 
Tandem Gait Heel 0 Toe 0 
Comment ________________________________________________ ___ 
Behaviour 
WPBIC 
Acting Out Raw Score 
Distractibility Raw Score 
Immaturity Raw Score 













Withdrawal Raw Score 











Concentration Persists well 0 Slightly distractible 0 
Very distractible 0 Gives up easily 0 
Activity Appropriate 0 Listless 0 Restless 0 
Cooperation/Motivation Good 0 Fair 0 
Shy 0 
Very Restless 0 
Poor 0 
Very Shy 0 Affect Appropriate 0 
Tearful 0 Over Cheerful 0 Labile 0 
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APPENDIX G - Mean Prorated IQ test Scores as per IQ Tests 










































































Cerebellar Astrocytoma (5) 
Craniopharyngioma (1) 




















42 out of 124 children alive. 
Survival shows 27 or 69% 
normal & useful lives i.e, work or 
schooL 
21.4% partial disability 
12% Stunted 
RT & age 6-
associated With stunted growth. 
42 children alive 3-15 years after TX, 
Despite differences in histology & 
predilection of tumours, RT can 
groups: 
3=superior, 10=average, 4=below 
average, 11 =subnormal, 2=severely 
subnormal. 
Mental handicap may be progressive 
but cannot be verified. 
Stature: 76% short. No child TX < 11 
years of age had height >1 OP, 
Visual: 37% correctable defect, 10% 
severe visual handicap, 10% blind, 
Hearing: 3% partial deaf, 3% total 
deaf. 
Emotional: 43% problems ranging 
from aggressive behaviour (11), 
solitary behaviour emotionally 
labile (6), insecurity suicide 


















N = 38 
R 
Descriptive 
























































Cerebral Hemispheres (8) 
Miscellaneous (9) 
Craniopharyngioma (11) 
Optic nerve glioma (6) 
Cerebellar Astrocytoma (6) 
Medulloblastoma (5) 
Midbrain tumours (3) 
Cerebral astrocytoma (2) 
Ependymoma (1) 
Pituitary adenoma (1) 

























31% IQ < 70,27% Bloom category 3 
or 4. 82% learning disabilities 
Astrocytoma: 19% IQ < 70; 19% IQ 70 
to 90; 62% FSIQ >90. Emotional & 
behavioural disorders 59% .. 
22 deceased, 9 alive, of those, 8 
tested 
School: 5=nonmal school/continuous 
employment, 2=special school. 
Mental retardation =3. Age: 2/3 
children <3 years of age at TX in 
mental retardation range. 
Stature: 50% < 25P 
Growth honmone secretion nonmal in 
5/6 patients. 
No effect of tumour siteltype. Age: 
Patients Tx. < 5 years lower scores. 
Trend for those with hemispheric 
tumours to have the best & those with 
craniopharyngiomas to have the worst 
outcomes. 
Bloom: 89% no disability 
55% IQ nonmal or above 
28% dull nonmal or borderline IQ 
17% mentally defective IQ. 
Unable to assess RT tumour dose 
and presence of mental retardation as 
all subjects received same dose of 
RT. 
Mental retardation associated with TX 
before age 3 years & tumours 
extending into the hypothalamus 
Behavioural disorders identified in 
38% of patients, 59% of mothers and 
43% of fathers. 
44% of patients with non-parasellar 





Anderson et Pre/ post test 
al. ,1983 
Descriptive 
N = 10 
Kun, Mulhern P 
& Crisco, 1983 
N = 30 
Chin & 
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Brain Stem Glioma (2) 
Cerebellar Astrocytoma (1) 
Posterior Fossa Tumours: 
Cerebellar Astrocytoma (7) 
Medulloblastoma (5) 
Mixed Glioma (2) 
Ependymoma (10) 
Supratentorial 










100% RT 80%, 
RT+Chemo= 
13% (2) Medullo 
Shunts=93% 
Thalamic Astrocytoma (3) Supratentorial: 
Hypothalamic Astrocytoma (2) Surgery 73% 
Suprasellar Germinoma (1) RT, 60%, 
Pineal Malignant Teratoma (1) Chemo = 1 
Pineal Tumour (1) thalamic tumour 
Medulloblasoma (10) 

















had endocrine deficiencies. 
Short stature found in 35% of non-
parasellar tumours 
50% 10 < 80; 20% 10 > 100. All had 
dementia, Learning Disability or 
Mental Retardation. 
4 children showed a deterioration of 
25 points in FSIO from pretest, prior to 
TX, to post test. Authors unable to 
determine if deterioration in FSIO due 
to RT, Chemotherapy or two 
modalities given in combination. 
Bloom Classification: 
80% no disabilities, 17% partially 
disabled, 3% totally disabled. 
10: 90+, 63% Mental Retardation 9%. 
No differentiation between Age at 
Diagnosis, increased ICP and low 10. 
Serial 10 testing (10): Stable 10 (5), 
Improved 10 (2), Deterioration 10 (2). 
Deterioration in 1 case associated 
with seizures. 
No correlation between shunts & 
neuropsychological changes. 
63% of school going sample in 
learning disability settings. 
Borderline Academic functioning (3) 
attributed to RT and problems with 
selective attending. 
Social emotional adjustment in normal 
range. Abnormal social and emotional 
functioning in 75% of sample after RT. 
Authors found factors responsible for 
impairment difficult to analyse. They 
suggest a greater than normal risk 
among children with supratentorial 
tumours and/or RT. 
Age: Patients < age 4 years at TX 
303 
Maruyama, Descriptive 12 yrs I yrs, Median 8 RT(10) ITPA, i major learning problems, those age 5 
1984, I yrs 6 mths WRAT, - 7 years at TX rated as satisfactory 
SDCT, passing in school work, those age> 9 
N = 10 Draw a man, years at TX no major impairment 
Bender Short stature common but endocrine 
Gestalt, tests generally negative, 
Karnofsky. 
Li, Winston & R 0-15yrs Not 5-47 yrs median • Astrocytomas (71) Surgery (99) Bloom 26% mild or no deficits, 24% 
Gimbrere, given 18 yrs • Medulloblastoma (11) VVBRT (30) Functional moderate or severe deficits, Young 
1984 Descriptive I • Ependymoma (10) Chemotherapy Scale age at TX, & cerebral astrocytoma are 
I • Other (10) (3) risk factors, Despite diverse 
N = 102 Biographical performance levels majority had 
data acceptable quality of life, High RT 
dose not associated with severe 
impairment Functional status, 
educational level +occupation highly 
J)ositively correlated 
"'"V "'" "'" R 2.5 yrs to 25 Subjects 3 to 7.7 yrs • Medulloblastoma (9) Surgery (9) WAIS,WISC- I Brain tumour patients had lower IQ's 
Plakes, Talent yrs 9.5 yrs • Sibling Control RT(9) R JASTAK I than siblings. Children <: 8 yrs at TX 
et al., 1984 (Median age to 31 yrs wide range most severely affected. FIQ, VIQ & 
Control sibling 7 yrs) (median achievement PIQ average to low average range. 
N = 18 group nearest age 14 I test. Difference in PIQ worse than VIQ in age to yrs) when compared to controls, 
subject Control RT dose no effect on IQ. Children <: 
7 yrs to 8 years of age at time of TX had lower 
Parametric 25 IIQ 
yrs(medi Educational Quotient of patient group 
t test an age I 12 -17 points lower than controls. 
12 yrs) Arithmetic scores between patients 
Age diff. and controls significantly different. 
Between Authors state young age and longer 
subjects time since TX, need to be investigated I 
I 
I and in prospective serial studies to clarify I 
I controls 
I 
the effect of RT on IQ scores. 
o to 6 
yrs. 
Milihel & P 2 yrs 4 mths I Not 6 mths • Posterior Fossa (11) I Posterior Fossa MSCA, Pis. > 6yrs of age improved IQ scores 
Kun, 1985 to 15 yrs 10 i given I I • Astrocytoma (3) I Group: I Vv'lSC-R over time, 11 % deteriorated in one or 
304 
Serial testing mths. • Medulloblasoma (6) Shunt 55% LBC, more parameters. 
N = 26 1 done after Median age • Mixed Glioma (1) Surgery 100% PIC, Pts <: 6 yrs of age 68% deteriorated in 
surgery and 6 7 yrs 8 • Ependymoma (1) IIIIBRT &RT 91 % VVRAT one or more areas of intellectual 
mths after RT. mths functioning with prominent difficulties 
• Supratentorial (15) in memory 8. selective attention. 
Parametric i • Cerebral Astrocytoma (6) Improvements noted in vounaer & 
t test 
I : Cerebral Ependymoma (1) 
Supratentorial older age groups over 
chi square Neuroblastoma (1) Group. younger age aroup had 
• Craniopharyngioma (1) Shunt 27% tendency to Surgery 80% older age group. • Hypothalamic (2) S+RT60% Children <: 6 years of age with • Pineal (3) RTonly 20% Supratentorial tumours less 
• Optic Glioma (1) improve cognitive performance 
those with PF tumours. 
Second evaluation 23% of children 
functioning below normal (IQ<: 80) 
with 50% of younger children & 11 % 
of older children in special education. 
All 4 children with cerebral 
hemisphere tumours had 
sensorimotor impairment. 
No significant effect found for 
sensorimotor impairment, age, tumour 
site, raised ICP and RT. 
Selective attention difficulties found in 
27% of children at initial evaluation 
and 15% at second evaluation. 40%-
50% of children had emotional 
problems. Authors note that causal 
effects of tumour location, TX, child's 
reaction to the disease and parental 
attitudes are unknown, & need further 
investiaation. 
Ellenberg, P 10 mths to NIA 14 yrs • Fourth Ventricle (22) Surgery (40) Bayley Scales Patients with hemispheric tumours 
McComb, 43 pis had 14 yrs. • Medulloblastoma (11) RFRT (14) IMSC-R. most impaired. Amount resected, 
Siegel et al., Serial Testing; Mean age I • Brain Stem glioma (5) IIIIBRT (23) McCarthy hydrocephalus & chemotherapy not 
1987. -1 mth after 7.5 yrs i I • Ependymoma (2) i Chemotherapy Bloom related to outcome. IQ drop in the RT diag. I I I • Maiionant A;;tmevlnma /1 \ (14) group evident by 1-3 yrs Child TX at 
305 
N = 73 -Post RT 





et a/., 1987 Parametric 
Stats type not 





8 mths to 16 Not 
yrs 6 mths, given 
mean age 7 
yrs 9 mths 
I 
I 
I. Third Ventricle (16) 
- , . 
• Hypothalamic Astrocytoma (3) 
• Suprasellar epedermoid 
tumour (1) 
• Chiasmatic Ependymoma (1) 
• Pinela Region Astrocytoma 
(2) 
• Pinealoma (1) 
• Malignant Terratoma (2) 
• Benign Terratoma (1) 
• Hemispheric (5) 
• Astrocytoma (4) 
• Gioblastoma (1) 
I 
I 
2.5 yrs to ! • Primitive Neuroectodermal 
9,5 yrs Tumour! Medulloblastoma 












! I Progressive 
7ys of age IQ loss over short period of 
time, Child TX < 5yrs of age with RT 
I with decline of up to 47 points. 
Tumour site; Significant decline in IQ 
! for 4th Ventricle tumours over time. 3m 
Ventricle tumours maintained IQ, 
Hemispheric tumours had downward 
non-significant trend, 
RT: Multivariate analysis indicated IQ 
drops attributed to Whole Brain RT 
rather than tumour site 
Chemo: No significant differences in 
mean IQ between groups receiving 
RT & Chemo (4th Ventricle tumours) 
and group receiving only RT (3m 
Ventricle tumours) 
Acute hydrocephalus not found to be 
a potent contributor to long-term IQ 
changes. 
No significant difference in IQ score 
found between partial and total 
tumour resections. 
Quality of Life according to Bloom 
classification; 19% no disability, 33% I 
mild disability, 40 % partially disabled, 










I Roux, 1987. R Not given 7.5 yrs- 3.8 to 11.2 yrs • ALL (30) 
18 yrs mean 7.8 yrs 
N = 69 mean 
11.8 yrs 
Sibling Not given I 5.3 yrs-
controls 17.5 yrs 




Sibling Not given Not Not given • Solid tumour - non hodgkins 
controls given lymphoma (22) 
I ~;:~" I I Sibling Not given Not given I controls • VVilms tumou r (17) 
I 


























diagnosis, complicated post operative 
courses & post operative infection had 
lower performance scores. 
Factors statistically associated with 
- --- -- - --
Significant difference between ALL 
FSIQ 78 & Siblings FSIQ 99 
ALL grp children from deprived SES 
no different to their control siblings, 
indicating that TX cause of difference 
in FSIQ scores. 
Solid tumour FSIQ 96.5 compared to 
I siblings FSIQ 98.4 
No significant difference in Bender 
scores between ALL & siblings and 
Solid tumour group & siblings. 
VMI scores for all subjects within age 
appropriate levels. 
Poor school performance and high 
I rate of school failure for ALL group. 
I 








Bordeaux, P Surgery Grp Surgery Grp = 1 Surgery Grp: 
Dowell, 4.6 yrs to mth • Brain Stem Glioma (1) 
Copeland et Serial Testing: 16.3 yrs • Craniopharyngioma (1) 
al., 1988 Pre TX median 10 • Astrocytoma (5) 
Post TX .3 yrs 
N = 19 
Parametric Surgery & Surgery Surgery & RT 
RT Grp &RT Grp = 3 t019 Surgery & RT Grp 
t test 4.5 yrs Grp mths median 11 • Medulloblastoma ((2) 
t013.5 yrs 5.7 yrs I mths • Astrocy1oma (4) 
I 
median 9.8 to 13.8 • Brain Stem Glioma (1) yrs yrs 
I median [ 
10.5 yrs 
~e, 15 mths to 2 to 5 yrs • Hemispheric (4) 
I Cohen Parker, 15 yrs • Midline (6) 
1988. • Posterior Fossa (6) 
sting 


































I lower FSIQ than older children. 
I GROWfH - Slow growth for all 
subjects during TX but growth rate I 
resumed to age appropriate height 
after TX. 
WAIS Comparisons of pre-therapy findings 
McCarthy with normative values using 
Word Fluency confidence intervals indicated that 
Peabody I both groups performed within the 
Picture average range on most measures. 
Vocabulary, Outstanding deficits at baseline were 
WRAT shown on fine motor, psychomotor 
BeeryVMI and language skills are likely to be 
Benton attributed to tumour related effects. 
Stereognosis, Comparisons of pre- versus post 
TMT A&B therapy tests findings indicated no 
Finger significant interval changes for either 
Tapping grps. Results suggest that Surgery 
! Pegboard and Radiotherapy are not associated 




McCarthy Prior to RT 69% of sample FSIQ 
Stanford Binet I >90,at year 4 post TX 31 % had mean 
W1SC-R, FSIQ >90. Significant declines did not 
WAIS-R occur until after latency of> 2 yrs. 
Young age at TX risk factor. _ .A. - .. .. . "'.-
significant factor In treatme 







N = 15 
Mulhern. 
Horowitz, 
Kovner et al., 
1989. 













Prior to RT 
I 9 mths to 15 
yrs 1 mth. 
I Mean 10 yrs 
10 mths 
2 mths to 2 
yrs 11 mths 
Median 19 
mths 
6 yrs 10 120 mths 
mths - range 4-104 
















Cerebellar Astrocytoma (5) 
Ependymoma (1) 
Medulloblastoma (8) 
Anaplastic Astrocytoma (4) 
Glioblastoma (1) 




















chemotherapy had FSIQ loss of 9-28 
points. All children TX with 
chemotherapy required special class 
placement compared to only 50% of 
those TX with RT. Study shows 
adverse affects of RT on intellectual 
function may be progressive over 
several vears. 
50% had major neuropsych. Dficits in 
cognitive flexibility, academic 
achievement, sensory, perceptual 
motor functions, and behaviour 
problems. Patients TX with RT most 
impaired. 
Mean FSIQ 77, no diff btwn VIQ & 
PIQ. Despite posterior fossa location, 
high rate of higher cognitive deficits 
found. Authors speculate that this is 
relevant for those pts receiving RT but 
puzzling for those not receiving RT. 
No relationship between Blooms 
functional rating & psychometric 
receiving chemother",nv nO,.!;n;n" 
mental development 
behaviour found in 6 children after RT. 
Only 2 children functioned in normal 
range for age. Results indicate that 
neurodevelopmental progress is a 
function of multiple factors, including 
neurologic & sensory motor deficits 
associated with the tumour, surgical 
309 
Packer, Sutton 
Atkins et aI., 
1989 
N = 32 



























Median 2 yrs • Malignant Primary CNS 
Tumours 
• Medulioblastoma/PNET (15) 
• Pineal tumours (2) 
• Suprasellar Germinoma (1) 
• Comparison Group 
I • 
Cerebellar Astrocytoma (14) 
I 
Malignant CNS Bayley 
Tumour Group: Stanford 
Surgery (18) Binet, 
CRT (18) W1SC-R 
Chemotherapy WAIS-R, 
to selected I WRAT, finger 
I cases. (13) Tapping 
I Comparison Grooved 
Group: Pegboard, 













antedated RT. Delaying RT will not 
necessarily improve child's functional 
status. 
-
had a mean decline of 25 points in 2 
yrs post TX. 
Surgery, RT & Chemo Grp at 2 yrs 
post TX had deficits in fine motor, 
visual spatial skills & memory 
difficulties. These deficits worsened 
over time. School performance was 
adversely affected by young age at 










Siegel et ai, 
1989 





































Mean = 5 yrs • 
Astrocytoma 
Mean = 3.25 yrs 
2 yrs I • 
Medulloblastoma (8) 
Cerebellar Astrocytoma (7) 
Medulloblastoma (20) 
Primary Pineal Tumours (4) 
Suprasella Germinomas (2) 
Cerebellar Astrocytoma (21) 
I
· Surgery (15) 





























school placement with help but 
younger children commenced school 
in special education facilities at Year 
2. Authors unable to evaluate the role 
of chemotherapy, although no 
evidence was shown that the 
chemotherapy protocol 
(CCNU,vincristine & cisplatinium) 
increased the incidence of intellectual 
functionif![. 
Both patient groups worse on 10 & 
attention measures than controls. 
Only medulloblastoma patients 
showed severe deficits (mean 
10=74.6). 
No RT astrocytoma grp 10 average 
range (106). 
2 yrs post diagnosis significant drop in 
full-scale la, verbal 10 & non-verbal 
10 In RT group. Not evident in Surgery 
group. Decline in FSIO significantly 
correlated with age. Children age < 7 
yrs. at TX median 10 = 87 compared 
to 102 for older children. Children age 
< 3 yrs at diagnosis are devastated 
those> 10 yrs at diagnosis are 
relatively spared. 10 deficits declined 
progressively in RT group over 2-year 
period. RT dose did not correlated 
with 10 change. Hydrocephalus, post 
- operative complications or 
chemotherapy did not correlate with 
overall 10 or change in 10. Fine motor 
speed & dexterity abnormal in both 
groups. No deterioration over time. 




Moore et al., 
1990 





























Mean 8 yrs 
1-3 days prior to • 
surgical • 
treatment • 
Cerebral Hemisphere (7) 
Infratentorial (12) 
Supratentorial midline (12) 
I 
All subjects 
tested prior to 





















RT group at 2 yrs post TX. Particularly l 
in those age< 7yrs at TX. Academic I 
performance declined over time in RT I 
grp & need for special schooling 
occurred. 
Total group performed within average 
range on all neuropsychological 
domains 
When subjects grouped according to 
tumour location: 71% cerebral 
hemisphere grp, 64% supratentorial 
grp, 73% infratentorial grp performed 
within or above normal limits. Apart 
from executive domain in which 
cerebral hemisphere grp's 
performance was statistically poorer 
than the other tumour grps. 
Children with infratentorial tumours 
had symptoms of headache & nausea 
for briefest period, < 3 months. 
Cerebral tumours had the longest 
period. 
Hydrocephalus occurred in 67% of 
infratentorial tumours, 58% of 
supratentorial tumours but not in 
cerebral tumours. 
Children with hydrocephalus scored 
lower on measures of intelligence, 
executive skills, visual motor abilities 
& fine motor skills. 50% of 
infratentorial group had cranial nerve 
312 
N = 120 
yrs to 20 yrs 










deficits. 67% of infratentorial group 
had cerebellar signs. Tumour location 
& symptom duration correlated with 
executive domain score. Significant 
correlation between cerebellar signs & 
visual motor & fine motor domain 
scores. Age did not correlate with any 
measure, except in executive domain 
indicating age did not contribute to 
differential perfonmance. 
Over representation of older children 
in cerebral group confounded results 
Survival- 60% 5 vear survival rate. 
53% 10 year survival rate. 
Surprisingly survival better in children 
TX < 6 years of age than older 
children. 
5 yrs post TX. 58% had IQs < 80 & 
40% nonmai academic level. 
10 yrs post TX only 13 pts from 
original grp tested - 2/13 (15%) pts 
IQ > 80: 5/13 pts IQ 60-80; 6/13 pts 
IQ<60. 
Children age < 3 yrs at TX had worst 
outcomes. Emotional & behavioural 
disorders found in 47% of pts 5 yrs 
post TX & worsened to 78% at 10 yrs 
post TX. 60% of pts attended special 
school 10 yrs post TX and no pt had 
nonmal employment. 
Neurological sequelae such as 
hearing loss and epilepsy became 
worse at 10 yrs post TX whereas 
ataxia & limb weakness improved 
sliahtlv & cranial nerve deficits abated. 
112 children deceased, 89 alive, 67 
tested. 
IQs < 80 in 22% of oatients. 
313 




















age of 17 
yrs 
19 yrs 




5 yrs to 16.5 yrs i • 
I Mean 10.3 yrs 
• 
Supratentorial (27 in total but 



























Dahl Test of 
memory & 
learning 
Supratentorial sites, hydrocephalus a 
presentation, hypothalamic 
involvement, RT & younger age at TX 
were risk factors. 
26% of pts with supratentorial tumours 
FSIQ < 80 compared with 17% in 
infratentorial grp. 
Quality of Life - 72% of supratentorial 
grp mild to severe neurological and 
physical disabilities as compared with 
44% in infratentorial grp 
Pts who had RT to whole neuraxis did 
less well in terms of IQ. 31 % had IQ < 
80. Of those cases 8 also received 
chemo as well as surgery & RT. No 
significant differences found between 
those whose TX included chemo and 
those who did not receive chemo. 
Long-term outcome after TX shows 
60% of patients have normal or higher 
IQ & 57% leading normal lives without 
neurological or physical disability. 
48 deceased, 68 survived, 56 subjects 
tested. 
RT most important factor for cognitive 
sequelae, whereas psychological 
emotional sequelae more frequent for 
supratentorial tumours. 
Pts with no disability (20) - survivors 
of cerebellar astrocy1oma. 
Pts with mild disability (17) - slow 
learners, had epilepsy, and lor ataxia 
with mild dysfunction. 
PIs with moderate (10) & severe (9) 
disability had mental retardation, 
psychological-emotional & visual 
impairment. 









































Mean 4.08 yrs 




























































with slow learning or mental 
retardation. 
Matched controlled social 
assessment: fewer pts were married, 
only one pt had a child, less pts 
completed high school. PIs who lived 
active lives mean quality of life score 
of 73 (range 40-100). Time to 
diagnosis, age, papiloedema at 
diagnosis and preoperative conditions 
not related to disability at follow up. 
Self reported quality of life was not 
related to severity of disability but to 
svcholoaical-emotional seauelae. 
CT Scan reconstruction of 88 brain 
regions coded with respect to tumour 
and related damage. Multiple 
regression procedures established 
patters of brain damage predictive of 
memory deficits. Two forms of 
memory revealed non overlapping 
focal neuro anatomical substrates; 
Memory for serial order pictures 
involved the limbic system and 
hypothalamic -pituitary axis, and 
working memory involved the pineal-
habenular region & anterior, & medial 
thalamic nuclei. Memory for 
semantically based word pictures 
unaffected by tumour location. 
Tumours classified according to both 
histology and regions of the brain. 
This complex coding is an attempt to 
analyse the lesion and the invasion of 
the lesion into other anatomical sites. 
Memory impairment was found in the 
entire sample. IQ based regression 
model accounted for less than a 
_ •• _""\' ___ ~LL..... 0 _1.._ .•. _-'.1.1..._", 
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i 
i , I 
I ~:r~~~' I R I~~~~~: 
Connelly I I 
et ai, 1991 Matched i Siblings 
Sibling I 12.3 yrs 










At least 5 yrs • 342 Brain Tumours 
Type :-
• Astrocytoma 56% 
• Glioma 8% 
Ependymoma 8% 
• Medulloblastoma 7% 
























quarter of the variance & showed that 
VIQ is not the main determinant of 
memory test performance 
Age at tumour onset accounted for 
13% of the variance in sequence 
memory and not the determinant of 
performance in the task. 
Memory and time from tumour 
diaanosis to test not sionificant. 
47 pts. Deceased of those 44 pts 
directly as a result of the primary 
tumour, treatment &/or a recurrence. 
342 subjects survived. 15% never 
employed. 37% health condition led to 
job change or work stoppage 
The health parameters: 
Emotional problems 12% _ 
problems 24% hearing problems 8%. 
Unable to drive cars 13%. Excellent 
health 38% poor health 5% never 
married 42% Unfavourable oualitv of 
life more frequent in males 
females in supratentorial tumours than 
infratentorial & those who receive RT. 
Age - young age at diagnosis 
significantly correlated with risk of 
never being employed, lower level of 
final education or never marrying. 
No histological diagnosiS was 
consistently associated with increased 
risk for any of the outcomes when 
survivors were compared to matched 
controls. Matched analysis less 
meaningful as most survivors had 
astrocytomas. Medulloblastoma 
survivors were most likely to have had 























After to RT & 
6 month 
intervals x 2 






10 yrs 6 
months, 
Subject 2-




























All, Wilms tumour. & 
neuroblastoma on treatment 
(20) 
All, Wilms tumour & 
neuroblastoma (8) off 
treatment 




































i Token Test. 
outcomes listed, Increased risk of 
death associated with RT TX, 
VIQ but not PIQ varied positively with 
age at RT TX. Severe deficits in serial 
position memory occurred with 
impaired hormone function and older 
age at tumour onset 
Severe deficits in working 
were associated with RT & 
tumour site that involved the m"u""mr 
/epithalamic brain regions. The 
authors discuss that the results are 
not fullv understood and the data 
_ the need for tumour markers 
include maturational rate, 
hormone status, RT history and 
principle site of tumour. 
Independent ratings by 6 clinicians 
found that 61% were in agreement as 
to the level of morbidity. Change of 
one level required in 89% of cases. 
Emotion & pain were the attributes 
that caused the most disagreement. 
Results supported the hypothesis that 
patients on TX suffered greater 
burdens of morbidity than those off 
TX. 
Brain tumour patients had lower 
functional abilities than All, Willms 
tumour or neuroblastoma patients, 
Pattern of language recovery after 
treatment in 3 subjects was variable, 
None of the subjects showed 
language defiCits at base line testing 
after surgery and during RT Thus 
deficits attributed to RT treatment. 
Authors state at 
317 
i 
Moore, Ater & 
Copeland, 
1992 






























3.6 yrs Average 6.2 yrs • Medulloblastoma (10) 
to 26.25 · Astrocytoma (grades I & II, -yrs sited in midline & cortical 
Mean 8 region (13) 
yrs • Ependymoma (3) 
• Pinealoma (1) 





Surgery (28) McCarthy, 
Cranial Stanford 
Irradiation (14) Binet, 
No cranial W1SC-R. 
















I varying outcome. 
Severe semantic lexical deficits 
detected immediately post treatment 
improved dramatically in the first six 
months after treatment. 
64% in No RT group FSIQ average or 
above average. 70% in RT group 
below average, 4 scores mentally 
retarded. RT group significantly lower 
PIQ than VIQ. No RT group showed 
opposite but non significant pattern 
Mean scores for RT grp lower than for 
No RT grp in all areas assessed & 
were significantly lower in intellectual, 
memory, attention, motor, and visual 
spatial skills with relative preservation 
of language abilities. Mean scores for 
No RT grp within average range in all 
cognitive areas except visual spatial 
skills which were significantly below 
age based normative means 
Endocrine deficits & growth 
retardation more prevalent in RT grp. 
Correlations between Age at Time of 
RT & neuropsychological functioning 
I not statistically significant. Possibly 
due to the fact that children treated at 
I an older age were not represented. 
Thus a larger sample was defined 
(58) composed of children TX with RT 
across a broader age range (11 mths 
to 18 yrs 4 mths, mean 7.3 yrs) 
In this analysis statistically significant 
correlations for general intellectual 
performance, academic and visual 
spatial domains, indicating that 




[ RT had higher scores in these skills. 
I Radcliffe, P 1.6 yrs to 19 Not 4 yrs • Medulloblastomai PNET (14) Surgery (19) Bayley, I Mean FSIQ fell significantly from 104 
I Packer, yrs needed • Germinomas (5) RT (19) Stanford 1 to 92 at follow up. Decline in FSIQ 
Atkins, Serial Median 8 I Chemotherapy Binet, occurred between baseline and year 
et al., 1992 Testing: yrs (14) WlSC-R, 2. None could be documented I WAIS-R between years 2 and 4. 
N = 19 Baseline Age inversely correlated with change 
Yr 1 in FSIQ over time. Children < 7 yrs at 
Sample Yr2 diagnosis mean FSIQ loss of 27 
dropped to Yr3 points. Child> 7 yrs. at diagnosis 
N=15 at year Yr4 showed no significant decrease. All 
12& 3 & N=7 at children age < 7 yrs at diagnosis 
year 4. Non received special education. 50% age 
I Parametric > 7 yrs at diagnosis received 
Wilcoxon, supplementary education. No 
Spearman difference in FSIQ scores between 
rank I children who were TX with 
I I 
Chemotherapy & those who not TX 
with Chemo. Disease location, extent 
of disease & post op complication did 
not affect outcome. 
Silber, P PNET PNET I Mean 3.6 yrs • PNET (24) Surgery (24) WPPSI, Higher RT doses related to greater 
Radcliffe, 
I Serial Testing 
Mean Mean 1.41 yrs - 18.57 • ALL (24) WBRT (24) WlSC, WISC- decline in IQ. 
Peckham 7.06yrs 7.19 yrs yrs Chemotherapy R, Multiple linear regression model 
et al., 1992 i 2 yrs before ALL Mean ALL (?) WAIS. WAIS- showed that children who receive 
RT 4.90 yrs Mean R 18GY radiation to the brain score 12.3 
N =48 First & last 4.85 yrs Stanford binet IQ points higher than those children 
test separated Bayley Test, who received 36 GY after correcting 
by at least 2 McCarthy for age at TX The younger age at TX 
yrs. Scales. the lower the IQ. An average increase 
of 11.9 IQ points between age 3 - 10 
Parametric years when first irradiated. 
Linear 
l regression I model I I II Type 1 & Type I 11 errors controlled by I 
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Barr, Furlong, 
Dawson et al., 
1993 








filled in by 
consortium of 

















2.1 yrs to 
8.11 yrs 
High risk: 
1 yr - 2 yrs 
or> 9 yrs 
Long Term: 
Not given 









in regular follow 
up 
in regular follow 
up 
15-20+ yrs 







Standard Risk Acute 
Lymphoblastic Leukemia 
(25) 
High Risk Acute 
Lymphoblastic Leukemia (30) 
Long Term survivors (10) (R 
study) 
Primary Brain Tumours 
Both Std Risk & 
High-Risk Grps 




other details not 
given. 
Long Term: Not 
; given 
Surgery 
+Chemo Grp (9) 
RT alone or RT 
+ Chemo Grp 
(11 ) 
Benign tumours 















Std Risk: 60% no morbidity, 8% co-
morbidity. 20% cognitive deficits. 
High Risk: 30% no morbidity, 23% co-
morbidity. « 26% emotional 
morbidity, > 36% cognitive morbidity) 
Long term: 50% morbidity 
Std & High Risk Grps: positive 
correlation btw emotional & cognitive 
deficits as well as radiation dose & 
emotional deficits. Negative 
correlation btw age at diagnosis & 
emotional deficit. 
Surgery+Chemo Grp: FSIO 130-72 
RT alone/RT +Chemo: FSIO: Average 
= 1; Below average =3; Borderline 
1, Mild mental retardation= 2; 
Profound delay =2 
Benign Grp: 10 range 114-75. Not 
tested =9 of which 8 regular class & 1 
leaming disabled. Overall 41% have 
normal neurological &10 functioning, 
13% borderline 10 or a degree of 
visual loss, 54% significant sequelae 
(10<80, blindness or paresis.) Pt's TX 
with chemotherapy alone or chemo-
nd delayed RT had better 
those TX with local RT. 
of Life affected by tumour 
, preoperative status, 
complications, increased intracranial 
pressure, post operative infection & 
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treatment. 
Feeny, Leiper, R Mean 5,9 8-25 yrs Mean 9,3 yrs • High risk ALL (69) Chemotherapy Multiattribute From clinical records: 
Barr et aI., yrs including Health Status 42% no deficits, 32% deficits in one 
1993 methorexate Classification attribute, 26% two or more deficits, 
Descriptive & RT (69) System Survivors had greater level of 
N=69 morbidity than general population in 
Great Britain (GB), 7% ALL reduced 
sensation compared to 1,9% children 
in GB, 28% ALL deficits in emotion, 
GB children have 2,1 %, 39% ALL 
I deficits in cognition GB children have 
0,9%, I Canadian population had poorer 
vision compared to ALL survivors & 
lower cognition compared to GB. 
Relative to population norms for GB, 
I 
ALL survivors had greater morbidity, 
Proportion of ALL survivors who enjoy 
normal health is similar to the 
Canadian general population, 
Billison, P Not given 2-17 yrs I 1 mth - 12 yrs • ALL (17) Not specified Multiattribute Questionnaire completed by parents 
Walker, 1994 I • Brain tumour (7) Health Status of children <8 yrs, parents & children Non I • Non Hodgkin's lymphoma (6) Classification of patients 8-14 yrs, patients only if> 
N=48 Parametric • Rhabdomyosarcoma (6) System 14 years, Thereafter doctor filled all 
Wilcoxon • Wilms tumour (4) the questionnaires, 
• Hodgkin's disease (2) Assessment completed by 
• Neuroblastoma (2) patient/parent and doctor in 48 or 76% 
I • Osteosarcoma (1) 
of the subjects, 
33% of parent/patients & 40% of 
I • Hepatoblastoma (1) doctors found no deficits, Statistically I • Teratoma (1) I analysis showed no significant 
I • Ewings Sarcoma (1) differences between the two health 
status scores, 
Gajjar, P ,9 yrs - 3 Not 4 yrs - 8,9 yrs 
I • 
Medulloblastoma (13) Surgery (13) Vineland 6 children are alive 4 yrs to 8,9 yrs 
Mulhern, yrs given Median 7,5 yrs Chemotherapy WlSC-R after the treatment. 
Heideman et I Serial Testing Median 2 
I 
(13- Of these Neurodevelopmental scores tended to 
aI" 1994 I AfterTX yrs early termination be below age norms at diagnosis, 






et al., 1994 
N = 32 
~yrs 
I Descriptive 













































chemotherapy in verbal 
& lor motor scales but then decreased 
during post TX. FSIQ at last follow up 
= 50 - 96, mean 70, significantly lower 
than age adjusted norms. Only 2 
children completed Chemo & 
received RT. 11 children had spread 
of tumour during Chemo. Of these 6 
children complete response to RT of 
which 3 are alive. 
Following incomplete response to 
Chemo, RT appears to produce long-
term disease free survival but 
neurodevelopmental deficits 
frequently occur. 
Only 13 of 32 pts tested. IQ < 90 for 
all pts. Mean IQ, achievement test 
scores in reading, spelling & maths 
higher in shunted pts than non-
shunted pts. Perceptual motor task 
performance below average in > 50% 
of sample. Motor dexterity more 
severely affected than perception. 
Learning problems & delayed physical 
growth & development found in 
majority of sample. Behavioral 
problems in 38% of sample reported 
by parents. Attention & organisational 
skills moderately to severely impaired 
in 46%. Total tumour resection 
significantly better than partial 
resection pts. Moderate to severe 
deficits worse in visual memory, 85% 
than verbal memory 46%. 13 of 23 
children in special education 
programs. 78% of children had 
learning problems. 74% delay in 
physical growth or development. 22% 
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needed hel in bathing or dressin 
Kao, P 1.5 yrs .6 yrs -6 yrs • Medulloblastoma (28) Surgery (2B) Bayley, Presence of adverse factors Le. 
Goldwein, 16.4 yrs Mean 3.6 yrs RT to various Stanford neurologic deficits, meningitis or shunt 
Schultz et at.. Median 6.8 sites {2B} Binet, infections, repeated surgery 
Serial Testing yrs Average Chemotherapy WlSC, correlated significantly with IQ deficits 
1994 Time from (20) WlSC-R after treatment. Presence of adverse 
Baseline prior baseline factors & age <: 6 yrs correlated 
N=2B to surgery; significantly with FSIQ decline after 
treatment. Significant correlation 
AfterRT between age <: 8 yrs & occurrence of 
adverse perioperative factors. No 
Year 1 ! 1,2 yrs correlation between 'NBRT dosage & 
neurocognitive deficits, No correlation 
Year 2 2.6 yrs between shunt placement prior to RT 
& neurocognitive deficit. 
Year 3 3.6 yrs Small number of subjects precluded 
determination of whether IQ losses 
Year 4 I 4.9 yrs represent the loss of prior skills or 










fGrp 1 R Not given Grp 1 Prior to TX Surgery to more WlSCR-R Neurologic Results: Grp 1 essentially 
6.5 yrs-
I • 
Neurofibromatosis (14) than half WRAT-R normal results: 
1994 3 Groups 13.5 yrs I children in Grp 2 Verbal Grp 2 high incidence of matched by Brain tumour Fluency, hydrocephalus, cerebellar 
N=42 SES,Age, Grp. Otherwise Beery VMI, abnormalities and moderate incidence 
Race, Sex, & all children Finger of cranial nerve abnormalities and 
Brain Tumour Grp 2 Grp 2 tested prior to Tapping, motor abnormalities, 
diagnosis 4.8yrs - • Brain Tumours of mixed TX Grooved Grp 3; majority no abnormalities with 
13.6 yrs origin: Pegboard, about a third of the Grp with difficulties 




Khatib et al., 
1994 















1.5 yrs - 5.6 yrs 
• Cerebellar Astrocytoma (3) 
• Optic Glioma (3) 
• Brain Stem Glioma (1) 
• Craniopharnygioma (1) 
Grp 3 
• Neurofibromatosis plus brain 
tumour 
• Optic Glioma 
• Cerebellar Astrocytoma (2) 
• Brain Stem Glioma (2) 




Dorsally Exophytic! Juvenile 
Pilocytic Astrocytoma (10) 
Fibrillary Astrocytoma (1) 









abnormalities, cranial nerve difficulty 
From & hydrocephalus. Significant 
Distractibility differences found in domains of 
Quotient of academic achievement, memory. 
WlSC-R visual spatial, distractibility. Overall 
Grp 2, the brain tumour only Grp. 
scored significantly higher than the 
other Grps in intelligence, academic 
achievement. visual spatial ability and 









tests scores were on a par for Grp 1 & 
2 with Grp 3 having the lower score. 
Results suggest that as a group 
children with brain tumours have 
normal cognitive abilities before TX 
with RT or Chemotherapy despite a 
higher number of neurosurgical 
procedures and neurologic 
abnormalities. 
Presenting symptoms included ataxia, 
vomiting, headache, 6th or in carnial 
nerve palsy with median duration of 
presenting symptoms lasting 5.5 
months prior to diagnosis. 
FSIQ ranged from 58 to 123 (median 
94) FSIQ scores not correlated with 
age at diagnosis, degree of tumour 
resection, Severity of IQ problems & 
severity of neurologic problems 
showed a significant inverse 
association. The need for a VP shunt 
not associated with intellectual delay. 
In general all the children had a low 
incidence of intellectual impairment & 
an adequate quality of life as defined 
by standardized measures of 
academic achievement and 
behavioural adiustment. 
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Although children with exophylic 
tumours TX with surgery only appear 
to have the most favourable 
neuropsychological outcomes, this 
advantage was more likely a result of 
fewer neurological deficits than the 
absence of RT. 
No advantage in sparing of 
neuropsychological functions found by 
RT Dose i.e. hyperfractionated as 
opposed to conventional RT to the 
brain stem. 
Nishiyama, R 3.75 yrs • Medulloblastoma (1) Surgery - Total WlSC-R Significant differences between the 
Funakoshi, Case report • Control Monozygotic Twin (1) (1 ) Tree Test patient and control on all three 
Izumato et a/., Monozygotlc- I I 
Postoperative administrations in FSIQ (67 versus 
1994 twin. I I chemotherapy 102; 70 versus 98; 64 versus 93) 
I (1) VIQ (80 versus 114; 78 versus 112; 
I 
N = 2 CNS Radiation 74 versus 98) 
(1) 
I 
PIQ (58 versus 88; 66 versus 83; 59 
Serial Testing 7.4 yrs 3.6yrs 
I 
versus 87). Lack of detail in the Tree 
I 8.4 yrs 4.6 yrs I Test of the patient compared to her 
9.75 yrs I 6 yrs twin indicated menial deterioration. 
Growth: The patient's radiated spine & 
Descriptive also the non radiated upper and 
lower limbs were shorter than her 
twin's. 
Seaver, R 1.25 yrs- 7.4 yrs 4.75 yrs -18.6 • Medulloblastoma (12) Surgery (18) WAIS-R, 17 pis. Attended school. IQ declined 
Geyer, 15 yrs - 32.4 yrs • Ependymoma (6) RT (18) WlSC -R, > 10 pOints for 4-6 subjects in first 5 
Sulzbacher et Non Mean 6 yrs yrs Mean 9. 3 yrs I Chemotherapy McCarthy yrs following TX. Significant decline in 
a/.,1994 Parametric Mean I (14) ! Scales, IQ > 20 points in 4-5 subjects < 6 yrs 
chi square, 15.3 Yrs Shunts VP (9) I WRAT-R, at diagnosis. 2-3 subjects> 6 yrs at , 
N = 18 Pearson I Washington diagnosis had stable IQ's. 17 subjects 
Product Structured administered WRAT -R had borderline 
Psychosocial performance in reading & spelling & 
Review & deficient performance in arithmetic. 
Inventory, Impaired J:Y_c~: 
ll.. .0, ,'<;. 





































































achievement correlated with young 
age at diagnosis .. 
Psychosocial adjustment rated as 
normal. Significant family problems 
reported on life span care, home 
health care, financial stress & stress 
of terminal illness. 
Quality of life acceptable. 
I 89 pts deceased, 67 pts survived, 57 
pts tested 
Neurological impairment shown in 
25% of sample, but more common in 
Supratentorial Grp. Endocrine 
dysfunction found in 78% of sample., 
more marked in parasellar tumours. 
39% of all the children are mentally 
retarded. No correlation found 
between year of diagnosis, age at 
treatment, presence of 
hydrocephalus, addition of 
chemotherapy, radiation dose or 
volume and severity of intellectual 
impairment. Multivariate analysis 
showed that epilepsy is the only 
significant variable associated with 
poor cognitive function. Long term 
morbidity found to be disabling in 58% 
of survivors. 







1 yrto 14 
Mann VVhitney yrs 
U test Median 7 
yrs 












4 -25 yrs 
Median 14 
3 - 25 yrs 
Median 8 yrs 
6 - 25 yrs 
Median 18 yrs 







(whole sample =50) 
All Subdivided: 
Superficial Astrocytoma (17) 
Deep Astrocytoma tumours 
(8) 
Superficial Astrocytoma (22) 
Deep Astrocytoma (3) 
RT (39) 
Sample: 
Surgery & RT 
Grp (25) 




Surgery & RT 
(14) 
Surgery & 












VVhole Grp & the subgroup i.e. 
Cerebellar Grp. In the VVhole Grp 
scores of Surgery & RT TX Grps 
worse than those TX by Surgery only 
where significant differences were 
shown in 10 & information processing. 
Children TX with Surgery & RT < 5 yrs 
old at diagnosis significantly worse 
than those not treated with RT. Age at 
diagnosis was not a significant factor 
in the cerebellar sub group. 
Special schooling required for 40% of 
sample as a VVhole TX with Surgery & 
RT & for 36% of Cerebellar Sub Grp 
Cerebellar Sub Grp: 
Significant differences between 
Surgery & RT Grp & Surgery only grp 
in 10, information processing scores 
& visual memory test scores, 
The difference was 22 points in FSIO 
16 points in VIO & 27 points in PIO 
between pts TX with Surgery & RT & 
those TX with Surgery only. 
Presence of posterior fossa tumour 
per sa does not appear to produce 
intellectual decline as those 
with Surgery only appear to have 
little impact on test scores whereas an 













































































Perioperative summary score strongly 
associated with poor 
neuropsychological outcome. Early 
age diagnosis < 6 yrs associated with 
a higher prevalence of obtunduration 
at presentation, hydrocephalus & 
surgery involving structures outside 
vermis. Tumour location & 
perioperative factors not related to 
age at diagnosis. 
Authors note that it is not possible to 
discern whether outcomes represent a 
combined impact of perioperative 
complications and early RT or 
whether complications though 
associated with age at diagnosis are 
not causal. 
Poor neurobehavioural outcomes may 
be related to more aggressive tumour 
growth or complications of initial 
therapy and not solely due to toxicity 
from RT. 
Neurological sequelae the same for 
both Grps. 50% of pts mild to 
moderate cerebellar syndrome, 9pts 
severe visual disturbances, 5 pts 
severe hearing loss at 5 & 10 yr 
assessments. 
IQ: Performance of Ependymoma Grp 
remained stable over the yrs with 56% 
with FSIQ > 90 at 10 yrs post TX. 
Medulloblastoma Grp deteriorated 
over the yrs 
43% of the Grp had FSIQ < 90 in year 
1 post TX, 22% in year 5 & 10% in 
year 10. 
The same pattern evident in school 
performance Ependymoma Grp 60-
328 
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Jordan, R I 7 -17 Not given 
Murdoch, I yrs 
Buttsworth et 4 Grps: 
5.5-12.9 yffi 1505-al. ,1995 I Closed Head • Severe Closed Head Injury 
I N=40 










GCS score 3-8 Battery 
On admission 
PFT: i 
70% attended normal school, but 20% 
had difficulties. 
Medulloblastoma Grp 43% at normal 
school 5 yrs post TX but this declined 
to 17% at year 10. 
Behaviour problems found in 20% of 
both Grps 1 to 2 yrs after TX, these 
remained stable in the Ependymoma 
Grp but regressed in the 
Medulloblastoma Grp to 40% at 5 yrs 
post TX & 56% at 10 yrs post TX. 
Post operative complications at 1 yr 
for both Grps showed 76% of subjects 
who had no complications had IQ's > 
90 whereas 28% who had 
complications had IQ's < 90 at 5 to 10 I 
yrs post TX. Intraoperative 
cardiovascular complications 
correlated with FSIQ < 90 5 to 10 yrs 
postTX. 
I Authors conclude that progressive 
deterioration is due to WBRT, post 
operative and intraoperative 
complications. However the 
contribution of chemotherapy to the 
sequelae is not discussed. In addition 
the total number of subjects at each 
time of examination are not given and 
only percentages are reported. This 
implies that the results may not be as 
dramatic as subject numbers would 
have lessened over a 10 yrs period. 
Performance of experimental grps 
compared to control grps matched 
for age, sex and education. In all 
three Grps areas of language 
competence were compromised by 
I the various brain injuries & all Grps 
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PFT Grp 1.09 - 17 - i Surgery (10) achieved poorer scores than Control 
I 
13.03 yrs I 15.07 I • Posterior Fossa Tumours (10) RT(7) Grps. Motor speech skills were ! yrs Chemo (1) spared for all experimental grps 
I except for 2 subjects in PFT grp. 
I ALL Grp 2.11 yrs - 8 6.04-16 ALL: I Outcome shows that there is a 
yrs yrs • ALL (10) RT +Chemo (10) similarity in language impairment in 
the 3 experimental grps despite TX 
Control Grp matched interventions of surgery, RT & chemo. 
for age • Control Grp (10) I 
Parametric 
Manova 
Kimmings, R Not 2.4 yrs - 9.5 yrs • Medulloblastoma (25) Surgery (25) Not formally 56% of the sample attended 
I Kleinlugtebeld, I given Mean 6.4 yrs RT (25) tested. mainstream education without any I Casey et al., Grp A: GrpA: need for remedial help. 44% required 
1995 Children Mean 7.6 Evaluation of remedial help in a normal school or 
At normal yrs Child's attended special school. 
N = 25 school performance Differences in academic potential 
I 
at school related to age 7 yrs at diagnosis and 
Grp B: Grp B I Mainstream the presence of post-operative 
Children at Mean 5.5yrs versus Special complications i.e. the need for a 
special school. shunt, large ventricular size & growth 
school. hormone replacement. 
! 
The authors note that the sample had 
Descriptive few young children (9/25) < 5ys old at I 
I diagnosis. This had the potential to 
increase the threshold at which age at 
I diagnosis became significant in the 
evaluation of school placement. 
Dennis, R 0.27 -12.19 0.82 -15.69 yrs • Medulloblastoma (25) Surgery (25) WISC Age at diagnosis and Time since 
Spiegler, yrs I Mean 6.16 yrs RT (25) Treatment made separate 
Hetherington Parametric Mean 5.38 Chemotherapy contributions to intellectual morbidity. 
I 
et al., 1996 ANOVA yrs (7) Pia appeared to measure some I I 
I general effects of diffuse cerebral , 
N = 25 I I insult because it varied with i 
, I 
I 
chronological age of child at tumour I 
I 
I I 





N = 13 
Whitton, 
Rhydderch, 
Furlong et a/., 
1997 








I Control Sibling 
I Grp 
post-op. 
4 mths post 
surgery 











































• Medulloblastoma (3) 
• Juvenile Astrocytoma (1) 
• Ependymoma (1) 
Hemispheric Grp:-
• Medulloblastoma (2) 
• Astrocytoma (2) 
Control Group:-
Siblinas (4) 
• Supratentorial (40) 
• Infratentorial (10) 





Local RT (44) 
Chemotherapy 
(14) 









Index Mark 2 
& Mark 3 
Bloom 
i Classification 
less sensrtive to age at diagnosis but 
declined with time since treatment. 
Auditory memory performance 
statistically worse in tumour patients 
than controls. Type of surgery & site 
of tumour not related to number of 
errors in any tested categories. The 
one child tested 2 yrs post surgery 
showed progressive improvement in 
performance of visual & auditory 
memory. Authors propose the results 
provide evidence that the cerebellum 
plays a role in integration of auditory 
stimuli. 
Questionnaire completed by 90% of 
respondents. 
10% of respondents did not report 
some form of morbidity & 80% 
reported multiple impairments. Most 
prevalent were in the attributes of 
sensation, emotion and cognition. 
50% reported pain. 
10 classified as no disability 
performance status & 7 as minimal 
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disability. 2 incapable of self-care. 11 
normal intelligence, 3 borderline 
intelligence, 4 mild mental retardation, 
1 moderate mental retardation. 
Mean FSIQ = 85,VIQ = 90, PIQ =85. 
No significant difference between 
rm~Sf!n(' .... of hvdroceohalus (FSIQ=83) 
psychosocial profiles to controls but 
are more likely to use avoidance 
strategies to manage problems. 
Age diagnosis & time since treatment 
strong predictors of outcome. 
Specifically older adolescents more 
prone to worry than younger 
adolescence. Authors note that it is 
important to understand psychosocial 
status of survivors to optimise their 
quality of life 
WISC-R I Tumour subjects TX with RT 
z scores, Mean 7 yrs Mean 4.8 yrs • Third Ventricle Tumours (17) No RT (21) Diagnostic with No RT on both focused & 
, Gordon I performed more poorly than those TX 
AN OVA • Fourth Ventricle Tumours (14) RT (12) System selective attention tasks 
I 
Later age at diagnosis correlated 
. significantly with higher selective 
I
, Ii attention scores. Shorter time since 
treatment correlated Significantly with 
unnm.' I higher focused attention scores & 
332 
I 
I higher selective attention scores, 
I ANOVA Mean 8,3 Mean 5,9 yrs I Third Ventricle (46) No RT (38) Recognition I ANOVA for working memory by both 
yrs I : Fourth Ventricle (18) RT(26) Memory Task I tumour location and RT showed no 
Memory effect for location but showed a 
significant main effect for RT Analysis 
N = 64 of interaction showed RT effect more 
pronounced in posterior Third 
Ventricle Grp and to some extent in 
Fourth Ventricle Grp. Age at 
Diagnosis & Time since Treatment 
were not correlated with working 
memory. 
ANOVA Children & Not given • Third Ventricle or Brain Stem RT (9) 
Implicit adolescents tumours (15) Both tumour & control Grps had high 
Memory • Controls (15) matched for age levels of explicit recognition after 1 hr. 
• & sex Tumour subjects showed less priming 
N = 15 than controls when tested under full or 
divided attention. No correlation 




- I· Jenkin, R <: 4 yrs > 21 yrs 37 yrs Primary tumours (23) Surgery (number Quality of Life 10 year survival rate =40%. Only 23 Danjoux. & not given) assessed by survivors tested. 
Greenberg, Descriptive Number of subjects of each tumour RT(number not neurological Quality of Life described as not good 
1998 type not given: I given) clinical as only 1 of every 3 survivors had a 
! examination normal life style, Shortfall was focal 
N = 222 • Astrocytoma low grade & neurological deficits in the domain of 
• Astrocytoma high grade Questionnaire motor functions, ambulation, vision & 
• Ependymoma hearing, which impaired ability to 
• Other types attend normal schooling. Thus only 1 
I I in 3 survivors will be able to live 
I : 
normal competitive lives. 
I Grill. Renaux, R 5-15 yrs Mean = Mean = 5.3 yrs Posterior Fossa TUri Surgery (19) VVPPSI-R Significant correlation between FSIQ 
Bulteau et af., I mean = 5.7 11.4 yrs Medulloblastoma (19) Chemotherapy: \N1SC-11 & CSI dose 
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I 1999 yrs • Ependymoma (12) Medullo (17) Kaufman-ABC I FSIQ 84.5 correlated with 0 Gy dose I Ependymoma Purdue i FSIQ 76.9 correlated with 25 Gy dose 
I 
Parametric: (4) Pegboard i FSIQ 63.7 correlated with 35 Gy dose 
N = 31 t test Chemotherapy not associated with 
. ANOVA Subjects impaired intellectual outcome . I 
I divided into 3 Verbal comprehension scores lower in I I 
I Grps according children who had received higher CSI I 
to CSI dose: doses. 
Grp 1 = 0 Gy No correlation between neuropsych 
, I (11) test scores & age at radiotherapy, 
Grp 2 = 25 Gy years since treatment, disease 
(11 ) 
I 
presentation and post operative 
Grp 3 = 35 Gy 
I 
complications. 
i (9) Correlation between FSIQ & SES just 
I 
short of significance, trend higher 
I 
FSIQ in wealthier subjects 
I 
Tumour type, presence of metastasis 
or incomplete resection correlated 
I 
with radiation dose & therefore 
associated with poorer intellectual 
outcome. 
Mulhern, R < 21 years • Medulloblastoma (MED =18) MEDGRP: W1SC-111 MRI Segmentation protocol done on 
Reddick, • Low Grade Astrocytoma I Surgery (18) WAIS-R all subjects and analyzed with FSIQ. i Palmer et al. Subjects Posterior Fossa CRT (18) 
1999 Parametric age • Tumours (LGA =18) Chemo (9) MED GRP significantly less normal 
N = 36 t test, matched white matter volumes on MRI and 
, Pearson between LGA GRP = 2.6 LGAGRP: lower FSIQ 82 compared to LGA 
Product groups yrs Surgery (18) GRP FSIQ 92.9. 
Moment mean age 
difference 
I 
CRT with or without chemotherapy 
=3.7 months induced destruction of normal white 
I 
matter volumes which can partially 
I explain intellectual and academic 
deficits in medulloblastoma survivors. 
I 
Results suggests that normal white 
matter is essential for IQ 
I 
development. The obtained model 




al .. 1999 

































Average 0.9 yrs 
Mean 12.5 yrs 










not CNS tumours (15) 

















patient's normal white matter may 
provide a more direct explanation for 
variations in FSIQ than patient's age 
at treatment. 
Pts and Controls similar on measures 
of emotional well-being. Pts better on 
dimensions of social functioning. 
Considerable psychological hardiness 
present in pts. 
Short duration No functional recovery over time of 
perceptions = the cerebellar system that underlies 
400 ms short duration perception. 
Long duration Younger age at treatment is not a 
estimations = protective factor. 
30-60 minutes Although no group differences present 
in the functional measures of long 
WISC-iii duration estimation, tumour related 
WAIS-R prospective memory deficits interfered I 
Digit span with the ability to produce long 
vvrv1S-R duration prospective estimates. 
(General The utilization of sensory & 




of Learning & 
Memory 
world spatiotemporal estimates were 
compromised in the case of more 
extensive cerebellar lesions & diffuse 
extracerebellar secondary lesions 
arising from treatment for 
medulloblastoma qrOUD. 
ALL: Acute Lymphoblastic Leukaemia; Bloom: Bloom Functional Rating Scale; Beery: Beery Developmental Scales of Visual Motor Integration; CBCl: Child Behaviour Checklist; Claesson-Dahl: 
Swedish Learning Test; Cronholm-Molder : Swedish Memory Test; CPT: Continuous Performance Test;CRT: Cranial Radiation Therapy; CSI: Craniospinal Irradiation; FSIQ: Full-scale Intelligence 
Quotient; HSPP . Harter Self Perception Profiles; ITPA: Illinois Test of Psycholinguistic Abilities: LBC: Louisville Behaviour Checklist; LLNB : Luria Nebraska Neuropsychological Battery; MSCA: 
McCarthy Scale of Children'S Abilities; MMPI; Minnesota Multiphasic Personality Inventory; NDC : Neurologic Dysfunction's of Children: P: Prospective; PlAT: Peabody Individual Achievement Test 
335 
pts: patients; PIC; Personality Inventory for Children; R: Retrospective; RA VL T: Rey Auditory Verbal Learning Test; RFRT : Restricted Field Radiotherapy; RFRT : Restricted Field Radiotherapy; 
SDCT; Siossom Drawing Co-ordination Test; SR: Selective Reminding; SRB : Swedish Adult IQ Test; TMT A & B; Trail Making Test A & B; TX: Treatment; WAIS: Wechsler Adult Intelligence Scale: 
; WBRT . Whole Brain Radiation Therapy; WCST: Wisconsin Card Sorting Test; WlSC: Wechsler Intelligence Scale for Children; W1SC-R: Wechsler Intelligence Scale for Children Revised; WMS : 
Weschler Memory Scale; WMSB . Wisconsin Motor Steadiness Battery: WPPSI: Wechsler Preschool and Primary Scale of Intelligence; VABS: Vineland Adaptive Behaviour Scales. 
In most cases the categories and diagnostic terminology reflect those of the authors. 
The numbers in parentheses are the number of patients in each category. 
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